Îñòàâüòå ññûëêó íà ýòó ñòðàíèöó â ñîöñåòÿõ:

Ïîèñê ïî áàçå äîêóìåíòîâ:

 

ÌÈÍÈÑÒÅÐÑÒÂÎ ÇÄÐÀÂÎÎÕÐÀÍÅÍÈß È ÌÅÄÈÖÈÍÑÊÎÉ ÏÐÎÌÛØËÅÍÍÎÑÒÈ

ÐÎÑÑÈÉÑÊÎÉ ÔÅÄÅÐÀÖÈÈ

 

ÁÞÐÎ ÏÎ ÐÅÃÈÑÒÐÀÖÈÈ ËÅÊÀÐÑÒÂÅÍÍÛÕ ÑÐÅÄÑÒÂ,

ÌÅÄÈÖÈÍÑÊÎÉ ÒÅÕÍÈÊÈ È ÈÇÄÅËÈÉ ÌÅÄÈÖÈÍÑÊÎÃÎ ÍÀÇÍÀ×ÅÍÈß

 

ÃÎÑÓÄÀÐÑÒÂÅÍÍÛÉ ÐÅÅÑÒÐ ËÅÊÀÐÑÒÂÅÍÍÛÕ ÑÐÅÄÑÒÂ

(Ïðîäîëæåíèå)

 

Ðàçäåë 2. ËÅÊÀÐÑÒÂÅÍÍÛÅ ÑÐÅÄÑÒÂÀ. (Ïðîäîëæåíèå)

 


 

┌──────────────────────────────────────────────────┬────────────────────────────────────────┬──────────────────────────────┬──────────────────────────────┬───────────────┐

│ Òîðãîâîå íàçâàíèå [ìåæä.íàçâàíèå] (Ñîñòàâ)          Ôàðì. ãðóïïà [Êîä ÀÒÑ]                    Ôîðìà âûïóñêà                   Ôèðìà (Ñòðàíà)         │ Íîìåð, Äàòà  

├──────────────────────────────────────────────────┼────────────────────────────────────────┼──────────────────────────────┼──────────────────────────────┼───────────────┤

│Çèííàò [Öåôóðîêñèì]                               │àíòèáèîòèê, öåôàëîñïîðèí [J01DA06]      │òàáëåòêè 125, 250, 500 ìã     │Glaxo (Âåëèêîáðèòàíèÿ)        │002873,       

                                                                                                                                                     │25.02.93      

                                                                                                                                                                    

│Çèííàò [Öåôóðîêñèì]                               │àíòèáèîòèê, öåôàëîñïîðèí [J01DA06]      │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Glaxo (Âåëèêîáðèòàíèÿ)        │002875,       

                                                                                          │125 ìã|5 ìë, 250 ìã|5 ìë                                    │25.02.93      

                                                                                                                                                                    

│Çèííàò [Öåôóðîêñèì]                               │àíòèáèîòèê, öåôàëîñïîðèí [J01DA06]      │ñóñïåíçèÿ îðàëüíàÿ (ñàøå)     │Glaxo (Âåëèêîáðèòàíèÿ)        │003101,        

                                                                                          │125, 250 ìã                                                 │28.06.93      

                                                                                                                                                                    

│Çèðòåê [Öåòèðèçèí]                                │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │êàïëè îðàëüíûå                │Ucb SA (Áåëüãèÿ)              │003689,       

                                                  │[R06AE07]                                                                                           │10.02.94      

                                                                                                                                                                    

│Çèðòåê [Öåòèðèçèí]                                │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ucb SA (Áåëüãèÿ)              │007193,       

                                                  │[R06AE07]                               │10 ìã                                                       │22.05.96      

                                                                                                                                                                    

│Çèòàçîíèóì [Òàìîêñèôåí]                           │àíòèýñòðîãåí [L02BA01]                  │òàáëåòêè 10 ìã                │Egis (Âåíãðèÿ)                │2766,         

                                                                                                                                                      │13.07.95,     

                                                                                                                                                      │22.03.84      

                                                                                                                                                                    

│Çîàöèä [Ìåòðîíèäàçîë]                             │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Tata Pharma (Èíäèÿ)           │002909,       

                                                                                          │500 ìã - 100 ìë                                             │17.03.93      

                                                                                                                                                                    

│Çîâèðàêñ [Àöèêëîâèð]                              │ïðîòèâîâèðóñíîå ñðåäñòâî                │òàáëåòêè 200 ìã; ïîðîøîê äëÿ  │Wellcome Foundation Ltd       │01356, 27.07.87│

                                                  │[D06BB03][J05AB01][S01AD03]             │ïðèãîòîâëåíèÿ èíôóçèîííîãî    │(Âåëèêîáðèòàíèÿ)                            

                                                                                          │ðàñòâîðà (ôëàêîíû) 250 ìã;                                                

                                                                                          │êðåì äëÿ íàðóæíîãî ïðèìåíåíèÿ │                                            

                                                                                          │5%; ìàçü ãëàçíàÿ 3%                                                       

                                                                                                                                                                    

│Çîâèðàêñ [Àöèêëîâèð]                              │ïðîòèâîâèðóñíîå ñðåäñòâî [J05AB01]      │òàáëåòêè 400, 800 ìã;         │Wellcome Foundation Ltd       │003577,       

                                                                                          │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │(Âåëèêîáðèòàíèÿ)              │10.12.93      

                                                                                          │200 ìã|5 ìë                                                               

                                                                                                                                                                    

│Çîêîð [Ñèìâàñòàòèí]                               │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AB01]   │òàáëåòêè 5, 10, 20 ìã         │Merck Sharp & Dohme           │005210,       

                                                                                                                        │(Íèäåðëàíäû)                  │03.08.94      

                                                                                                                                                                    

│Çîëàäåêñ [Ãîçåðåëèí]                              │ëþòåèíèçèðóþùåãî ãîðìîíà èíãèáèòîð      │äåïî (êàïñóëà â øïðèöå) 10.8  │Zeneca Ltd (Âåëèêîáðèòàíèÿ)   │006813,       

                                                  │ñåêðåöèè [L02AE03]                      │ìã                                                          │09.11.95      

                                                                                                                                                                    

│Çîëàäåêñ [Ãîçåðåëèí]                              │ëþòåèíèçèðóþùåãî ãîðìîíà èíãèáèòîð      │äåïî (êàïñóëà â øïðèöå) 3.6 ìã│Ici Pharmaceuticals           │003038,       

                                                  │ñåêðåöèè [L02AE03]                                                    │(Âåëèêîáðèòàíèÿ)              │07.06.93      

                                                                                                                                                                    

│Çîëàäåêñ [Ãîçåðåëèí]                              │ëþòåèíèçèðóþùåãî ãîðìîíà èíãèáèòîð      │äåïî (êàïñóëà â øïðèöå) 3.6 ìã│Zeneca Pharma Pt (Èíäîíåçèÿ)  │006193,       

                                                  │ñåêðåöèè [L02AE03]                                                                                  │16.06.95      

                                                                                                                                                                     

│Çîëäàê [Àëïðàçîëàì]                               │òðàíêâèëèçàòîð [N05BA12]                │òàáëåòêè 0.25, 0.5 ìã         │Cadila Laboratories Ltd       │003822,       

                                                                                                                        │(Èíäèÿ)                       │05.04.94      

                                                                                                                                                                     

│Çîëîãàí {ìåòàìèçîë 0.5 ã, ïèòîôåíîí 5 ìã,         │àíàëüãåòè÷åñêîå è ñïàçìîëèòè÷åñêîå      │òàáëåòêè; ðàñòâîð äëÿ èíúåêöèé│M.J.Pharmaceuticals Ltd       │006339,       

│ôåíïèâåðèíèé 0.1 ìã}                              │ñðåäñòâî [N02BB52]                                                    │(Èíäèÿ)                       │02.08.95      

                                                                                                                                                                     

│Çîëîôò [Ñåðòðàëèí]                                │àíòèäåïðåññàíò [N06AB06]                │òàáëåòêè 50, 100 ìã           │Pfizer (Âåëèêîáðèòàíèÿ)       │005324,       

                                                                                                                                                      │15.09.94      

                                                                                                                                                                     

│Çîëñåð [Îìåïðàçîë]                                │ïðîòèâîÿçâåííîå ñðåäñòâî [A02BC01]      │êàïñóëû 20 ìã                 │Arobindo Pharma Ltd (Èíäèÿ)   │007069,       

                                                                                                                                                      │08.02.96      

                                                                                                                                                                    

│Çîëôèí [Öåôàçîëèí]                                │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Ipca Laboratories Ltd (Èíäèÿ) │005996,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │25.04.95      

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Çîðàí [Ðàíèòèäèí]                                 │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 150 ìã               │Dr.Reddy's Laboratories Ltd   │002401,       

                                                  │[A02BA02]                                                             │(Èíäèÿ)                       │30.01.92      

                                                                                                                                                                    

│Çîôðàí [Îíäàíñåòðîí]                              │ñåðîòîíèíîâûõ ðåöåïòîðîâ àíòàãîíèñò     │òàáëåòêè 4 ìã, 8 ìã; ðàñòâîð  │Glaxo (Âåëèêîáðèòàíèÿ)        │003015,       

                                                  │[A04AA01]                               │äëÿ èíúåêöèé (àìïóëû) 2 ìã/ìë │                              │31.05.93      

                                                                                          │- 2 ìë, 4 ìë                                                              

                                                                                                                                                                    

│Çîôðàí [Îíäàíñåòðîí]                              │ñåðîòîíèíîâûõ ðåöåïòîðîâ àíòàãîíèñò     │òàáëåòêè 4 ìã; ðàñòâîð äëÿ    │Glaxo (Èíäîíåçèÿ)             │006268,       

                                                  │[A04AA01]                               │èíúåêöèé (àìïóëû) 2 ìã/ìë                                   │12.07.95      

                                                                                                                                                                    

│Èáèäðîêñèë [Öåôàäðîêñèë]                          │àíòèáèîòèê, öåôàëîñïîðèí [J01DA09]      │êàïñóëû 250, 500 ìã; ïîðîøîê  │Amoun Pharmaceutical          │005709,       

                                                                                          │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé    │Industries Co, Apic (Åãèïåò)  │31.01.95      

                                                                                          │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                              

                                                                                          │ìë, 250 ìã|5 ìë                                                           

                                                                                                                                                                    

│Èáóêëèí {èáóïðîôåí 400 ìã, ïàðàöåòàìîë 325 ìã}    │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 400 ìã/325 ìã        │Dr.Reddy's Laboratories Ltd   │003630,       

                                                  │ñðåäñòâî [N02B]                                                       │(Èíäèÿ)                       │19.01.94      

                                                                                                                                                                    

│Èáóêëèí þíèîð {èáóïðîôåí 100 ìã, ïàðàöåòàìîë 125  │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 100 ìã/125 ìã        │Dr.Reddy's Laboratories Ltd   │003631,       

│ìã}                                               │ñðåäñòâî [N02B]                                                       │(Èíäèÿ)                       │19.01.94      

                                                                                                                                                                    

│Èáóïðîí [Èáóïðîôåí]                               │ÍÏÂÑ [M02AA13]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ludwig Merckle GmbH (Àâñòðèÿ) │006259,       

                                                                                          │200, 400, 600 ìã                                            │10.07.95      

                                                                                                                                                                    

│Èáóïðîô [Èáóïðîôåí]                               │ÍÏÂÑ [M02AA13]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │CT-Arzneimittel Chemishe      │003444,       

                                                                                          │200, 400, 600 ìã              │Tempelchof GmbH (Ãåðìàíèÿ)    │22.10.93      

                                                                                                                                                                    

│Èáóïðîôåí [Èáóïðîôåí]                             │ÍÏÂÑ [M02AA13]                          │ñóñïåíçèÿ îðàëüíàÿ            │Polfa (ÏÍÐ)                   │2930, 30.06.89 │

                                                                                                                                                                    

│Èáóïðîôåí [Èáóïðîôåí]                             │ÍÏÂÑ [M02AA13]                          │äðàæå 200 ìã                  │Polfa, Pabianickie Zaklady    │2716,         

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │01.02.83,     

                                                                                                                                                      │03.07.95      

                                                                                                                                                                    

│Èáóïðîôåí [Èáóïðîôåí]                             │ÍÏÂÑ [M02AA13]                          │òàáëåòêè 200, 400, 600, 800 ìã│Rugby (ÑØÀ)                   │005006,       

                                                                                                                                                      │15.06.94      

                                                                                                                                                                    

│Èáóïðîôåí Íèêîìåä [Èáóïðîôåí]                     │ÍÏÂÑ [M02AA13]                          │òàáëåòêè 400, 600 ìã          │Nycomed Dak AS (Äàíèÿ)        │003367,       

                                                                                                                                                      │28.09.93      

                                                                                                                                                                    

│Èáóïðîôåí-Òåâà [Èáóïðîôåí]                        │ÍÏÂÑ [M02AA13]                          │òàáëåòêè 200, 400 ìã          │Teva Pharmaceutical           │003173,       

                                                                                                                        │Industries Ltd (Èçðàèëü)      │02.08.93      

                                                                                                                                                                     

│Èáóñàí [Èáóïðîôåí]                                │ÍÏÂÑ [M02AA13]                          │òàáëåòêè 200, 400 ìã          │Sanofi-Winthrop               │006251,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │06.07.95      

                                                                                                                                                                     

│Èáóñòðèí [Èíäîáóôåí]                              │àíòèàãðåãàíòíîå ñðåäñòâî [B01AC10]      │òàáëåòêè 200 ìã               │Pharmacia (Èòàëèÿ)            │007215,       

                                                                                                                                                      │18.06.96      

                                                                                                                                                                     

│Èáóòàä [Èáóïðîôåí]                                │ÍÏÂÑ [M02AA13]                          │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Tad Pharmazeutisches Werk     │003375,       

                                                                                          │îáîëî÷êîé 200, 400, 600 ìã    │GmbH (Ãåðìàíèÿ)               │05.10.93      

                                                                                                                                                                     

│Èáóòàä [Èáóïðîôåí]                                │ÍÏÂÑ [M02AA13]                          │ôèëìòàáëåòêè                  │Tad Pharmazeutisches Werk     │005220,       

                                                                                                                        │GmbH (Ãåðìàíèÿ)               │10.08.94      

                                                                                                                                                                    

│Èâèìèöèí [Àìèêàöèí]                               │àíòèáèîòèê, àìèíîãëèêîçèä [J01GB06]     │ðàñòâîð äëÿ èíúåêöèé          │Fds Private Ltd (Èíäèÿ)       │003407,       

                                                                                          │(ôëàêîíû) 2 ìë - 100, 250,                                  │12.10.93      

                                                                                          │500 ìã                                                                    

                                                                                                                                                                    

│Èäàðóáèöèí [Èäàðóáèöèí]                           │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DB06]      │êàïñóëû 5, 10, 25 ìã          │Farmitalia Carlo Erba (Èòàëèÿ)│005608,       

                                                                                                                                                      │27.12.94      

                                                                                                                                                                    

│Èäàðóáèöèí (Çàâåäîñ) [Èäàðóáèöèí]                 │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DB06]      │ëèîôèëèç.ïîðîøîê äëÿ          │Farmitalia Carlo Erba (Èòàëèÿ)│002559,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │14.07.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 5 ìã                                                   

                                                                                                                                                                    

│Èç 5 ìîíî-Ðàòèîôàðì [Èçîñîðáèä ìîíîíèòðàò]        │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20, 40 ìã            │Ratiopharm GmbH & Co          │005130,       

                                                                                                                        │(Ãåðìàíèÿ)                    │14.07.94      

                                                                                                                                                                    

│Èçèêîì [Ëåâîäîïà+êàðáèäîïà] {ëåâîäîïà 0.25 ã,     │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè                      │Isis Pharma GmbH (Ãåðìàíèÿ)   │007263,       

│êàðáèäîïà ãèäðàò 26.99 ìã}                        │[N04BA02]                                                                                           │25.07.96      

                                                                                                                                                                    

│Èçèêîì ìèòå [Ëåâîäîïà+êàðáèäîïà] {ëåâîäîïà 100    │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè 100 ìã/25 ìã         │Isis Pharma GmbH (Ãåðìàíèÿ)   │003624,       

│ìã, êàðáèäîïà 25 ìã}                              │[N04BA02]                                                                                           │11.01.94      

                                                                                                                                                                    

│Èçî Ìàê [Èçîñîðáèä äèíèòðàò]                      │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │òàáëåòêè 5 ìã; êàïñóëû ðåòàðä │Mack (ÔÐÃ)                    │003105,       

                                                                                          │60 ìã; ñïðåé 20 ìë                                          │28.06.93      

                                                                                                                                                                    

│Èçî Ìàê ðåòàðä [Èçîñîðáèä äèíèòðàò]               │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû 20, 40 ìã             │Mack (ÔÐÃ)                    │01429, 26.04.88│

                                                                                                                                                                    

│Èçî Ìàê ðåòàðä [Èçîñîðáèä äèíèòðàò]               │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû 20, 40, 60 ìã         │Slovakofarma SA (Ñëîâàêèÿ)    │005159,       

                                                                                                                                                      │20.07.94      

                                                                                                                                                                    

│Èçî-Ýðåìôàò 150 {èçîíèàçèä 100 ìã, ðèôàìïèöèí 150 │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AM02] │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Fatol Arzneimittel GmbH       │006976,       

│ìã}                                                                                                                     │(Ãåðìàíèÿ)                    │12.01.96      

                                                                                                                                                                    

│Èçîáàð {òðèàìòåðåí 150 ìã, ìåòèêëîòèàçèä 5 ìã}    │äèóðåòè÷åñêîå êîìáèíèðîâàííîå ñðåäñòâî  │òàáëåòêè                      │Laboratoires Jaques Logeais   │007094,       

                                                  │[C03EA]                                                               │(Ôðàíöèÿ)                     │16.02.96      

                                                                                                                                                                    

│Èçîäèíèò [Èçîñîðáèä äèíèòðàò]                     │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │òàáëåòêè 10 ìã; òàáëåòêè äëÿ  │Pharmachim (Áîëãàðèÿ)         │2799, 06.05.85 │

                                                                                          │ðàññàñûâàíèÿ; òàáëåòêè ðåòàðä │                                            

                                                                                          │20 ìã                                                                     

                                                                                                                                                                    

│Èçîçèä 200 [Èçîíèàçèä]                            │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AC01] │òàáëåòêè 200 ìã               │Fatol Arzneimittel GmbH       │006448,       

                                                                                                                        │(Ãåðìàíèÿ)                    │29.08.95      

                                                                                                                                                                    

│Èçîêàðä 20 [Èçîñîðáèä äèíèòðàò]                   │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû 20 ìã                 │Dar Al Dava (Èîðäàíèÿ)        │002964,       

                                                                                                                                                      │16.04.93      

                                                                                                                                                                    

│Èçîêàðä 40 [Èçîñîðáèä äèíèòðàò]                   │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû 40 ìã                 │Dar Al Dava (Èîðäàíèÿ)        │002964,       

                                                                                                                                                      │16.04.93       

                                                                                                                                                                    

│Èçîêåò [Èçîñîðáèä äèíèòðàò]                       │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │ðàñòâîð äëÿ èíôóçèé (àìïóëû)  │Schwarz Pharma AG (Ãåðìàíèÿ)  │01074,        

                                                                                          │0.1% - 10 ìë; êðåì                                          │04.05.84,      

                                                                                                                                                      │24.01.95      

                                                                                                                                                                    

│Èçîêåò [Èçîñîðáèä äèíèòðàò]                       │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │òàáëåòêè ðåòàðä 60 ìã;        │Schwarz Pharma AG (ÔÐÃ)       │01692, 27.10.89│

                                                                                          │àýðîçîëü                                                                  

                                                                                                                                                                    

│Èçîêåò [Èçîñîðáèä äèíèòðàò]                       │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Schwarz Pharma AG (Ãåðìàíèÿ)  │002544,       

                                                                                          │0.1% - 50, 100 ìë                                           │08.07.92      

                                                                                                                                                                    

│Èçîêåò [Èçîñîðáèä äèíèòðàò]                       │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │òàáëåòêè 5 ìã                 │Schwarz Pharma AG (Ãåðìàíèÿ)  │003942,       

                                                                                                                                                      │25.05.94      

                                                                                                                                                                    

│Èçîêåò [Èçîñîðáèä äèíèòðàò]                       │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │òàáëåòêè ðåòàðä 20, 40, 60    │Schwarz Pharma AG (Ãåðìàíèÿ)  │005710,       

                                                                                          │ìã; êàïñóëû ðåòàðä 120 ìã                                   │01.02.95      

                                                                                                                                                                    

│Èçîêåò [Èçîñîðáèä äèíèòðàò]                       │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │àýðîçîëü (ôëàêîíû) 1.25       │Schwarz Pharma AG (Ãåðìàíèÿ)  │006598,       

                                                                                          │ìã|äîçà - 15 ìë                                             │28.11.95      

                                                                                                                                                                    

│Èçîëèïàí [Äåêñôåíôëóðàìèí]                        │àíîðåêñèãåííîå ñðåäñòâî [A08AA04]       │êàïñóëû 15 ìã                 │Laboratoires Servier (Ôðàíöèÿ)│005191,       

                                                                                                                                                      │28.07.94      

                                                                                                                                                                    

│Èçîëîíã [Èçîñîðáèä äèíèòðàò]                      │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû ïðîëîíãèðîâàííîãî     │Cts Chemical Industries Ltd   │006088,       

                                                                                          │äåéñòâèÿ 20, 40 ìã            │(Èçðàèëü)                     │23.05.95      

                                                                                                                                                                    

│Èçîìîíàò [Èçîñîðáèä ìîíîíèòðàò]                   │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 40 ìã                │Boehringer Mannheim GmbH      │002094,       

                                                                                                                        │(Àâñòðèÿ)                     │02.04.91      

                                                                                                                                                                    

│Èçîìîíèò Ãåêñàë [Èçîñîðáèä ìîíîíèòðàò]            │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20, 40 ìã            │Hexal Pharma GmbH (Ãåðìàíèÿ)  │006874,       

                                                                                                                                                      │05.12.95      

                                                                                                                                                                    

│Èçîïòèí [Âåðàïàìèë]                               │ÁÌÊÊ [C08DA01]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Birlesik Alman Ilaclary AS    │002298,       

                                                                                          │40, 80 ìã                     │(Òóðöèÿ)                      │05.12.91      

                                                                                                                                                                    

│Èçîïòèí [Âåðàïàìèë]                               │ÁÌÊÊ [C08DA01]                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Birlesik Alman Ilaclary AS    │002919,       

                                                                                          │5 ìã - 2 ìë                   │(Òóðöèÿ)                      │29.03.93      

                                                                                                                                                                    

│Èçîïòèí [Âåðàïàìèë]                               │ÁÌÊÊ [C08DA01]                          │òàáëåòêè â îáîëî÷êå èç ñàõàðà │Knoll AG (ÔÐÃ)                │002518,       

                                                                                          │40, 80 ìã; ðàñòâîð äëÿ                                      │19.06.92      

                                                                                          │èíúåêöèé (àìïóëû) 5 ìã - 2 ìë │                                            

                                                                                                                                                                    

│Èçîïòèí [Âåðàïàìèë]                               │ÁÌÊÊ [C08DA01]                          │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Knoll AG (ÔÐÃ)                │002634,       

                                                                                          │îáîëî÷êîé 40, 80 ìã                                         │22.09.92      

                                                                                                                                                                    

│Èçîïòèí ÑÐ [Âåðàïàìèë]                            │ÁÌÊÊ [C08DA01]                          │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Birlesik Alman Ilaclary AS    │003190,       

                                                                                          │îáîëî÷êîé çàìåäëåííîãî        │(Òóðöèÿ)                      │04.08.93      

                                                                                          │âûñâîáîæäåíèÿ 240 ìã                                                      

                                                                                                                                                                    

│Èçîïòèí ÑÐ [Âåðàïàìèë]                            │ÁÌÊÊ [C08DA01]                          │òàáëåòêè ðåòàðä 240 ìã        │Knoll AG (ÔÐÃ)                │002048,       

                                                                                                                                                      │28.02.91      

                                                                                                                                                                    

│Èçîïòèí ÑÐ [Âåðàïàìèë]                            │ÁÌÊÊ [C08DA01]                          │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Knoll AG (ÔÐÃ)                │002519,       

                                                                                          │îáîëî÷êîé 120 ìã                                            │19.06.92      

                                                                                                                                                                    

│Èçîïòî-êàðáàõîë [Êàðáàõîë]                        │ì-õîëèíîìèìåòèê [S01EB02]               │êàïëè ãëàçíûå (ôëàêîíû) 1.5%, │Alcon-Kouvrer SA (Áåëüãèÿ)    │005885,       

                                                                                          │3%                                                          │31.03.95      

                                                                                                                                                                     

│Èçîïòî-êàðïèí [Ïèëîêàðïèí]                        │ì-õîëèíîìèìåòèê [S01EB01]               │ðàñòâîð îôòàëüìîëîãè÷åñêèé    │Alcon-Kouvrer SA (Áåëüãèÿ)    │006925,       

                                                                                          │(ôëàêîíû) 1%, 2%, 4%                                        │20.12.95      

                                                                                                                                                                     

│Èçîñîðá ðåòàðä [Èçîñîðáèä äèíèòðàò]               │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû 20 ìã                 │Zdravle (Þãîñëàâèÿ)           │01123,        

                                                                                                                                                      │05.09.95,     

                                                                                                                                                      │10.12.84      

                                                                                                                                                                    

│Èçîòóðîí                                          │âàçîêîíñòðèêòîðíîå ñðåäñòâî [C01CX]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │(Ìîëäîâà)                     │96/185/3      

                                                                                          │10% - 1 ìë                                                                 

                                                                                                                                                                    

│Èçîôàí Èíñóëèí ÃÌ [Èíñóëèí-ÑðÄ] {èíñóëèí          │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Galenika (ÑÔÐÞ)               │002182,       

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé}                                                            │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │08.07.91      

                                                                                                                                                                    

│Èëâàãèí [Ìåòàìèçîë íàòðèÿ]                        │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ðàñòâîð äëÿ  │M.J.Exports Ltd (Èíäèÿ)       │007424,       

                                                  │ñðåäñòâî [N02BB02]                      │èíúåêöèé (àìïóëû) 50%;                                      │09.04.96      

                                                                                          │ðàñòâîð äëÿ èíúåêöèé                                                      

                                                                                          │(ôëàêîíû) 50%                                                             

                                                                                                                                                                    

│Èëîçîí [Ýðèòðîìèöèí]                              │àíòèáèîòèê, ìàêðîëèä [J01FA01]          │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Eli Lilly (ÑØÀ)               │006723,       

                                                                                          │125 ìã|5 ìë, 250 ìã|5 ìë                                    │18.10.95      

                                                                                                                                                                    

│Èìàï [Ôëóñïèðèëåí]                                │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AG01]     │ñóñïåíçèÿ äëÿ âíóòðèìûøå÷íûõ  │Gedeon Richter (Âåíãðèÿ)      │2707,         

                                                                                          │èíúåêöèé (àìïóëû) 4 ìã - 2 ìë │                              │06.12.82,     

                                                                                                                                                      │19.12.94      

                                                                                                                                                                    

│Èìåêñ [Òåòðàöèêëèí]                               │àíòèáèîòèê, òåòðàöèêëèí [D06AA04]       │ìàçü                          │Merz Co GmbH (ÔÐÃ)            │002855,       

                                                                                                                                                      │18.02.93      

                                                                                                                                                                    

│Èìèãðàí [Ñóìàòðèïòàí]                             │ïðîòèâîìèãðåíîçíîå ñðåäñòâî [N02CX04]   │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Glaxo (Âåëèêîáðèòàíèÿ)        │003316,       

                                                                                          │îáîëî÷êîé 100 ìã; ðàñòâîð äëÿ │                              │10.09.93      

                                                                                          │èíúåêöèé (øïðèöû) 6 ìã - 0.5                                              

                                                                                          │ìë; ðàñòâîð äëÿ èíúåêöèé                                                  

                                                                                          │(øïðèöû) 6 ìã - 0.5 ìë /â                                                 

                                                                                          │êîìïëåêòå ñ àóòîèíæåêòîðîì/                                               

                                                                                                                                                                    

│Èìèäèë [Êëîòðèìàçîë]                              │ïðîòèâîãðèáêîâîå ñðåäñòâî               │êðåì 1%; òàáëåòêè âàãèíàëüíûå │Lyka Labs Ltd (Èíäèÿ)         │003108,       

                                                  │[D01AC01][G01AF02]                      │100, 200, 500 ìã                                            │29.06.93      

                                                                                                                                                                    

│Èììóíîãëîáóëèí [Èììóíîãëîáóëèí (â/â ââåäåíèå)]    │èììóíîñòèìóëÿòîð [J06BA02]              │ëèîôèëèç.ïîðîøîê äëÿ          │Biochemie GmbH (Àâñòðèÿ)      │006628,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │24.01.96      

                                                                                          │ðàñòâîðà (ôëàêîíû) 0.5, 1, 3, │                                            

                                                                                          │6 ã /â êîìïëåêòå ñ                                                        

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Èìîâàí [Çîïèêëîí]                                 │ñíîòâîðíîå ñðåäñòâî [N05CF01]           │òàáëåòêè 7.5 ìã               │Eczacibasi (Òóðöèÿ)           │005906,       

                                                                                                                                                      │04.04.95      

                                                                                                                                                                    

│Èìîâàí [Çîïèêëîí]                                 │ñíîòâîðíîå ñðåäñòâî [N05CF01]           │òàáëåòêè 7.5 ìã               │Rhone-Poulenc Rorer (Ôðàíöèÿ) │002584,       

                                                                                                                                                      │30.07.92      

                                                                                                                                                                    

│Èìîäèóì [Ëîïåðàìèä]                               │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │òàáëåòêè; êàïñóëû; ðàñòâîð    │Gedeon Richter (Âåíãðèÿ)      │2697, 28.04.82 │

                                                                                                                                                                    

│Èìîäèóì [Ëîïåðàìèä]                               │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │êàïñóëû 2 ìã; ðàñòâîð         │Janssen Pharmaceutica         │002349,       

                                                                                          │îðàëüíûé 0.2 ìã/ìë            │(Áåëüãèÿ)                     │16.01.92      

                                                                                                                                                                    

│Èìïðàìèí [Èìèïðàìèí]                              │àíòèäåïðåññàíò [N06AA02]                │òàáëåòêè 25 ìã                │Sun Pharmaceutical Industries │003157,       

                                                                                                                        │Ltd (Èíäèÿ)                   │19.07.93      

                                                                                                                                                                     

│Èìóðàí [Àçàòèîïðèí]                               │öèòîñòàòè÷åñêîå ñðåäñòâî [L04AX01]      │òàáëåòêè 50 ìã                │Glaxo-Wellcome                │007260,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │25.07.96      

                                                                                                                                                                     

│Èíàïðîë [Íàïðîêñåí]                               │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250, 500 ìã          │Bilim Ilac Sanayi (Òóðöèÿ)    │002404,       

                                                                                                                                                      │30.01.92      

                                                                                                                                                                     

│Èíãàêîðò [Ôëóíèçîëèä]                             │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │àýðîçîëü (áàëëîíû) 6 ìë       │Boehringer Ingelheim          │003436,       

                                                  │ïðèìåíåíèÿ [R03BA03]                                                  │International GmbH (Ãåðìàíèÿ) │19.10.93      

                                                                                                                                                                     

│Èíäåðàë [Ïðîïðàíîëîë]                             │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè 40 ìã                │Galenika (Þãîñëàâèÿ)          │00267,        

                                                                                                                                                      │01.08.85,     

                                                                                                                                                      │10.01.74      

                                                                                                                                                                    

│Èíäåðàë [Ïðîïðàíîëîë]                             │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè 40 ìã                │Ici (Âåëèêîáðèòàíèÿ)          │00142,        

                                                                                                                                                      │09.02.87,     

                                                                                                                                                      │28.05.71      

                                                                                                                                                                    

│Èíäåðàë [Ïðîïðàíîëîë]                             │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Zeneca Pharmaceuticals        │007198,       

                                                                                          │(ôëàêîíû) 40 ìã               │(Âåëèêîáðèòàíèÿ)              │24.05.96      

                                                                                                                                                                    

│Èíäåðàë ËÀ [Ïðîïðàíîëîë]                          │áåòà-àäðåíîáëîêàòîð [C07AA05]           │êàïñóëû 160 ìã                │Zeneca Ltd (Âåëèêîáðèòàíèÿ)   │003909,       

                                                                                                                                                      │13.05.94      

                                                                                                                                                                    

│Èíäèêàðäèí [Ïðîïðàíîëîë]                          │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè 10, 40, 80 ìã        │Arab Pharmaceutical           │003669,       

                                                                                                                        │Manufacturing Co Ltd          │03.02.94      

                                                                                                                        │(Èîðäàíèÿ)                                  

                                                                                                                                                                    

│Èíäîáåíå [Èíäîìåòàöèí]                            │ÍÏÂÑ [M01AB01][M02AA23]                 │êàïñóëû 25, 50 ìã; ñâå÷è 50,  │Ludwig Merckle GmbH (Àâñòðèÿ) │003327,       

                                                                                          │100 ìã; ãåëü (òóáû) 1% - 50,                                │13.09.93      

                                                                                          │100 ã                                                                     

                                                                                                                                                                    

│Èíäîâàçèí {èíäîìåòàöèí 3%, òðîêñåâàçèí 2%}        │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî äëÿ      │ãåëü                          │Pharmachim (ÍÐÁ)              │2962, 03.01.90 │

                                                  │ìåñòíîãî ïðèìåíåíèÿ [M02AA23]                                                                                     

                                                                                                                                                                    

│Èíäîâèñ Å.Ñ. [Èíäîìåòàöèí]                        │ÍÏÂÑ [M01AB01]                          │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Cts Chemical Industries Ltd   │005962,       

                                                                                          │îáîëî÷êîé 25 ìã               │(Èçðàèëü)                     │13.04.95      

                                                                                                                                                                    

│Èíäîìåò-Ðàòèîôàðì [Èíäîìåòàöèí]                   │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25, 50 ìã             │Ratiopharm GmbH & Co          │005126,       

                                                                                                                        │(Ãåðìàíèÿ)                    │14.07.94      

                                                                                                                                                                    

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │òàáëåòêè 25 ìã                │Sanavita Gesundcheitsmittel & │005857,       

                                                                                                                        │Co Kg (Ãåðìàíèÿ)              │23.03.95      

                                                                                                                                                                    

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25 ìã                 │Belupo (Õîðâàòèÿ)             │005737,       

                                                                                                                                                      │13.02.95      

                                                                                                                                                                    

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │ñâå÷è 50, 100 ìã              │Berlin-Chemie AG (ÔÐÃ)        │002507,       

                                                                                                                                                      │09.06.92      

                                                                                                                                                                    

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25 ìã                 │Chinoin (ÂÍÐ)                 │2928, 30.06.89 │

                                                                                                                                                                    

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25, 50 ìã; ñâå÷è 50,  │Nycomed Dak AS (Äàíèÿ)        │003365,       

                                                                                          │100 ìã                                                      │28.09.93      

                                                                                                                                                                    

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │äðàæå                         │Pharmachim (Áîëãàðèÿ)         │2321,         

                                                                                                                                                      │07.05.73,     

                                                                                                                                                      │28.04.84      

                                                                                                                                                                     

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M02AA23]                          │ìàçü 10%                      │Pharmachim (Áîëãàðèÿ)         │2818, 06.02.86 │

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │ñâå÷è                         │Pharmachim (ÍÐÁ)              │2922, 20.04.89 │

                                                                                                                                                                     

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25 ìã                 │Promed Exports Pvt Ltd (Èíäèÿ)│005265,       

                                                                                                                                                      │24.08.94      

                                                                                                                                                                     

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25, 50 ìã, êàïñóëû    │Rugby (ÑØÀ)                   │005373,       

                                                                                          │ïðîëîíãèðîâàííîãî äåéñòâèÿ 75 │                              │28.09.94      

                                                                                          │ìã                                                                         

                                                                                                                                                                    

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │òàáëåòêè 25 ìã                │Tramedico Pharma Bv (Áåëüãèÿ) │007565,       

                                                                                                                                                      │04.06.96      

                                                                                                                                                                    

│Èíäîìåòàöèí [Èíäîìåòàöèí]                         │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25 ìã                 │Watson Laboratories Inc (ÑØÀ) │003647,       

                                                                                                                                                      │31.01.94      

                                                                                                                                                                    

│Èíäîìåòàöèí (Ìîâèìåä) [Èíäîìåòàöèí]               │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25, 50 ìã             │Mir Pharmaceutical            │007678,       

                                                                                                                        │Inc/pharbita B.V.             │23.07.96      

                                                                                                                        │(íèäåðëàíäû) (ÑØÀ)                          

                                                                                                                                                                    

│Èíäîìèí [Èíäîìåòàöèí]                             │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25 ìã; ñâå÷è 100 ìã   │Al-Hikma Pharmaceuticals      │002897,       

                                                                                                                        │(Èîðäàíèÿ)                    │11.03.93      

                                                                                                                                                                    

│Èíäîïàí [Èíäîìåòàöèí]                             │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25 ìã                 │Panacea Biotec Ltd (Èíäèÿ)    │005638,       

                                                                                                                                                      │11.01.95      

                                                                                                                                                                    

│Èíäîòàðä [Èíäîìåòàöèí]                            │ÍÏÂÑ [M01AB01]                          │êàïñóëû ðåòàðä 75 ìã          │Cts Chemical Industries Ltd   │005686,       

                                                                                                                        │(Èçðàèëü)                     │24.01.95      

                                                                                                                                                                    

│Èíäîöèä [Èíäîìåòàöèí]                             │ÍÏÂÑ [S01BC01]                          │ñóñïåíçèÿ ãëàçíàÿ (ôëàêîíû) 1%│Merck Sharp & Dohme B.V.      │006909,       

                                                                                                                        │(Ãîëëàíäèÿ)                   │19.12.95      

                                                                                                                                                                    

│Èíìóíîôåðîí [Ôîñôîãëèêîïåïòèêàë]                  │èììóíîñòèìóëÿòîð [L03AX]                │êàïñóëû 500 ìã; ïîðîøîê       │Laboratorious Andromaco SA    │003170,       

                                                                                          │îðàëüíûé (ñàøå) 500 ìã        │(Èñïàíèÿ)                     │23.07.93      

                                                                                                                                                                    

│Èííîëèð 1% [Îêñèòåòðàöèêëèí]                      │àíòèáèîòèê, òåòðàöèêëèí [S01AA04]       │êàïëè ãëàçíûå (ôëàêîíû) 1%    │Innotech International        │007066,       

                                                                                                                        │(Ôðàíöèÿ)                     │08.02.96      

                                                                                                                                                                    

│Èíîçèå-Ô [Èíîçèí]                                 │ìåòàáîëè÷åñêîå ñðåäñòâî [C01EB]         │òàáëåòêè                      │Roussel Morishita Co, Ltd     │00150,        

                                                                                                                        │(ßïîíèÿ)                      │14.07.71,     

                                                                                                                                                      │16.03.83,     

                                                                                                                                                      │20.01.95      

                                                                                                                                                                    

│Èíñèäîí [Îïèïðàìîë]                               │àíòèäåïðåññàíò [N06AA05]                │äðàæå 50 ìã                   │Ciba-Geigy (Øâåéöàðèÿ)        │00078,        

                                                                                                                                                      │07.12.70,     

                                                                                                                                                      │30.10.87      

                                                                                                                                                                    

│Èíñïðèí {àöåòèëñàëèöèëîâàÿ êèñëîòà 0.35 ã,        │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè ðàñòâîðèìûå 324 ìã   │Win-Medicare Ltd (Èíäèÿ)      │005224,       

│êàëüöèÿ êàðáîíàò 105 ìã, ëèìîííàÿ êèñëîòà 35 ìã}  │ñðåäñòâî [N02BA51]                                                                                  │12.08.94      

                                                                                                                                                                    

│Èíñòåíîí {ãåêñîáåíäèí 10 ìã, ýòàìèâàí 50 ìã,      │ñïàçìîëèòè÷åñêîå ñðåäñòâî [C01EX]       │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Alkaloid (ÑÔÐÞ)               │00393,        

│ýòîôèëëèí 100 ìã - àìïóëà; ãåêñîáåíäèí 20 ìã,                                             │2 ìë; äðàæå                                                 │02.02.77,     

│ýòàìèâàí 60 ìã, ýòîôèëëèí 60 ìã}                                                                                                                      │15.02.91      

                                                                                                                                                                    

│Èíñòåíîí {ãåêñîáåíäèí 10 ìã, ýòàìèâàí 50 ìã,      │ñïàçìîëèòè÷åñêîå ñðåäñòâî [C01EX]       │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hafslund Nycomed Pharma AG    │002556,       

│ýòîôèëëèí 100 ìã - àìïóëà; ãåêñîáåíäèí 20 ìã,                                             │2 ìë; òàáëåòêè ïîêðûòûå       │(Àâñòðèÿ)                     │14.07.92      

│ýòàìèâàí 60 ìã, ýòîôèëëèí 60 ìã - òàáëåòêà}                                               │îáîëî÷êîé                                                                 

                                                                                                                                                                     

│Èíñòèëëàãåëü {ëèäîêàèí 2 ã, õëîðãåêñèäèí 50 ìã,   │àíòèñåïòè÷åñêîå ñðåäñòâî [N01BB52]      │ãåëü (øïðèö îäíîðàçîâûé) 6,   │Farco-Pharma GmbH (ÔÐÃ)       │02012, 20.11.90│

│ìåòèëãèäðîêñèáåíçîàò 60 ìã, ïðîïèëãèäðîêñèáåíçîàò │                                        │11 ìë                                                                     

│25 ìã - 100 ã}                                                                                                                                                       

                                                                                                                                                                    

│Èíñóëèí Àêòðàïèä [Èíñóëèí-ÁÄ] {èíñóëèí            │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Novo Industry (Äàíèÿ)         │01264, 28.03.86│

│íåéòðàëüíûé, ñâèíîé}                                                                      │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                                 

                                                                                                                                                                    

│Èíñóëèí Àêòðàïèä [Èíñóëèí-ÁÄ] {èíñóëèí            │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ñóñïåíçèÿ äëÿ èíúåêöèé        │Torrent Exports Ltd (Èíäèÿ)   │01915, 19.07.90│

│íåéòðàëüíûé, ñâèíîé}                                                                      │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                                 

                                                                                                                                                                    

│Èíñóëèí Àêòðàïèä HM [Èíñóëèí-ÁÄ] {èíñóëèí         │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé 40 ÅÄ/ìë │Novo Industry (Äàíèÿ)         │01406, 25.01.88│

│íåéòðàëüíûé, ÷åëîâå÷åñêèé}                                                                                                                                          

                                                                                                                                                                    

│Èíñóëèí Àêòðàïèä HM [Èíñóëèí-ÁÄ] {èíñóëèí         │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé 40 ÅÄ/ìë │Torrent Exports Ltd (Èíäèÿ)   │01918, 19.07.90│

│íåéòðàëüíûé, ÷åëîâå÷åñêèé}                                                                                                                                          

                                                                                                                                                                    

│Èíñóëèí Àêòðàïèä HM ïåíôèë [Èíñóëèí-ÁÄ] {èíñóëèí  │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé (ïåíôèë) │Novo Industry (Äàíèÿ)         │01408, 25.01.88│

│íåéòðàëüíûé, ÷åëîâå÷åñêèé}                                                                │100 ÅÄ/ìë - 1.5 ìë                                                        

                                                                                                                                                                    

│Èíñóëèí Àêòðàïèä ÌÊ [Èíñóëèí-ÁÄ] {èíñóëèí         │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Torrent Exports Ltd (Èíäèÿ)   │002245,       

│íåéòðàëüíûé, ìîíîêîìïîíåíòíûé ñâèíîé}                                                     │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │11.10.91      

                                                                                                                                                                    

│Èíñóëèí Àêòðàïèä ÌÑ [Èíñóëèí-ÁÄ] {èíñóëèí         │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé 40 ÅÄ/ìë │Novo Industry (Äàíèÿ)         │01401, 25.01.88│

│íåéòðàëüíûé, ìîíîêîìïîíåíòíûé ñâèíîé}                                                                                                                               

                                                                                                                                                                    

│Èíñóëèí Èçîôàíèêóì ÂÎ-Ñ [Èíñóëèí-ÑðÄ] {èíñóëèí    │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Polfa, Tarchominskie Zaklady  │005184,       

│ñâèíîé ìîíîêîìïîíåíòíûé}                                                                  │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                    

│Èíñóëèí Èçîôàíèêóì ÕÎ-Ñ [Èíñóëèí-ÑðÄ] {èíñóëèí    │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Polfa, Tarchominskie Zaklady  │005185,       

│ñâèíîé ìîíîêîìïîíåíòíûé}                                                                  │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                    

│Èíñóëèí Ëåíòå [Èíñóëèí-ÑðÄ] {èíñóëèí              │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Novo Industry (Äàíèÿ)         │01261, 28.03.86│

│öèíê-ñóñïåíçèÿ, ñâèíîé: àìîðôíûé 30%,                                                     │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                                

│êðèñòàëëè÷åñêèé 70%}                                                                                                                                                

                                                                                                                                                                    

│Èíñóëèí Ëåíòå [Èíñóëèí-ÑðÄ] {èíñóëèí              │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Torrent Exports Ltd (Èíäèÿ)   │01912, 19.07.90│

│öèíê-ñóñïåíçèÿ, ñâèíîé: àìîðôíûé 30%,                                                     │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                                

│êðèñòàëëè÷åñêèé 70%}                                                                                                                                                

                                                                                                                                                                    

│Èíñóëèí Ëåíòå ÂÎ-Ñ [Èíñóëèí-ÑðÄ] {èíñóëèí ñâèíîé  │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Polfa, Tarchominskie Zaklady  │005179,       

│ìîíîêîìïîíåíòíûé}                                                                         │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                    

│Èíñóëèí Ëåíòå ÕÎ-Ñ [Èíñóëèí-ÑðÄ] {èíñóëèí ñâèíîé  │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Polfa, Tarchominskie Zaklady  │005181,       

│ìîíîêîìïîíåíòíûé}                                                                         │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                    

│Èíñóëèí Ëåíòå GP [Èíñóëèí-ÑðÄ] {èíñóëèí           │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Galenika (ÑÔÐÞ)               │002181,       

│öèíê-ñóñïåíçèÿ, ìîíîêîìïîíåíòíûé ãîâÿæèé:                                                 │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │08.07.91      

│àìîðôíûé 30%, êðèñòàëëè÷åñêèé 70%}                                                                                                                                  

                                                                                                                                                                    

│Èíñóëèí Ëåíòå MC [Èíñóëèí-ÑðÄ] {èíñóëèí           │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé 40     │Novo Industry (Äàíèÿ)         │01403, 25.01.88│

│öèíê-ñóñïåíçèÿ, ìîíîêîìïîíåíòíûé ñìåøàííûé:                                               │ÅÄ/ìë                                                                     

│àìîðôíûé 30%, êðèñòàëëè÷åñêèé 70%}                                                                                                                                  

                                                                                                                                                                    

│Èíñóëèí Ëåíòå ÑÏÏ [Èíñóëèí-ÑðÄ] {èíñóëèí          │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Galenika (ÑÔÐÞ)               │002441,        

│öèíê-ñóñïåíçèÿ, ìîíîêîìïîíåíòíûé ñâèíîé: àìîðôíûé │                                        │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │25.11.91      

│30%, êðèñòàëëè÷åñêèé 70%}                                                                                                                                           

                                                                                                                                                                     

│Èíñóëèí Ìàêñèðàïèä ÂÎ-Ñ [Èíñóëèí-ÁÄ] {èíñóëèí     │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Polfa, Tarchominskie Zaklady  │005187,       

│ñâèíîé ìîíîêîìïîíåíòíûé}                                                                  │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                   

                                                                                                                                                                    

│Èíñóëèí Ìàêñèðàïèä ÕÎ-Ñ [Èíñóëèí-ÁÄ] {èíñóëèí     │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Polfa, Tarchominskie Zaklady  │005186,       

│ñâèíîé ìîíîêîìïîíåíòíûé}                                                                  │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                    

│Èíñóëèí Ìîíîòàðä HM [Èíñóëèí-ÑðÄ] {èíñóëèí        │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé 40     │Novo Industry (Äàíèÿ)         │01407, 25.01.88│

│öèíê-ñóñïåíçèÿ, ÷åëîâå÷åñêèé: àìîðôíûé 30%,                                               │ÅÄ/ìë                                                                     

│êðèñòàëëè÷åñêèé 70%}                                                                                                                                                

                                                                                                                                                                    

│Èíñóëèí Ìîíîòàðä HM [Èíñóëèí-ÑðÄ] {èíñóëèí        │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé 40     │Torrent Exports Ltd (Èíäèÿ)   │01919, 19.07.90│

│öèíê-ñóñïåíçèÿ, ÷åëîâå÷åñêèé: àìîðôíûé 30%,                                               │ÅÄ/ìë                                                                     

│êðèñòàëëè÷åñêèé 70%}                                                                                                                                                

                                                                                                                                                                    

│Èíñóëèí Ìîíîòàðä MC [Èíñóëèí-ÑðÄ] {èíñóëèí        │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé 40     │Novo Industry (Äàíèÿ)         │01402, 25.01.88│

│öèíê-ñóñïåíçèÿ, ìîíîêîìïîíåíòíûé ñâèíîé: àìîðôíûé │                                        │ÅÄ/ìë                                                                     

│30%, êðèñòàëëè÷åñêèé 70%}                                                                                                                                           

                                                                                                                                                                    

│Èíñóëèí Ìîíîòàðä MC [Èíñóëèí-ÑðÄ] {èíñóëèí        │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé 40     │Torrent Exports Ltd (Èíäèÿ)   │003040,       

│öèíê-ñóñïåíçèÿ, ìîíîêîìïîíåíòíûé ñâèíîé: àìîðôíûé │                                        │ÅÄ/ìë                                                       │07.06.93      

│30%, êðèñòàëëè÷åñêèé 70%}                                                                                                                                           

                                                                                                                                                                    

│Èíñóëèí Ïðîòàôàí HM ïåíôèëë [Èíñóëèí-ÑðÄ]         │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Novo Nordisk (Äàíèÿ)          │002138,       

│{èíñóëèí èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé}                                                   │(ïåíôèë) 100 ÅÄ/ìë - 1.5 ìë                                 │24.05.91      

                                                                                                                                                                    

│Èíñóëèí ðàñòâîðèìûé íåéòðàëüíûé ÂÎ-Ñ [Èíñóëèí-ÁÄ] │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Polfa, Tarchominskie Zaklady  │005188,       

│{èíñóëèí ñâèíîé ìîíîêîìïîíåíòíûé}                                                         │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                    

│Èíñóëèí ðàñòâîðèìûé íåéòðàëüíûé ÕÎ-Ñ [Èíñóëèí-ÁÄ] │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Polfa, Tarchominskie Zaklady  │005189,       

│{èíñóëèí ñâèíîé ìîíîêîìïîíåíòíûé}                                                         │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                    

│Èíñóëèí Ñ [Èíñóëèí-ÁÄ]                            │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Hoechst AG (Ãåðìàíèÿ)         │006174,       

                                                                                          │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │13.06.95      

                                                                                                                                                                    

│Èíñóëèí Ñåìèëåíòå ÂÎ-Ñ [Èíñóëèí-ÑðÄ] {èíñóëèí     │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Polfa, Tarchominskie Zaklady  │005183,       

│ñâèíîé ìîíîêîìïîíåíòíûé}                                                                  │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                    

│Èíñóëèí Ñåìèëåíòå ÕÎ-Ñ [Èíñóëèí-ÑðÄ] {èíñóëèí     │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Polfa, Tarchominskie Zaklady  │005182,       

│ñâèíîé ìîíîêîìïîíåíòíûé}                                                                  │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                    

│Èíñóëèí Ñåìèëåíòå ÌÊ [Èíñóëèí-ÑðÄ] {èíñóëèí       │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ðàñòâîð äëÿ èíúåêöèé          │Torrent Exports Ltd (Èíäèÿ)   │002246,       

│öèíê-ñóñïåíçèÿ, ìîíîêîìïîíåíòíûé ñâèíîé: àìîðôíûé │                                        │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │11.10.91      

│100%}                                                                                                                                                               

                                                                                                                                                                    

│Èíñóëèí Óëüòðàëåíòå ÂÎ-Ñ [Èíñóëèí-ÄëÄ] {èíñóëèí   │èíñóëèí äëèòåëüíîãî äåéñòâèÿ [A10AA04]  │ñóñïåíçèÿ äëÿ èíúåêöèé        │Polfa, Tarchominskie Zaklady  │005178,       

│ñâèíîé ìîíîêîìïîíåíòíûé}                                                                  │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                    

│Èíñóëèí Óëüòðàëåíòå ÕÎ-Ñ [Èíñóëèí-ÄëÄ] {èíñóëèí   │èíñóëèí äëèòåëüíîãî äåéñòâèÿ [A10AA04]  │ñóñïåíçèÿ äëÿ èíúåêöèé        │Polfa, Tarchominskie Zaklady  │005180,        

│ñâèíîé ìîíîêîìïîíåíòíûé}                                                                  │(ôëàêîíû) 400 ÌÅ/10 ìë, 800   │Farmaceutyczne SA (Ïîëüøà)    │27.07.94      

                                                                                          │ÌÅ/10 ìë                                                                  

                                                                                                                                                                     

│Èíñóëèí Óëüòðàëåíòå MC [Èíñóëèí-ÄëÄ] {èíñóëèí     │èíñóëèí äëèòåëüíîãî äåéñòâèÿ [A10AA04]  │ñóñïåíçèÿ äëÿ èíúåêöèé        │Torrent Exports Ltd (Èíäèÿ)   │003039,       

│öèíê-ñóñïåíçèÿ êðèñòàëëè÷åñêèé, ìîíîêîìïîíåíòíûé                                          │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │07.06.93      

│ãîâÿæèé}                                                                                                                                                             

                                                                                                                                                                    

│Èíñóëèí Óëüòðàòàðä HM [Èíñóëèí-ÄëÄ] {èíñóëèí      │èíñóëèí äëèòåëüíîãî äåéñòâèÿ [A10AA04]  │ñóñïåíçèÿ äëÿ èíúåêöèé 40     │Novo Industry (Äàíèÿ)         │01462, 02.08.88│

│öèíê-ñóñïåíçèÿ êðèñòàëëè÷åñêèé, ÷åëîâå÷åñêèé}                                             │ÅÄ/ìë                                                                      

                                                                                                                                                                    

│Èíñóëèí Óëüòðàòàðä HM [Èíñóëèí-ÄëÄ] {èíñóëèí      │èíñóëèí äëèòåëüíîãî äåéñòâèÿ [A10AA04]  │ñóñïåíçèÿ äëÿ èíúåêöèé 40     │Torrent Exports Ltd (Èíäèÿ)   │01920, 19.07.90│

│öèíê-ñóñïåíçèÿ êðèñòàëëè÷åñêèé, ÷åëîâå÷åñêèé}                                             │ÅÄ/ìë                                                                     

                                                                                                                                                                    

│Èíñóëîíã ÑÏÏ [Èíñóëèí-ÑðÄ] {èíñóëèí               │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Pliva (ÑÔÐÞ)                  │01637, 30.06.89│

│öèíê-ñóñïåíçèÿ, ìîíîêîìïîíåíòíûé ñâèíîé: àìîðôíûé │                                        │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                                

│30%, êðèñòàëëè÷åñêèé 70%}                                                                                                                                           

                                                                                                                                                                    

│Èíñóëðàï [Èíñóëèí-ÁÄ] {èíñóëèí íåéòðàëüíûé,       │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Pliva (Þãîñëàâèÿ)             │01384, 16.11.87│

│ìîíîêîìïîíåíòíûé ñìåøàííûé}                                                               │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                                

                                                                                                                                                                    

│Èíñóëðàï ÑÏÏ [Èíñóëèí-ÁÄ] {èíñóëèí íåéòðàëüíûé,   │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Pliva (ÑÔÐÞ)                  │01636, 30.06.89│

│ìîíîêîìïîíåíòíûé ñâèíîé}                                                                  │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                                

                                                                                                                                                                    

│Èíñóìàí Áàçàë [Èíñóëèí-ÑðÄ] {èíñóëèí              │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (ÔÐÃ)              │002342,       

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé}                                                            │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │15.01.92      

                                                                                                                                                                    

│Èíñóìàí Áàçàë [Èíñóëèí-ÑðÄ] {èíñóëèí              │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (Ãåðìàíèÿ)         │005613,       

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé}                                                            │(ôëàêîíû) 100 ÅÄ/ìë - 5 ìë                                  │04.01.95      

                                                                                                                                                                    

│Èíñóìàí Áàçàë 100 äëÿ Îïòèïåíà [Èíñóëèí-ÑðÄ]      │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (Ãåðìàíèÿ)         │005617,       

│{èíñóëèí èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé}                                                   │(ïåíôèë) 100 ÌÅ/ìë - 3 ìë                                   │04.01.95      

                                                                                                                                                                    

│Èíñóìàí Êîìá 15/85 [Èíñóëèí-Êîìá] {èíñóëèí        │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (ÔÐÃ)              │002344,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 15%; èíñóëèí                                                    │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │15.01.92      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 85%}                                                                                                                                  

                                                                                                                                                                    

│Èíñóìàí Êîìá 15/85 [Èíñóëèí-Êîìá] {èíñóëèí        │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (Ãåðìàíèÿ)         │005615,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 15%; èíñóëèí                                                    │(ôëàêîíû) 100 ÌÅ/ìë - 5 ìë                                  │04.01.95      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 85%}                                                                                                                                  

                                                                                                                                                                    

│Èíñóìàí Êîìá 25/75 [Èíñóëèí-Êîìá] {èíñóëèí        │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (ÔÐÃ)              │002343,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 25%; èíñóëèí                                                    │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │15.01.92      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 75%}                                                                                                                                  

                                                                                                                                                                    

│Èíñóìàí Êîìá 25/75 [Èíñóëèí-Êîìá] {èíñóëèí        │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (Ãåðìàíèÿ)         │005614,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 25%; èíñóëèí                                                    │(ôëàêîíû) 100 ÅÄ/ìë - 5 ìë                                  │04.01.95      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 75%}                                                                                                                                  

                                                                                                                                                                    

│Èíñóìàí Êîìá 25/75 äëÿ îïòèïåíà [Èíñóëèí-Êîìá]    │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (ÔÐÃ)              │002348,       

│{èíñóëèí íåéòðàëüíûé, ÷åëîâå÷åñêèé 25%; èíñóëèí                                           │(àìïóëû äëÿ øïðèöðó÷êè) 100                                 │15.01.92      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 75%}                                                        │ÅÄ/ìë                                                                     

                                                                                                                                                                    

│Èíñóìàí Êîìá 50/50 [Èíñóëèí-Êîìá] {èíñóëèí        │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (ÔÐÃ)              │002345,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 50%; èíñóëèí                                                    │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │15.01.92      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 50%}                                                                                                                                  

                                                                                                                                                                    

│Èíñóìàí Êîìá 50/50 [Èíñóëèí-Êîìá] {èíñóëèí        │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (Ãåðìàíèÿ)         │005616,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 50%; èíñóëèí                                                    │(ôëàêîíû) 100 ÌÅ/ìë - 5 ìë                                  │04.01.95       

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 50%}                                                                                                                                  

                                                                                                                                                                    

│Èíñóìàí Ðàïèä [Èíñóëèí-ÁÄ] {èíñóëèí íåéòðàëüíûé,  │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Hoechst AG (ÔÐÃ)              │002346,        

│÷åëîâå÷åñêèé}                                                                             │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │15.01.92      

                                                                                                                                                                    

│Èíñóìàí Ðàïèä [Èíñóëèí-ÁÄ] {èíñóëèí íåéòðàëüíûé,  │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Hoechst AG (Ãåðìàíèÿ)         │005612,       

│÷åëîâå÷åñêèé}                                                                             │(ôëàêîíû) 100 ÅÄ/ìë - 5 ìë                                  │04.01.95      

                                                                                                                                                                    

│Èíñóìàí Ðàïèä äëÿ îïòèïåíà [Èíñóëèí-ÁÄ] {èíñóëèí  │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû  │Hoechst AG (ÔÐÃ)              │002347,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé}                                                                │äëÿ øïðèöðó÷êè) 100 ÅÄ/ìë                                   │15.01.92      

                                                                                                                                                                    

│Èíòàë [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò       │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R03BC01] │ïîðîøîê äëÿ èíãàëÿöèé         │Fisons Plc (Âåëèêîáðèòàíèÿ)   │006671,       

│äèíàòðèÿ}                                                                                 │(êàïñóëû) 20 ìã                                             │27.03.96      

                                                                                                                                                                    

│Èíòàë [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò       │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R03BC01] │àýðîçîëü äîçèðîâàííûé 1       │Fisons Plc (Âåëèêîáðèòàíèÿ)   │006056,       

│äèíàòðèÿ}                                                                                 │ìã|äîçà, 5 ìã|äîçà; ðàñòâîð                                 │17.05.95      

                                                                                          │äëÿ ðàñïûëåíèÿ (àìïóëû) 1%                                                

                                                                                                                                                                    

│Èíòàë [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò       │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R03BC01] │ïîðîøîê äëÿ èíãàëÿöèé         │Lek (Þãîñëàâèÿ)               │00327,        

│äèíàòðèÿ}                                                                                 │(êàïñóëû) 20 ìã                                             │02.09.86,     

                                                                                                                                                      │31.01.75      

                                                                                                                                                                    

│Èíòàë ïëþñ {êðîìîãëèêàò äèíàòðèÿ 1 ìã,            │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R01AC51] │àýðîçîëü äîçèðîâàííûé         │Fisons Plc (Âåëèêîáðèòàíèÿ)   │006261,       

│ñàëüáóòàìîë 120.5 ìêã}                                                                                                                                │11.07.95      

                                                                                                                                                                    

│Èíòàì-10 [Òàìîêñèôåí]                             │àíòèýñòðîãåí [L02BA01]                  │òàáëåòêè 10 ìã                │Intas                         │005765,       

                                                                                                                        │International-Pharmaceuticals │20.02.95      

                                                                                                                        │(Èíäèÿ)                                     

                                                                                                                                                                    

│Èíòåòðèêñ {òèëèõèíîë 50 ìã, òèëáðîõèíîë 200 ìã,   │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │êàïñóëû                       │Beaufour-Ipsen International  │002545,       

│òèëèõèíîë äîäåöèë ñóëüôàò 50 ìã}                  │ñðåäñòâî [J01M]                                                       │(Ôðàíöèÿ)                     │08.07.92      

                                                                                                                                                                    

│Èíòåòðèêñ {òèëèõèíîë 50 ìã, òèëáðîõèíîë 200 ìã,   │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │êàïñóëû                       │Farmakos (ÑÔÐÞ)               │002146,       

│òèëèõèíîë äîäåöèë ñóëüôàò 50 ìã}                  │ñðåäñòâî [J01M]                                                                                     │28.05.91      

                                                                                                                                                                    

│Èíòðàãëîáèí [Èììóíîãëîáóëèí (â/â ââåäåíèå)]       │èììóíîñòèìóëÿòîð [J06BA02]              │ðàñòâîð äëÿ èíúåêöèé 10, 20 ìë│Biotest Pharma GmbH (ÔÐÃ)     │006313,       

                                                                                                                                                      │24.07.95      

                                                                                                                                                                    

│Èíòðàãëîáèí [Èììóíîãëîáóëèí (â/â ââåäåíèå)]       │èììóíîñòèìóëÿòîð [J06BA02]              │ðàñòâîð äëÿ âíóòðèâåííîãî     │Biotest Pharma GmbH (Ãåðìàíèÿ)│007210,       

                                                                                          │ââåäåíèÿ (ôëàêîíû) 5% - 50,                                 │10.06.96      

                                                                                          │100 ìë                                                                    

                                                                                                                                                                    

│Èíòðàçîëèí [Öåôàçîëèí]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Laboratoire Torlan (Èñïàíèÿ)  │006237,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà 1 ã                                  │30.06.95      

                                                                                                                                                                    

│Èíòðàëèïèä {ñîåâîå ìàñëî 100 ã, ôîñôîëèïèäû       │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ    │ýìóëüñèÿ äëÿ èíôóçèé æèðîâàÿ  │Pharmacia (Øâåöèÿ)            │006504,       

│ÿè÷íûå 12 ã, ãëèöåðèí 22.5 ã - 1 ë; ñîåâîå ìàñëî  │[B05BA02]                               │(ôëàêîíû) 10%, 20%                                          │18.09.95      

│200 ã, ôîñôîëèïèäû ÿè÷íûå 12 ã, ãëèöåðèí 22.5 ã - │                                                                                                                  

│1 ë }                                                                                                                                                               

                                                                                                                                                                    

│Èíòðàëèïèä 30% {ñîåâîå ìàñëî, ôîñôîëèïèäû,        │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ    │ýìóëüñèÿ äëÿ èíôóçèé æèðîâàÿ  │Kabi Pharmacia (Øâåöèÿ)       │002938,       

│ãëèöåðîë}                                         │[B05BA02]                               │(ôëàêîíû) 300 ìã/ìë                                         │30.03.93      

                                                                                                                                                                    

│Èíòðàòàêñèì [Öåôîòàêñèì]                          │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratoire Torlan (Èñïàíèÿ)  │007076,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │13.02.96      

                                                                                          │ðàñòâîðà (ôëàêîíû) 0.5, 1 ã                                               

                                                                                                                                                                    

│Èíòðàôóçèí {àìèíîêèñëîòû}                         │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ    │ðàñòâîð äëÿ èíôóçèé 10%       │Pfrimmer-Kabi GmbH (ÔÐÃ)      │002264,        

                                                  │[B05BA01]                                                                                           │21.10.91      

                                                                                                                                                                    

│Èíòðèì [Êî-òðèìîêñàçîë] {òðèìåòîïðèì 80 ìã,       │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 80 ìã/400 ìã         │Intas                         │005764,        

│ñóëüôàìåòîêñàçîë 400 ìã}                          │ñðåäñòâî [J01EE01]                                                    │International-Pharmaceuticals │20.02.95      

                                                                                                                        │(Èíäèÿ)                                     

                                                                                                                                                                     

│Èíòðîí À [Èíòåðôåðîí àëüôà]                       │èììóíîñòèìóëÿòîð [L03AA04]              │ëèîôèëèç.ïîðîøîê äëÿ          │Schering-Plough (ÑØÀ)         │002313,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │09.01.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 3000000,                                                

                                                                                          │5000000, 10000000, 30000000 ÌÅ│                                            

                                                                                                                                                                    

│Èíòóññèí [Áóòàìèðàò]                              │ïðîòèâîêàøëåâîå ñðåäñòâî [R05DB13]      │òàáëåòêè 5 ìã                 │Slovakofarma SA (Ñëîâàêèÿ)    │2904,         

                                                                                                                                                      │15.08.88,     

                                                                                                                                                      │23.06.94      

                                                                                                                                                                    

│Èíóòðàë Èíñóëèí ÃÌ [Èíñóëèí-ÁÄ] {èíñóëèí          │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Galenika (ÑÔÐÞ)               │002183,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé}                                                                │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │08.07.91      

                                                                                                                                                                    

│Èíóòðàë ÑÏÏ [Èíñóëèí-ÁÄ] {èíñóëèí íåéòðàëüíûé,    │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Galenika (ÑÔÐÞ)               │002442,       

│ìîíîêîìïîíåíòíûé ñâèíîé}                                                                  │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë                                  │25.11.91      

                                                                                                                                                                    

│Èíôåçîë 40 {àìèíîêèñëîòû, ìèíåðàëüíûå ñîëè}       │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ    │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Berlin-Chemie AG (Ãåðìàíèÿ)   │006594,       

                                                  │[B05BA10]                                                                                           │09.11.95      

                                                                                                                                                                    

│Èíôëóáåíå {ïàðàöåòàìîë 500 ìã, ýòèëýôðèí 5 ìã,    │ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ludwig Merckle GmbH (Àâñòðèÿ) │006714,       

│áóòåòàìàò äèãèäðîãåíöèòðàò 20 ìã, õëîðôåíàìèí 2   │ïðîñòóäû [R05X]                                                                                     │18.10.95      

│ìã, öèêëàìàò}                                                                                                                                                       

                                                                                                                                                                    

│Èíôóêîë Ãýê 6% è 10% [Äåêñòðàí, ìîë.ìàññà îêîëî   │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05AA05]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Serum-Werk Bernburg AG        │007141,       

│200000]                                                                                   │6%, 10%                       │(Ãåðìàíèÿ)                    │12.03.96      

                                                                                                                                                                    

│ÈÍÕ [Èçîíèàçèä]                                   │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AC01] │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Sanavita Gesundcheitsmittel & │005859,       

                                                                                          │100, 200, 300 ìã              │Co Kg (Ãåðìàíèÿ)              │23.03.95      

                                                                                                                                                                    

│Èíõèáåéñ [Öèëàçàïðèë]                             │ÀÊÔ áëîêàòîð [C09AA08]                  │ôèëìòàáëåòêè 0.5, 1, 2.5, 5 ìã│Hoffmann La Roche (Øâåéöàðèÿ) │002719,       

                                                                                                                                                      │26.11.92      

                                                                                                                                                                    

│Èíúåñïðèí [Àöåòèëñàëèöèëàò ëèçèíà]                │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ãðàíóëû îðàëüíûå (ïàêåòû) 900 │Laboratorious Andromaco SA    │003693,       

                                                  │ñðåäñòâî [N02BA13]                      │ìã; ãðàíóëû îðàëüíûå ôîðòå    │(Èñïàíèÿ)                     │11.02.94      

                                                                                          │(ïàêåòû) 1800 ìã; ïîðîøîê                                                 

                                                                                          │äîçèðîâàííûé äëÿ äåòåé                                                    

                                                                                          │(ïàêåòû) 450 ìã;                                                          

                                                                                          │ëèîôèëèç.ïîðîøîê äëÿ                                                      

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 0.9, 1.8 ã │                                            

                                                                                          │/â êîìïëåêòå ñ ðàñòâîðèòåëåì/ │                                            

                                                                                                                                                                    

│ÈÎÐ Ò3                                            │[V03AX]                                 │ðàñòâîð äëÿ âíóòðèâåííîãî     │Center Of Molecular           │007008,       

                                                                                          │ââåäåíèÿ (ôëàêîíû) 5 ìã - 5 ìë│Immunobiology (Êóáà)          │24.01.96      

                                                                                                                                                                    

│Èïåíòàë {ëèïàçà 10 ÅÄ, àìèëàçà 10 ÅÄ, ïðîòåàçà 17 │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │äðàæå ñ êèøå÷íîðàñòâîðèìîé    │Ipca Laboratories Ltd (Èíäèÿ) │002660,       

│ÅÄ, æåë÷è êîìïîíåíòû 17 ìã, ãåìèöåëëþëàçà 50 ìã}  │[A09AA02]                               │îáîëî÷êîé                                                   │13.10.92      

                                                                                                                                                                    

│Èïåðòðîôàí [Ìåïàðòðèöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî [A01AB16]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Spa (Èòàëèÿ)                  │002315,       

                                                                                          │50000 ÅÄ                                                    │10.01.92      

                                                                                                                                                                    

│Èïåðòðîôàí 40 (Ìåïàðòðèöèí) [Ìåïàðòðèöèí]         │ïðîòèâîìèêðîáíîå ñðåäñòâî [A01AB16]     │òàáëåòêè ïîêðûòûå             │Spa (Èòàëèÿ)                  │007465,       

                                                                                          │êèøå÷íîðàñòâîðèìîé îáîëî÷êîé                                │23.04.96       

                                                                                          │40 ìã                                                                     

                                                                                                                                                                    

│Èïîëèïèä [Ãåìôèáðîçèë]                            │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AC04]   │òàáëåòêè 600 ìã; êàïñóëû 300  │Medochemie Ltd (Êèïð)         │003008,        

                                                                                          │ìã                                                          │28.05.93      

                                                                                                                                                                    

│Èïðàäîë [Ãåêñîïðåíàëèí]                           │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè 0.5 ìã; ðàñòâîð äëÿ  │Hafslund Nycomed Pharma AG    │002557,       

                                                  │[R03AC06][R03CC05]                      │èíúåêöèé (àìïóëû) 5 ìêã - 2   │(Àâñòðèÿ)                     │14.07.92      

                                                                                          │ìë; àýðîçîëü äîçèðîâàííûé 0.2 │                                            

                                                                                          │ìã|äîçà                                                                    

                                                                                                                                                                    

│Èïðåí [Èáóïðîôåí]                                 │ÍÏÂÑ [M02AA13]                          │òàáëåòêè 200 ìã               │Nycomed Dak AS (Äàíèÿ)        │003366,       

                                                                                                                                                      │28.09.93      

                                                                                                                                                                    

│Èïðîíàë [Ïðîêñèáàðáàë]                            │òðàíêâèëèçàòîð [N05CA]                  │òàáëåòêè 50 ìã                │Polfa (Ïîëüøà)                │2595,         

                                                                                                                                                      │09.02.79,     

                                                                                                                                                      │21.06.90      

                                                                                                                                                                    

│Èðàëãåçèê {ïàðàöåòàìîë 162.5 ìã, êîôåèí 32.5 ìã,  │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Darou Paksh Pharmaceutical    │006829,       

│àöåòèëñàëèöèëîâàÿ êèñëîòà 325 ìã}                 │ñðåäñòâî [N02BA51]                                                    │Company (Èðàí)                │13.11.95      

                                                                                                                                                                    

│Èðîâèò {æåëåçà ôóìàðàò 0.3 ã, öèàíîêîáàëàìèí 15   │ãåìîïîýçà ñòèìóëÿòîð, ïðåïàðàò æåëåçà   │êàïñóëû                       │Mesco Laboratories Ltd (Èíäèÿ)│002960,       

│ìêã, ôîëèåâàÿ êèñëîòà 1.5 ìã, ëèçèí 50 ìã,        │[B03AE01]                                                                                           │12.04.93      

│àñêîðáèíîâàÿ êèñëîòà 75 ìã}                                                                                                                                         

                                                                                                                                                                    

│Èðóêñîë {êëîñòðèäèîïåïòèäàçà À 0.6 ÅÄ,            │àíòèñåïòè÷åñêîå ñðåäñòâî [D03BA52]      │ìàçü                          │Knoll AG (ÔÐÃ)                │002792,       

│õëîðàìôåíèêîë 10 ìã - 1 ã}                                                                                                                            │12.01.93      

                                                                                                                                                                    

│Èðóêñîë {êëîñòðèäèîïåïòèäàçà À 0.6 ÅÄ,            │àíòèñåïòè÷åñêîå ñðåäñòâî [D03BA52]      │ìàçü                          │Pliva (Þãîñëàâèÿ)             │00506, 25.10.77│

│õëîðàìôåíèêîë 10 ìã - 1 ã}                                                                                                                                          

                                                                                                                                                                    

│ÈÑÄÍ [Èçîñîðáèä äèíèòðàò]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû ðåòàðä 20, 40, 60 ìã  │CT-Arzneimittel Chemishe      │005776,       

                                                                                                                        │Tempelchof GmbH (Ãåðìàíèÿ)    │24.02.95      

                                                                                                                                                                    

│Èñèïåí [Ïèïåðàöèëëèí]                             │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Krka (Ñëîâåíèÿ)               │002312,       

                                                  │[J01CA12]                               │èíúåêöèîííîãî ðàñòâîðà                                      │09.01.92      

                                                                                          │(ôëàêîíû) 1 ã, 2 ã                                                        

                                                                                                                                                                    

│Èòðîï [Èïðàòðîïèÿ áðîìèä]                         │ì-õîëèíîáëîêàòîð [A03AB]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Boehringer Ingelheim GmbH     │01862, 01.06.90│

                                                                                          │10 ìã; ðàñòâîð äëÿ èíúåêöèé   │(ÔÐÃ)                                       

                                                                                          │(àìïóëû) 0.5 ìã - 1 ìë                                                    

                                                                                                                                                                    

│Èôèçîë [Öåôàçîëèí]                                │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ðàñòâîð äëÿ èíúåêöèé          │Unique Pharmaceutical         │003811,       

                                                                                          │(ôëàêîíû) 250, 500, 1000 ìã   │Laboratories (Èíäèÿ)          │31.03.94      

                                                                                                                                                                    

│Èôèìîë [Ïàðàöåòàìîë]                              │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñèðîï (ôëàêîíû) 125 ìã|5 ìë - │Unique Pharmaceutical         │003491,       

                                                  │ñðåäñòâî [N02BE01]                      │600, 100 ìë                   │Laboratories (Èíäèÿ)          │04.11.93      

                                                                                                                                                                    

│Èôèðàë [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò      │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [S01GX01] │êàïëè íàçàëüíûå 2%; ðàñòâîð   │Unique Pharmaceutical         │003916,       

│äèíàòðèÿ}                                                                                 │îôòàëüìîëîãè÷åñêèé (ôëàêîíû)  │Laboratories (Èíäèÿ)          │17.05.94      

                                                                                          │2% - 5 ìë                                                                 

                                                                                                                                                                    

│Èôèðàë [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò      │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R03BC01] │ïîðîøîê äëÿ èíãàëÿöèé         │Unique Pharmaceutical         │007194,       

│äèíàòðèÿ}                                                                                 │(êàïñóëû) 20 ìã               │Laboratories (Èíäèÿ)          │22.05.96      

                                                                                                                                                                    

│Èôèöåô [Öåôòðèàêñîí]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA13]      │ëèîôèëèç.ïîðîøîê äëÿ          │Unique Pharmaceutical         │003810,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Laboratories (Èíäèÿ)          │31.03.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 250, 500,                                              

                                                                                          │1000 ìã                                                                    

                                                                                                                                                                    

│Èôèöèïðî [Öèïðîôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã; ðàñòâîð │Unique Pharmaceutical         │003722,       

                                                  │[J01MA02]                               │äëÿ èíôóçèé (ôëàêîíû) 200 ìã  │Laboratories (Èíäèÿ)          │24.02.94       

                                                                                          │- 100 ìë                                                                  

                                                                                                                                                                    

│Éåíàìàçîë [Êëîòðèìàçîë]                           │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC01]     │êðåì 1%                       │Jenapharm GmbH (Ãåðìàíèÿ)     │003554,       

                                                                                                                                                      │07.12.93      

                                                                                                                                                                    

│Éåíàìàçîë [Êëîòðèìàçîë]                           │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC01]     │êðåì 2%                       │Jenapharm GmbH (Ãåðìàíèÿ)     │003555,       

                                                                                                                                                      │07.12.93      

                                                                                                                                                                    

│Éåíàìàçîë 100 [Êëîòðèìàçîë]                       │ïðîòèâîãðèáêîâîå ñðåäñòâî [G01AF02]     │òàáëåòêè âàãèíàëüíûå          │Jenapharm GmbH (Ãåðìàíèÿ)     │003557,       

                                                                                                                                                      │07.12.93      

                                                                                                                                                                    

│Éåíàìàçîë 200 [Êëîòðèìàçîë]                       │ïðîòèâîãðèáêîâîå ñðåäñòâî [G01AF02]     │òàáëåòêè âàãèíàëüíûå          │Jenapharm GmbH (Ãåðìàíèÿ)     │003556,       

                                                                                                                                                      │07.12.93      

                                                                                                                                                                    

│Éåíàìåòèäèí [Öèìåòèäèí]                           │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200, 400, 800 ìã     │Jenapharm GmbH (Ãåðìàíèÿ)     │005060,       

                                                  │[A02BA01]                                                                                           │30.06.94      

                                                                                                                                                                    

│Éåíîêñèôåí 10 [Òàìîêñèôåí]                        │àíòèýñòðîãåí [L02BA01]                  │òàáëåòêè 10 ìã                │Jenapharm GmbH (Ãåðìàíèÿ)     │006761,       

                                                                                                                                                      │31.10.95      

                                                                                                                                                                    

│Éåíîêñèôåí 20 [Òàìîêñèôåí]                        │àíòèýñòðîãåí [L02BA01]                  │òàáëåòêè 20 ìã                │Jenapharm GmbH (Ãåðìàíèÿ)     │006762,       

                                                                                                                                                      │31.10.95      

                                                                                                                                                                    

│Éåíîêñèôåí 30 [Òàìîêñèôåí]                        │àíòèýñòðîãåí [L02BA01]                  │òàáëåòêè 30 ìã                │Jenapharm GmbH (Ãåðìàíèÿ)     │006763,       

                                                                                                                                                      │31.10.95      

                                                                                                                                                                    

│Éîäèä 100 [Êàëèÿ éîäèä]                           │ïðåïàðàò éîäà, ðåãóëÿòîð ñèíòåçà        │òàáëåòêè 100 ìêã              │E.Merck (Ãåðìàíèÿ)            │005409,       

                                                  │òèðîêñèíà [R05CA02]                                                                                 │19.10.94      

                                                                                                                                                                    

│Éîäèä 200 [Êàëèÿ éîäèä]                           │ïðåïàðàò éîäà, ðåãóëÿòîð ñèíòåçà        │òàáëåòêè 200 ìêã              │E.Merck (Ãåðìàíèÿ)            │005409,       

                                                  │òèðîêñèíà [R05CA02]                                                                                 │19.10.94      

                                                                                                                                                                    

│Éîäòèðîêñ {ëåâîòèðîêñèí 100 ìêã, êàëèÿ éîäèä      │òèðåîèäíîå ñðåäñòâî [H03AA02]           │òàáëåòêè 100 ìêã/130.8 ìêã    │E.Merck (Ãåðìàíèÿ)            │005591,       

│130.8 ìêã}                                                                                                                                            │21.12.94      

                                                                                                                                                                    

│Éîíîñòåðèë {íàòðèé 3.151 ã, êàëèé 156 ìã, êàëüöèé │ðåãèäðàòèðóþùåå ñðåäñòâî [B05BB]        │ðàñòâîð äëÿ èíôóçèé           │Fresenius (ÔÐÃ)               │002539,       

│66 ìã, ìàãíèé 30 ìã, õëîð 3.9 ã, àöåòàòû 2.173 ã                                                                                                      │02.07.92      

│- 1 ë}                                                                                                                                                              

                                                                                                                                                                    

│Ê-Ëàéò [Êàëèÿ õëîðèä]                             │ïðåïàðàò êàëèÿ [A12BA01]                │òàáëåòêè øèïó÷èå ëèìîííûå 25, │Bristol-Myers Squibb (ÑØÀ)    │006946,       

                                                                                          │50 ìýêâ; òàáëåòêè øèïó÷èå                                   │26.12.95      

                                                                                          │àïåëüñèíîâûå 25, 50 ìýêâ                                                  

                                                                                                                                                                    

│Êàáèêèíàçà [Ñòðåïòîêèíàçà]                        │ôèáðèíîëèòè÷åñêîå ñðåäñòâî [B01AD01]    │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pharmacia (Øâåöèÿ)            │006210,       

                                                                                          │èíôóçèîííîãî ðàñòâîðà                                       │21.06.95      

                                                                                          │(ôëàêîíû) 250000 ÌÅ                                                       

                                                                                                                                                                    

│Êàáèêèíàçà [Ñòðåïòîêèíàçà]                        │ôèáðèíîëèòè÷åñêîå ñðåäñòâî [B01AD01]    │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Kabi Pharmacia (Øâåöèÿ)       │002708,       

                                                                                          │èíôóçèîííîãî ðàñòâîðà                                       │24.11.92      

                                                                                          │(ôëàêîíû) 1500000 ÌÅ                                                      

                                                                                                                                                                    

│Êàâåðäæåêò [Àëïðîñòàäèë]                          │âàçîäèëàòèðóþùåå ñðåäñòâî [C01EA01]     │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Upjohn (Áåëüãèÿ)              │005834,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │16.03.95      

                                                                                          │(ôëàêîíû) 20 ìêã /â êîìïëåêòå │                                            

                                                                                          │ñ ðàñòâîðèòåëåì/                                                           

                                                                                                                                                                    

│Êàâåðäæåêò [Àëïðîñòàäèë]                          │âàçîäèëàòèðóþùåå ñðåäñòâî [C01EA01]     │ïîðîøîê ñòåðèëüíûé (ôëàêîíû)  │N.V.Upjohn SA (Áåëüãèÿ)       │007095,       

                                                                                          │10, 20 ìêã /â êîìïëåêòå ñ                                   │19.02.96       

                                                                                          │øïðèöîì îäíîðàçîâûì ñ                                                     

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                     

│Êàâåðèë [Âåðàïàìèë]                               │ÁÌÊÊ [C08DA01]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Remedica Ltd - Minnex (Êèïð)  │006817,       

                                                                                          │40, 80 ìã                                                   │10.11.95      

                                                                                                                                                                     

│Êàâèçèä [Ïèðàçèíàìèä]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 500 ìã               │Tata Pharma (Èíäèÿ)           │002699,       

                                                                                                                                                      │02.12.92      

                                                                                                                                                                    

│Êàâèíòîí [Âèíïîöåòèí] {áàðâèíêà ìàëîãî àëêàëîèä}  │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AX]       │òàáëåòêè 5 ìã; ðàñòâîð äëÿ    │Gedeon Richter (Âåíãðèÿ)      │2602,         

                                                                                          │èíúåêöèé (àìïóëû) 10 ìã - 2 ìë│                              │12.04.90,     

                                                                                                                                                      │18.06.79      

                                                                                                                                                                    

│Êàâèíòîí [Âèíïîöåòèí] {áàðâèíêà ìàëîãî àëêàëîèä}  │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AX]       │òàáëåòêè 5 ìã                 │Themis Chemicals Ltd (Èíäèÿ)  │003871,       

                                                                                                                                                      │26.04.94      

                                                                                                                                                                    

│Êàëãåëü {ëèäîêàèí 0.33%, öåòèëïèðèäèíèé 0.1%}     │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [A01AD11] │ãåëü çóáíîé (òóáû)            │Wellcome Foundation Ltd       │005670,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │23.01.95      

                                                                                                                                                                    

│Êàëäîïà [Ëåâîäîïà]                                │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè 250, 500 ìã          │Cadila Laboratories Ltd       │002463,       

                                                  │[N04BA01]                                                             │(Èíäèÿ)                       │27.04.92      

                                                                                                                                                                    

│Êàëèé ïåíèñòûé {êàëèÿ öèòðàò, êàëèÿ ãèäðîêàðáîíàò}│ïðåïàðàò êàëèÿ [A12BA30]                │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Zdravle (Þãîñëàâèÿ)           │007067,       

                                                                                          │îðàëüíîãî ðàñòâîðà (ïàêåòèêè) │                              │08.02.96      

                                                                                                                                                                    

│Êàëèé-íîðìèí [Êàëèÿ õëîðèä]                       │ïðåïàðàò êàëèÿ [A12BA01]                │òàáëåòêè                      │Alkaloida (Âåíãðèÿ)           │2954, 25.10.89 │

                                                                                                                                                                    

│Êàëèìèí ôîðòå [Ïèðèäîñòèãìèí áðîìèä]              │àíòèõîëèíýñòåðàçíîå ñðåäñòâî [N07AA02]  │äðàæå 60 ìã                   │Arzneimittelwerk Dresden Feb  │00190,        

                                                                                                                        │(ÃÄÐ)                         │18.05.84,     

                                                                                                                                                      │24.02.72      

                                                                                                                                                                    

│Êàëèìèí ôîðòå [Ïèðèäîñòèãìèí áðîìèä]              │àíòèõîëèíýñòåðàçíîå ñðåäñòâî [N07AA02]  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Arzneimittelwerk Dresden GmbH │006593,       

                                                                                          │5 ìã/ìë                       │(Ãåðìàíèÿ)                    │02.11.95      

                                                                                                                                                                    

│Êàëèíîð {êàëèÿ öèòðàò, êàëèÿ ãèäðîêàðáîíàò,       │ïðåïàðàò êàëèÿ [A12BA30]                │òàáëåòêè øèïó÷èå              │Knoll AG (Ãåðìàíèÿ)           │006788,       

│ëèìîííàÿ êèñëîòà - 40 ììîëü êàëèÿ}                                                                                                                    │02.11.95      

                                                                                                                                                                    

│Êàëèïîç ïðîëîíãàòóì [Êàëèÿ õëîðèä]                │ïðåïàðàò êàëèÿ [A12BA01]                │òàáëåòêè ïðîëîíãèðîâàííîãî    │Polfa, Poznanskie Zaklady     │006384,       

                                                                                          │äåéñòâèÿ 750 ìã               │Farmaceutyczne SA (Ïîëüøà)    │09.08.95      

                                                                                                                                                                    

│Êàëèïñîë [Êåòàìèí]                                │íàðêîòè÷åñêîå íåèíãàëÿöèîííîå ñðåäñòâî  │ðàñòâîð äëÿ èíúåêöèé          │Gedeon Richter (Âåíãðèÿ)      │2691,         

                                                  │[N01AX03]                               │(ôëàêîíû) 10 ìë                                             │01.12.94,     

                                                                                                                                                      │26.02.82      

                                                                                                                                                                    

│Êàëèÿ îðîòàò [Îðîòîâàÿ êèñëîòà]                   │ãåïàòîïðîòåêòîð [A05BA]                 │òàáëåòêè 500 ìã               │Natur Product (Ôðàíöèÿ)       │007015,       

                                                                                                                                                      │26.01.96      

                                                                                                                                                                    

│Êàëèÿ-ìàãíèÿ-àñïàðàãèíàò [Êàëèÿ, ìàãíèÿ           │ïðåïàðàò êàëèÿ è ìàãíèÿ [A12BA51]       │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Berlin-Chemie AG (ÔÐÃ)        │00645,        

│àñïàðàãèíàò] {àñïàðàãèíîâàÿ êèñëîòà 1.516 ã,                                              │500 ìë                                                      │08.04.94,     

│êàëèÿ ãèäðîêñèä 0.39 ã, ìàãíèÿ îêñèä 111.6 ìã,                                                                                                        │17.05.89,     

│ñîðáèòîë 2 ã - 100 ìë}                                                                                                                                │25.12.78      

                                                                                                                                                                    

│Êàëìåçå [Ëîðàçåïàì]                               │òðàíêâèëèçàòîð [N05BA06]                │òàáëåòêè 1 ìã, 2 ìã           │Themis Chemicals Ltd (Èíäèÿ)  │002206,       

                                                                                                                                                      │31.07.91      

                                                                                                                                                                     

│Êàëìîïèðîë [Ïèðîêñèêàì]                           │ÍÏÂÑ [M02AA07]                          │êàïñóëû 20 ìã                 │Faran Laboratories SA (Ãðåöèÿ)│003665,       

                                                                                                                                                      │01.02.94      

                                                                                                                                                                     

│Êàëìïîóç [Äèàçåïàì]                               │òðàíêâèëèçàòîð [N05BA01]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ranbaxy Laboratories Ltd      │005241,       

                                                                                          │10 ìã - 2 ìë                  │(Èíäèÿ)                       │19.08.94      

                                                                                                                                                                     

│Êàëïîë [Ïàðàöåòàìîë]                              │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñóñïåíçèÿ îðàëüíàÿ äëÿ äåòåé  │Wellcome Foundation Ltd       │002465,       

                                                  │ñðåäñòâî [N02BE01]                      │120 ìã|5 ìë                   │(Âåëèêîáðèòàíèÿ)              │27.04.92      

                                                                                                                                                                     

│Êàëïîë 6 ïëþñ [Ïàðàöåòàìîë]                       │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñóñïåíçèÿ îðàëüíàÿ 250 ìã|5 ìë│Wellcome Foundation Ltd       │002466,       

                                                  │ñðåäñòâî [N02BE01]                                                    │(Âåëèêîáðèòàíèÿ)              │27.04.92      

                                                                                                                                                                    

│Êàëüïèðåí [Ýíàëàïðèë]                             │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 5, 10, 20 ìã         │Medochemie Ltd (Êèïð)         │003009,       

                                                                                                                                                      │28.05.93      

                                                                                                                                                                    

│Êàëüöèãàðä [Íèôåäèïèí]                            │ÁÌÊÊ [C08CA05]                          │êàïñóëû 5, 10 ìã; òàáëåòêè    │Torrent Exports Ltd (Èíäèÿ)   │01975, 03.10.90│

                                                                                          │ðåòàðä 20 ìã                                                              

                                                                                                                                                                    

│Êàëüöèé Ñ {àñêîðáèíîâàÿ êèñëîòà 0.5 ã, êàëüöèÿ    │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │òàáëåòêè øèïó÷èå              │Slovakofarma SA (Ñëîâàêèÿ)    │005900,       

│ëàêòàò-ãëóöåïòàò 0.5 ã, êàëüöèÿ êàðáîíàò 165.6 ìã}│[A11GB01]                                                                                           │04.04.95      

                                                                                                                                                                    

│Êàëüöèé-Ä3 Íèêîìåä {êàëüöèÿ êàðáîíàò 1250 ìã,     │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │òàáëåòêè æåâàòåëüíûå          │Nycomed Pharma AG (Íîðâåãèÿ)  │007620,       

│ýðãîêàëüöèôåðîë 200 ÌÅ}                           │[A12AX]                                                                                             │05.07.96      

                                                                                                                                                                    

│Êàëüöèé-Ñ 1000 Ñàíäîç {êàëüöèÿ ëàêòàò 1 ã,        │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │òàáëåòêè øèïó÷èå              │Sandoz Pharma (Øâåéöàðèÿ)     │005960,       

│êàëüöèÿ ãëþêîíàò 1 ã, êàëüöèÿ êàðáîíàò 327 ìã,    │[A11GB01]                                                                                           │13.04.95      

│àñêîðáèíîâàÿ êèñëîòà 1 ã, íàòðèÿ ãèäðîêàðáîíàò 1                                                                                                                    

│ã, äåêñòðîçà 2 ã}                                                                                                                                                   

                                                                                                                                                                    

│Êàëüöèé-Ñàíäîç [Êàëüöèÿ ãëþêîíàò]                 │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Sandoz (india) Ltd (Èíäèÿ)    │005538,       

                                                  │[A12AA03]                               │øèïó÷èå 500 ìã; ñèðîï îðàëüíûé│                              │05.12.94      

                                                                                                                                                                    

│Êàëüöèé-Ñàíäîç [Êàëüöèÿ ãëþêîíàò]                 │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Sandoz (india) Ltd (Èíäèÿ)    │006749,       

                                                  │[A12AA03]                               │10%                                                         │24.10.95      

                                                                                                                                                                    

│Êàëüöèé-Ñàíäîç ôîðòå [Êàëüöèÿ ãëþêîíàò]           │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │òàáëåòêè øèïó÷èå              │Sandoz Pharma (Øâåéöàðèÿ)     │006199,       

                                                  │[A12AA03]                                                                                           │20.06.95      

                                                                                                                                                                    

│Êàëüöèïàðèí [Ãåïàðèí]                             │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Laboratoires Choay (Ôðàíöèÿ)  │00769, 30.05.80│

                                                                                          │5000 ÌÅ/0.2 ìë, 12500 ÌÅ/0.5                                              

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Êàëüöèóìôîëèíàò-Ýáåâå [Êàëüöèÿ ôîëèíàò]           │âèòàìèí [V03AF03]                       │êàïñóëû 15 ìã; ðàñòâîð äëÿ    │Ebewe Arzneimittel GmbH       │006634,       

                                                                                          │èíúåêöèé 3 ìã/1 ìë, 30 ìã/3   │(Àâñòðèÿ)                     │31.01.96      

                                                                                          │ìë, 100 ìã/10 ìë                                                          

                                                                                                                                                                    

│Êàëüöèÿ ãëþêîíàò [Êàëüöèÿ ãëþêîíàò]               │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │òàáëåòêè 500 ìã               │Natur Product (Ôðàíöèÿ)       │007418,       

                                                  │[A12AA03]                                                                                           │05.04.96      

                                                                                                                                                                    

│Êàëüöèÿ ôîëèíàò [Êàëüöèÿ ôîëèíàò]                 │âèòàìèí [V03AF03]                       │êàïñóëû 100 ìã; ðàñòâîð äëÿ   │Ebewe Arzneimittel GmbH       │003070,       

                                                                                          │èíúåêöèé (àìïóëû) 200 ìã - 10 │(Àâñòðèÿ)                     │17.06.93      

                                                                                          │ìë; ðàñòâîð äëÿ èíúåêöèé                                                  

                                                                                          │(ôëàêîíû) 300 ìã - 20 ìë                                                  

                                                                                                                                                                    

│Êàìåçîë [Ìåòðîíèäàçîë]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 200 ìã               │Cadila Laboratories Ltd       │003395,       

                                                                                                                        │(Èíäèÿ)                       │08.10.93      

                                                                                                                                                                    

│Êàìïèöèëèí [Àìïèöèëëèí]                           │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │êàïñóëû 250, 500 ìã; ïîðîøîê  │Cadila Laboratories Ltd       │00914,         

                                                  │[J01CA01]                               │(ôëàêîíû) 500 ìã              │(Èíäèÿ)                       │24.05.84,     

                                                                                                                                                      │24.10.94      

                                                                                                                                                                     

│Êàíäèáåíå [Êëîòðèìàçîë]                           │ïðîòèâîãðèáêîâîå ñðåäñòâî               │òàáëåòêè âàãèíàëüíûå 100, 200 │Ludwig Merckle GmbH (Àâñòðèÿ) │003329,       

                                                  │[D01AC01][G01AF02]                      │ìã; êðåì 1%; ðàñòâîð äëÿ                                    │13.09.93      

                                                                                          │íàðóæíîãî ïðèìåíåíèÿ 1%                                                    

                                                                                                                                                                    

│Êàíäèä {êëîòðèìàçîë 1%, áåêëîìåòàçîí 0.025%}      │ïðîòèâîãðèáêîâîå ñðåäñòâî [D07BC]       │êðåì 1%                       │Glenmark Pharmaceuticals Ltd  │006264,       

                                                                                                                        │(Èíäèÿ)                       │11.07.95      

                                                                                                                                                                    

│Êàíäèä [Êëîòðèìàçîë]                              │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC01]     │êðåì 1%; ëîñüîí 1%            │Glenmark Pharmaceuticals Ltd  │002915,       

                                                                                                                        │(Èíäèÿ)                       │29.03.93      

                                                                                                                                                                    

│Êàíäèä-B3 [Êëîòðèìàçîë]                           │ïðîòèâîãðèáêîâîå ñðåäñòâî [G01AF02]     │òàáëåòêè âàãèíàëüíûå 200 ìã   │Glenmark Pharmaceuticals Ltd  │005898,       

                                                                                                                        │(Èíäèÿ)                       │15.03.95      

                                                                                                                                                                    

│Êàíäèä-Â1 [Êëîòðèìàçîë]                           │ïðîòèâîãðèáêîâîå ñðåäñòâî [G01AF02]     │òàáëåòêè âàãèíàëüíûå 500 ìã   │Glenmark Pharmaceuticals Ltd  │005823,       

                                                                                                                        │(Èíäèÿ)                       │15.03.95      

                                                                                                                                                                    

│Êàíäèä-Â6 [Êëîòðèìàçîë]                           │ïðîòèâîãðèáêîâîå ñðåäñòâî [G01AF02]     │òàáëåòêè âàãèíàëüíûå 100 ìã   │Glenmark Pharmaceuticals Ltd  │005899,       

                                                                                                                        │(Èíäèÿ)                       │15.03.95      

                                                                                                                                                                    

│Êàíåñòåí [Êëîòðèìàçîë]                            │ïðîòèâîãðèáêîâîå ñðåäñòâî               │ðàñòâîð 1%; êðåì 1%; òàáëåòêè │Bayer AG (Ãåðìàíèÿ)           │00425,        

                                                  │[D01AC01][G01AF02]                      │âàãèíàëüíûå                                                 │24.12.76,     

                                                                                                                                                      │29.06.88      

                                                                                                                                                                    

│Êàíåñòåí [Êëîòðèìàçîë]                            │ïðîòèâîãðèáêîâîå ñðåäñòâî               │òàáëåòêè âàãèíàëüíûå;         │Egis (ÂÍÐ)                    │2568,         

                                                  │[D01AC01][G01AF02]                      │ðàñòâîð; ìàçü                                               │05.07.78,     

                                                                                                                                                      │18.08.89      

                                                                                                                                                                    

│Êàîïåêòàò [Àòòàïóëãèò] {àëþìèíèÿ ñèëèêàò, ìàãíèÿ  │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07BC04]     │òàáëåòêè 750 ìã               │Upjohn (ÑØÀ)                  │003282,       

│ñèëèêàò}                                                                                                                                              │30.08.93      

                                                                                                                                                                    

│Êàîïåêòàò Àòòàïóëüãèò [Àòòàïóëãèò] {àëþìèíèÿ      │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07BC04]     │ñóñïåíçèÿ îðàëüíàÿ 600 ìã -   │Upjohn (ÑØÀ)                  │003410,       

│ñèëèêàò, ìàãíèÿ ñèëèêàò}                                                                  │15 ìë                                                       │12.10.93      

                                                                                                                                                                    

│ÊÀÏÄ 2 {íàòðèé, êàëüöèé, ìàãíèé, õëîð, ìîëî÷íàÿ   │ðàñòâîð äëÿ ïåðèòîíåàëüíîãî äèàëèçà     │ðàñòâîð                       │Inex Hemofarm (Þãîñëàâèÿ)     │01529, 12.12.88│

│êèñëîòà, ãëþêîçà 1.5%; îñìîëÿðíîñòü 358}          │[B05D]                                                                                                            

                                                                                                                                                                    

│ÊÀÏÄ 2Ê {íàòðèé, êàëüöèé, ìàãíèé, õëîð, ìîëî÷íàÿ  │ðàñòâîð äëÿ ïåðèòîíåàëüíîãî äèàëèçà     │ðàñòâîð                       │Fresenius (ÔÐÃ)               │01310, 11.11.86│

│êèñëîòà, ãëþêîçà 1.5%; îñìîëÿðíîñòü 362}          │[B05D]                                                                                                            

                                                                                                                                                                    

│ÊÀÏÄ 2Ê {íàòðèé, êàëüöèé, ìàãíèé, õëîð, ìîëî÷íàÿ  │ðàñòâîð äëÿ ïåðèòîíåàëüíîãî äèàëèçà     │ðàñòâîð                       │Inex Hemofarm (Þãîñëàâèÿ)     │01528, 12.12.88│

│êèñëîòà, ãëþêîçà 1.5%; îñìîëÿðíîñòü 362}          │[B05D]                                                                                                            

                                                                                                                                                                    

│ÊÀÏÄ 3 {íàòðèé, êàëüöèé, ìàãíèé, õëîð, ìîëî÷íàÿ   │ðàñòâîð äëÿ ïåðèòîíåàëüíîãî äèàëèçà     │ðàñòâîð                       │Inex Hemofarm (Þãîñëàâèÿ)     │01527, 12.12.88│

│êèñëîòà, êàëèé, ãëþêîçà 4.25%; îñìîëÿðíîñòü 511}  │[B05D]                                                                                                            

                                                                                                                                                                    

│ÊÀÏÄ 3Ê {íàòðèé, êàëüöèé, ìàãíèé, õëîð, ìîëî÷íàÿ  │ðàñòâîð äëÿ ïåðèòîíåàëüíîãî äèàëèçà     │ðàñòâîð                       │Fresenius (ÔÐÃ)               │01310, 11.11.86│

│êèñëîòà, ãëþêîçà 4.25%; îñìîëÿðíîñòü 511}         │[B05D]                                                                                                            

                                                                                                                                                                    

│ÊÀÏÄ 3Ê {íàòðèé, êàëüöèé, ìàãíèé, õëîð, ìîëî÷íàÿ  │ðàñòâîð äëÿ ïåðèòîíåàëüíîãî äèàëèçà     │ðàñòâîð                       │Inex Hemofarm (Þãîñëàâèÿ)     │01526, 12.12.88│

│êèñëîòà, êàëèé, ãëþêîçà 4.25%; îñìîëÿðíîñòü 511}  │[B05D]                                                                                                            

                                                                                                                                                                    

│ÊÀÏÄ 4 {íàòðèé, êàëüöèé, ìàãíèé, õëîð, ìîëî÷íàÿ   │ðàñòâîð äëÿ ïåðèòîíåàëüíîãî äèàëèçà     │ðàñòâîð                       │Inex Hemofarm (Þãîñëàâèÿ)     │01525, 12.12.88│

│êèñëîòà, ãëþêîçà 2.3%; îñìîëÿðíîñòü 401}          │[B05D]                                                                                                            

                                                                                                                                                                    

│ÊÀÏÄ 4Ê {íàòðèé, êàëüöèé, ìàãíèé, õëîð, ìîëî÷íàÿ  │ðàñòâîð äëÿ ïåðèòîíåàëüíîãî äèàëèçà     │ðàñòâîð                       │Inex Hemofarm (Þãîñëàâèÿ)     │01524, 12.12.88│

│êèñëîòà, ãëþêîçà 2.3%; îñìîëÿðíîñòü 405}          │[B05D]                                                                                                            

                                                                                                                                                                    

│Êàïåêò [Àòòàïóëãèò] {àëþìèíèÿ ñèëèêàò, ìàãíèÿ     │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07BC04]     │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Eipico (Åãèïåò)               │003257,        

│ñèëèêàò}                                                                                  │120 ìë                                                      │23.08.93      

                                                                                                                                                                    

│Êàïëè Áðîíõîâåðí [Àìáðîêñîë]                      │îòõàðêèâàþùåå ñðåäñòâî [R05CB06]        │êàïëè äëÿ ïðèåìà âíóòðü       │Pharma Wernigerode GmbH       │006963,       

                                                                                          │(ôëàêîíû)                     │(Ãåðìàíèÿ)                    │09.01.96      

                                                                                                                                                                    

│Êàïîçèä {êàïòîïðèë 12.5 ìã, ãèäðîõëîðîòèàçèä 12.5 │ãèïîòåíçèâíîå êîìáèíèðîâàííîå ñðåäñòâî  │òàáëåòêè 25, 50 ìã            │Bristol-Myers Squibb (ÑØÀ)    │003362,       

│ìã; êàïòîïðèë 25 ìã, ãèäðîõëîðîòèàçèä 25 ìã}      │[C09BA01]                                                                                           │27.09.93      

                                                                                                                                                                    

│Êàïîêàðä [Êàïòîïðèë]                              │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 25, 50 ìã            │Dar Al Dava (Èîðäàíèÿ)        │003357,       

                                                                                                                                                      │21.09.93      

                                                                                                                                                                    

│Êàïîòåí [Êàïòîïðèë]                               │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 12.5 ìã              │Bristol-Myers Squibb (ÑØÀ)    │002459,       

                                                                                                                                                      │24.04.92      

                                                                                                                                                                    

│Êàïîòåí [Êàïòîïðèë]                               │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 25, 50 ìã            │F.Bristol-Myers Squibb, A     │006885,       

                                                                                                                        │Division Of Squibb Industria  │13.12.95      

                                                                                                                        │Farmaceutica SA (Èñïàíèÿ)                   

                                                                                                                                                                    

│Êàïîòåí [Êàïòîïðèë]                               │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 25, 50 ìã            │Squibb (Âåëèêîáðèòàíèÿ)       │01124, 20.12.84│

                                                                                                                                                                    

│Êàïîòåí [Êàïòîïðèë]                               │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 25, 50 ìã            │Fako Ilaclary AS (Òóðöèÿ)     │002158,       

                                                                                                                                                      │17.06.91      

                                                                                                                                                                    

│Êàïîòåí [Êàïòîïðèë]                               │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 25, 50 ìã            │Zorka (Þãîñëàâèÿ)             │01371, 31.08.87│

                                                                                                                                                                    

│Êàïðèë [Êàïòîïðèë]                                │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 12.5, 25, 50 ìã      │Boryung Pharmaceutical Co Ltd │002779,       

                                                                                                                        │(Êîðåÿ Þæíàÿ)                 │29.12.92      

                                                                                                                                                                    

│Êàïðèë [Êàïòîïðèë]                                │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 25, 50 ìã            │Mustafa Nevzat Ilac Sanayi AS │002444,       

                                                                                                                        │(Òóðöèÿ)                      │03.04.92      

                                                                                                                                                                    

│Êàïñèêàì {êàìôîðà 3 ã, áåíçèëíèêîòèíàò 2 ã,       │ìåñòíîðàçäðàæàþùåå ñðåäñòâî [M02AX]     │ìàçü (òóáû)                   │Òàëëèííñêèé Ôàðìàöåâòè÷åñêèé  │007129,       

│òåðïåíòèíîâîå ìàñëî, âàíèëèíîàìèä}                                                                                      │Çàâîä (Ýñòîíèÿ)               │05.03.96      

                                                                                                                                                                    

│Êàïòîïðèë [Êàïòîïðèë]                             │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 12.5, 25, 50 ìã      │Krka (Ñëîâåíèÿ)               │006349,       

                                                                                                                                                      │07.08.95      

                                                                                                                                                                    

│Êàðáàäàê [Êàðáàìàçåïèí]                           │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AF01]    │òàáëåòêè 200 ìã               │Cadila Laboratories Ltd       │003698,       

                                                                                                                        │(Èíäèÿ)                       │15.02.94      

                                                                                                                                                                    

│Êàðáàìàçåïèí [Êàðáàìàçåïèí]                       │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AF01]    │òàáëåòêè 100, 200 ìã          │Nycomed Dak AS (Äàíèÿ)        │002925,       

                                                                                                                                                      │29.03.93      

                                                                                                                                                                    

│Êàðáàìàçåïèí-Òåâà [Êàðáàìàçåïèí]                  │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AF01]    │òàáëåòêè 200 ìã               │Teva Pharmaceutical           │003174,       

                                                                                                                        │Industries Ltd (Èçðàèëü)      │02.08.93      

                                                                                                                                                                    

│Êàðáàïèí [Êàðáàìàçåïèí]                           │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AF01]    │òàáëåòêè 200 ìã               │Hemofarm D.D. (Þãîñëàâèÿ)     │003794,       

                                                                                                                                                      │29.03.94      

                                                                                                                                                                    

│Êàðáàñàí [Êàðáàìàçåïèí]                           │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AF01]    │òàáëåòêè 200 ìã               │Sanofi-Winthrop (Ãåðìàíèÿ)    │006249,       

                                                                                                                                                      │06.07.95      

                                                                                                                                                                    

│Êàðáàñàí ðåòàðä [Êàðáàìàçåïèí]                    │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AF01]    │òàáëåòêè 400 ìã               │Sanofi-Winthrop (Ãåðìàíèÿ)    │006248,       

                                                                                                                                                      │06.07.95      

                                                                                                                                                                     

│Êàðáàòîë [Êàðáàìàçåïèí]                           │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AF01]    │òàáëåòêè 200 ìã               │Dar Al Dava (Èîðäàíèÿ)        │002586,       

                                                                                                                                                      │30.07.92      

                                                                                                                                                                     

│Êàðáàòîë [Êàðáàìàçåïèí]                           │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AF01]    │òàáëåòêè 100, 200, 400 ìã     │Torrent Exports Ltd (Èíäèÿ)   │002761,       

                                                                                                                                                      │17.12.92      

                                                                                                                                                                     

│Êàðáàõîë [Êàðáàõîë]                               │ì-õîëèíîìèìåòèê [S01EB02]               │êàïëè ãëàçíûå 3%              │Polfa, Warszawskie Zaklady    │2648,         

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │07.07.95,     

                                                                                                                                                      │08.12.80      

                                                                                                                                                                    

│Êàðáèäîïà è Ëåâîäîïà - Òåâà [Ëåâîäîïà+êàðáèäîïà]  │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè                      │Teva Pharmaceutical           │007541,       

│{êàðáèäîïà 10 ìã, ëåâîäîïà 100 ìã; êàðáèäîïà 25   │[N04BA02]                                                             │Industries Ltd (Èçðàèëü)      │27.05.96      

│ìã, ëåâîäîïà 100 ìã; êàðáèäîïà 25 ìã, ëåâîäîïà                                                                                                                      

│250 ìã}                                                                                                                                                             

                                                                                                                                                                    

│Êàðáî ìåäèöèíàëèñ [Àêòèâèðîâàííûé óãîëü]          │ýíòåðîñîðáèðóþùåå ñðåäñòâî [A07BA01]    │òàáëåòêè; êàïñóëû             │Paul Hauser Chepharin         │002790,       

                                                                                                                        │(Àâñòðèÿ)                     │12.01.93      

                                                                                                                                                                    

│Êàðáîëîíã [Àêòèâèðîâàííûé óãîëü]                  │ýíòåðîñîðáèðóþùåå ñðåäñòâî [A07BA01]    │ïîðîøîê (ïàêåòû) 5, 10, 100,  │(Óêðàèíà)                     │92/210/11     

                                                                                          │150 ã; ïîðîøîê (ïàêåòû) 3, 4, │                                            

                                                                                          │5 êã                                                                      

                                                                                                                                                                    

│Êàðáîïëàòèí [Êàðáîïëàòèí]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA02]      │ðàñòâîð äëÿ èíúåêöèé          │Delta West (Àâñòðàëèÿ)        │006244,       

                                                                                          │(ôëàêîíû) 10 ìã/ìë                                          │04.07.95      

                                                                                                                                                                    

│Êàðáîïëàòèí-Òåâà [Êàðáîïëàòèí]                    │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA02]      │ëèîôèëèç.ïîðîøîê äëÿ          │Teva Pharmaceutical           │005865,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Industries Ltd (Èçðàèëü)      │27.03.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 50, 150,                                               

                                                                                          │450 ìã                                                                    

                                                                                                                                                                    

│Êàðáîöèñòåèí [Êàðáîöèñòåèí]                       │îòõàðêèâàþùåå ñðåäñòâî [R05CB03]        │êàïñóëû 375 ìã; ñèðîï äëÿ     │ICN-Galenika (Þãîñëàâèÿ)      │007590,       

                                                                                          │äåòåé (ôëàêîíû) 125 ìã|5 ìë - │                              │19.06.96      

                                                                                          │200 ìë; ñèðîï (ôëàêîíû) 250                                               

                                                                                          │ìã|5 ìë - 200 ìë                                                          

                                                                                                                                                                    

│Êàðäèêåò [Èçîñîðáèä äèíèòðàò]                     │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │òàáëåòêè ðåòàðä 20, 40, 60 ìã │Schwarz Pharma AG (ÔÐÃ)       │02021, 03.12.90│

                                                                                                                                                                    

│Êàðäèêåò [Èçîñîðáèä äèíèòðàò]                     │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû ðåòàðä 120 ìã         │Schwarz Pharma AG (ÔÐÃ)       │002174,       

                                                                                                                                                      │13.12.93      

                                                                                                                                                                    

│Êàðäèêñ [Èçîñîðáèä äèíèòðàò]                      │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû äëèòåëüíîãî           │Yamanouchi Europe B.V.        │006452,       

                                                                                          │âûñâîáîæäåíèÿ 20, 40 ìã       │(Íèäåðëàíäû)                  │30.08.95      

                                                                                                                                                                    

│Êàðäèêýï [Èçîñîðáèä äèíèòðàò]                     │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû 20, 40 ìã             │Natco Pharma Ltd (Èíäèÿ)      │003074,       

                                                                                                                                                      │23.06.93      

                                                                                                                                                                    

│Êàðäèë [Äèëòèàçåì]                                │ÁÌÊÊ [C08DB01]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Orion Pharmaceutica           │01812, 19.04.90│

                                                                                          │120 ìã                        │(Ôèíëÿíäèÿ)                                 

                                                                                                                                                                    

│Êàðäèë (Äèëçåì) [Äèëòèàçåì]                       │ÁÌÊÊ [C08DB01]                          │òàáëåòêè 60 ìã                │Orion Pharmaceutica           │01508, 26.10.88│

                                                                                                                        │(Ôèíëÿíäèÿ)                                 

                                                                                                                                                                    

│Êàðäèîãàðä ÑÐ [Èçîñîðáèä äèíèòðàò]                │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │êàïñóëû 20 ìã                 │Amoun Pharmaceutical          │003262,       

                                                                                                                        │Industries Co, Apic (Åãèïåò)  │24.08.93      

                                                                                                                                                                    

│Êàðäèîêñàí [Äåêñðàçîêñàí]                         │ïðîôèëàêòèêà êàðäèîòîêñè÷íîñòè ïðè      │ëèîôèëèç.ïîðîøîê äëÿ          │Eurocetus (Íèäåðëàíäû)        │002995,       

                                                  │îíêîõèìèîòåðàïèè [V03AB]                │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                  │26.05.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 500 ìã /â                                               

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Êàðäîíèò [Èçîñîðáèä äèíèòðàò]                     │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │òàáëåòêè 40, 60, 80 ìã        │Polfa, Warszawskie Zaklady    │003843,        

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │08.04.94      

                                                                                                                                                                    

│Êàðäîïðèë [Êàïòîïðèë]                             │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 25, 50 ìã            │Beximco Pharmaceuticals Ltd   │005114,       

                                                                                                                        │(Áàíãëàäåø)                   │11.07.94      

                                                                                                                                                                    

│Êàðäóðà [Äîêñàçîçèí]                              │àëüôà-àäðåíîáëîêàòîð [C02CA04]          │òàáëåòêè 1, 2, 4, 8 ìã        │Pfizer (Ãåðìàíèÿ)             │005369,       

                                                                                                                                                      │27.09.94      

                                                                                                                                                                    

│Êàðäþðà [Äîêñàçîçèí]                              │àëüôà-àäðåíîáëîêàòîð [C02CA04]          │òàáëåòêè 2 ìã, 4 ìã           │Pliva SA (Õîðâàòèÿ)           │006076,       

                                                                                                                                                      │22.05.95      

                                                                                                                                                                    

│Êàðñèë [Ñèëèáèíèí]                                │ãåïàòîïðîòåêòîð [A05BA03]               │äðàæå                         │Bulgarska Rosa (Áîëãàðèÿ)     │002360,       

                                                                                                                                                      │23.01.92      

                                                                                                                                                                    

│Êàðñèë [Ñèëèáèíèí]                                │ãåïàòîïðîòåêòîð [A05BA03]               │äðàæå                         │Pharmachim (Áîëãàðèÿ)         │2778, 29.06.84 │

│Êàðñèë [Ñèëèáèíèí]                                │ãåïàòîïðîòåêòîð [A05BA03]               │êàïñóëû 70, 100 ìã; ñèðîï 1%  │Pharmachim (ÍÐÁ)              │2990, 30.10.90 │

                                                                                                                                                                    

│Êàñîäåêñ [Áèêàëóòàìèä]                            │àíòèàíäðîãåí [L02BB03]                  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Zeneca Ltd (Âåëèêîáðèòàíèÿ)   │006992,       

                                                                                          │50 ìã                                                       │18.01.96      

                                                                                                                                                                    

│Êàññàäàí [Àëïðàçîëàì]                             │òðàíêâèëèçàòîð [N05BA12]                │òàáëåòêè 0.25, 0.5 ìã         │Arzneimittelwerk Dresden GmbH │002851,       

                                                                                                                        │(Ãåðìàíèÿ)                    │16.02.93      

                                                                                                                                                                    

│Êàñòîðîâîå ìàñëî                                  │ñëàáèòåëüíîå ñðåäñòâî [A06AB05]         │êàïñóëû 500 ìã                │Biogal SA (Âåíãðèÿ)           │006319,       

                                                                                                                                                      │26.07.95      

                                                                                                                                                                    

│Êàòàëèí [Ïèðåíîêñèí]                              │ïðîòèâîêàòàðàêòíîå ñðåäñòâî [S01XA]     │òàáëåòêè äëÿ ïðèãîòîâëåíèÿ    │Takeda Chemical Industries    │01098,        

                                                                                          │ãëàçíûõ êàïåëü /â êîìïëåêòå ñ │Ltd (ßïîíèÿ)                  │21.07.94,     

                                                                                          │ðàñòâîðèòåëåì 15 ìë/                                        │27.07.84      

                                                                                                                                                                    

│Êàòàïðåñàí [Êëîíèäèí]                             │àëüôà2-àäðåíîñòèìóëÿòîð öåíòðàëüíûé     │òàáëåòêè 0.075, 0.15 ìã;      │Boehringer Ingelheim          │005845,       

                                                  │[S01EA04]                               │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │(Ãåðìàíèÿ)                    │28.03.95      

                                                                                          │0.15 ìã/1 ìë                                                              

                                                                                                                                                                    

│Êàòåäæåëü Ñ [Õëîðãåêñèäèí]                        │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AC02]      │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Montavit Pharmawerk GmbH      │005288,       

                                                                                                                        │(Àâñòðèÿ)                     │01.09.94      

                                                                                                                                                                    

│Êàòåäæåëü ñ ëèäîêàèíîì {õëîðãåêñèäèí, ëèäîêàèí}   │àíòèñåïòè÷åñêîå ñðåäñòâî [N01BB52]      │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Montavit Pharmawerk GmbH      │005287,       

                                                                                                                        │(Àâñòðèÿ)                     │01.09.94      

                                                                                                                                                                    

│Êàòåíîë [Àòåíîëîë]                                │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè 50, 100 ìã           │Cadila Laboratories Ltd       │003301,       

                                                  │[C07AB03]                                                             │(Èíäèÿ)                       │03.09.93      

                                                                                                                                                                    

│Êàòèôåí [Êåòîòèôåí]                               │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │òàáëåòêè 1 ìã                 │General Drug House (Òàéëàíä)  │005177,       

                                                                                                                                                      │26.07.94      

                                                                                                                                                                    

│Êàòîïèë [Êàïòîïðèë]                               │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 25, 50 ìã            │Galenika (Þãîñëàâèÿ)          │01498, 13.10.88│

                                                                                                                                                                    

│Êàôåðãîò {ýðãîòàìèí 1 ìã, êîôåèí 100 ìã}          │ïðîòèâîìèãðåíîçíîå ñðåäñòâî [N02CA52]   │òàáëåòêè                      │Sandoz Urunleri Ilac (Òóðöèÿ) │002188,       

                                                                                                                                                      │08.07.91      

                                                                                                                                                                    

│Êàôôåòèí {ïðîïèôåíàçîí 0.21 ã, ïàðàöåòàìîë 0.25   │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Alkaloid (Ìàêåäîíèÿ)          │002603,       

│ã, êîôåèí 50 ìã, êîäåèí 10 ìã}                    │ñðåäñòâî [N02BE51]                                                                                  │08.09.92      

                                                                                                                                                                    

│Êâàìàòåë [Ôàìîòèäèí]                              │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ôèëìòàáëåòêè 20, 40 ìã        │Gedeon Richter (Âåíãðèÿ)      │005607,        

                                                  │[A02BA03]                                                                                           │27.12.94      

                                                                                                                                                                    

│Êâàìàòåë [Ôàìîòèäèí]                              │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ëèîôèëèç.ïîðîøîê äëÿ          │Gedeon Richter (Âåíãðèÿ)      │006431,        

                                                  │[A02BA03]                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │23.08.95      

                                                                                          │ðàñòâîðà 20 ìã /â êîìïëåêòå ñ │                                            

                                                                                          │ðàñòâîðèòåëåì/                                                             

                                                                                                                                                                    

│Êâåñòðàí [Êîëåñòèðàìèí]                           │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AD01]   │ñàøå (ïîðîøîê)                │Bristol-Myers Squibb (Èòàëèÿ) │006956,       

                                                                                                                                                      │04.01.96      

                                                                                                                                                                    

│Êâåñòðàí [Êîëåñòèðàìèí]                           │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AD01]   │ïîðîøîê                       │Bristol-Myers Company Ltd     │00241, 23.06.75│

                                                                                                                        │(Àíãëèÿ)                                    

                                                                                                                                                                    

│Êâèíàêñ {äèãèäðîàçàïåíòàöåíïîëèñóëüôîíàò íàòðèÿ   │ïðîòèâîêàòàðàêòíîå ñðåäñòâî [S01XA]     │êàïëè ãëàçíûå                 │Alcon Pharmaceutical Ltd (ÑØÀ)│002515,       

│0.015 ìã, íèïàãèí 0.065 ìã, íèïàçîë 0.035 ìã,                                                                                                         │18.06.92      

│òèìåðîñàë 0.002 ìã - 1 ìë}                                                                                                                                          

                                                                                                                                                                    

│Êâèíîëîêñ [Íîðôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Kopran Ltd (Èíäèÿ)            │005150,       

                                                  │[J01MA06]                                                                                           │20.07.94      

                                                                                                                                                                    

│Êâèíòîð [Öèïðîôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã; ðàñòâîð │Torrent Exports Ltd (Èíäèÿ)   │002668,       

                                                  │[J01MA02]                               │äëÿ èíôóçèé (ôëàêîíû) 200 ìã                                │27.10.92      

                                                                                          │- 100 ìë                                                                  

                                                                                                                                                                    

│Êåàë [Ñóêðàëüôàò]                                 │ïðîòèâîÿçâåííîå ñðåäñòâî [A02BX02]      │òàáëåòêè 1 ã                  │Biogalenique (Ôðàíöèÿ)        │005516,       

                                                                                                                                                      │21.11.94      

                                                                                                                                                                    

│Êåéòåí [Öåôïèðîì]                                 │àíòèáèîòèê, öåôàëîñïîðèí [J01DA37]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Roussel Uclaf (Ôðàíöèÿ)       │006676,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │29.09.95      

                                                                                          │(ôëàêîíû) 0.25, 0.5, 1, 2 ã                                               

                                                                                                                                                                    

│Êåëôèïðèì {òðèìåòîïðèì 0.25 ã,                    │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │êàïñóëû 250 ìã/200 ìã; ñèðîï  │Farmitalia Carlo Erba (Èòàëèÿ)│003776,       

│ñóëüôàìåòîêñèïèðåäàçèí 0.25 ã}                    │ñðåäñòâî [J01EE]                                                                                    │18.03.94      

                                                                                                                                                                    

│Êåíàêîðò [Òðèàìöèíîëîí]                           │ãëþêîêîðòèêîñòåðîèä [H02AB08]           │òàáëåòêè                      │Squibb (Âåëèêîáðèòàíèÿ)       │00353,        

                                                                                                                                                      │02.09.86,     

                                                                                                                                                      │09.07.75      

                                                                                                                                                                    

│Êåíàëîã [Òðèàìöèíîëîí]                            │ãëþêîêîðòèêîñòåðîèä [H02AB08]           │ñóñïåíçèÿ äëÿ èíúåêöèé        │Bristol-Myers Squibb          │007652,       

                                                                                          │(àìïóëû) 10 ìã/ìë, 40 ìã/ìë - │(Ãåðìàíèÿ)                    │19.07.96      

                                                                                          │1 ìë; ñóñïåíçèÿ äëÿ èíúåêöèé                                              

                                                                                          │(ôëàêîíû) 10 ìã/ìë, 40 ìã/ìë                                              

                                                                                          │- 5 ìë                                                                    

                                                                                                                                                                    

│Êåíàëîã [Òðèàìöèíîëîí]                            │ãëþêîêîðòèêîñòåðîèä [D07AB09]           │êðåì 0.1%; ìàçü 0.1%          │Bristol-Myers Squibb,         │00784,        

                                                                                                                        │E.R.Squibb & Sons Ltd         │14.08.80,     

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │25.10.95      

                                                                                                                                                                    

│Êåíàëîã [Òðèàìöèíîëîí]                            │ãëþêîêîðòèêîñòåðîèä [H02AB08]           │ñóñïåíçèÿ äëÿ èíúåêöèé 10, 40 │Squibb (Âåëèêîáðèòàíèÿ)       │00353,        

                                                                                          │ìã/ìë                                                       │02.09.86,     

                                                                                                                                                      │09.07.75      

                                                                                                                                                                    

│Êåíàëîã [Òðèàìöèíîëîí]                            │ãëþêîêîðòèêîñòåðîèä [H02AB08]           │òàáëåòêè 2, 4, 8 ìã; ðàñòâîð  │Krka (Ñëîâåíèÿ)               │00309,        

                                                                                          │(àìïóëû) 40 ìã/ìë                                           │01.12.94,     

                                                                                                                                                      │11.07.74,     

                                                                                                                                                      │15.06.84      

                                                                                                                                                                    

│Êåíàëîã 40 [Òðèàìöèíîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB08]           │ñóñïåíçèÿ äëÿ èíúåêöèé        │Berlin-Chemie AG (Ãåðìàíèÿ)   │006639,        

                                                                                          │(àìïóëû) 40 ìã - 1 ìë                                       │08.02.96      

                                                                                                                                                                    

│Êåíàëîã îðàáåéç [Òðèàìöèíîëîí]                    │ãëþêîêîðòèêîñòåðîèä [A01AC01]           │ïàñòà äëÿ îáðàáîòêè ïîëîñòè   │Bristol-Myers Squibb,         │006181,        

                                                                                          │ðòà 0.1%                      │E.R.Squibb & Sons Ltd         │14.06.95      

                                                                                                                        │(Âåëèêîáðèòàíèÿ)                            

                                                                                                                                                                     

│Êåðàòîëàí {êàðáàìèä, ìîëî÷íàÿ êèñëîòà, áåòàèí}    │êåðàòîëèòè÷åñêîå ñðåäñòâî [D02AE]       │êðåì                          │Pharmachim (ÍÐÁ)              │3012, 22.03.91 │

                                                                                                                                                                    

│Êåòàëàð [Êåòàìèí]                                 │íàðêîòè÷åñêîå íåèíãàëÿöèîííîå ñðåäñòâî  │ðàñòâîð äëÿ èíúåêöèé          │Eczacibasi (Òóðöèÿ)           │005799,       

                                                  │[N01AX03]                               │(ôëàêîíû) 5% - 10 ìë                                        │02.03.95      

                                                                                                                                                                    

│Êåòàëàð [Êåòàìèí]                                 │íàðêîòè÷åñêîå íåèíãàëÿöèîííîå ñðåäñòâî  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hemofarm D.D. (Þãîñëàâèÿ)     │003806,       

                                                  │[N01AX03]                               │10, 50 ìã/ìë                                                │29.03.94      

                                                                                                                                                                    

│Êåòàìèí [Êåòàìèí]                                 │íàðêîòè÷åñêîå íåèíãàëÿöèîííîå ñðåäñòâî  │ðàñòâîð äëÿ èíúåêöèé          │Astrapin (Ãåðìàíèÿ)           │005214,       

                                                  │[N01AX03]                               │(ôëàêîíû) 10, 50 ìã/ìë                                      │09.08.94      

                                                                                                                                                                    

│Êåòàìèí [Êåòàìèí]                                 │íàðêîòè÷åñêîå íåèíãàëÿöèîííîå ñðåäñòâî  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Pan Pharma (Ôðàíöèÿ)          │002675,       

                                                  │[N01AX03]                               │250 ìã - 5 ìë                                               │30.10.92      

                                                                                                                                                                    

│Êåòàìèíà ãèäðîõëîðèä [Êåòàìèí]                    │íàðêîòè÷åñêîå íåèíãàëÿöèîííîå ñðåäñòâî  │ðàñòâîð äëÿ èíúåêöèé          │J.R.Sharma Overseas Ltd       │003454,       

                                                  │[N01AX03]                               │(ôëàêîíû) 50 ìã/ìë - 10 ìë    │(Èíäèÿ)                       │25.10.93      

                                                                                                                                                                    

│Êåòàìèíà ãèäðîõëîðèä [Êåòàìèí]                    │íàðêîòè÷åñêîå íåèíãàëÿöèîííîå ñðåäñòâî  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Themis Chemicals Ltd (Èíäèÿ)  │002888,       

                                                  │[N01AX03]                               │500 ìã - 10 ìë                                              │02.03.93      

                                                                                                                                                                    

│Êåòàíåñò [Êåòàìèí]                                │íàðêîòè÷åñêîå íåèíãàëÿöèîííîå ñðåäñòâî  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Godecke/parke-Davis (Ãåðìàíèÿ)│007144,       

                                                  │[N01AX03]                               │1 ìë - 10, 50 ìã; ðàñòâîð äëÿ │                              │14.03.96      

                                                                                          │èíúåêöèé (ôëàêîíû) 1 ìë - 10, │                                            

                                                                                          │50 ìã                                                                     

                                                                                                                                                                    

│Êåòàíîâ [Êåòîðîëàê]                               │ÍÏÂÑ [M01AB15]                          │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Ranbaxy Laboratories Ltd      │005049,       

                                                                                          │èíúåêöèé (àìïóëû) 30 ìã/1 ìë  │(Èíäèÿ)                       │28.06.94      

                                                                                                                                                                    

│Êåòàñìà [Êåòîòèôåí]                               │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │òàáëåòêè 1 ìã                 │Sun Pharmaceutical Industries │002766,       

                                                                                                                        │Ltd (Èíäèÿ)                   │17.12.92      

                                                                                                                                                                    

│Êåòîíàë [Êåòîïðîôåí]                              │ÍÏÂÑ [M01AE03][M02AA10]                 │òàáëåòêè ðåòàðä 150 ìã;       │Lek D.D. (Ñëîâåíèÿ)           │005504,       

                                                                                          │êàïñóëû 50 ìã; ñâå÷è 100 ìã;                                │16.11.94      

                                                                                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                            

                                                                                          │100 ìã/2 ìë; êðåì (òóáû) 50                                               

                                                                                          │ìã|1 ã                                                                    

                                                                                                                                                                    

│Êåòîíàë [Êåòîïðîôåí]                              │ÍÏÂÑ [M01AE03]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lek D.D. (Ñëîâåíèÿ)           │005753,       

                                                                                          │100 ìã                                                      │15.02.95      

                                                                                                                                                                    

│Êåòîïðîôåí [Êåòîïðîôåí]                           │ÍÏÂÑ [M01AE03]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │CT-Arzneimittel Chemishe      │003437,       

                                                                                          │50, 100 ìã; ñâå÷è 100 ìã      │Tempelchof GmbH (Ãåðìàíèÿ)    │20.10.93      

                                                                                                                                                                    

│Êåòîïðîôåí [Êåòîïðîôåí]                           │ÍÏÂÑ [M01AE03]                          │êàïñóëû ðåòàðä 200 ìã         │Valpharma SA (Ñàí Ìàðèíî)     │005721,       

                                                                                                                                                      │06.02.95      

                                                                                                                                                                    

│Êåòîïðîôåí-Ðàòèîôàðì [Êåòîïðîôåí]                 │ÍÏÂÑ [M01AE03]                          │ôèëìòàáëåòêè 50, 100 ìã       │Ratiopharm GmbH & Co          │005127,       

                                                                                                                        │(Ãåðìàíèÿ)                    │14.07.94      

                                                                                                                                                                    

│Êåòîðîë [Êåòîðîëàê]                               │ÍÏÂÑ [M01AB15]                          │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Dr.Reddy's Laboratories Ltd   │002684,       

                                                                                          │èíúåêöèé (àìïóëû) 30 ìã - 1 ìë│(Èíäèÿ)                       │10.11.92      

                                                                                                                                                                     

│Êåòîòèô [Êåòîòèôåí]                               │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │òàáëåòêè 1 ìã; ñèðîï îðàëüíûé │Kopran Ltd (Èíäèÿ)            │005452,       

                                                                                          │1 ìã|5 ìë                                                   │02.11.94      

                                                                                                                                                                     

│Êåòîòèôåí [Êåòîòèôåí]                             │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │òàáëåòêè 1 ìã                 │Indopharma (Èíäîíåçèÿ)        │005067,       

                                                                                                                                                      │30.06.94      

                                                                                                                                                                     

│Êåòîòèôåí [Êåòîòèôåí]                             │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │òàáëåòêè 1 ìã; ñèðîï 100 ìë   │Pharmachim (Áîëãàðèÿ)         │003496,       

                                                                                                                                                      │10.11.93      

                                                                                                                                                                     

│Êåòîòèôåí [Êåòîòèôåí]                             │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │òàáëåòêè 1 ìã                 │Polfa, Warszawskie Zaklady    │005565,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │14.12.94      

                                                                                                                                                                    

│Êåòîòèôåí-Ðèâîôàðì [Êåòîòèôåí]                    │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │òàáëåòêè 1 ìã; ñèðîï 1 ìã|5 ìë│Rivopharm SA (Øâåéöàðèÿ)      │005457,       

                                                                                                                                                      │04.11.94      

                                                                                                                                                                    

│Êåòîô [Êåòîòèôåí]                                 │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06AX17] │êàïñóëû 1 ìã                  │Hexal Pharma GmbH (Ãåðìàíèÿ)  │003826,       

                                                                                                                                                      │05.04.94      

                                                                                                                                                                    

│Êåòîöåô [Öåôóðîêñèì]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA06]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pliva (Þãîñëàâèÿ)             │00760, 19.05.80│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 250, 750, 1500 ìã                                               

                                                                                                                                                                    

│Êåòðîäîë [Êåòîðîëàê]                              │ÍÏÂÑ [M01AB15]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Deva Holding AS (Òóðöèÿ)      │005375,       

                                                                                          │10 ìã; ðàñòâîð äëÿ èíúåêöèé                                 │29.09.94      

                                                                                          │(àìïóëû) 30 ìã/ìë                                                         

                                                                                                                                                                    

│Êåôàäèì [Öåôòàçèäèì]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA11]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Liily SA (Èñïàíèÿ)            │002367,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │27.01.92      

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                                        

                                                                                                                                                                    

│Êåôåêñèí [Öåôàëåêñèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │òàáëåòêè 250, 500 ìã; ãðàíóëû │Eczacibasi (Òóðöèÿ)           │002238,       

                                                                                          │äëÿ ïðèãîòîâëåíèÿ ìèêñòóðû 50 │                              │27.08.91      

                                                                                          │ìã/ìë                                                                     

                                                                                                                                                                    

│Êåôçîë [Öåôàçîëèí]                                │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Eli Lilly (Èòàëèÿ)            │007150,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà 0.5, 1 │                              │18.03.96      

                                                                                          │ã                                                                         

                                                                                                                                                                    

│Êåôçîë [Öåôàçîëèí]                                │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │M.J.Exports Private Ltd       │00949, 06.12.82│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Èíäèÿ)                                     

                                                                                                                                                                    

│Êåôëåêñ [Öåôàëåêñèí]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │òàáëåòêè 500 ìã; êàïñóëû 250, │Eli Lilly (Èòàëèÿ)            │007168,       

                                                                                          │500 ìã; ãðàíóëû äëÿ                                         │27.03.96      

                                                                                          │ïðèãîòîâëåíèÿ îðàëüíîé                                                    

                                                                                          │ñóñïåíçèè (ôëàêîíû) 125 ìã|5                                              

                                                                                          │ìë, 250 ìã|5 ìë                                                           

                                                                                                                                                                    

│Êåôîòåêñ [Öåôîòàêñèì]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Gepac International (Èíäèÿ)   │002710,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │24.11.92      

                                                                                          │(ôëàêîíû) 250, 500, 1000 ìã                                               

                                                                                                                                                                    

│Êåôóðîêñ [Öåôóðîêñèì]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA06]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Eli Lilly (ÑØÀ)               │007553,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │30.05.96      

                                                                                          │(ôëàêîíû) 0.75, 1.5 ã                                                     

                                                                                                                                                                    

│Êèáåðíèí [Àíòèòðîìáèí III]                        │àíòèêîàãóëÿíò [B01AB02]                 │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Behringwerke AG (ÔÐÃ)         │002496,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │02.06.92      

                                                                                          │(ôëàêîíû) 500, 1000 ÅÄ /â                                                  

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Êèíåäðèë {ìîêñàñòèí 25 ìã, êîôåèí 30 ìã}          │ïðîòèâîðâîòíîå ñðåäñòâî [A04AD]         │òàáëåòêè                      │Slovakofarma SA (Ñëîâàêèÿ)    │2290,          

                                                                                                                                                      │01.06.72,     

                                                                                                                                                      │23.06.94      

                                                                                                                                                                     

│Êèíåêñ [Ôóðîñåìèä]                                │äèóðåòè÷åñêîå ñðåäñòâî [C03CA01]        │òàáëåòêè 40 ìã; ðàñòâîð äëÿ   │Unique Pharmaceutical         │005195,       

                                                                                          │èíúåêöèé (àìïóëû) 10 ìã/ìë    │Laboratories (Èíäèÿ)          │01.08.94      

                                                                                                                                                                     

│Êèíåòàë-400 [Ïåíòîêñèôèëëèí]                      │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AD03]     │òàáëåòêè 400 ìã               │Cipla Ltd (Èíäèÿ)             │002530,       

                                                                                                                                                      │01.07.92      

                                                                                                                                                                    

│Êèðèí [Ñïåêòèíîìèöèí]                             │àíòèáèîòèê [J01XX04]                    │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Medochemie Ltd (Êèïð)         │005611,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │04.01.95      

                                                                                          │(ôëàêîíû) 2 ã                                                             

                                                                                                                                                                    

│Êèòíîñ [Ýòîôàìèä]                                 │ïðîòèâîïðîòîçîéíîå ñðåäñòâî [P01AC03]   │òàáëåòêè 200 ìã; ñóñïåíçèÿ    │Farmitalia Carlo Erba (Èòàëèÿ)│003497,       

                                                                                          │îðàëüíàÿ (ôëàêîíû) 2% - 100 ìë│                              │10.11.93      

                                                                                                                                                                    

│Êèòðèë [Ãðàíèçåòðîí]                              │ñåðîòîíèíîâûõ ðåöåïòîðîâ àíòàãîíèñò     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Smithkline Beecham            │005086,       

                                                  │[A04AA02]                               │1 ìã/1 ìë                     │Pharmaceuticals               │05.07.94      

                                                                                                                        │(Âåëèêîáðèòàíèÿ)                            

                                                                                                                                                                    

│Êèòðèë [Ãðàíèçåòðîí]                              │ñåðîòîíèíîâûõ ðåöåïòîðîâ àíòàãîíèñò     │òàáëåòêè 1 ìã                 │Smithkline Beecham            │005712,       

                                                  │[A04AA02]                                                             │Pharmaceuticals               │02.02.95      

                                                                                                                        │(Âåëèêîáðèòàíèÿ)                            

                                                                                                                                                                    

│Êëàâîöèí [Êëàâóëàíîâàÿ êèñëîòà+àìîêñèöèëëèí]      │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │òàáëåòêè 375, 625 ìã; ïîðîøîê │Pliva (Õîðâàòèÿ)              │003550,       

│{êëàâóëàíîâàÿ êèñëîòà, àìîêñèöèëëèí}              │[J01CR02]                               │äëÿ ïðèãîòîâëåíèÿ                                           │07.12.93      

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 600, 1200 ìã; ñèðîï │                                            

                                                                                          │125 ìã/31 ìã|5 ìë; ñèðîï                                                  

                                                                                          │ôîðòå 250 ìã/62.5 ìã|5 ìë                                                 

                                                                                                                                                                    

│Êëàâóíàò [Êëàâóëàíîâàÿ êèñëîòà+àìîêñèöèëëèí]      │àíòèáèîòèê êîìáèíèðîâàííûé [J01CR02]    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Atabay Ilac Fabrikasi AS      │007495,       

│{àìîêñèöèëëèí 500 ìã, êëàâóëàíîâàÿ êèñëîòà 125 ìã}│                                        │625 ìã                        │(Òóðöèÿ)                      │13.05.96      

                                                                                                                                                                    

│Êëàðèíàçå {ëîðàòàäèí 5 ìã, ïñåâäîýôåäðèí 120 ìã}  │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R06A]    │òàáëåòêè ïðîëîíãèðîâàííîãî    │Schering-Plough (Áåëüãèÿ)     │005806,       

                                                                                          │äåéñòâèÿ 5 ìã/120 ìã                                        │07.03.95      

                                                                                                                                                                    

│Êëàðèòèí [Ëîðàòàäèí]                              │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 10 ìã                │Schering-Plough (ÑØÀ)         │002829,       

                                                  │[R06AX13]                                                                                           │08.02.93      

                                                                                                                                                                    

│Êëàðèòèí [Ëîðàòàäèí]                              │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ñèðîï (ôëàêîíû) 1 ìã/ìë       │Schering-Plough (ÑØÀ)         │005277,       

                                                  │[R06AX13]                                                                                           │30.08.94      

                                                                                                                                                                    

│Êëàðèòèí [Ëîðàòàäèí]                              │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │ñèðîï (ôëàêîíû) 1 ìã/1 ìë;    │Schering-Plough (Èíäîíåçèÿ)   │006055,       

                                                  │[R06AX13]                               │òàáëåòêè 10 ìã                                              │17.05.95      

                                                                                                                                                                    

│Êëàôîðàí [Öåôîòàêñèì]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Hoechst Pharmaceutical        │003433,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Èíäîíåçèÿ)                   │19.10.93      

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Êëàôîðàí [Öåôîòàêñèì]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Turk Hoechst AS (Òóðöèÿ)      │01570, 19.04.89│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Êëàôîðàí [Öåôîòàêñèì]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Laboratoires Roussel (Ôðàíöèÿ)│00905,         

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │20.10.93,     

                                                                                          │(ôëàêîíû) 0.5, 1 ã                                          │25.03.82      

                                                                                                                                                                     

│Êëàôîðàí [Öåôîòàêñèì]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Roussel Iberica (Èñïàíèÿ)     │002425,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │31.01.92      

                                                                                          │(ôëàêîíû) 1 ã                                                              

                                                                                                                                                                    

│Êëàôîðàí [Öåôîòàêñèì]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Roussel Pharma (Èòàëèÿ)       │002424,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │31.01.92      

                                                                                          │(ôëàêîíû) 1 ã                                                             

                                                                                                                                                                    

│Êëàôîðàí [Öåôîòàêñèì]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Servo-Michal (Þãîñëàâèÿ)      │00958, 08.12.82│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà 0.5, 1 │                                            

                                                                                          │ã                                                                         

                                                                                                                                                                    

│Êëàôîòàêñèì [Öåôîòàêñèì]                          │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Sun Pharmaceutical Industries │007099,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │Ltd (Èíäèÿ)                   │22.02.96      

                                                                                          │(ôëàêîíû) 250, 500, 1000 ìã                                               

                                                                                                                                                                    

│Êëàöèä [Êëàðèòðîìèöèí]                            │àíòèáèîòèê, ìàêðîëèä [J01FA09]          │òàáëåòêè 250 ìã; ïîðîøîê äëÿ  │Abbott Laboratories (Èòàëèÿ)  │005372,       

                                                                                          │ïðèãîòîâëåíèÿ ñóñïåíçèè                                     │28.09.94      

                                                                                          │(ôëàêîíû) 125 ìã|5 ìë                                                     

                                                                                                                                                                    

│Êëàöèä [Êëàðèòðîìèöèí]                            │àíòèáèîòèê, ìàêðîëèä [J01FA09]          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Abbott-France (Ôðàíöèÿ)       │005380,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │03.10.94      

                                                                                          │(ôëàêîíû) 500 ìã                                                          

                                                                                                                                                                    

│Êëåêñàí [Ýíîêñàïàðèí] {ãåïàðèí íèçêîìîëåêóëÿðíûé} │àíòèêîàãóëÿíò ïðÿìîé [B01AB05]          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Rhone-Poulenc Rorer (Ôðàíöèÿ) │002607,       

                                                                                          │20 ìã/0.2 ìë, 40 ìã/0.4 ìë,                                 │09.09.92      

                                                                                          │60 ìã/0.6 ìë, 80 ìã/0.8 ìë,                                               

                                                                                          │100 ìã/1 ìë; ðàñòâîð äëÿ                                                  

                                                                                          │èíúåêöèé (øïðèöû) - 20 ìã/0.2 │                                            

                                                                                          │ìë, 40 ìã/0.4 ìë                                                          

                                                                                                                                                                    

│Êëåìàñòèí [Êëåìàñòèí]                             │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 1 ìã                 │Polfa, Warszawskie Zaklady    │006350,       

                                                  │[R06AA04]                                                             │Farmaceutyczne SA (Ïîëüøà)    │07.08.95      

                                                                                                                                                                    

│Êëåìàñòèí ôóìàðàò [Êëåìàñòèí]                     │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 1.34 ìã, 2.68 ìã     │Mir Pharmaceutical Inc/Lemmon │007680,       

                                                  │[R06AA04]                                                             │(ÑØÀ)                         │23.07.96      

                                                                                                                                                                    

│Êëåíáóòåðîë [Êëåíáóòåðîë]                         │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │ñèðîï                         │Pharmachim (ÍÐÁ)              │2976, 19.06.90 │

                                                  │[R03CC13]                                                                                                         

                                                                                                                                                                    

│Êëåíáóòåðîë [Êëåíáóòåðîë]                         │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè 0.02 ìã              │Pharmachim (Áîëãàðèÿ)         │003962,       

                                                  │[R03CC13]                                                                                           │31.05.94      

                                                                                                                                                                    

│Êëèàöèë [Ôåíîêñèìåòèëïåíèöèëëèí]                  │àíòèáèîòèê, ïåíèöèëëèí [J01CE02]        │ôèëìòàáëåòêè 1.2 ìåãà;        │Hoechst AG (Ãåðìàíèÿ)         │005420,       

                                                                                          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ                                   │25.10.94      

                                                                                          │ñèðîïà (ôëàêîíû)                                                          

                                                                                                                                                                    

│Êëèàöèë [Ôåíîêñèìåòèëïåíèöèëëèí]                  │àíòèáèîòèê, ïåíèöèëëèí [J01CE02]        │ôèëìòàáëåòêè 1.2 ìåãà;        │Turk Hoechst AS (Òóðöèÿ)      │005905,       

                                                                                          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ                                   │04.04.95      

                                                                                          │ñóñïåíçèè (ôëàêîíû) 300000                                                

                                                                                          │ÌÅ/5 ìë                                                                   

                                                                                                                                                                    

│Êëèâàðèí [Ðåâèïàðèí] {ãåïàðèí íèçêîìîëåêóëÿðíûé}  │àíòèêîàãóëÿíò ïðÿìîé [B01AB08]          │ðàñòâîð äëÿ èíúåêöèé (øïðèö   │Knoll AG, Basf Pharma         │005535,       

                                                                                          │îäíîðàçîâûé) 1750 ÅÄ - 0.25 ìë│(Ãåðìàíèÿ)                    │05.12.94      

                                                                                                                                                                     

│Êëèìåí {öèïðîòåðîí 1 ìã, ýñòðàäèîë âàëåðàò 2 ìã - │ïðîòèâîêëèìàêòåðè÷åñêîå ñðåäñòâî        │äðàæå                         │Schering AG (Ãåðìàíèÿ)        │003451,       

│10 äðàæå; ýñòðàäèîë âàëåðàò 2 ìã - 11 äðàæå}      │[G03HB01]                                                                                           │25.10.93      

                                                                                                                                                                     

│Êëèìèöèí [Êëèíäàìèöèí]                            │àíòèáèîòèê, àçàëèä [J01FF01]            │êàïñóëû 150 ìã; ðàñòâîð äëÿ   │Lek (Ñëîâåíèÿ)                │002327,       

                                                                                          │èíúåêöèé (àìïóëû) 300 ìã - 2                                │14.01.92      

                                                                                          │ìë                                                                         

                                                                                                                                                                    

│Êëèìîíîðì {ýñòðàäèîë 2 ìã - òàáëåòêà æåëòàÿ (9);  │ïðîòèâîêëèìàêòåðè÷åñêîå ñðåäñòâî        │äðàæå                         │Jenapharm GmbH (Ãåðìàíèÿ)     │003452,       

│ëåâîíîðãåñòðåë 0.15 ìã, ýñòðàäèîë 2 ìã - òàáëåòêà │[G03FB09]                                                                                           │25.10.93      

│áèðþçîâàÿ (12)}                                                                                                                                                     

                                                                                                                                                                    

│Êëèíäàìèöèí [Êëèíäàìèöèí]                         │àíòèáèîòèê, àçàëèä [J01FF01]            │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Lisapharma (Èòàëèÿ)           │005547,       

                                                                                          │600 ìã - 4 ìë                                               │06.12.94      

                                                                                                                                                                    

│Êëèíäàöèí [Êëèíäàìèöèí]                           │àíòèáèîòèê, àçàëèä [J01FF01]            │êàïñóëû 150 ìã                │United Pharmaceutical         │002946,       

                                                                                                                        │Manufactoring Co Ltd          │31.03.93      

                                                                                                                        │(Èîðäàíèÿ)                                  

                                                                                                                                                                    

│Êëèíîêñèí [Êëèíäàìèöèí]                           │àíòèáèîòèê, àçàëèä [J01FF01]            │êàïñóëû 150 ìã; ðàñòâîð äëÿ   │Deva Holding AS (Òóðöèÿ)      │002433,       

                                                                                          │èíúåêöèé (àìïóëû) 300 ìã - 2                                │25.03.92      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Êëèíîðèë [Ñóëèíäàê]                               │ÍÏÂÑ [M01AB02]                          │òàáëåòêè 200 ìã               │Merck Sharp & Dohme (ÑØÀ)     │003152,       

                                                                                                                                                      │12.07.93      

                                                                                                                                                                    

│Êëèîí [Ìåòðîíèäàçîë]                              │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Gedeon Richter (Âåíãðèÿ)      │2869, 31.08.87 │

                                                                                          │0.5%                                                                      

                                                                                                                                                                    

│Êëèîí [Ìåòðîíèäàçîë]                              │ïðîòèâîìèêðîáíîå ñðåäñòâî [D06BX01]     │ìàçü                          │Gedeon Richter (Âåíãðèÿ)      │002525,       

                                                                                                                                                      │22.06.92      

                                                                                                                                                                    

│Êëèîí-Ä {ìåòðîíèäàçîë 0.1 ã, ìèêîíàçîë 0.1 ã}     │ïðîòèâîìèêðîáíîå ñðåäñòâî [G01AF20]     │òàáëåòêè âàãèíàëüíûå 100      │Gedeon Richter (Âåíãðèÿ)      │002724,       

                                                                                          │ìã/100 ìã                                                   │02.12.92      

                                                                                                                                                                    

│Êëèîñòîì {ìåòðîíèäàçîë 50 ìã, òðèêëîçàí 1 ìã - 1  │àíòèñåïòè÷åñêîå ñðåäñòâî [D06C]         │ìàçü                          │Gedeon Richter (Âåíãðèÿ)      │002229,       

│ã}                                                                                                                                                    │17.09.91      

                                                                                                                                                                    

│Êëèôò [Ìåïðîñöèëëàðèí]                            │êàðäèîòîíè÷åñêîå ñðåäñòâî [C01AB]       │òàáëåòêè 0.25 ìã              │Knoll AG (ÔÐÃ)                │01296, 27.08.86│

                                                                                                                                                                    

│Êëîáåêñ [Êëîêñàöèëëèí]                            │àíòèáèîòèê, ïåíèöèëëèí                  │êàïñóëû 500 ìã; ïîðîøîê äëÿ   │Beximco Pharmaceuticals Ltd   │006061,       

                                                  │ïåíèöèëëèíàçîóñòîé÷èâûé [J01CF02]       │ïðèãîòîâëåíèÿ ñèðîïà 125 ìã|5 │(Áàíãëàäåø)                   │18.05.95      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Êëîäåðì [Êëîáåòàçîë]                              │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │êðåì 0.05%; ìàçü 0.05%        │United Pharmaceutical         │002947,       

                                                  │ïðèìåíåíèÿ [D07AB01]                                                  │Manufactoring Co Ltd          │31.03.93      

                                                                                                                        │(Èîðäàíèÿ)                                  

                                                                                                                                                                    

│Êëîêñàöèëëèí [Êëîêñàöèëëèí]                       │àíòèáèîòèê, ïåíèöèëëèí                  │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Sanavita Gesundcheitsmittel & │006755,       

                                                  │ïåíèöèëëèíàçîóñòîé÷èâûé [J01CF02]       │èíúåêöèîííîãî ðàñòâîðà        │Co Kg (Ãåðìàíèÿ)              │27.10.95      

                                                                                          │(ôëàêîíû) 250, 500 ìã                                                     

                                                                                                                                                                    

│Êëîêñàöèëëèí [Êëîêñàöèëëèí]                       │àíòèáèîòèê, ïåíèöèëëèí                  │êàïñóëû 250, 500 ìã           │Mir Pharmaceutical            │007676,       

                                                  │ïåíèöèëëèíàçîóñòîé÷èâûé [J01CF02]                                     │Inc/biocraft Laboratories Inc │23.07.96      

                                                                                                                        │(ÑØÀ)                                       

                                                                                                                                                                    

│Êëîìàçîë [Êëîòðèìàçîë]                            │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC01]     │êðåì (òóáû) 1%                │Pharmaline Ltd (Ëèâàí)        │007119,       

                                                                                                                                                      │01.03.96      

                                                                                                                                                                     

│Êëîìèä [Êëîìèôåí]                                 │ýñòðîãåí [G03GB02]                      │òàáëåòêè 50 ìã                │Marion Merrel Dow (Ôðàíöèÿ)   │003455,       

                                                                                                                                                      │25.10.93      

                                                                                                                                                                     

│Êëîíàçåïàì [Êëîíàçåïàì]                           │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AE01]    │òàáëåòêè 0.5 ìã               │Polfa, Tarchominskie Zaklady  │007573,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │05.06.96      

                                                                                                                                                                     

│Êëîíàçåïàì [Êëîíàçåïàì]                           │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AE01]    │òàáëåòêè 2 ìã                 │Polfa, Tarchominskie Zaklady  │2702,         

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │06.12.82,     

                                                                                                                                                      │12.07.94      

                                                                                                                                                                    

│Êëîíàêîì-Ð {àìïèöèëëèí 250 ìã, êëîêñàöèëëèí 250   │àíòèáèîòèê êîìáèíèðîâàííûé [J01CR50]    │êàïñóëû                       │M.J.Pharmaceuticals Ltd       │007038,       

│ìã}                                                                                                                     │(Èíäèÿ)                       │02.02.96      

                                                                                                                                                                    

│Êëîíàêîì-Õ {àìîêñèöèëëèí 250 ìã, êëîêñàöèëëèí 250 │àíòèáèîòèê êîìáèíèðîâàííûé [J01CR50]    │êàïñóëû                       │M.J.Pharmaceuticals Ltd       │007039,       

│ìã}                                                                                                                     │(Èíäèÿ)                       │02.02.96      

                                                                                                                                                                    

│Êëîïàìèä [Êëîïàìèä]                               │äèóðåòè÷åñêîå ñðåäñòâî [C03BA03]        │òàáëåòêè 20 ìã                │Polfa, Rzeszowskie Zaklady    │003787,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │25.03.94      

                                                                                                                                                                    

│Êëîðñåïò [Òðîêëîñåí íàòðèÿ] {äèõëîðèçîöèàíóðàò    │àíòèñåïòè÷åñêîå ñðåäñòâî [D08A]         │òàáëåòêè; ãðàíóëû             │Medentech Ltd (Èðëàíäèÿ)      │007010,       

│íàòðèÿ 7 - 694 ìã, 17 - 1670 ìã, 87 - 8680 ìã}                                                                                                        │24.01.96      

                                                                                                                                                                    

│Êëîðöåô [Öåôàëåêñèí]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250, 500 ìã           │M.J.Pharmaceuticals Ltd       │003137,       

                                                                                                                        │(Èíäèÿ)                       │01.07.93      

                                                                                                                                                                    

│Êëîñòèëáåãèò [Êëîìèôåí]                           │ýñòðîãåí [G03GB02]                      │òàáëåòêè 50 ìã                │Egis (Âåíãðèÿ)                │2517,         

                                                                                                                                                      │02.02.77,     

                                                                                                                                                      │11.06.91      

                                                                                                                                                                    

│Êëîòðèìàçîë [Êëîòðèìàçîë]                         │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC01]     │àýðîçîëü (ôëàêîíû) 10 ìã/ìë - │CT-Arzneimittel Chemishe      │003084,       

                                                                                          │40 ìë                         │Tempelchof GmbH (Ãåðìàíèÿ)    │17.06.93      

                                                                                                                                                                    

│Êëîòðèìàçîë [Êëîòðèìàçîë]                         │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC01]     │êðåì (òóáû) 10 ìã/1 ã         │CT-Arzneimittel Chemishe      │005775,       

                                                                                                                        │Tempelchof GmbH (Ãåðìàíèÿ)    │24.02.95      

                                                                                                                                                                    

│Êëîòðèìàçîë [Êëîòðèìàçîë]                         │ïðîòèâîãðèáêîâîå ñðåäñòâî               │òàáëåòêè âàãèíàëüíûå; ðàñòâîð │Polfa (Ïîëüøà)                │2583,         

                                                  │[D01AC01][G01AF02]                      │1%; êðåì 1%                                                 │23.06.86,     

                                                                                                                                                      │25.10.78      

                                                                                                                                                                    

│Êëîôàí [Êëîòðèìàçîë]                              │ïðîòèâîãðèáêîâîå ñðåäñòâî [G01AF02]     │òàáëåòêè âàãèíàëüíûå 100, 200 │Fanny Pharmaceuticals (Èíäèÿ) │005346,       

                                                                                          │ìã                                                          │21.09.94      

                                                                                                                                                                    

│Êëîôåçîí [Êëîôåçîí] {êëîôåêñàìèä, ôåíèëáóòàçîí}   │ÍÏÂÑ [M01AA05]                          │ñâå÷è 400 ìã                  │Polfa (Ïîëüøà)                │002742,       

                                                                                                                                                      │11.12.92      

                                                                                                                                                                    

│Êëîôðàíèë [Êëîìèïðàìèí]                           │àíòèäåïðåññàíò [N06AA04]                │òàáëåòêè 25 ìã                │Sun Pharmaceutical Industries │003055,       

                                                                                                                        │Ltd (Èíäèÿ)                   │08.06.93      

                                                                                                                                                                    

│Êíàâîí [Êåòîïðîôåí]                               │ÍÏÂÑ [M01AE03]                          │êàïñóëû 50 ìã                 │Podravka-Belupo (Þãîñëàâèÿ)   │01235, 27.12.85│

                                                                                                                                                                    

│Êî-êîäàìîë {êîäåèí 8 ìã, ïàðàöåòàìîë 0.5 ã}       │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 8 ìã/500 ìã          │Cox Pharmaceuticals           │003202,       

                                                  │ñðåäñòâî [N02BE51]                                                    │(Âåëèêîáðèòàíèÿ)              │09.08.93      

                                                                                                                                                                    

│Êî-ðåíèòåê {ýíàëàïðèë 10 ìã, ãèäðîõëîðîòèàçèä 25  │ãèïîòåíçèâíîå êîìáèíèðîâàííîå ñðåäñòâî  │òàáëåòêè 10 ìã/25 ìã          │Merck Sharp & Dohme (ÑØÀ)     │003079,       

│ìã}                                               │[C09BA02]                                                                                           │17.06.93      

                                                                                                                                                                    

│Êî-ðåíèòåê {ýíàëàïðèë 20 ìã, ãèäðîõëîðîòèàçèä     │ãèïîòåíçèâíîå êîìáèíèðîâàííîå ñðåäñòâî  │òàáëåòêè 20 ìã/12.5 ìã        │Merck Sharp & Dohme           │005840,       

│12.5 ìã}                                          │[C09BA02]                                                             │(Ãîëëàíäèÿ)                   │28.03.95       

                                                                                                                                                                    

│Êî-òðèìîêñàçîë [Êî-òðèìîêñàçîë] {ñóëüôàìåòîêñàçîë │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 480, 960 ìã; ãðàíóëû │Sanavita Gesundcheitsmittel & │006790,       

│400 ìã, òðèìåòîïðèì 80 ìã; ñóëüôàìåòîêñàçîë 800   │ñðåäñòâî [J01EE01]                      │äëÿ ïðèãîòîâëåíèÿ îðàëüíîé    │Co Kg (Ãåðìàíèÿ)              │03.11.95       

│ìã, òðèìåòîïðèì 160 ìã}                                                                   │ñóñïåíçèè (ôëàêîíû) 240 ìã|5                                              

                                                                                          │ìë                                                                        

                                                                                                                                                                     

│Êî-òðèìîêñàçîë-Ðèâîôàðì [Êî-òðèìîêñàçîë]          │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 120, 480, 960 ìã;    │Rivopharm SA (Øâåéöàðèÿ)      │003891,       

│{ñóëüôàìåòîêñàçîë 400 ìã, òðèìåòîïðèì 80 ìã;      │ñðåäñòâî [J01EE01]                      │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)                                │04.05.94      

│ñóëüôàìåòîêñàçîë 800 ìã, òðèìåòîïðèì 160 ìã;                                              │240 ìã|5 ìë                                                                

│ñóëüôàìåòîêñàçîë 100 ìã, òðèìåòîïðèì 20 ìã}                                                                                                                         

                                                                                                                                                                    

│Êî-òðèìîêñàçîë-Òåâà [Êî-òðèìîêñàçîë]              │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 400 ìã/80 ìã, 800    │Teva Pharmaceutical           │003175,       

│{ñóëüôàìåòîêñàçîë 400 ìã, òðèìåòîïðèì 80 ìã;      │ñðåäñòâî [J01EE01]                      │ìã/160 ìã; ñóñïåíçèÿ îðàëüíàÿ │Industries Ltd (Èçðàèëü)      │02.08.93      

│ñóëüôàìåòîêñàçîë 800 ìã, òðèìåòîïðèì 160 ìã}                                              │200 ìã/40 ìã|5 ìë                                                         

                                                                                                                                                                    

│Êîàêñèë [Òèàíåïòèí]                               │àíòèäåïðåññàíò [N06AA]                  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Servier (Ôðàíöèÿ)│003784,       

                                                                                          │12.5 ìã                                                     │25.03.94      

                                                                                                                                                                    

│Êîàëãåëü 60 {àëãåëäðàò 3.5 ã, ìàãíèÿ ãèäðîêñèä    │àíòàöèäíîå ñðåäñòâî [A02AX]             │ñóñïåíçèÿ (ôëàêîíû) 200 ìë    │Pharmachim (Áîëãàðèÿ)         │003931,       

│3.5 ã - 100 ìë}                                                                                                                                       │23.05.94      

                                                                                                                                                                    

│Êîãèòóì {êàëèÿ àöåòèëàìèíîñóêöèíàò 0.25 ã,        │íîîòðîïíîå ñðåäñòâî [N06BX]             │ðàñòâîð îðàëüíûé (àìïóëû) 10  │Marion Merrel Dow (Ôðàíöèÿ)   │003144,       

│ëåâóëîçà 1 ã, ìåòèëãèäðîêñèáåíçîàò 15 ìã}                                                 │ìë                                                          │07.07.93      

                                                                                                                                                                    

│Êîäèïðîíò {êîäåèí 30 ìã, ôåíèëòîëîêñàìèí 10 ìã -  │ïðîòèâîêàøëåâîå ñðåäñòâî [R05DA20]      │êàïñóëû; ñèðîï (ôëàêîíû) 100 ã│Heinrich Mack Nachf.          │007470,       

│êàïñóëà; êîäåèí 200 ìã, ôåíèëòîëîêñàìèí 66 ìã -                                                                         │(Ãåðìàíèÿ)                    │25.04.96      

│ñèðîï}                                                                                                                                                              

                                                                                                                                                                    

│Êîçààð [Ëîçàðòàí]                                 │àíãèîòåíçèíà II ðåöåïòîðîâ àíòàãîíèñò   │òàáëåòêè 50 ìã                │Merck Sharp & Dohme           │006366,       

                                                  │[C09CA01]                                                             │(Ãîëëàíäèÿ)                   │08.08.95      

                                                                                                                                                                    

│Êîêàðáîêñèëàçà [Êîêàðáîêñèëàçà]                   │ìåòàáîëè÷åñêîå ñðåäñòâî [A11DA]         │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Polfa (Ïîëüøà)                │2184,         

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │02.10.70,     

                                                                                          │(àìïóëû) 50 ìã /â êîìïëåêòå ñ │                              │28.04.84      

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Êîëáèîöèí {òåòðàöèêëèí 0.5 ã, õëîðàìôåíèêîë 0.5   │àíòèñåïòè÷åñêîå ñðåäñòâî [S01AA20]      │êàïëè ãëàçíûå; ìàçü ãëàçíàÿ   │S.I.F.I. Spa (Èòàëèÿ)         │01921, 19.07.90│

│ã, êîëèñòèí 18 ìëí ÅÄ - 100 ìë; òåòðàöèêëèí 0.5                                                                                                                     

│ã, õëîðàìôåíèêîë 1 ã, êîëèñòèí 18 ìëí ÅÄ - ìàçü                                                                                                                     

│100 ã}                                                                                                                                                              

                                                                                                                                                                    

│Êîëäàêò {ôåíèëïðîïàíàìèí 50 ìã, õëîðôåíàìèí 8 ìã  │ïðîòèâîêîíãåñòèâíîå ñðåäñòâî [R01BA51]  │êàïñóëû; ñèðîï                │Natco Fine Pharmaceuticals    │002803,       

│- êàïñóëà; ôåíèëïðîïàíàìèí 2 ìã, õëîðôåíàìèí 0.4                                                                        │Ltd (Èíäèÿ)                   │13.01.93      

│ìã - 1 ìë}                                                                                                                                                          

                                                                                                                                                                    

│Êîëäàð {ôåíèëïðîïàíîëàìèí 50 ìã, õëîðôåíàìèí 8 ìã}│ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │êàïñóëû çàìåäëåííîãî          │Aurobindo Pharma Ltd (Èíäèÿ)  │006785,       

                                                  │ïðîñòóäû [R05X]                         │âûñâîáîæäåíèÿ                                               │02.11.95      

                                                                                                                                                                    

│Êîëäåêñ-Òåâà {õëîðôåíàìèí 2 ìã, ôåíèëýôðèí 10 ìã, │ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │êàïëåòû                       │Teva Pharmaceutical           │007092,       

│ïàðàöåòàìîë 0.3 ã, êîôåèí 30 ìã}                  │ïðîñòóäû [R05X]                                                       │Industries Ltd (Èçðàèëü)      │15.02.96      

                                                                                                                                                                    

│Êîëäðåêñ {ïàðàöåòàìîë 0.5 ã, ôåíèëýôåäðèí 50 ìã,  │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Smithkline Beecham Consumer   │007247,       

│êîôåèí 25 ìã, òåðïèíãèäðàò 20 ìã, àñêîðáèíîâàÿ    │ñðåäñòâî [N02BE51]                                                    │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

│êèñëîòà 30 ìã}                                                                                                                                                      

                                                                                                                                                                    

│Êîëäðåêñ - ïîðîøîê ëèìîííûé {ïàðàöåòàìîë 0.75 ã,  │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ïîðîøîê                       │Sterling Health               │003033,       

│ôåíèëýôåäðèí 10 ìã, àñêîðáèíîâàÿ êèñëîòà 60 ìã}   │ñðåäñòâî [N02BE51]                                                    │(Âåëèêîáðèòàíèÿ)              │03.06.93      

                                                                                                                                                                     

│Êîëäðåêñ - ïîðîøîê ÷åðíîñìîðîäèííûé {ïàðàöåòàìîë  │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ïîðîøîê                       │Sterling Health               │003032,       

│0.75 ã, ôåíèëýôåäðèí 10 ìã, àñêîðáèíîâàÿ êèñëîòà  │ñðåäñòâî [N02BE51]                                                    │(Âåëèêîáðèòàíèÿ)              │03.06.93      

│60 ìã}                                                                                                                                                               

                                                                                                                                                                    

│Êîëäðåêñ õîòðåì ñî âêóñîì ëèìîíà {ïàðàöåòàìîë     │ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │ïîðîøîê (ñàøå)                │Smithkline Beecham Consumer   │007427,       

│0.75 ã, ôåíèëýôðèí 10 ìã, àñêîðáèíîâàÿ êèñëîòà 70 │ïðîñòóäû [R05X]                                                       │Healthcare (Âåëèêîáðèòàíèÿ)   │09.04.96      

│ìã}                                                                                                                                                                 

                                                                                                                                                                    

│Êîëäðåêñ õîòðåì ñî âêóñîì ÷åðíîé ñìîðîäèíû        │ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │ïîðîøîê (ñàøå)                │Smithkline Beecham Consumer   │007428,       

│{ïàðàöåòàìîë 0.75 ã, ôåíèëýôðèí 10 ìã,            │ïðîñòóäû [R05X]                                                       │Healthcare (Âåëèêîáðèòàíèÿ)   │09.04.96      

│àñêîðáèíîâàÿ êèñëîòà 70 ìã}                                                                                                                                         

                                                                                                                                                                    

│Êîëåñòèð [Êîëåñòèðàìèí]                           │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AD01]   │ïîðîøîê (ïàêåòèêè) 9.5 ã      │CT-Arzneimittel Chemishe      │007561,       

                                                                                                                        │Tempelchof GmbH (Ãåðìàíèÿ)    │03.06.96      

                                                                                                                                                                    

│Êîëèìèöèí [Êîëèñòèí]                              │àíòèáèîòèê, ïîëèïåïòèä [J01XB01]        │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Kayaku Antibiotics Reseach Co │00051,        

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │Ltd (ßïîíèÿ)                  │07.09.83,     

                                                                                          │500000, 1000000, 2000000 ÌÅ                                 │11.03.70      

                                                                                                                                                                    

│Êîëèðêóçè Áåòàìèäà {áåòàìåòàçîí, ñóëüôàöåòàìèä}   │ãëþêîêîðòèêîñòåðîèä [S01CA05]           │êàïëè ãëàçíûå (ôëàêîíû) 5 ìë; │Laboratorious Cusi (Èñïàíèÿ)  │003237,       

                                                                                          │êàïëè óøíûå (ôëàêîíû) 5 ìë                                  │16.08.93      

                                                                                                                                                                    

│Êîëôàðèò [Àöåòèëñàëèöèëîâàÿ êèñëîòà]              │ÍÏÂÑ [N02BA01]                          │òàáëåòêè 500 ìã               │Bayer AG (ÔÐÃ)                │01475, 25.08.88│

                                                                                                                                                                    

│Êîëõèöèí [Êîëõèöèí] {áåçâðåìåííèêà âåëèêîëåïíîãî  │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî [M04AC01]│òàáëåòêè 1 ìã                 │Roussel Uclaf (Ôðàíöèÿ)       │01954, 07.09.90│

│àëêàëîèä}                                                                                                                                                           

                                                                                                                                                                    

│Êîëõèöèí [Êîëõèöèí] {áåçâðåìåííèêà âåëèêîëåïíîãî  │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî [M04AC01]│òàáëåòêè ïîêðûòûå îáîëî÷êîé 1 │(Ãðóçèÿ)                      │92/210/6      

│àëêàëîèä}                                                                                 │ìã                                                                        

                                                                                                                                                                    

│Êîìá-Èíñóëèí Ñ [Èíñóëèí-Êîìá]                     │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Hoechst AG (Ãåðìàíèÿ)         │006176,       

                                                                                          │(ôëàêîíû) 40 ÌÅ/ìë - 10 ìë                                  │13.06.95      

                                                                                                                                                                    

│Êîìáàíòðèí [Ïèðàíòåë]                             │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CC01]   │òàáëåòêè æåâàòåëüíûå;         │Pfizer (Áåëüãèÿ)              │00323,        

                                                                                          │ñóñïåíçèÿ îðàëüíàÿ                                          │05.07.75,     

                                                                                                                                                      │13.11.86      

                                                                                                                                                                    

│Êîìáèâåíò {èïðàòðîïèóì áðîìèä 0.02 ìã,            │áðîíõîäèëàòèðóþùåå ñðåäñòâî [R03AK04]   │àýðîçîëü äîçèðîâàííûé 200 äîç │Boehringer Ingelheim S.A.R.L. │007556,       

│ñàëüáóòàìîë 0.12 ìã - äîçà}                                                               │(ôëàêîíû) - 10 ìë             │(Ôðàíöèÿ)                     │30.05.96      

                                                                                                                                                                    

│Êîìáèñòåðèë FGX 24 {ôðóêòîçà 60 ã, êñèëèò 30 ã,   │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ    │ðàñòâîð äëÿ èíôóçèé           │Fresenius (ÔÐÃ)               │01289, 23.05.86│

│äåêñòðîçà 33 ã}                                   │[B05BA04]                                                                                                         

                                                                                                                                                                    

│Êîìáèñòåðèë FGX 40 {ôðóêòîçà 100 ã, êñèëèò 50 ã,  │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ    │ðàñòâîð äëÿ èíôóçèé           │Fresenius (ÔÐÃ)               │01290, 23.05.86│

│äåêñòðîçà 50 ã}                                   │[B05BA03]                                                                                                         

                                                                                                                                                                    

│Êîìáóòîë [Ýòàìáóòîë]                              │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │òàáëåòêè 100, 200, 400, 600,  │Lupin Laboratories Ltd (Èíäèÿ)│02039, 14.01.91│

                                                                                          │800, 1000 ìã                                                              

                                                                                                                                                                    

│Êîìïåíñàí {äèãèäðîêñèàëþìèíèÿ íàòðèÿ öèòðàò}      │àíòàöèäíîå ñðåäñòâî [A02AX]             │òàáëåòêè 340 ìã; ñóñïåíçèÿ    │Pfizer (Ãåðìàíèÿ)             │005155,       

                                                                                          │îðàëüíàÿ (ôëàêîíû) 340 ìã|5                                 │20.07.94      

                                                                                          │ìë - 150 ìë; ñóñïåíçèÿ                                                    

                                                                                          │îðàëüíàÿ (ïàêåòû) 340 ìã|5 ìë │                                            

                                                                                          │- 5 ìë                                                                    

                                                                                                                                                                    

│Êîìïëàìèí [Êñàíòèíîëà íèêîòèíàò]                  │àíòèàãðåãàíòíîå ñðåäñòâî [C04AD02]      │äðàæå ðåòàðä 500 ìã; ðàñòâîð  │ICN-Galenika (Þãîñëàâèÿ)      │006584,       

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 150                                   │16.10.95      

                                                                                          │ìã/ìë - 2, 10 ìë                                                           

                                                                                                                                                                    

│Êîíâóëåêñ [Âàëüïðîåâàÿ êèñëîòà] {âàëüïðîàò íàòðèÿ}│ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AG01]    │òàáëåòêè 300 ìã               │Gerot Pharmazeutika (Àâñòðèÿ) │00842,        

                                                                                                                                                      │10.12.81,      

                                                                                                                                                      │23.06.92      

                                                                                                                                                                    

│Êîíâóëåêñ [Âàëüïðîåâàÿ êèñëîòà] {âàëüïðîàò íàòðèÿ}│ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AG01]    │êàïñóëû 150, 300 ìã; ìèêñòóðà │Leiras (Ôèíëÿíäèÿ)            │006613,       

                                                                                          │50 ìã/ìë                                                    │21.12.95      

                                                                                                                                                                    

│Êîíâóëüñîôèí [Âàëüïðîåâàÿ êèñëîòà] {âàëüïðîàò     │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AG01]    │òàáëåòêè 300 ìã               │Arzneimittelwerk Dresden Feb  │01231, 25.12.85│

│êàëüöèÿ}                                                                                                                │(ÃÄÐ)                                       

                                                                                                                                                                    

│Êîíäèëàéí Íèêîìåä [Ïîäîôèëëîòîêñèí] {ïîäîôèëëà    │öèòîñòàòè÷åñêîå ñðåäñòâî [D06BB04]      │ðàñòâîð äëÿ íàðóæíîãî         │Hafslund Nycomed Pharma AG    │006832,       

│ùèòîâèäíîãî ïðåïàðàò}                                                                     │ïðèìåíåíèÿ (ôëàêîíû) 5 ìã/ìë  │(Àâñòðèÿ)                     │15.11.95      

                                                                                                                                                                    

│Êîíäèëèí [Ïîäîôèëëîòîêñèí] {ïîäîôèëëà ùèòîâèäíîãî │öèòîñòàòè÷åñêîå ñðåäñòâî [D06BB04]      │ðàñòâîð äëÿ íàðóæíîãî         │Yamanouchi Europe B.V.        │006311,       

│ïðåïàðàò}                                                                                 │ïðèìåíåíèÿ (ôëàêîíû) 0.5%     │(Íèäåðëàíäû)                  │24.07.95      

                                                                                                                                                                    

│Êîíêîð [Áèñîïðîëîë]                               │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │ôèëìòàáëåòêè 5, 10 ìã         │E.Merck (Ãåðìàíèÿ)            │005469,       

                                                  │[C07AB07]                                                                                           │09.11.94      

                                                                                                                                                                    

│Êîíïèí [Èçîñîðáèä ìîíîíèòðàò]                     │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20, 40 ìã            │Tad Pharmazeutisches Werk     │006270,       

                                                                                                                        │GmbH (Ãåðìàíèÿ)               │12.07.95      

                                                                                                                                                                    

│Êîíñóïðåí [Öèêëîñïîðèí]                           │èììóíîäåïðåññàíò [L04AA01]              │ðàñòâîð îðàëüíûé              │Galena (×åõèÿ)                │005274,       

                                                                                                                                                      │30.08.94      

                                                                                                                                                                    

│Êîíòàê 400 {õëîðôåíàìèí 4 ìã, ôåíèëïðîïàíîëàìèí   │ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │êàïñóëû                       │Smithkline Beecham Consumer   │007517,       

│50 ìã}                                            │ïðîñòóäû [R05X]                                                       │Healthcare (Âåëèêîáðèòàíèÿ)   │17.05.96      

                                                                                                                                                                    

│Êîíòåìíîë [Ëèòèÿ êàðáîíàò]                        │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AN01]     │òàáëåòêè 500 ìã               │Slovakofarma SA (Ñëîâàêèÿ)    │2958,         

                                                                                                                                                      │23.06.94,     

                                                                                                                                                      │26.12.89      

                                                                                                                                                                    

│Êîíòðàêòóáåêñ {ëóêà ðåï÷àòîãî ÷åøóåê ýêñòðàêò 10  │àíòèêîàãóëÿíò ïðÿìîé äëÿ ìåñòíîãî       │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Merz Co GmbH (Ãåðìàíèÿ)       │003887,       

│ã, ãåïàðèí 5000 ÌÅ, àëàíòîèí 10 ã,                │ïðèìåíåíèÿ [C05BA53]                                                                                │28.04.94      

│ìåòèëãèäðîêñèáåíçîàò 150 ìã}                                                                                                                                        

                                                                                                                                                                    

│Êîíòðàñïàçìèí [Êëåíáóòåðîë]                       │áåòà2-àäðåíîñòèìóëÿòîð ñåëåêòèâíûé      │òàáëåòêè                      │Arzneimittelwerk Dresden Feb  │01424, 17.03.88│

                                                  │[R03CC13]                                                             │(ÃÄÐ)                                       

                                                                                                                                                                    

│Êîíòðèêàë [Àïðîòèíèí]                             │ïðîòåîëèçà èíãèáèòîð [B02AB01]          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Arzneimittelwerk Dresden GmbH │00124,        

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Ãåðìàíèÿ)                    │03.02.95,     

                                                                                          │(àìïóëû) 10000 ÅÄ /â                                        │10.05.84,     

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                  │19.03.71      

                                                                                                                                                                    

│Êîíöåíòðèí [Ýñöèí]                                │àíãèîïðîòåêòîðíîå ñðåäñòâî [C05CX]      │ãåëü (òóáû); ðàñòâîð äëÿ      │CT-Arzneimittel Chemishe      │006519,       

                                                                                          │íàðóæíîãî ïðèìåíåíèÿ (ôëàêîíû)│Tempelchof GmbH (Ãåðìàíèÿ)    │20.09.95      

                                                                                                                                                                    

│Êîíöåïòðîë [Íîíîêñèíîë]                           │êîíòðàöåïòèâíîå ñðåäñòâî [G02BB]        │ñâå÷è âàãèíàëüíûå 150 ìã      │Cilag International AG        │003494,       

                                                                                                                        │(Øâåéöàðèÿ)                   │04.11.93      

                                                                                                                                                                    

│Êîðâàòîí [Ìîëñèäîìèí]                             │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DX12]     │òàáëåòêè ôîðòå 4 ìã; òàáëåòêè │Hoechst AG (Ãåðìàíèÿ)         │003903,       

                                                                                          │ðåòàðä 8 ìã                                                 │11.05.94      

                                                                                                                                                                    

│Êîðâèòîë [Ìåòîïðîëîë]                             │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè 50, 100 ìã           │Berlin-Chemie AG (Ãåðìàíèÿ)   │005056,       

                                                  │[C07AB02]                                                                                           │29.06.94      

                                                                                                                                                                    

│Êîðãàðä [Íàäîëîë]                                 │áåòà-àäðåíîáëîêàòîð [C07AA12]           │òàáëåòêè 40, 80 ìã            │Bristol-Myers Squibb          │003313,        

                                                                                                                        │(Èíäîíåçèÿ)                   │09.09.93      

                                                                                                                                                                    

│Êîðãàðä [Íàäîëîë]                                 │áåòà-àäðåíîáëîêàòîð [C07AA12]           │òàáëåòêè 40, 80 ìã            │Bristol-Myers Squibb Egypt    │002219,        

                                                                                                                        │(Åãèïåò)                      │20.08.91      

                                                                                                                                                                    

│Êîðãàðä [Íàäîëîë]                                 │áåòà-àäðåíîáëîêàòîð [C07AA12]           │òàáëåòêè 40, 80 ìã            │E.R.Squibb & Sons Ltd         │006623,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │11.01.96      

                                                                                                                                                                    

│Êîðãàðä [Íàäîëîë]                                 │áåòà-àäðåíîáëîêàòîð [C07AA12]           │òàáëåòêè 40, 80 ìã            │Fako Ilaclary AS (Òóðöèÿ)     │002159,       

                                                                                                                                                      │17.06.91      

                                                                                                                                                                    

│Êîðäàíóì [Òàëèíîëîë]                              │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé [C07AB]│ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Arzneimittelwerk Dresden Feb  │00429,        

                                                                                          │10 ìã - 5 ìë                  │(ÃÄÐ)                         │16.06.88,     

                                                                                                                                                      │24.12.76      

                                                                                                                                                                    

│Êîðäàíóì 50 [Òàëèíîëîë]                           │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé [C07AB]│äðàæå                         │Arzneimittelwerk Dresden GmbH │003066,       

                                                                                                                        │(Ãåðìàíèÿ)                    │16.06.93      

                                                                                                                                                                    

│Êîðäàðîí [Àìèîäàðîí]                              │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BD01]     │òàáëåòêè 200 ìã               │Dogu Ilac Fabricasi AS        │002848,       

                                                                                                                        │(Òóðöèÿ)                      │16.02.93      

                                                                                                                                                                    

│Êîðäàðîí [Àìèîäàðîí]                              │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BD01]     │òàáëåòêè 200 ìã               │Krka (Ñëîâåíèÿ)               │00300,        

                                                                                                                                                      │14.05.74,     

                                                                                                                                                      │15.06.84,     

                                                                                                                                                      │29.03.95      

                                                                                                                                                                    

│Êîðäàðîí [Àìèîäàðîí]                              │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BD01]     │ðàñòâîð äëÿ âíóòðèâåííîãî     │Krka (ÑÔÐÞ)                   │00829,        

                                                                                          │ââåäåíèÿ (àìïóëû) 150 ìã - 3                                │10.06.91,     

                                                                                          │ìë                                                          │21.11.80      

                                                                                                                                                                    

│Êîðäàðîí [Àìèîäàðîí]                              │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BD01]     │òàáëåòêè 200 ìã               │Sanofi/labaz (Ôðàíöèÿ)        │00491,        

                                                                                                                                                      │01.09.77,     

                                                                                                                                                      │16.06.88      

                                                                                                                                                                    

│Êîðäàðîí [Àìèîäàðîí]                              │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BD01]     │òàáëåòêè 200 ìã               │Torrent Exports Ltd (Èíäèÿ)   │01866, 04.06.90│

                                                                                                                                                                    

│Êîðäàôåí [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa (ÏÍÐ)                   │2920, 20.04.89 │

                                                                                          │10 ìã                                                                     

                                                                                                                                                                    

│Êîðäàôëåêñ [Íèôåäèïèí]                            │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Egis (Âåíãðèÿ)                │005954,       

                                                                                          │10 ìã                                                       │13.04.95      

                                                                                                                                                                    

│Êîðäèïèí [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Krka (Þãîñëàâèÿ)              │01496, 03.10.88│

                                                                                          │îáîëî÷êîé 10 ìã                                                           

                                                                                                                                                                    

│Êîðäèïèí-ðåòàðä [Íèôåäèïèí]                       │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ðåòàðä 20 ìã         │Krka (ÑÔÐÞ)                   │002223,       

                                                                                                                                                      │27.08.91      

                                                                                                                                                                    

│Êîðåáåðîí [Íàòðèÿ ôòîðèä]                         │ïðåïàðàò ôòîðà [A12CD01]                │äðàæå 20 ìã                   │Arzneimittelwerk Dresden Feb  │01229, 25.12.85│

                                                                                                                        │(ÃÄÐ)                                       

                                                                                                                                                                    

│Êîðèíôàð [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │äðàæå 10 ìã                   │Arzneimittelwerk Dresden GmbH │002854,       

                                                                                                                        │(ÔÐÃ)                         │17.02.93      

                                                                                                                                                                    

│Êîðèíôàð [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │äðàæå ðåòàðä 20 ìã            │Arzneimittelwerk Dresden GmbH │002942,       

                                                                                                                        │(ÔÐÃ)                         │31.03.93      

                                                                                                                                                                    

│Êîðèíôàð [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │êàïëè îðàëüíûå (ôëàêîíû) 20   │Arzneimittelwerk Dresden GmbH │005229,        

                                                                                          │ìã/ìë                         │(Ãåðìàíèÿ)                    │17.08.94      

                                                                                                                                                                    

│Êîðìàãíåçèí [Ìàãíèÿ ñóëüôàò]                      │âàçîäèëàòèðóþùåå ñðåäñòâî [B05XA05]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Worwag Pharma GmbH (Ãåðìàíèÿ) │006765,        

                                                                                          │10%, 20%                                                    │31.10.95      

                                                                                                                                                                    

│Êîðñîäèë [Õëîðãåêñèäèí]                           │àíòèñåïòè÷åñêîå ñðåäñòâî [A01AB03]      │ïîëîñêàíèå ðòà                │Smithkline Beecham            │006010,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │03.05.95      

                                                                                                                                                                    

│Êîðòåô [Ãèäðîêîðòèçîí]                            │ãëþêîêîðòèêîñòåðîèä [H02AB09]           │òàáëåòêè 5, 10, 20 ìã         │Upjohn Company (ÑØÀ)          │007509,       

                                                                                                                                                      │15.05.96      

                                                                                                                                                                    

│Êîðòèàçåì [Äèëòèàçåì]                             │ÁÌÊÊ [C08DB01]                          │òàáëåòêè                      │Hemofarm D.D. (Þãîñëàâèÿ)     │006294,       

                                                                                                                                                      │17.07.95      

                                                                                                                                                                    

│Êîðòèíåôô [Ôëóäðîêîðòèçîí]                        │ãëþêîêîðòèêîñòåðîèä [H02AA02]           │ìàçü ãëàçíàÿ 0.1%             │Jelfa SA (Ïîëüøà)             │006616,       

                                                                                                                                                      │29.12.95      

                                                                                                                                                                    

│Êîðòèíåôô [Ôëóäðîêîðòèçîí]                        │ãëþêîêîðòèêîñòåðîèä [H02AA02]           │òàáëåòêè 0.1 ìã               │Polfa, Pabianickie Zaklady    │007522,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │21.05.96      

                                                                                                                                                                    

│Êîñìåãåí [Äàêòèíîìèöèí]                           │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DA01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Merck Sharp & Dohme           │003445,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Íèäåðëàíäû)                  │22.10.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 0.5 ìã                                                 

                                                                                                                                                                    

│Êîòðèì-Ðàòèîôàðì [Êî-òðèìîêñàçîë]                 │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 480 ìã; òàáëåòêè     │Ratiopharm GmbH & Co          │003414,       

│{ñóëüôàìåòîêñàçîë 400 ìã, òðèìåòîïðèì 80 ìã;      │ñðåäñòâî [J01EE01]                      │ôîðòå 960 ìã; ñîê äëÿ         │(Ãåðìàíèÿ)                    │12.10.93      

│ñóëüôàìåòîêñàçîë 800 ìã, òðèìåòîïðèì 160 ìã}                                              │âçðîñëûõ (ôëàêîíû) 100 ìë                                                 

                                                                                                                                                                    

│Êîòðèìîêñàçîë [Êî-òðèìîêñàçîë] {ñóëüôàìåòîêñàçîë  │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 400 ìã/80 ìã;        │Promed Exports Pvt Ltd (Èíäèÿ)│003046,       

│400 ìã, òðèìåòîïðèì 80 ìã}                        │ñðåäñòâî [J01EE01]                      │ñóñïåíçèÿ îðàëüíàÿ 200 ìã/40                                │08.06.93      

                                                                                          │ìã|5 ìë                                                                   

                                                                                                                                                                    

│Êîòðèìîêñàçîë [Êî-òðèìîêñàçîë] {ñóëüôàìåòîêñàçîë, │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 120, 480, 960 ìã;    │Wave International (Èíäèÿ)    │007158,       

│òðèìåòîïðèì}                                      │ñðåäñòâî [J01EE01]                      │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)                                │20.03.96      

                                                                                          │240 ìã|5 ìë                                                               

                                                                                                                                                                    

│Êîòðèìîë [Êî-òðèìîêñàçîë] {ñóëüôàìåòîêñàçîë 400   │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 480, 960 ìã;         │Ipca Laboratories Ltd (Èíäèÿ) │005153,       

│ìã, òðèìåòîïðèì 80 ìã; ñóëüôàìåòîêñàçîë 800 ìã,   │ñðåäñòâî [J01EE01]                      │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)                                │20.07.94      

│òðèìåòîïðèì 160 ìã}                                                                       │200 ìã/40 ìã|5 ìë, 400 ìã/80                                              

                                                                                          │ìã|5 ìë                                                                   

                                                                                                                                                                    

│Êðåîí {ïàíêðåàòèí 0.3 ã, ëèïàçà 8000 ÌÅ, àìèëàçà  │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │êàïñóëû 300 ìã                │Kali-Chemie Pharma GmbH (ÔÐÃ) │002057,       

│9000 ÌÅ, ïðîòåàçà 450 ÌÅ}                         │[A09AA02]                                                                                           │04.03.91      

                                                                                                                                                                    

│Êðèîáóëèí ÒÈÌ 3 (Ôàêòîð VIII ÷åëîâåêà             │ãåìîñòàòè÷åñêîå ñðåäñòâî [B02BD]        │ëèîôèëèç.ïîðîøîê äëÿ          │Immuno AG (Àâñòðèÿ)           │005807,       

│êîíöåíòðèðîâàííûé) [Ôàêòîð ñâåðòûâàíèÿ êðîâè VIII │                                        │ïðèãîòîâëåíèÿ âíóòðèâåííîãî                                 │07.03.95      

│è IX â êîìáèíàöèè] {ôàêòîð ñâåðòûâàíèÿ êðîâè VIII}│                                        │ðàñòâîðà (ôëàêîíû) 250, 500,                                              

                                                                                          │1000 ÌÅ /â êîìïëåêòå ñ                                                    

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Êðèîñòàò ÑÄ-2 [Ôàêòîð ñâåðòûâàíèÿ êðîâè VIII è IX │ãåìîñòàòè÷åñêîå ñðåäñòâî [B02BD]        │ëèîôèëèç.ïîðîøîê äëÿ          │Grifols SA (Èñïàíèÿ)          │002820,       

│â êîìáèíàöèè] {ôàêòîð ñâåðòûâàíèÿ êðîâè VIII}                                             │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │19.01.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 250, 500,                                              

                                                                                          │1000 ÅÄ                                                                   

                                                                                                                                                                    

│Êðèñòåïèí {äèãèäðîýðãîêðèñòèí 0.58 ìã, ðåçåðïèí   │ãèïîòåíçèâíîå êîìáèíèðîâàííîå ñðåäñòâî  │äðàæå                         │Lechiva (×åõèÿ)               │2537,         

│0.1 ìã, êëîïàìèä 5 ìã}                            │[C02LA51]                                                                                           │16.12.93,     

                                                                                                                                                      │17.01.78       

                                                                                                                                                                    

│Êðîìî [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò       │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî           │êàïëè ãëàçíûå (ôëàêîíû        │CT-Arzneimittel Chemishe      │007440,       

│äèíàòðèÿ}                                         │[R01AC01][S01GX01]                      │ïëàñòèêîâûå) 10 ìã - 0.5 ìë;  │Tempelchof GmbH (Ãåðìàíèÿ)    │15.04.96       

                                                                                          │ñïðåé íàçàëüíûé (ôëàêîíû) 2.8 │                                            

                                                                                          │ìã|äîçà                                                                   

                                                                                                                                                                     

│Êðîìîãåêñàë [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî           │êàïëè ãëàçíûå (ôëàêîíû) 2%;   │Hexal Pharma GmbH (Ãåðìàíèÿ)  │005980,       

│äèíàòðèÿ}                                         │[R01AC01][S01GX01]                      │ñïðåé íàçàëüíûé (ôëàêîíû) 2%                                │19.04.95      

                                                                                                                                                                     

│Êðîìîãåí èíãàëÿòîð [Êðîìîãëèöèåâàÿ êèñëîòà]       │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R03BC01] │àýðîçîëü äîçèðîâàííûé 1       │Norton Healthcare Ltd         │005243,       

│{êðîìîãëèêàò äèíàòðèÿ}                                                                    │ìã|äîçà, 5 ìã|äîçà            │(Âåëèêîáðèòàíèÿ)              │19.08.94      

                                                                                                                                                                    

│Êðîìîãëèí [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò   │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî           │ðàñòâîð äëÿ èíãàëÿöèé         │Ludwig Merckle GmbH (Àâñòðèÿ) │002981,       

│äèíàòðèÿ}                                         │[R01AC01][R03BC01]                      │(àìïóëû) 20 ìã - 2 ìë;                                      │27.04.93      

                                                                                          │àýðîçîëü äîçèðîâàííûé 1                                                   

                                                                                          │ìã/0.05 ìë; àýðîçîëü íàçàëüíûé│                                            

                                                                                                                                                                    

│Êðîìîãëèöèí-Ðàòèîôàðì [Êðîìîãëèöèåâàÿ êèñëîòà]    │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R03BC01] │àýðîçîëü äîçèðîâàííûé 1       │Ratiopharm GmbH & Co          │005001,       

│{êðîìîãëèêàò äèíàòðèÿ}                                                                    │ìã|äîçà                       │(Ãåðìàíèÿ)                    │15.06.94      

                                                                                                                                                                    

│Êðîìîëèí [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò    │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî           │ïîðîøîê äëÿ èíãàëÿöèé         │Ilsan Iltash AS (Òóðöèÿ)      │003894,       

│äèíàòðèÿ}                                         │[R01AC01][R03BC01]                      │(êàïñóëû çåëåíûå) 20 ìã;                                    │04.05.94      

                                                                                          │ïîðîøîê äëÿ èíãàëÿöèé                                                     

                                                                                          │(êàïñóëû êðàñíûå) 20 ìã;                                                  

                                                                                          │àýðîçîëü íàçàëüíûé                                                        

                                                                                          │(ïóëüâåðèçàòîð) 2%                                                        

                                                                                                                                                                    

│Êðîìîëèí [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò    │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R03BC01] │ïîðîøîê äëÿ èíãàëÿöèé         │Orion Pharmaceutica           │002073,       

│äèíàòðèÿ}                                                                                 │(êàïñóëû) 20 ìã               │(Ôèíëÿíäèÿ)                   │14.03.91      

                                                                                                                                                                    

│Êðîìîñîë [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò    │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R01AC01] │àýðîçîëü íàçàëüíûé 2.6        │Polfa, Rzeszowskie Zaklady    │007566,       

│äèíàòðèÿ}                                                                                 │ìã/äîçà (ôëàêîíû ñ äîçàòîðîì) │Farmaceutyczne SA (Ïîëüøà)    │04.06.96      

                                                                                          │2% - 28 ìë                                                                

                                                                                                                                                                    

│Êñàíàêñ [Àëïðàçîëàì]                              │òðàíêâèëèçàòîð [N05BA12]                │òàáëåòêè 1 ìã, 2 ìã           │Upjohn (Áåëüãèÿ)              │002317,       

                                                                                                                                                      │10.01.92      

                                                                                                                                                                    

│Êñàíàêñ [Àëïðàçîëàì]                              │òðàíêâèëèçàòîð [N05BA12]                │òàáëåòêè 0.25, 0.5 ìã         │N.V.Upjohn SA (Áåëüãèÿ)       │006663,       

                                                                                                                                                      │20.03.96      

                                                                                                                                                                    

│Êñàíàêñ ðåòàðä [Àëïðàçîëàì]                       │òðàíêâèëèçàòîð [N05BA12]                │òàáëåòêè 0.5, 1, 2, 3 ìã      │Upjohn (Áåëüãèÿ)              │007661,       

                                                                                                                                                      │22.07.96      

                                                                                                                                                                    

│Êñåíèä [Äèêëîôåíàê]                               │ÍÏÂÑ [M01AB05]                          │òàáëåòêè 25, 50 ìã; òàáëåòêè  │Biogalenique (Ôðàíöèÿ)        │003209,       

                                                                                          │ðåòàðä 100 ìã; ñâå÷è 25, 100                                │09.08.93      

                                                                                          │ìã; ðàñòâîð äëÿ èíúåêöèé                                                  

                                                                                          │(àìïóëû) 75 ìã - 3 ìë                                                     

                                                                                                                                                                    

│Êñèëåñòåçèí [Ëèäîêàèí]                            │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C01BB01] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Espe (Ãåðìàíèÿ)               │003378,       

                                                                                          │20 ìã - 1.8 ìë                                              │12.10.93      

                                                                                                                                                                    

│Êñèëîäîíò [Ëèäîêàèí]                              │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C01BB01] │ðàñòâîð äëÿ èíúåêöèé          │Molteni Pharmaceuticals       │002952,       

                                                                                          │(êàïñóëû-àìïóëû) 2% - 1.8 ìë; │(Èòàëèÿ)                      │31.03.93      

                                                                                          │ðàñòâîð äëÿ èíúåêöèé 2%                                                   

                                                                                          │(êàïñóëû-àìïóëû ñ àäðåíàëèíîì │                                            

                                                                                          │- 1:50000, 1:80000, 1:100000) │                                            

                                                                                          │1.8 ìë                                                                    

                                                                                                                                                                     

│Êñèëîêàèí [Ëèäîêàèí]                              │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C01BB01] │ðàñòâîð äëÿ èíúåêöèé          │Astra (Øâåöèÿ)                │007090,       

                                                                                          │(ôëàêîíû) 1%, 2%                                            │15.02.96      

                                                                                                                                                                     

│Êñèëîêàèí àäðåíàëèí {ëèäîêàèí, ýïèíåôðèí}         │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [N01BB52] │ðàñòâîð äëÿ èíúåêöèé          │Astra (Øâåöèÿ)                │007091,       

                                                                                          │(ôëàêîíû) 5 ìã/ìë + 5 ìêã/ìë, │                              │15.02.96      

                                                                                          │10 ìã/ìë + 5 ìêã/ìë, 20 ìã/ìë │                                             

                                                                                          │+ 5 ìêã/ìë                                                                

                                                                                                                                                                    

│Êñèëîêàèí àäðåíàëèí {ëèäîêàèí, ýïèíåôðèí}         │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [N01BB52] │ðàñòâîð äëÿ èíúåêöèé          │Astra (Øâåöèÿ)                │007166,       

                                                                                          │(êàðòðèäæè) 20 ìã/12.5 ìêã                                  │27.03.96      

                                                                                                                                                                    

│Êñèëîìåòàçîëèí [Êñèëîìåòàçîëèí]                   │àëüôà-àäðåíîñòèìóëÿòîð [R01AA07]        │ãåëü (òóáû) 0.05%, 0.1%       │Polfa, Poznanskie Zaklady     │006522,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │20.09.95      

                                                                                                                                                                    

│Êñèëîìåòàçîëèí [Êñèëîìåòàçîëèí]                   │àëüôà-àäðåíîñòèìóëÿòîð [R01AA07]        │êàïëè íàçàëüíûå 0.05%, 0.1%   │Polfa, Rzeszowskie Zaklady    │005541,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │05.12.94      

                                                                                                                                                                    

│Êñèëîðîëëàíä áåç àäðåíàëèíà [Ëèäîêàèí]            │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C01BB01] │ðàñòâîð äëÿ èíúåêöèé          │Pierre Rolland (Ôðàíöèÿ)      │005104,       

                                                                                                                                                      │06.07.94      

                                                                                                                                                                    

│Êñèëîðîëëàíä ñ àäðåíàëèíîì {ëèäîêàèí 2%,          │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [N01BB52] │ðàñòâîð äëÿ èíúåêöèé          │Pierre Rolland (Ôðàíöèÿ)      │005103,       

│ýïèíåôðèí 1:80000}                                                                                                                                    │06.07.94      

                                                                                                                                                                    

│Êñèëîðîëëàíä ñ íîðàäðåíàëèíîì {ëèäîêàèí 2%,       │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [N01BB52] │ðàñòâîð äëÿ èíúåêöèé          │Pierre Rolland (Ôðàíöèÿ)      │005105,       

│íîðýïèíåôðèí 1:80000}                                                                                                                                 │06.07.94      

                                                                                                                                                                    

│Êñèìåëèí [Êñèëîìåòàçîëèí]                         │àëüôà-àäðåíîñòèìóëÿòîð [R01AA07]        │ñïðåé íàçàëüíûé 15 ìë - 0.5,  │Nycomed Dak AS (Äàíèÿ)        │003255,       

                                                                                          │1 ìã/ìë; êàïëè íàçàëüíûå                                    │20.08.93      

                                                                                          │(ôëàêîíû ïëàñòèêîâûå) 10 ìë - │                                            

                                                                                          │0.5, 1 ìã/ìë; êàïëè íàçàëüíûå │                                            

                                                                                          │(àìïóëû ïëàñòèêîâûå) 0.3 ìë - │                                            

                                                                                          │0.5, 1 ìã/ìë                                                              

                                                                                                                                                                    

│Êóçèêðîì [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò    │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [S01GX01] │ðàñòâîð îôòàëüìîëîãè÷åñêèé    │Laboratorious Cusi (Èñïàíèÿ)  │003235,       

│äèíàòðèÿ}                                                                                 │(ôëàêîíû) 4% - 10 ìë                                        │16.08.93      

                                                                                                                                                                    

│Êóçèìîëîë [Òèìîëîë]                               │áåòà-àäðåíîáëîêàòîð [S01ED01]           │êàïëè ãëàçíûå 0.25%, 0.5%     │Laboratorious Cusi (Èñïàíèÿ)  │003162,       

                                                                                                                                                      │19.07.93      

                                                                                                                                                                    

│Êóêñàíîðì [Àòåíîëîë]                              │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè 50, 100 ìã           │Tad Pharmazeutisches Werk     │003374,       

                                                  │[C07AB03]                                                             │GmbH (Ãåðìàíèÿ)               │05.10.93      

                                                                                                                                                                    

│Êóêñàöèëëèí [Àìîêñèöèëëèí]                        │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │òàáëåòêè ïîêðûòûå îáîëî÷êîé 1 │Tad Pharmazeutisches Werk     │006273,       

                                                  │[J01CA04]                               │ã                             │GmbH (Ãåðìàíèÿ)               │12.07.95      

                                                                                                                                                                    

│Êóëüïàí-Ñ {ïàðàöåòàìîë 0.5 ã, ìåòèîíèí 0.25 ã}    │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Daewoong Pharmaceutical Co    │002536,       

                                                  │ñðåäñòâî [N02BE51]                                                    │Ltd (Êîðåÿ Þæíàÿ)             │02.07.92      

                                                                                                                                                                    

│Êóïåð -Ò Êó 200                                   │êîíòðàöåïòèâíîå âíóòðèìàòî÷íîå ñðåäñòâî │êîíòðàöåïòèâ âíóòðèìàòî÷íûé   │Leiras (Ôèíëÿíäèÿ)            │00704,        

                                                  │[G02BA02]                                                                                           │16.04.90,     

                                                                                                                                                      │23.08.79      

                                                                                                                                                                    

│Êóïèð                                             │äåçèíòîêñèêàöèîííîå ñðåäñòâî [V03AB]    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │(Óçáåêèñòàí)                  │94/302/7      

                                                                                          │0.15% - 2 ìë                                                              

                                                                                                                                                                    

│Êóïðåíèë [Ïåíèöèëëàìèí]                           │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî [M01CC01]│òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa, Kutnowskie Zaklady     │2763,         

                                                                                          │250 ìã                        │Farmaceutyczne SA (Ïîëüøà)    │01.12.83,     

                                                                                                                                                      │25.04.95       

                                                                                                                                                                    

│Êóðàíòèë [Äèïèðèäàìîë]                            │âàçîäèëàòèðóþùåå ñðåäñòâî [B01AC07]     │äðàæå 25, 75 ìã               │Berlin-Chemie AG (ÔÐÃ)        │002395,       

                                                                                                                                                      │29.01.92       

                                                                                                                                                                    

│Êóðàíòèë N25 (Äèïèðèäàìîë) [Äèïèðèäàìîë]          │âàçîäèëàòèðóþùåå ñðåäñòâî [B01AC07]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Berlin-Chemie AG (Ãåðìàíèÿ)   │007485,       

                                                                                          │25 ìã                                                       │05.05.96      

                                                                                                                                                                    

│Êóðàíòèë N75 (Äèïèðèäàìîë) [Äèïèðèäàìîë]          │âàçîäèëàòèðóþùåå ñðåäñòâî [B01AC07]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Berlin-Chemie AG (Ãåðìàíèÿ)   │007484,       

                                                                                          │75 ìã                                                       │05.05.96      

                                                                                                                                                                    

│Êóòèâåéò [Ôëóòèêàçîí]                             │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │êðåì (òóáû) 0.05%; ìàçü       │Glaxo (Âåëèêîáðèòàíèÿ)        │006517,       

                                                  │ïðèìåíåíèÿ [D07AC17]                    │(òóáû) 0.005%                                               │20.09.95      

                                                                                                                                                                    

│Ë-àëàíèí                                          │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00827,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-àðãèíèí                                         │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00813,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-àðãèíèí                                         │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00980, 23.12.82│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ë-àñïàðàãèí                                       │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00820,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │09.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-àñïàðàãèíîâàÿ êèñëîòà                           │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00818,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │09.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-àñïàðàãèíîâàÿ êèñëîòà                           │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00961, 23.12.82│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ë-âàëèí                                           │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00826,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-âàëèí                                           │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00978, 23.12.82│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ë-ãèñòåãèí                                        │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00823,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │09.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-ãèñòèäèí                                        │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00981, 23.12.82│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ë-ãëóòàìèí                                        │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00964, 23.12.82│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ë-ãëóòàìèíîâàÿ êèñëîòà                            │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00817,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-ãëóòàìèíîâàÿ êèñëîòà                            │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00963, 23.12.82│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                     

                                                                                                                                                                    

│Ë-èçîëåéöèí                                       │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00822,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,      

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-ëåéöèí                                          │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00819,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │09.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                     

│Ë-ëèçèí                                           │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00810,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-ëèçèí àöåòàò                                    │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00983, 23.12.82│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ë-ìåòèîíèí                                        │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00824,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │09.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-ïðîëèí                                          │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00814,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-ñåðèí                                           │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00808,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │09.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-ñåðèí                                           │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00974, 23.12.82│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ë-òèðîçèí                                         │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00821,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-òèðîçèí                                         │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00977, 23.12.82│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ë-òèðîêñèí [Ëåâîòèðîêñèí]                         │òèðåîèäíîå ñðåäñòâî [H03AA01]           │òàáëåòêè 100 ìêã              │Henning Berlin GmbH (Ãåðìàíèÿ)│02001, 01.11.90│

                                                                                                                                                                    

│Ë-òèðîêñèí 50 Áåðëèí Õåìè [Ëåâîòèðîêñèí]          │òèðåîèäíîå ñðåäñòâî [H03AA01]           │òàáëåòêè 50 ìêã               │Berlin-Chemie AG (Ãåðìàíèÿ)   │003226,       

                                                                                                                                                      │11.08.93      

                                                                                                                                                                    

│Ë-òèðîêñèí-100 Áåðëèí Õåìè [Ëåâîòèðîêñèí]         │òèðåîèäíîå ñðåäñòâî [H03AA01]           │òàáëåòêè 100 ìêã              │Berlin-Chemie AG (Ãåðìàíèÿ)   │003226,       

                                                                                                                                                      │11.08.93      

                                                                                                                                                                    

│Ë-òðåîíèí                                         │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00812,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-òðåîíèí                                         │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00975, 23.12.82│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ë-òðèïòîôàí                                       │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00815,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-òðèïòîôàí                                       │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │01009, 22.06.83│

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ë-ôåíèëàëàíèí                                     │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00811,         

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                     

│Ë-ôåíèëàëàíèí                                     │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Kyowa Hakko Kogyo Co Ltd      │00972,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ       │(ßïîíèÿ)                      │21.07.94,     

                                                                                                                                                      │23.12.82      

                                                                                                                                                                    

│Ë-öèñòåèí                                         │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00816,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │08.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ë-öèñòèí                                          │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ,   │àìèíîêèñëîòà äëÿ              │Ajinomoto Co Inc (ßïîíèÿ)     │00809,        

                                                  │àìèíîêèñëîòà [B05BA01]                  │ïàðåíòåðàëüíîãî ïèòàíèÿ                                     │09.12.93,     

                                                                                                                                                      │20.10.80      

                                                                                                                                                                    

│Ëàãîäåí                                           │ãåìîñòàòè÷åñêîå ñðåäñòâî [B02BX]        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │(Óêðàèíà)                     │92/221/3      

                                                                                          │0.5% - 10 ìë                                                              

                                                                                                                                                                    

│Ëàäèîìèë [Ìàïðîòèëèí]                             │àíòèäåïðåññàíò [N06AA21]                │òàáëåòêè 25, 50 ìã; ðàñòâîð   │Pliva (Õîðâàòèÿ)              │002548,       

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 25 ìã - │                              │08.07.92      

                                                                                          │2 ìë                                                                      

                                                                                                                                                                    

│Ëàçèêñ [Ôóðîñåìèä]                                │äèóðåòè÷åñêîå ñðåäñòâî [C03CA01]        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hoechst (Èíäèÿ)               │01197, 04.11.85│

                                                                                          │2 ìë                                                                      

                                                                                                                                                                    

│Ëàçèêñ [Ôóðîñåìèä]                                │äèóðåòè÷åñêîå ñðåäñòâî [C03CA01]        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hoechst AG (ÔÐÃ)              │00063,        

                                                                                          │20 ìã - 2 ìë; òàáëåòêè 40 ìã                                │20.12.83,     

                                                                                                                                                      │30.10.70      

                                                                                                                                                                    

│Ëàçèêñ [Ôóðîñåìèä]                                │äèóðåòè÷åñêîå ñðåäñòâî [C03CA01]        │òàáëåòêè 40 ìã                │Hoechst Ltd (Èíäèÿ)           │003730,       

                                                                                                                                                      │25.02.94      

                                                                                                                                                                    

│Ëàçèêñ [Ôóðîñåìèä]                                │äèóðåòè÷åñêîå ñðåäñòâî [C03CA01]        │òàáëåòêè 40 ìã; ðàñòâîð äëÿ   │Hoechst-Roussel               │005022,       

                                                                                          │èíúåêöèé (àìïóëû) 1% - 2, 4,  │Pharmaceutical (ÑØÀ)          │20.06.94      

                                                                                          │10 ìë                                                                     

                                                                                                                                                                    

│Ëàçèêñ [Ôóðîñåìèä]                                │äèóðåòè÷åñêîå ñðåäñòâî [C03CA01]        │òàáëåòêè 40 ìã; ðàñòâîð äëÿ   │Turk Hoechst AS (Òóðöèÿ)      │005024,       

                                                                                          │èíúåêöèé (àìïóëû) 1% - 2 ìë                                 │20.06.94      

                                                                                                                                                                    

│Ëàçèêñ [Ôóðîñåìèä]                                │äèóðåòè÷åñêîå ñðåäñòâî [C03CA01]        │òàáëåòêè 40 ìã; ðàñòâîð äëÿ   │Servo-Michal (Þãîñëàâèÿ)      │00200,        

                                                                                          │èíúåêöèé (àìïóëû) 20 ìã - 2 ìë│                              │21.02.85,     

                                                                                                                                                      │24.02.72      

                                                                                                                                                                    

│Ëàçèëàêòîí {ñïèðîíîëàêòîí 50, 100 ìã, ôóðîñåìèä   │äèóðåòè÷åñêîå êîìáèíèðîâàííîå ñðåäñòâî  │êàïñóëû 50, 100 ìã            │Hoechst AG (Ãåðìàíèÿ)         │005308,       

│20 ìã}                                            │[C03EB01]                                                                                           │12.09.94      

                                                                                                                                                                    

│Ëàçîëâàí [Àìáðîêñîë]                              │îòõàðêèâàþùåå ñðåäñòâî [R05CB06]        │òàáëåòêè 30 ìã; ðàñòâîð äëÿ   │Boehringer Ingelheim          │007174,       

                                                                                          │èíúåêöèé (àìïóëû) 15 ìã - 2   │International GmbH (Ãåðìàíèÿ) │04.04.96      

                                                                                          │ìë; ðàñòâîð îðàëüíûé                                                      

                                                                                          │(ôëàêîíû) 15 ìã - 2 ìë;                                                   

                                                                                          │ðàñòâîð äëÿ èíãàëÿöèé                                                     

                                                                                          │(ôëàêîíû) 15 ìã - 2 ìë; ñèðîï │                                            

                                                                                          │(ôëàêîíû) 15 ìã - 5 ìë                                                    

                                                                                                                                                                    

│Ëàéäðîêñèë [Öåôàäðîêñèë]                          │àíòèáèîòèê, öåôàëîñïîðèí [J01DA09]      │êàïñóëû 500 ìã; òàáëåòêè 1000 │Lyka Labs Ltd (Èíäèÿ)         │003533,        

                                                                                          │ìã; ïîðîøîê äëÿ ïðèãîòîâëåíèÿ │                              │30.11.93      

                                                                                          │îðàëüíîé ñóñïåíçèè (ôëàêîíû)                                              

                                                                                          │40 ìë - 125 ìã|5 ìë, 250 ìã|5 │                                             

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ëàéïðîêâèí [Öèïðîôëîêñàöèí]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Lyka Labs Ltd (Èíäèÿ)         │003109,       

                                                  │[J01MA02]                                                                                           │29.06.93      

                                                                                                                                                                    

│Ëàêðèñèí [Ãèïðîìåëëîçà]                           │îôòàëüìîëîãè÷åñêîå ñðåäñòâî [S01KA02]   │êàïëè ãëàçíûå                 │Spofa (×ÑÑÐ)                  │2925, 16.05.89 │

│{ãèäðîêñèïðîïèëìåòèëöåëëþëîçà 60 ìã, áîðíàÿ                                                                                                                         

│êèñëîòà 82.5 ìã, íàòðèÿ òåòðàáîðàò 20 ìã - 1 ìë}                                                                                                                    

                                                                                                                                                                    

│Ëàêðèñèôè [Ãèïðîìåëëîçà]                          │îôòàëüìîëîãè÷åñêîå ñðåäñòâî [S01KA02]   │êàïëè ãëàçíûå                 │S.I.F.I. Spa (Èòàëèÿ)         │01922, 19.07.90│

│{ãèäðîêñèïðîïèëìåòèëöåëëþëîçà 0.9 ã, íàòðèÿ                                                                                                                         

│ôîñôàò 0.8 ã, íàòðèÿ ôîñôàò 1.8 ã, áåíçàëêîíèé 10 │                                                                                                                  

│ìã, ÝÄÒÀ äèíàòðèÿ 0.1 ã, íàòðèÿ õëîðèä 0.2 ã -                                                                                                                      

│100 ìë}                                                                                                                                                             

                                                                                                                                                                    

│Ëàêñàêîäèë [Áèñàêîäèë]                            │ñëàáèòåëüíîå ñðåäñòâî [A06AB02]         │òàáëåòêè 5 ìã                 │Torrent Exports Ltd (Èíäèÿ)   │002247,       

                                                                                                                                                      │11.10.91      

                                                                                                                                                                    

│Ëàêñáåíå [Áèñàêîäèë]                              │ñëàáèòåëüíîå ñðåäñòâî [A06AB02]         │òàáëåòêè ïîêðûòûå îáîëî÷êîé 5 │Ludwig Merckle GmbH (Àâñòðèÿ) │003028,       

                                                                                          │ìã; ñâå÷è 10 ìã                                             │01.06.93      

                                                                                                                                                                    

│Ëàêñèãàë {íàòðèÿ ïèêîñóëüôàò 7.5 ìã, ñîðáèòîë 640 │ñëàáèòåëüíîå ñðåäñòâî [A06AB58]         │êàïëè                         │Galena (×åõèÿ)                │006620,       

│ìã, ìåòèëïàðàáåí 2.06 ìã - 1 ìë}                                                                                                                      │11.01.96      

                                                                                                                                                                    

│Ëàêñîìàã [Ìàãíèÿ ãèäðîêñèä]                       │ñëàáèòåëüíîå ñðåäñòâî [A02AA04]         │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Eipico (Åãèïåò)               │003258,       

                                                                                          │125 ìë                                                      │23.08.93      

                                                                                                                                                                    

│Ëàêñîôèí [Ìàãíèÿ ãèäðîêñèä] {ìàãíèÿ ãèäðîêñèä,    │ñëàáèòåëüíîå ñðåäñòâî [A02AA04]         │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Eipico (Åãèïåò)               │003259,       

│ïàðàôèí}                                                                                  │125 ìë                                                      │23.08.93      

                                                                                                                                                                    

│Ëàêòàìèë {àëãåëäðàò 250 ìã, ìàãíèÿ ãèäðîêñèä 400  │àíòàöèäíîå ñðåäñòâî [A02AX]             │òàáëåòêè 250 ìã/400 ìã;       │Beximco Pharmaceuticals Ltd   │006200,       

│ìã}                                                                                       │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │(Áàíãëàäåø)                   │21.06.95      

                                                                                          │175 ìã/225 ìã|5 ìë                                                        

                                                                                                                                                                    

│Ëàêòîäåë [Áðîìîêðèïòèí]                           │äîôàìèí-ñòèìóëÿòîð [N04BC01]            │òàáëåòêè 2.5 ìã               │Amoun Pharmaceutical          │005979,       

                                                                                                                        │Industries Co, Apic (Åãèïåò)  │19.04.95      

                                                                                                                                                                    

│Ëàêòîñîðáàë {àëüáóìèí 50 ã, ñîðáèòîë 200 ã,       │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05AA]       │ðàñòâîð äëÿ èíôóçèé (áóòûëêè  │(Óêðàèíà)                     │92/210/9      

│íàòðèÿ ëàêòàò 7% 312 ã, íàòðèÿ õëîðèä 8 ã,                                                │äëÿ êðîâè) 50, 100, 200 ìë                                                

│êàëüöèÿ õëîðèä 0.1 ã, êàëèÿ õëîðèä 75 ìã, íàòðèÿ                                                                                                                    

│ãèäðîêàðáîíàò 0.1 ã, íàòðèÿ êàïðèëàò 3 ã - 1 ë}                                                                                                                     

                                                                                                                                                                    

│Ëàêòðàçà [Ëàêòàçà]                                │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │êàïñóëû 250 ìã                │Schwarz Pharma Kremers Urban  │007543,       

                                                  │[A09AA]                                                               │Company (ÑØÀ)                 │27.05.96      

                                                                                                                                                                    

│Ëàêòóëîçà [Ëàêòóëîçà]                             │ñëàáèòåëüíîå ñðåäñòâî [A06AD11]         │ñèðîï (ôëàêîíû) 300 ìë        │Eipico (Åãèïåò)               │003260,       

                                                                                                                                                      │23.08.93      

                                                                                                                                                                    

│Ëàêòóëîçà ñèðîï [Ëàêòóëîçà]                       │ñëàáèòåëüíîå ñðåäñòâî [A06AD11]         │ñèðîï (ôëàêîíû)               │Poli Industria Chimica Spa    │006855,       

                                                                                                                        │(Èòàëèÿ)                      │24.11.95      

                                                                                                                                                                    

│Ëàìàäèí [Ìåòîêñàëåí]                              │ôîòîñåíñèáèëèçèðóþùåå ñðåäñòâî [D05AD02]│òàáëåòêè 10 ìã                │Alkaloid (ÑÔÐÞ)               │002075,       

                                                                                                                                                      │14.03.91      

                                                                                                                                                                    

│Ëàìèçèë [Òåðáèíàôèí]                              │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01BA02]     │òàáëåòêè 250 ìã               │Sandoz Pharma (Øâåéöàðèÿ)     │002826,        

                                                                                                                                                      │01.02.93      

                                                                                                                                                                    

│Ëàìèçèë [Òåðáèíàôèí]                              │ïðîòèâîãðèáêîâîå ñðåäñòâî               │òàáëåòêè 125 ìã; êðåì 1%      │Sandoz Pharma (Øâåéöàðèÿ)     │003886,        

                                                  │[D01AE15][D01BA02]                                                                                  │28.04.94      

                                                                                                                                                                    

│Ëàìèêòàë [Ëàìîòðèäæèí]                            │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AX09]    │òàáëåòêè 25, 50, 100 ìã       │Wellcome Foundation Ltd       │002568,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │27.07.92      

                                                                                                                                                                    

│Ëàìîç [Àëïðàçîëàì]                                │òðàíêâèëèçàòîð [N05BA12]                │òàáëåòêè 0.25, 0.5, 1 ìã      │M.J.Pharmaceuticals Ltd       │007041,       

                                                                                                                        │(Èíäèÿ)                       │02.02.96      

                                                                                                                                                                    

│Ëàíàãåñèê {ìåôåíàìîâàÿ êèñëîòà, ïàðàöåòàìîë}      │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Tata Pharma (Èíäèÿ)           │002212,       

                                                  │ñðåäñòâî [N02BE51]                                                                                  │19.08.91      

                                                                                                                                                                    

│Ëàíàäåðì [Ìèêîíàçîë]                              │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC02]     │êðåì (òóáû) 2%                │Milpharma (Àâñòðàëèÿ)         │005392,       

                                                                                                                                                      │13.10.94      

                                                                                                                                                                    

│Ëàíâèñ [Òèîãóàíèí]                                │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BB03]      │òàáëåòêè 40 ìã                │Glaxo-Wellcome                │007261,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │25.07.96      

                                                                                                                                                                    

│Ëàíèêîð [Äèãîêñèí]                                │êàðäèîòîíè÷åñêîå ñðåäñòâî [C01AA05]     │òàáëåòêè 0.25 ìã              │Pliva (Þãîñëàâèÿ)             │01352, 29.07.87│

                                                                                                                                                                    

│Ëàíèêîð [Äèãîêñèí]                                │êàðäèîòîíè÷åñêîå ñðåäñòâî [C01AA05]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Pliva (ÑÔÐÞ)                  │01827, 22.05.90│

                                                                                          │0.25 ìã - 1 ìë                                                            

                                                                                                                                                                    

│Ëàíèòîï [Ìåòèëäèãîêñèí]                           │êàðäèîòîíè÷åñêîå ñðåäñòâî [C01AA08]     │òàáëåòêè                      │Boehringer Mannheim GmbH      │00904, 25.03.82│

                                                                                                                        │(Ãåðìàíèÿ)                                  

                                                                                                                                                                    

│Ëàíèòîï [Ìåòèëäèãîêñèí]                           │êàðäèîòîíè÷åñêîå ñðåäñòâî [C01AA08]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Boehringer Mannheim GmbH      │002164,       

                                                                                          │0.2 ìã - 2 ìë                 │(Àâñòðèÿ)                     │19.06.91      

                                                                                                                                                                    

│Ëàíîêñèí [Äèãîêñèí]                               │êàðäèîòîíè÷åñêîå ñðåäñòâî [C01AA05]     │òàáëåòêè 0.25 ìã              │Wellcome Foundation Ltd       │002878,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │25.02.93      

                                                                                                                                                                    

│Ëàðèïðîíò {ëèçîöèì 10 ìã, äåêâàëèíèÿ õëîðèä 0.25  │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî äëÿ      │òàáëåòêè                      │Mack (Ãåðìàíèÿ)               │00641,        

│ã}                                                │ìåñòíîãî ïðèìåíåíèÿ [R02AA20]                                                                       │07.12.78,     

                                                                                                                                                      │17.04.90      

                                                                                                                                                                    

│Ëàñïàë {àöåòèëñàëèöèëîâàÿ êèñëîòà 0.5 ã,          │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ïîðîøîê îðàëüíûé äëÿ äåòåé    │Laboratoires Synthelabo       │005476,       

│àìèíîóêñóñíàÿ êèñëîòà 0.1 ã}                      │ñðåäñòâî [N02BA51]                      │(ïàêåòèêè) 180 ìã; ïîðîøîê    │(Ôðàíöèÿ)                     │10.11.94      

                                                                                          │îðàëüíûé äëÿ âçðîñëûõ                                                     

                                                                                          │(ïàêåòèêè) 250, 500, 1000 ìã; │                                            

                                                                                          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ                                                 

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 0.5, 1 ã /â                                                     

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Ëàñòåò [Ýòîïîçèä]                                 │öèòîñòàòè÷åñêîå ñðåäñòâî [L01CB01]      │êàïñóëû 100 ìã; ðàñòâîð äëÿ   │Nippon Kayaku Co Ltd (ßïîíèÿ) │002045,       

                                                                                          │èíúåêöèé 100 ìã                                             │22.02.91      

                                                                                                                                                                    

│Ëàòèêîðò [Ãèäðîêîðòèçîí]                          │ãëþêîêîðòèêîñòåðîèä [D07AA02]           │êðåì; ìàçü                    │Polfa (Ïîëüøà)                │2881, 04.01.88 │

                                                                                                                                                                    

│Ëàòèêîðò [Ãèäðîêîðòèçîí]                          │ãëþêîêîðòèêîñòåðîèä [D07AA02]           │ëîñüîí 0.1%                   │Polfa, Jelfa (Ïîëüøà)         │005107,       

                                                                                                                                                      │08.07.94      

                                                                                                                                                                    

│Ëàöèïèë [Ëàöèäèïèí]                               │ÁÌÊÊ [C08CA09]                          │òàáëåòêè 2 ìã, 4 ìã           │Glaxo (Èñïàíèÿ)               │005045,       

                                                                                                                                                      │27.06.94      

                                                                                                                                                                     

│Ëåàêàäèí                                          │èììóíîñòèìóëÿòîð [L03A]                 │òàáëåòêè 0.1 ã                │(Ëàòâèÿ)                      │96/185/4      

│Ëåâàìèçîëà ãèäðîõëîðèä [Ëåâàìèçîë]                │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CE01]   │òàáëåòêè 150 ìã               │(Óêðàèíà)                     │94/158/12     

                                                                                                                                                                     

│Ëåâîäîïà [Ëåâîäîïà]                               │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè 250, 500 ìã          │Tamilnadu Dadha               │003939,       

                                                  │[N04BA01]                                                             │Pharmaceuticals Ltd (Èíäèÿ)   │25.05.94      

                                                                                                                                                                     

│Ëåâîäîïà+êàðáèäîïà [Ëåâîäîïà+êàðáèäîïà] {ëåâîäîïà │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè                      │Dabur India Ltd (Èíäèÿ)       │002059,       

│0.25 ã, êàðáèäîïà 25 ìã}                          │[N04BA02]                                                                                           │12.03.91      

                                                                                                                                                                     

│Ëåãàëîí [Ñèëèáèíèí]                               │ãåïàòîïðîòåêòîð [A05BA03]               │äðàæå 70 ìã; êàïñóëû 140 ìã   │Dr.Madaus AG (Ãåðìàíèÿ)       │003473,       

                                                                                                                                                      │01.11.93      

                                                                                                                                                                    

│Ëåãàëîí-35 [Ñèëèáèíèí]                            │ãåïàòîïðîòåêòîð [A05BA03]               │äðàæå 35 ìã                   │Madaus AG (Ãåðìàíèÿ)          │00503,        

                                                                                                                                                      │06.10.77,     

                                                                                                                                                      │15.07.94      

                                                                                                                                                                    

│Ëåäîêñèíà [Öèêëîôîñôàìèä]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01AA01]      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lemery (Ìåêñèêà)              │006214,       

                                                                                          │50 ìã; ëèîôèëèç.ïîðîøîê äëÿ                                 │22.06.95      

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 100, 200,                                              

                                                                                          │500, 1000 ìã                                                              

                                                                                                                                                                    

│Ëåéêåðàí [Õëîðàìáóöèë]                            │öèòîñòàòè÷åñêîå ñðåäñòâî [L01AA02]      │òàáëåòêè 2 ìã, 5 ìã           │Wellcome Foundation Ltd       │002580,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │28.07.92      

                                                                                                                                                                    

│Ëåéêîâàðèí-Òåâà [Êàëüöèÿ ôîëèíàò]                 │âèòàìèí [V03AF03]                       │òàáëåòêè 15 ìã;               │Teva Pharmaceutical           │005522,       

                                                                                          │ëèîôèëèç.ïîðîøîê äëÿ          │Industries Ltd (Èçðàèëü)      │22.11.94      

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 50 ìã;                                                 

                                                                                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                            

                                                                                          │3 ìã/ìë; ðàñòâîð äëÿ èíúåêöèé │                                            

                                                                                          │(ôëàêîíû) 10 ìã/ìë - 5, 10,                                               

                                                                                          │20, 30, 50 ìë                                                             

                                                                                                                                                                    

│Ëåéêîâîðèí Ca Ëàõåìà 10, 25 [Êàëüöèÿ ôîëèíàò]     │âèòàìèí [V03AF03]                       │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Lachema (×åõèÿ)               │003111,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │29.06.93      

                                                                                          │(ôëàêîíû) 10, 25 ìã                                                       

                                                                                                                                                                    

│Ëåéêîâîðèí êàëüöèÿ [Êàëüöèÿ ôîëèíàò]              │âèòàìèí [V03AF03]                       │ëèîôèëèç.ïîðîøîê äëÿ          │Lederle (ÑØÀ)                 │003123,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │30.06.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 50, 100,                                               

                                                                                          │350 ìã; ðàñòâîð äëÿ èíúåêöèé                                              

                                                                                          │(àìïóëû) 3 ìã/ìë; òàáëåòêè                                                

                                                                                          │ïîêðûòûå îáîëî÷êîé 5, 10, 15                                              

                                                                                          │ìã                                                                        

                                                                                                                                                                    

│Ëåéêîìàêñ [Ìîëãðàìîñòèì]                          │ëåéêîïîýçà ñòèìóëÿòîð [L03AA03]         │ëèîôèëèç.ïîðîøîê äëÿ          │Sandoz Pharma (Øâåéöàðèÿ)     │002487,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │27.05.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 50, 150,                                               

                                                                                          │400, 700, 1500 ìêã                                                        

                                                                                                                                                                    

│Ëåéêîìàêñ [Ìîëãðàìîñòèì]                          │ëåéêîïîýçà ñòèìóëÿòîð [L03AA03]         │ëèîôèëèç.ïîðîøîê äëÿ          │Schering-Plough (ÑØÀ)         │002487,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │27.05.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 50, 150,                                               

                                                                                          │400, 700, 1500 ìêã                                                        

                                                                                                                                                                    

│Ëåéíàçà [Àñïàðàãèíàçà]                            │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XX02]      │ëèîôèëèç.ïîðîøîê äëÿ          │Kyowa Hakko Kogyo Co Ltd      │003094,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(ßïîíèÿ)                      │24.06.93       

                                                                                          │ðàñòâîðà (ôëàêîíû) 5000,                                                  

                                                                                          │10000 ÌÅ                                                                  

                                                                                                                                                                     

│Ëåêàäîë [Ïàðàöåòàìîë]                             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Lek D.D. (Ñëîâåíèÿ)           │006708,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │11.10.95      

                                                                                                                                                                     

│Ëåêîâèò Ñ-Ñà {àñêîðáèíîâàÿ êèñëîòà 0.5 ã, êàëüöèÿ │âèòàìèí [A11GB01]                       │òàáëåòêè øèïó÷èå              │Lek (Ñëîâåíèÿ)                │002420,       

│êàðáîíàò 0.6 ã}                                                                                                                                       │16.03.92      

                                                                                                                                                                     

│Ëåêîíèë [Îêñèìåòàçîëèí]                           │àëüôà-àäðåíîñòèìóëÿòîð [R01AA05]        │êàïëè íàçàëüíûå 0.05%         │Lek D.D. (Ñëîâåíèÿ)           │006485,       

                                                                                                                                                      │11.09.95      

                                                                                                                                                                    

│Ëåêîíèë Ð [Îêñèìåòàçîëèí]                         │àëüôà-àäðåíîñòèìóëÿòîð [R01AA05]        │êàïëè íàçàëüíûå äëÿ äåòåé     │Lek D.D. (Ñëîâåíèÿ)           │006484,       

                                                                                          │0.025%                                                      │11.09.95      

                                                                                                                                                                    

│Ëåêîïòèí [Âåðàïàìèë]                              │ÁÌÊÊ [C08DA01]                          │äðàæå 40, 80, 120 ìã;         │Lek (Ñëîâåíèÿ)                │002791,       

                                                                                          │òàáëåòêè ðåòàðä 240 ìã;                                     │12.01.93      

                                                                                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                            

                                                                                          │5 ìã - 2 ìë                                                               

                                                                                                                                                                    

│Ëåêðîëèí [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò    │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [S01GX01] │êàïëè ãëàçíûå (ôëàêîíû) 20    │Leiras (Ôèíëÿíäèÿ)            │005610,       

│äèíàòðèÿ}                                                                                 │ìã/ìë - 10 ìë; êàïëè ãëàçíûå                                │28.12.94      

                                                                                          │(òþáèê êàïåëüíèöà) 20 ìã/ìë - │                                            

                                                                                          │0.25 ìë                                                                   

                                                                                                                                                                    

│Ëåêñèëèóì [Áðîìàçåïàì]                            │òðàíêâèëèçàòîð [N05BA08]                │òàáëåòêè 1.5, 3, 6 ìã         │Alkaloid (Þãîñëàâèÿ)          │01149, 18.03.85│

│Ëåêñîòàí [Áðîìàçåïàì]                             │òðàíêâèëèçàòîð [N05BA08]                │òàáëåòêè 1.5, 3, 6 ìã         │Hoffmann La Roche (Øâåéöàðèÿ) │00633, 06.10.78│

                                                                                                                                                                    

│Ëåíäàöèí [Öåôòðèàêñîí]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA13]      │ëèîôèëèç.ïîðîøîê äëÿ          │Lek (Ñëîâåíèÿ)                │002448,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │03.04.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 250, 1000                                              

                                                                                          │ìã                                                                        

                                                                                                                                                                    

│Ëåíäîðìèí [Áðîòèçîëàì]                            │ñíîòâîðíîå ñðåäñòâî [N05CD09]           │òàáëåòêè 0.25 ìã              │Boehringer Ingelheim GmbH     │006266,       

                                                                                                                        │(Ãåðìàíèÿ)                    │11.07.95      

                                                                                                                                                                    

│Ëåíòå Èëåòèí II [Èíñóëèí-ÑðÄ] {èíñóëèí            │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Eli Lilly & Elanco (ÑØÀ)      │02034, 28.12.90│

│öèíê-ñóñïåíçèÿ, ìîíîêîìïîíåíòíûé ñâèíîé: àìîðôíûé │                                        │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë,                                               

│30%, êðèñòàëëè÷åñêèé 70%}                                                                 │100 ÅÄ/ìë - 10 ìë                                                         

                                                                                                                                                                    

│Ëåïîíåêñ [Êëîçàïèí]                               │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AH02]     │òàáëåòêè 25, 100 ìã; ðàñòâîð  │Bosnalijek (Þãîñëàâèÿ)        │01369, 31.08.87│

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 50 ìã - │                                            

                                                                                          │2 ìë                                                                      

                                                                                                                                                                    

│Ëåïîíåêñ [Êëîçàïèí]                               │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AH02]     │òàáëåòêè 25, 100 ìã           │Sandoz Pharma Ltd (Øâåéöàðèÿ) │006666,       

                                                                                                                                                      │20.03.96      

                                                                                                                                                                    

│Ëåïðîòåê [Ñèëèáèíèí]                              │ãåïàòîïðîòåêòîð [A05BA03]               │äðàæå 35 ìã                   │Zdravle (ÑÔÐÞ)                │002143,       

                                                                                                                                                      │27.05.91      

                                                                                                                                                                    

│Ëåðèâîí [Ìèàíñåðèí]                               │àíòèäåïðåññàíò [N06AX03]                │òàáëåòêè 30 ìã                │N.V.Organon (Íèäåðëàíäû)      │01035,        

                                                                                                                                                      │09.06.94,     

                                                                                                                                                      │09.09.83      

                                                                                                                                                                    

│Ëåñêîë [Ôëóâàñòàòèí]                              │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AB04]   │êàïñóëû 20, 40 ìã             │Sandoz Pharma (Øâåéöàðèÿ)     │005055,       

                                                                                                                                                      │29.06.94      

                                                                                                                                                                    

│Ëåöåäèë [Ôàìîòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 20, 40 ìã            │Zdravle (Þãîñëàâèÿ)           │003049,        

                                                  │[A02BA03]                                                                                           │08.06.93      

                                                                                                                                                                    

│Ëè-áóòîë [Ýòàìáóòîë]                              │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │òàáëåòêè 200, 400, 800 ìã     │Lyka Labs Ltd (Èíäèÿ)         │002292,        

                                                                                                                                                      │21.11.91      

                                                                                                                                                                    

│Ëèáåêñèí [Ïðåíîêñäèàçèí]                          │ïðîòèâîêàøëåâîå ñðåäñòâî [R05DB18]      │òàáëåòêè                      │Chinoin (Âåíãðèÿ)             │2671,          

                                                                                                                                                      │10.11.81,     

                                                                                                                                                      │20.02.92      

                                                                                                                                                                     

│Ëèáðàêñ {õëîðäèàçåïîêñèä 5 ìã, êëèäèíèé 2.5 ìã}   │òðàíêâèëèçàòîð [N05BX]                  │äðàæå                         │Hoffmann La Roche (Øâåéöàðèÿ) │00462,        

                                                                                                                                                      │20.06.88,     

                                                                                                                                                      │24.12.76      

                                                                                                                                                                    

│Ëèâèàë [Òèáîëîí]                                  │àíàáîëè÷åñêîå ñòåðîèäíîå ñðåäñòâî       │òàáëåòêè 2.5 ìã               │N.V.Organon (Íèäåðëàíäû)      │005966,       

                                                  │[G03DC05]                                                                                           │14.04.95      

                                                                                                                                                                    

│Ëèâî-ëàê [Ëàêòóëîçà]                              │ñëàáèòåëüíîå ñðåäñòâî [A06AD11]         │ñèðîï (ôëàêîíû) 240 ìë        │Panacea Drugs Private Ltd     │003611,       

                                                                                                                        │(Èíäèÿ)                       │22.12.93      

                                                                                                                                                                    

│Ëèãíîêàèíà õëîðãèäðàò [Ëèäîêàèí]                  │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C01BB01] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Polfa, Warszawskie Zaklady    │006979,       

                                                                                          │1%, 2%                        │Farmaceutyczne SA (Ïîëüøà)    │12.01.96      

                                                                                                                                                                    

│Ëèäàïðèì {ñóëüôàìåòðîë 100 ìã, òðèìåòîïðèì 20 ìã; │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 400 ìã/80 ìã;        │Alkaloid (Ìàêåäîíèÿ)          │003017,       

│ñóëüôàìåòðîë 400 ìã, òðèìåòîïðèì 80 ìã}           │ñðåäñòâî [J01EE03]                      │òàáëåòêè äëÿ äåòåé 100 ìã/20                                │31.05.93      

                                                                                          │ìã; ñóñïåíçèÿ îðàëüíàÿ äëÿ                                                

                                                                                          │äåòåé (ôëàêîíû) 200 ìã/40                                                 

                                                                                          │ìã|5 ìë - 100 ìë                                                          

                                                                                                                                                                    

│Ëèäàïðèì {ñóëüôàìåòðîë 100 ìã, òðèìåòîïðèì 20 ìã; │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè äëÿ äåòåé 120 ìã;    │Hafslund Nycomed (Àâñòðèÿ)    │002192,       

│ñóëüôàìåòðîë 400 ìã, òðèìåòîïðèì 80 ìã;           │ñðåäñòâî [J01EE03]                      │òàáëåòêè 480 ìã; òàáëåòêè                                   │11.07.91      

│ñóëüôàìåòðîë 800 ìã, òðèìåòîïðèì 160 ìã}                                                  │ôîðòå 960 ìã; ðàñòâîð äëÿ                                                 

                                                                                          │âíóòðèâåííîãî ââåäåíèÿ                                                    

                                                                                          │(ôëàêîíû) 250 ìë; ñóñïåíçèÿ                                               

                                                                                          │äëÿ äåòåé 240 ìã|5 ìë                                                     

                                                                                                                                                                    

│Ëèäåâèí [Äèñóëüôèðàì]                             │ñðåäñòâî äëÿ ëå÷åíèÿ àëêîãîëèçìà        │òàáëåòêè                      │Ajc Pharma (Ôðàíöèÿ)          │006238,       

                                                  │[V03AA01]                                                                                           │30.06.95      

                                                                                                                                                                    

│Ëèäîêàèí [Ëèäîêàèí]                               │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [D04AB01] │àýðîçîëü 10%                  │Egis (Âåíãðèÿ)                │2519,         

                                                                                                                                                      │03.09.91,     

                                                                                                                                                      │14.04.77      

                                                                                                                                                                    

│Ëèäîêàèí [Ëèäîêàèí]                               │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C01BB01] │ðàñòâîð äëÿ âíóòðèìûøå÷íûõ    │Egis (Âåíãðèÿ)                │2622,         

                                                                                          │èíúåêöèé (àìïóëû) 10% - 2 ìë                                │05.11.92,     

                                                                                                                                                      │18.02.80      

                                                                                                                                                                    

│Ëèäîêàèí [Ëèäîêàèí]                               │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C01BB01] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Egit (Âåíãðèÿ)                │2391,         

                                                                                          │2% - 2, 10 ìë                                               │15.10.74,     

                                                                                                                                                      │22.05.85      

                                                                                                                                                                    

│Ëèäîêàèí-Òåâà [Ëèäîêàèí]                          │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C01BB01] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Teva Pharmaceutical           │007612,       

                                                                                          │1%, 2%, 4% - 5, 10 ìë         │Industries Ltd (Èçðàèëü)      │28.06.96      

                                                                                                                                                                    

│Ëèäîêàèíà ãèäðîõëîðèä 1% Áðàóí [Ëèäîêàèí]         │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C01BB01] │ðàñòâîð äëÿ èíúåêöèé          │B.Braun Melsungen AG          │007602,       

                                                                                          │(ôëàêîíû) 1% - 50, 100 ìë     │(Ãåðìàíèÿ)                    │21.06.96      

                                                                                                                                                                    

│Ëèäîêàèíà ãèäðîõëîðèä 2% Áðàóí [Ëèäîêàèí]         │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [C01BB01] │ðàñòâîð äëÿ èíúåêöèé          │B.Braun Melsungen AG          │007601,       

                                                                                          │(ôëàêîíû) 2% - 50, 100 ìë     │(Ãåðìàíèÿ)                    │21.06.96       

                                                                                                                                                                    

│Ëèçàâèð [Àöèêëîâèð]                               │ïðîòèâîâèðóñíîå ñðåäñòâî                │òàáëåòêè 200, 400, 800 ìã;    │Lisapharma (Èòàëèÿ)           │005494,       

                                                  │[D06BB03][J05AB01]                      │êðåì (òóáû) 5%                                              │15.11.94       

                                                                                                                                                                    

│Ëèçèð [Ëèçèíîïðèë]                                │ÀÊÔ áëîêàòîð [C09AA03]                  │òàáëåòêè 5, 10 ìã             │Kopran Ltd (Èíäèÿ)            │005108,       

                                                                                                                                                      │08.07.94      

                                                                                                                                                                    

│Ëèçî-Á {ëèçîöèì 20 ìã, ïèðèäîêñèí 10 ìã}          │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî äëÿ      │òàáëåòêè ñóáëèíãâàëüíûå       │Bosnalijek (Þãîñëàâèÿ)        │00933, 03.08.82│

                                                  │ìåñòíîãî ïðèìåíåíèÿ [R02AA20]                                                                                      

                                                                                                                                                                    

│Ëèçîëèí [Öåôàçîëèí]                               │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Lyka Labs Ltd (Èíäèÿ)         │002257,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │17.10.91      

                                                                                          │(ôëàêîíû) 250, 500, 1000 ìã                                               

                                                                                                                                                                    

│Ëèêàöèí [Àìèêàöèí]                                │àíòèáèîòèê, àìèíîãëèêîçèä [J01GB06]     │ðàñòâîð äëÿ èíúåêöèé          │Lisapharma (Èòàëèÿ)           │01711, 12.12.89│

                                                                                          │(àìïóëû)500 ìã/2 ìë, 1000                                                 

                                                                                          │ìã/4 ìë                                                                   

                                                                                                                                                                    

│Ëèêàöèí [Àìèêàöèí]                                │àíòèáèîòèê, àìèíîãëèêîçèä [J01GB06]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Lisapharma (Èòàëèÿ)           │005493,       

                                                                                          │100 ìã - 2 ìë                                               │15.11.94      

                                                                                                                                                                    

│Ëèêðåàçà [Ïàíêðåàòèí]                             │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │êàïñóëû 370 ìã                │Laboratoires Laphal (Ôðàíöèÿ) │007585,       

                                                  │[A09AA02]                                                                                           │14.06.96      

                                                                                                                                                                    

│Ëèíêîìèöèíà ãèäðîõëîðèä [Ëèíêîìèöèí]              │àíòèáèîòèê, àçàëèä [J01FF02]            │ðàñòâîð äëÿ èíúåêöèé          │Shin Poong Ltd (Êîðåÿ Þæíàÿ)  │002780,       

                                                                                          │(ôëàêîíû) 600 ìã - 2 ìë                                     │29.12.92      

                                                                                                                                                                    

│Ëèíêîöèí [Ëèíêîìèöèí]                             │àíòèáèîòèê, àçàëèä [J01FF02]            │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Eczacibasi (Òóðöèÿ)           │002572,       

                                                                                          │300 ìã/ìë - 2 ìë                                            │27.07.92      

                                                                                                                                                                    

│Ëèíêîöèí [Ëèíêîìèöèí]                             │àíòèáèîòèê, àçàëèä [J01FF02]            │êàïñóëû 500 ìã; ðàñòâîð äëÿ   │Upjohn SA (Áåëüãèÿ)           │00087,        

                                                                                          │èíúåêöèé (ôëàêîíû) 300 ìã/ìë                                │07.12.70,     

                                                                                          │- 2 ìë                                                      │11.05.95,     

                                                                                                                                                      │29.11.84      

                                                                                                                                                                    

│Ëèíîñèí [Ëèíêîìèöèí]                              │àíòèáèîòèê, àçàëèä [J01FF02]            │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Deva Holding AS (Òóðöèÿ)      │002434,       

                                                                                          │600 ìã - 2 ìë                                               │25.03.92      

                                                                                                                                                                    

│Ëèîðåçàë [Áàêëîôåí]                               │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03BX01]     │òàáëåòêè 10, 25 ìã            │Ciba-Geigy (Øâåéöàðèÿ)        │00361,        

                                                                                                                                                      │07.10.75,     

                                                                                                                                                      │19.12.89      

                                                                                                                                                                    

│Ëèîðîäèí-äåïî [Ôëóôåíàçèí]                        │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AB02]     │ðàñòâîð äëÿ âíóòðèìûøå÷íûõ    │Rodleben Pharma GmbH          │006048,       

                                                                                          │èíúåêöèé ìàñëÿíûé (àìïóëû) 25 │(Ãåðìàíèÿ)                    │17.05.95      

                                                                                          │ìã - 2 ìë                                                                 

                                                                                                                                                                    

│Ëèîòîí 1000 [Ãåïàðèí]                             │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]          │ãåëü 100000ÅÄ/100 ã           │Menarini A. (Èòàëèÿ)          │003749,       

                                                                                                                                                      │10.03.94      

                                                                                                                                                                    

│Ëèïàíîð [Öèïðîôèáðàò]                             │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AC08]   │êàïñóëû 100 ìã                │Sanofi-Winthrop (Ôðàíöèÿ)     │005660,       

                                                                                                                                                      │16.01.95      

                                                                                                                                                                    

│Ëèïàíòèë [Ôåíîôèáðàò]                             │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AC05]   │êàïñóëû 100 ìã                │Lecleark & Co (Øâåéöàðèÿ)     │002196,       

                                                                                                                                                      │18.07.91      

                                                                                                                                                                    

│Ëèïàíòèë 200 Ì [Ôåíîôèáðàò]                       │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AC05]   │êàïñóëû 200 ìã                │Laboratoires Furnie Sca       │005646,       

                                                                                                                        │(Ôðàíöèÿ)                     │13.01.95      

                                                                                                                                                                     

│Ëèïî-Ìåðö [Ýòîôèáðàò]                             │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AC09]   │êàïñóëû 300 ìã; êàïñóëû       │Merz Co GmbH (ÔÐÃ)            │002856,       

                                                                                          │ðåòàðä 500 ìã                                               │18.02.93      

                                                                                                                                                                     

│Ëèïîìàë [Ïðîáóêîë]                                │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AX02]   │òàáëåòêè 250 ìã               │Alkaloid (Ìàêåäîíèÿ)          │002655,       

                                                                                                                                                      │09.10.92      

                                                                                                                                                                     

│Ëèïîñòàáèë {ôîñôîëèïèäû, òåîôèëëèí, íèêîòèíîâàÿ   │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AX]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Bosnalijek (Þãîñëàâèÿ)        │01516, 15.11.88│

│êèñëîòà}                                                                                  │500 ìã - 10 ìë; êàïñóëû ôîðòå │                                            

                                                                                          │350 ìã                                                                     

                                                                                                                                                                    

│Ëèïîñòàáèë {ôîñôîëèïèäû 500 ìã, ïèðèäîêñèí 4 ìã,  │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AX]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│00885,        

│íèêîòèíîâàÿ êèñëîòà 2 ìã, àäåíîçèí ìîíîôîñôàò 2                                           │500 ìã - 10 ìë; êàïñóëû ôîðòå │                              │10.01.94,     

│ìã - 10 ìë; ôîñôîëèïèäû 300 ìã, ýòîôèëëèí 50 ìã - │                                        │300 ìã                                                      │29.10.81      

│êàïñóëà}                                                                                                                                                            

                                                                                                                                                                    

│Ëèïîñòàáèë {ôîñôîëèïèäû 250 ìã, ïèðèäîêñèí 2 ìã,  │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AX]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Rhone-Poulenc Rorer (Ãåðìàíèÿ)│006317,       

│íèêîòèíîâàÿ êèñëîòà 1 ìã, àäåíîçèí ìîíîôîñôàò 1                                           │250 ìã - 5 ìë                                               │26.07.95      

│ìã - 5 ìë}                                                                                                                                                          

                                                                                                                                                                    

│Ëèïîñòàò [Ïðàâàñòàòèí]                            │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AB03]   │òàáëåòêè 10, 20 ìã            │Bristol-Myers Squibb (ÑØÀ)    │006859,       

                                                                                                                                                      │24.11.95      

                                                                                                                                                                    

│Ëèïîñòàò [Ïðàâàñòàòèí]                            │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AB03]   │òàáëåòêè 10, 20 ìã            │Bristol-Myers Squibb (Èòàëèÿ) │007030,       

                                                                                                                                                      │31.01.96      

                                                                                                                                                                    

│Ëèïîôóíäèí ÌÑÒ/ËÑÒ {ñîåâîå ìàñëî, ôîñôîëèïèäû}    │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ    │ýìóëüñèÿ äëÿ èíôóçèé          │B.Braun Melsungen AG          │006111,       

                                                  │[B05BA02]                               │(ôëàêîíû) 10% - 100, 250, 500 │(Ãåðìàíèÿ)                    │25.05.95      

                                                                                          │ìë; ýìóëüñèÿ äëÿ èíôóçèé                                                  

                                                                                          │(ôëàêîíû) 20% - 100, 250, 500 │                                            

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ëèñòåíîí [Ñóêñàìåòîíèÿ õëîðèä]                    │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03AB01]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hafslund Nycomed Pharma AG    │003035,       

                                                                                          │100 ìã - 5 ìë                 │(Àâñòðèÿ)                     │03.06.93      

                                                                                                                                                                    

│Ëèñòåíîí [Ñóêñàìåòîíèÿ õëîðèä]                    │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03AB01]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Unique Pharmaceutical         │005197,       

                                                                                          │2% - 5 ìë                     │Laboratories (Èíäèÿ)          │01.08.94      

                                                                                                                                                                    

│Ëèòîñàí-ÑÐ [Ëèòèÿ êàðáîíàò]                       │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AN01]     │òàáëåòêè 400 ìã               │Sun Pharmaceutical Industries │003681,       

                                                                                                                        │Ltd (Èíäèÿ)                   │09.02.94      

                                                                                                                                                                    

│Ëèôîðàí [Öåôîòàêñèì]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ëèîôèëèç.ïîðîøîê äëÿ          │Lyka Labs Ltd (Èíäèÿ)         │006422,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │21.08.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 0.25, 0.5, │                                            

                                                                                          │1 ã                                                                       

                                                                                                                                                                    

│Ëî-ôåìåíàë {íîðãåñòðåë 0.3 ìã, ýòèíèëýñòðàäèîë    │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA06]      │òàáëåòêè 0.3 ìã/0.03 ìã       │Wyeth Ayerst (ÑØÀ)            │005161,       

│0.03 ìã}                                                                                                                                              │20.07.94      

                                                                                                                                                                    

│Ëîäåðèêñ [Ñåòàñòàòèí]                             │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 1 ìã                 │Egis (Âåíãðèÿ)                │002201,       

                                                  │[R06A]                                                                                              │30.07.91      

                                                                                                                                                                    

│Ëîêàêîðòåí [Ôëóìåòàçîí]                           │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │êðåì 0.02%; ìàçü 0.02%        │Ciba-Geigy (Øâåéöàðèÿ)        │00032,        

                                                  │ïðèìåíåíèÿ [D07AB03]                                                                                │11.02.70,     

                                                                                                                                                      │30.10.87      

                                                                                                                                                                    

│Ëîêàñàëåí {ôëóìåòàçîí ïèâàëàò 0.2 ìã, ñàëèöèëîâàÿ │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │ìàçü                          │Ciba-Geigy (Øâåéöàðèÿ)        │00072,        

│êèñëîòà 30 ìã - 1 ã}                              │ïðèìåíåíèÿ [D07XB01]                                                                                │02.11.70,     

                                                                                                                                                      │30.10.87       

                                                                                                                                                                    

│Ëîêèò [Îìåïðàçîë]                                 │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîòîííîãî    │êàïñóëû 20 ìã                 │Kopran Ltd (Èíäèÿ)            │005402,       

                                                  │íàñîñà èíãèáèòîð [A02BC01]                                                                          │17.10.94       

                                                                                                                                                                    

│Ëîêîèä [Ãèäðîêîðòèçîí]                            │ãëþêîêîðòèêîñòåðîèä [D07AA02]           │êðåì 0.1%; ìàçü 0.1%; ëîñüîí  │Yamanouchi Europe B.V.        │006322,       

                                                                                          │0.1%; ëèïîêðåì 0.1%           │(Íèäåðëàíäû)                  │26.07.95      

                                                                                                                                                                    

│Ëîêîèä êðåëî [Ãèäðîêîðòèçîí]                      │ãëþêîêîðòèêîñòåðîèä [D07AA02]           │ýìóëüñèÿ äëÿ íàðóæíîãî        │Yamanouchi Europe B.V.        │006312,       

                                                                                          │ïðèìåíåíèÿ (ôëàêîíû) 0.1%     │(Íèäåðëàíäû)                  │24.07.95      

                                                                                                                                                                    

│Ëîêðåí [Áåòàêñîëîë]                               │áåòà-àäðåíîáëîêàòîð [S01ED02]           │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Synthelabo       │005809,       

                                                                                          │20 ìã                         │(Ôðàíöèÿ)                     │07.03.95      

                                                                                                                                                                    

│Ëîêñîí 400 [Íîðôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Braun & Berk Pharmaceutical   │005622,       

                                                  │[J01MA06]                                                             │Private Ltd (Èíäèÿ)           │05.01.95      

                                                                                                                                                                    

│Ëîìèð [Èñðàäèïèí]                                 │ÁÌÊÊ [C08CA03]                          │òàáëåòêè 2.5 ìã               │Sandoz Pharma (Øâåéöàðèÿ)     │002637,       

                                                                                                                                                      │25.09.92      

                                                                                                                                                                    

│Ëîìèð [Èñðàäèïèí]                                 │ÁÌÊÊ [C08CA03]                          │êàïñóëû ðåòàðä 5 ìã; ðàñòâîð  │Sandoz Pharma (Øâåéöàðèÿ)     │003587,       

                                                                                          │äëÿ èíúåêöèé 1 ìã - 10 ìë                                   │14.12.93      

                                                                                                                                                                    

│Ëîìóçîë [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò     │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R01AC01] │àýðîçîëü íàçàëüíûé            │Fisons (Âåëèêîáðèòàíèÿ)       │002222,       

│äèíàòðèÿ}                                                                                 │äîçèðîâàííûé                                                │20.08.91      

                                                                                                                                                                    

│Ëîìóçîë [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò     │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R01AC01] │ñïðåé íàçàëüíûé 2%            │Fisons Plc (Ôðàíöèÿ)          │006673,       

│äèíàòðèÿ}                                                                                                                                             │29.09.95      

                                                                                                                                                                    

│Ëîìóñòèí [Ëîìóñòèí]                               │öèòîñòàòè÷åñêîå ñðåäñòâî [L01AD02]      │òàáëåòêè 40 ìã                │Polfa (Ïîëüøà)                │002813,       

                                                                                                                                                      │19.01.93      

                                                                                                                                                                    

│Ëîíãàñòåðèë 40 {äåêñòðàí 100 ã, ñîðáèòîë 50}      │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05AA05]     │ðàñòâîð äëÿ èíôóçèé           │Fresenius (ÔÐÃ)               │002540,       

                                                                                                                                                      │02.07.92      

                                                                                                                                                                    

│Ëîíãàöåô [Öåôòðèàêñîí]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA13]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Galenika (Þãîñëàâèÿ)          │01355, 27.07.87│

                                                                                          │âíóòðèâåííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 250, 1000 ìã;                                                   

                                                                                          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ                                                 

                                                                                          │âíóòðèìûøå÷íîãî ðàñòâîðà                                                  

                                                                                          │(ôëàêîíû) 250, 1000 ìã                                                    

                                                                                                                                                                    

│Ëîíèòåí [Ìèíîêñèäèë]                              │âàçîäèëàòèðóþùåå ñðåäñòâî [C02DC01]     │òàáëåòêè 5 ìã                 │Upjohn Ltd (Âåëèêîáðèòàíèÿ)   │007017,       

                                                                                                                                                      │26.01.96      

                                                                                                                                                                    

│Ëîïåäèóì [Ëîïåðàìèä]                              │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │òàáëåòêè 2 ìã; êàïñóëû 2 ìã   │Hexal Pharma GmbH (ÔÐÃ)       │003183,       

                                                                                                                                                      │03.08.93      

                                                                                                                                                                    

│Ëîïåäèóì ÈÇÎ [Ëîïåðàìèä]                          │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │òàáëåòêè øèïó÷èå 2 ìã         │Hexal Pharma GmbH (Ãåðìàíèÿ)  │005141,       

                                                                                                                                                      │18.07.94      

                                                                                                                                                                    

│Ëîïåðàìèä [Ëîïåðàìèä]                             │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │êàïñóëû 2 ìã                  │Norton Healthcare Ltd         │005597,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │26.12.94      

                                                                                                                                                                    

│Ëîïåðàìèä [Ëîïåðàìèä]                             │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │òàáëåòêè 2 ìã                 │Polfa, Warszawskie Zaklady    │006201,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │21.06.95      

                                                                                                                                                                    

│Ëîïåðàìèä [Ëîïåðàìèä]                             │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │òàáëåòêè 2 ìã                 │Serta SA (Áåëüãèÿ)            │003691,       

                                                                                                                                                      │11.02.94       

                                                                                                                                                                    

│Ëîïåðàìèä -Ðàòèîôàðì [Ëîïåðàìèä]                  │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé 2 │Ratiopharm GmbH & Co          │005971,       

                                                                                          │ìã                            │(Ãåðìàíèÿ)                    │18.04.95       

                                                                                                                                                                    

│Ëîïåðàìèä-Ðèâîôàðì [Ëîïåðàìèä]                    │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │êàïñóëû 2 ìã                  │Rivopharm SA (Øâåéöàðèÿ)      │005131,       

                                                                                                                                                      │15.07.94      

                                                                                                                                                                    

│Ëîïðåñîð [Ìåòîïðîëîë]                             │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Ciba-Geigy (Øâåéöàðèÿ)        │02029, 13.12.90│

                                                  │[C07AB02]                               │îáîëî÷êîé 50, 100 ìã; ðàñòâîð │                                             

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 5 ìã -                                              

                                                                                          │5 ìë                                                                      

                                                                                                                                                                    

│Ëîïðåñîð [Ìåòîïðîëîë]                             │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ciba-Geigy (Øâåéöàðèÿ)        │002236,       

                                                  │[C07AB02]                               │ðåòàðä 200 ìã                                               │27.08.91      

                                                                                                                                                                    

│Ëîðâàñ [Èíäàïàìèä]                                │ÁÌÊÊ [C03BA11]                          │òàáëåòêè 2.5 ìã               │Torrent Exports Ltd (Èíäèÿ)   │003639,       

                                                                                                                                                      │24.01.94      

                                                                                                                                                                    

│Ëîðèçîí [Öåôîïåðàçîí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA32]      │ëèîôèëèç.ïîðîøîê äëÿ          │Laboratories Atral SA         │002705,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Ïîðòóãàëèÿ)                  │23.11.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 1 ã /â                                                 

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Ëîðèíäåí [Ôëóìåòàçîí]                             │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │ýìóëüñèÿ                      │Polfa (Ïîëüøà)                │2460,         

                                                  │ïðèìåíåíèÿ [D07AB03]                                                                                │01.03.76,     

                                                                                                                                                      │27.03.87      

                                                                                                                                                                    

│Ëîðèíäåí À {ôëóìåòàçîí ïèâàëàò 0.2 ã, ñàëèöèëîâàÿ │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │ìàçü                          │Polfa (Ïîëüøà)                │2586,         

│êèñëîòà 30 ìã - 1 ã}                              │ïðèìåíåíèÿ [D07XB01]                                                                                │09.12.93,     

                                                                                                                                                      │25.10.78      

                                                                                                                                                                    

│Ëîðèíäåí Ñ {ôëóìåòàçîí ïèâàëàò 0.2 ìã, êëèîõèíîë  │ãëþêîêîðòèêîñòåðîèä äëÿ ìåñòíîãî        │ìàçü                          │Polfa (Ïîëüøà)                │2308,         

│30 ìã - 1 ã}                                      │ïðèìåíåíèÿ [D07XB01]                                                                                │02.04.76,     

                                                                                                                                                      │04.11.87      

                                                                                                                                                                    

│Ëîñåê [Îìåïðàçîë]                                 │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîòîííîãî    │êàïñóëû 20 ìã                 │Astra (Øâåöèÿ)                │003229,       

                                                  │íàñîñà èíãèáèòîð [A02BC01]                                                                          │11.08.93      

                                                                                                                                                                    

│Ëîòåíñèí [Áåíàçåïðèë]                             │ÀÊÔ áëîêàòîð [C09AA07]                  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ciba-Geigy (Øâåéöàðèÿ)        │003019,       

                                                                                          │10, 20 ìã                                                   │01.06.93      

                                                                                                                                                                    

│Ëîòðèäåðì {áåòàìåòàçîí äèïðîïèîíàò, êëîòðèìàçîë}  │ãëþêîêîðòèêîñòåðîèä+ïðîòèâîìèêðîáíîå    │êðåì (òóáû) 15, 30 ã          │Schering-Plough (Áåëüãèÿ)     │007581,       

                                                  │ñðåäñòâî [D07BC01]                                                                                  │13.06.96      

                                                                                                                                                                    

│Ëîôàò [Ôåíîôèáðàò]                                │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AC05]   │êàïñóëû äëèòåëüíîãî           │Ethypharm (Ôðàíöèÿ)           │005271,       

                                                                                          │âûñâîáîæäåíèÿ 250 ìã                                        │24.08.94      

                                                                                                                                                                    

│Ëóáðèôèëì {ïàðàôèí áåëûé 0.6 ã, ïàðàôèí æèäêèé    │îôòàëüìîëîãè÷åñêîå ñðåäñòâî [S01XA]     │ìàçü ãëàçíàÿ (òóáû)           │Laboratorious Cusi (Èñïàíèÿ)  │005070,       

│0.3 ã, æèð 0.1 ã}                                                                                                                                     │01.07.94      

                                                                                                                                                                    

│Ëóâàòðåí [Ìîïåðîí]                                │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AD04]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Cilag-Chemie (Øâåéöàðèÿ)      │00701, 07.09.79│

                                                                                          │5 ìã/1 ìë                                                                 

                                                                                                                                                                    

│Ëóïîöåò [Ïàðàöåòàìîë]                             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñèðîï (ôëàêîíû) 120 ìã|5 ìë   │Belupo (Õîðâàòèÿ)             │005315,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │14.09.94      

                                                                                                                                                                    

│Ëþäèîìèë [Ìàïðîòèëèí]                             │àíòèäåïðåññàíò [N06AA21]                │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Ciba-Geigy (Øâåéöàðèÿ)        │00364,        

                                                                                          │îáîëî÷êîé 10, 25, 50 ìã                                     │07.10.75,      

                                                                                                                                                      │19.12.89      

                                                                                                                                                                    

│Ëþäèîìèë [Ìàïðîòèëèí]                             │àíòèäåïðåññàíò [N06AA21]                │òàáëåòêè 75 ìã                │Ciba-Geigy (Øâåéöàðèÿ)        │01280, 22.05.86│

│Ëþäèîìèë [Ìàïðîòèëèí]                             │àíòèäåïðåññàíò [N06AA21]                │àìïóëû                        │Ciba-Geigy (Øâåéöàðèÿ)        │00364, 07.10.75│

                                                                                                                                                                    

│Ëþäèîìèë [Ìàïðîòèëèí]                             │àíòèäåïðåññàíò [N06AA21]                │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Ciba-Geigy (Èñïàíèÿ)          │002269,       

                                                                                          │îáîëî÷êîé 25 ìã                                             │25.10.91      

                                                                                                                                                                    

│Ëþäèîìèë [Ìàïðîòèëèí]                             │àíòèäåïðåññàíò [N06AA21]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ciba-Geigy (Èíäîíåçèÿ)        │003192,       

                                                                                          │25 ìã                                                       │05.08.93      

                                                                                                                                                                    

│Ëþäèîìèë [Ìàïðîòèëèí]                             │àíòèäåïðåññàíò [N06AA21]                │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Ciba-Geigy Ilac (Òóðöèÿ)      │002069,       

                                                                                          │îáîëî÷êîé 25, 75 ìã; ðàñòâîð                                │14.03.91      

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 25 ìã - │                                            

                                                                                          │2 ìë                                                                      

                                                                                                                                                                    

│Ëþñîïðåññ [Íèòðåíäèïèí]                           │ÁÌÊÊ [C08CA08]                          │òàáëåòêè 20 ìã                │Instituto Lusofarmaco (Èòàëèÿ)│007603,       

                                                                                                                                                      │24.06.96      

                                                                                                                                                                    

│Ëþòðåëåô [Ãîíàäîðåëèí]                            │ðåëèçèíã ãîðìîí ëþòåèíèçèðóþùèé         │ëèîôèëèç.ïîðîøîê äëÿ          │Ferring Arzneimittel GmbH     │002601,       

                                                  │[H01CA01]                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(ÔÐÃ)                         │01.09.92      

                                                                                          │ðàñòâîðà (ôëàêîíû) 0.8, 3.2 ìã│                                            

                                                                                                                                                                    

│Ìààëîêñ {àëãåëäðàò 0.4 ã, ìàãíèÿ ãèäðîêñèä 0.4 ã} │àíòàöèäíîå ñðåäñòâî [A02AX]             │òàáëåòêè 400 ìã/400 ìã        │Berlin-Chemie AG (ÔÐÃ)        │002900,       

                                                                                                                                                      │11.03.93      

                                                                                                                                                                    

│Ìààëîêñ {àëãåëäðàò 3.49 ã, ìàãíèÿ ãèäðîêñèä 3.99  │àíòàöèäíîå ñðåäñòâî [A02AX]             │òàáëåòêè; ñóñïåíçèÿ (ïàêåòû)  │Rhone-Poulenc Rorer (Ôðàíöèÿ) │002608,       

│ã - 100 ìë, àëãåëäðàò 0.4 ã, ìàãíèÿ ãèäðîêñèä 0.4 │                                        │15 ìë; ñóñïåíçèÿ (ôëàêîíû)                                  │09.09.92      

│ã - òàáëåòêà}                                                                             │250 ìë                                                                    

                                                                                                                                                                    

│Ìààëîêñ ïëþñ {àëãåëäðàò, ìàãíèÿ ãèäðîêñèä,        │àíòàöèäíîå ñðåäñòâî [A02AF]             │òàáëåòêè ñ ëèìîííûì âêóñîì;   │Rhone-Poulenc Rorer (ÑØÀ)     │006915,       

│ñèìåòèêîí}                                                                                │òàáëåòêè ñ âèøíåâûì âêóñîì                                  │19.12.95      

                                                                                                                                                                    

│Ìààëîêñ ïëþñ ïîâûøåííîé àêòèâíîñòè {àëãåëäðàò 350 │àíòàöèäíîå ñðåäñòâî [A02AF]             │òàáëåòêè ñ ìÿòíûì âêóñîì;     │Rhone-Poulenc Rorer (ÑØÀ)     │006912,       

│ìã, ìàãíèÿ ãèäðîêñèä 350 ìã, ñèìåòèêîí 30 ìã -                                            │ñóñïåíçèÿ îðàëüíàÿ ñ ìÿòíûì                                 │19.12.95      

│òàáëåòêà; àëãåëäðàò 500 ìã, ìàãíèÿ ãèäðîêñèä 450                                          │âêóñîì (ôëàêîíû); ñóñïåíçèÿ                                               

│ìã, ñèìåòèêîí 40 ìã - 5 ìë}                                                               │îðàëüíàÿ ñ ëèìîííûì âêóñîì                                                

                                                                                          │(ôëàêîíû); ñóñïåíçèÿ îðàëüíàÿ │                                            

                                                                                          │ñ âèøíåâûì âêóñîì (ôëàêîíû)                                               

                                                                                                                                                                    

│Ìààëîêñ-70 {àëãåëäðàò 9 ã, ìàãíèÿ ãèäðîêñèä 6 ã - │àíòàöèäíîå ñðåäñòâî [A02AX]             │ñóñïåíçèÿ (ïàêåòû) 10 ìë;     │Rhone-Poulenc Rorer (Ôðàíöèÿ) │002609,       

│100 ìë}                                                                                   │ñóñïåíçèÿ (ôëàêîíû) 250 ìë                                  │09.09.92      

                                                                                                                                                                    

│Ìàáðîí [Òðàìàäîë]                                 │àíàëüãåòè÷åñêîå ñðåäñòâî öåíòðàëüíîãî   │êàïñóëû 50 ìã; ðàñòâîð äëÿ    │Medochemie Ltd (Êèïð)         │002574,       

                                                  │äåéñòâèÿ [N02AX02]                      │èíúåêöèé (àìïóëû) 100 ìã - 2                                │28.07.92      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ìàãàëôèë 800 [Ìàãàëäðàò]                          │àíòàöèäíîå ñðåäñòâî [A02AD02]           │òàáëåòêè 800 ìã               │Philopharm GmbH Quedlinburg   │003658,       

                                                                                                                        │(Ãåðìàíèÿ)                    │01.02.94      

                                                                                                                                                                    

│Ìàãàëüäðàò [Ìàãàëäðàò]                            │àíòàöèäíîå ñðåäñòâî [A02AD02]           │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Philopharm GmbH Quedlinburg   │006502,       

                                                                                          │10 ìë; ñóñïåíçèÿ îðàëüíàÿ     │(Ãåðìàíèÿ)                    │14.09.95      

                                                                                          │(ïàêåòèêè) 10 ìë                                                          

                                                                                                                                                                    

│Ìàãíàòîë {àëåêñèòàë 0.3 ã, êàëèÿ ãèäðîêàðáîíàò    │àíòàöèäíîå ñðåäñòâî [A02AX]             │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Sterling Health               │005780,       

│0.1 ã, ìàãíèÿ êàðáîíàò 0.1 ã}                                                                                           │(Âåëèêîáðèòàíèÿ)              │24.02.95      

                                                                                                                                                                    

│Ìàãíå Á6 {ìàãíèÿ ëàêòàò 0.5 ã, ïèðèäîêñèí 0.125 ã}│ïðåïàðàò ìàãíèÿ [A12CC06]               │òàáëåòêè ïîêðûòûå îáîëî÷êîé;  │Sanofi-Winthrop (Ôðàíöèÿ)     │006287,        

                                                                                          │ðàñòâîð îðàëüíûé (àìïóëû)                                   │14.07.95      

                                                                                                                                                                    

│Ìàãíåðîò [Ìàãíèÿ îðîòàò]                          │ìåòàáîëè÷åñêîå ñðåäñòâî [A12CC09]       │òàáëåòêè 500 ìã               │Worwag Pharma GmbH (Ãåðìàíèÿ) │006463,        

                                                                                                                                                      │04.09.95      

                                                                                                                                                                    

│Ìàãíåñîë [Ìàãíèÿ öèòðàò]                          │ïðåïàðàò ìàãíèÿ [A12CC04]               │òàáëåòêè øèïó÷èå 150 ìã       │Krka (Ñëîâåíèÿ)               │002483,       

                                                                                                                                                      │27.05.92      

                                                                                                                                                                    

│Ìàãíèë {àöåòèëñàëèöèëîâàÿ êèñëîòà, ìàãíèÿ îêñèä}  │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 150, 500 ìã;         │Nycomed Dak (Äàíèÿ)           │007569,       

                                                  │ñðåäñòâî [N02BA51]                      │ýíòåðîòàáëåòêè 100, 500 ìã                                  │04.06.96      

                                                                                                                                                                    

│Ìàäîïàð {ëåâîäîïà 100, 200 ìã, áåíñåðàçèä 25, 50  │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │êàïñóëû 125, 250 ìã           │Hoffmann La Roche (Øâåéöàðèÿ) │00457,        

│ìã}                                               │[N04BA02]                                                                                           │02.02.77,     

                                                                                                                                                      │12.09.88      

                                                                                                                                                                    

│Ìàäîïàð {ëåâîäîïà 100 ìã, áåíñåðàçèä 25 ìã}       │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │êàïñóëû                       │ICN-Galenika (Þãîñëàâèÿ)      │007262,       

                                                  │[N04BA02]                                                                                           │25.07.96      

                                                                                                                                                                    

│Ìàæåïòèë [Òèîïðîïåðàçèí]                          │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AB08]     │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Rhone-Poulenc Rorer (Ôðàíöèÿ) │006604,       

                                                                                          │èíúåêöèé 10 ìã - 1 ìë                                       │20.12.95      

                                                                                                                                                                    

│Ìàæåïòèë [Òèîïðîïåðàçèí]                          │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AB08]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Rhone-Poulenc (india) Ltd     │002148,       

                                                                                          │10 ìã; ðàñòâîð äëÿ èíúåêöèé   │(Èíäèÿ)                       │29.05.91      

                                                                                          │(àìïóëû) 1% - 1 ìë                                                        

                                                                                                                                                                    

│Ìàæåïòèë [Òèîïðîïåðàçèí]                          │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AB08]     │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Torrent Exports Ltd (Èíäèÿ)   │002081,       

                                                                                          │îáîëî÷êîé 10 ìã; ðàñòâîð äëÿ                                │15.03.91      

                                                                                          │èíúåêöèé (àìïóëû) 1% - 1 ìë                                               

                                                                                                                                                                    

│Ìàçåïèí [Êàðáàìàçåïèí]                            │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AF01]    │òàáëåòêè 200 ìã               │ICN-Galenika (Þãîñëàâèÿ)      │003333,       

                                                                                                                                                      │14.09.93      

                                                                                                                                                                    

│Ìàêìèðîð [Íèôóðàòåë]                              │ïðîòèâîìèêðîáíîå ñðåäñòâî, íèòðîôóðàí   │äðàæå 200 ìã; ñâå÷è 250 ìã    │Poli Industria Chimica Spa    │002224,       

                                                  │[G01AX05]                                                             │(Èòàëèÿ)                      │27.08.91      

                                                                                                                                                                    

│Ìàêìèðîð êîìïëåêñ 500 [Íèôóðàòåë]                 │ïðîòèâîìèêðîáíîå ñðåäñòâî, íèòðîôóðàí   │êðåì âàãèíàëüíûé; ñâå÷è       │Poli (Èòàëèÿ)                 │005534,       

                                                  │[G01AX05]                                                                                           │05.12.94      

                                                                                                                                                                    

│Ìàêðîïåí [Ìèäåêàìèöèí]                            │àíòèáèîòèê, ìàêðîëèä [J01FA03]          │òàáëåòêè 400 ìã; ïîðîøîê äëÿ  │Krka (Ñëîâåíèÿ)               │002563,       

                                                                                          │ïðèãîòîâëåíèÿ îðàëüíîé                                      │16.07.92      

                                                                                          │ñóñïåíçèè 175 ìã|5 ìë                                                     

                                                                                                                                                                    

│Ìàêðîôåð {æåëåçà ãëþêîíàò 695 ìã, àñêîðáèíîâàÿ    │ãåìîïîýçà ñòèìóëÿòîð, ïðåïàðàò æåëåçà   │òàáëåòêè øèïó÷èå              │Pharmavit (Âåíãðèÿ)           │006901,       

│êèñëîòà 100 ìã}                                   │[B03AE10]                                                                                           │18.12.95      

                                                                                                                                                                    

│Ìàêñàêâèí [Ëîìåôëîêñàöèí]                         │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Searle (ÑØÀ)                  │002583,       

                                                  │[J01MA07]                               │400 ìã                                                      │30.07.92      

                                                                                                                                                                    

│Ìàêñèãàí {ìåòàìèçîë 0.5 ã,                        │àíàëüãåòè÷åñêîå è ñïàçìîëèòè÷åñêîå      │òàáëåòêè 0.6 ã                │Unichem Laboratories Ltd      │002134,       

│ïèïåðèäèíýòîêñèêàðáìåòîêñè áåíçîôåíîí 5 ìã,       │ñðåäñòâî [N02BB52]                                                    │(Èíäèÿ)                       │24.05.91      

│äèôåíèëïèïåðèäèíýòèëàöåòàìèä áðîììåòèëàò 0.1 ìã}                                                                                                                    

                                                                                                                                                                    

│Ìàêñèäåêñ [Äåêñàìåòàçîí]                          │ãëþêîêîðòèêîñòåðîèä [S01BA01]           │êàïëè ãëàçíûå (ôëàêîíû) 0.1%  │Alcon-Kouvrer SA (Áåëüãèÿ)    │005884,       

                                                                                                                                                      │31.03.95      

                                                                                                                                                                    

│Ìàêñèäåêñ [Äåêñàìåòàçîí]                          │ãëþêîêîðòèêîñòåðîèä [S01BA01]           │ìàçü ãëàçíàÿ (òóáû) 0.1%      │Alcon-Kouvrer SA (Áåëüãèÿ)    │006280,       

                                                                                                                                                      │13.07.95      

                                                                                                                                                                     

│Ìàêñèòðîë {äåêñàìåòàçîí 0.1%, íåîìèöèí 0.5%,      │ãëþêîêîðòèêîñòåðîèä+ïðîòèâîìèêðîáíîå    │êàïëè ãëàçíûå (ôëàêîíû)       │Alcon-Kouvrer SA (Áåëüãèÿ)    │005886,       

│ïîëèìèêñèí  6000 ÅÄ}                             │ñðåäñòâî [S01CA01]                                                                                  │31.03.95      

                                                                                                                                                                     

│Ìàêñèòðîë {äåêñàìåòàçîí 0.1%, íåîìèöèí 0.5%,      │ãëþêîêîðòèêîñòåðîèä+ïðîòèâîìèêðîáíîå    │ìàçü ãëàçíàÿ (òóáû)           │Alcon-Kouvrer SA (Áåëüãèÿ)    │006417,       

│ïîëèìèêñèí  6000 ÅÄ}                             │ñðåäñòâî [S01CA01]                                                                                  │16.08.95      

                                                                                                                                                                     

│Ìàëèàçèí [Áàðáåêñàêëîí]                           │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AA04]    │äðàæå 25, 100 ìã              │Knoll AG, Basf Pharma         │006597,       

                                                                                                                        │(Ãåðìàíèÿ)                    │27.11.95      

                                                                                                                                                                     

│Ìàëüòîôåð [Æåëåçà ïîëèèçîìàëüòîçàò]               │ãåìîïîýçà ñòèìóëÿòîð, ïðåïàðàò æåëåçà   │ðàñòâîð îðàëüíûé (ôëàêîíû)    │Vifor (Øâåéöàðèÿ)             │005642,       

                                                  │[B03AB05]                                                                                           │12.01.95      

                                                                                                                                                                    

│Ìàëüòîôåð Ôîë {æåëåçà ïîëèèçîìàëüòîçàò 100 ìã,    │ãåìîïîýçà ñòèìóëÿòîð, ïðåïàðàò æåëåçà   │òàáëåòêè æåâàòåëüíûå 100      │Vifor (Øâåéöàðèÿ)             │005643,       

│ôîëèåâàÿ êèñëîòà 0.35 ìã}                         │[B03AE10]                               │ìã/0.35 ìã                                                  │12.01.95      

                                                                                                                                                                    

│Ìàìîìèò [Àìèíîãëþòåòèìèä]                         │ñòåðîèäîâ ñèíòåçà èíãèáèòîð [L02BG01]   │òàáëåòêè 250 ìã               │Pliva (ÑÔÐÞ)                  │01567, 17.04.89│

                                                                                                                                                                    

│Ìàíäîë [Öåôàìàíäîë]                               │àíòèáèîòèê, öåôàëîñïîðèí [J01DA07]      │ëèîôèëèç.ïîðîøîê äëÿ          │Eli Lilly (Èòàëèÿ)            │007079,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │13.02.96      

                                                                                          │ðàñòâîðà (ôëàêîíû) - 0.5, 1,                                              

                                                                                          │2 ã                                                                       

                                                                                                                                                                    

│Ìàíèíèë [Ãëèáåíêëàìèä]                            │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 1.75, 3.5 ìã         │Berlin-Chemie AG (Ãåðìàíèÿ)   │006165,       

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BB01]                                                                       │13.06.95      

                                                                                                                                                                    

│Ìàíèíèë 5 [Ãëèáåíêëàìèä]                          │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 5 ìã                 │Berlin-Chemie AG (Ãåðìàíèÿ)   │003740,       

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BB01]                                                                       │03.03.94      

                                                                                                                                                                    

│Ìàííèòîë [Ìàííèòîë]                               │äèóðåòè÷åñêîå ñðåäñòâî [B05BC01]        │ðàñòâîð äëÿ èíôóçèé 20%       │Eczacibasi (Òóðöèÿ)           │01883, 25.06.90│

                                                                                                                                                                    

│Ìàííèòîë 20% [Ìàííèòîë]                           │äèóðåòè÷åñêîå ñðåäñòâî [B05BC01]        │ðàñòâîð äëÿ âíóòðèâåííûõ      │Core Parenterals Ltd (Èíäèÿ)  │007110,       

                                                                                          │èíúåêöèé (ôëàêîíû) 20%                                      │27.02.96      

                                                                                                                                                                    

│Ìàíóñàí [Õëîðãåêñèäèí]                            │àíòèñåïòè÷åñêîå ñðåäñòâî [D08AC02]      │ðàñòâîð äëÿ íàðóæíîãî         │Polfa, Lodzkie Zaklady        │007660,       

                                                                                          │ïðèìåíåíèÿ (ôëàêîíû           │Farmaceutyczne SA (Ïîëüøà)    │22.07.96      

                                                                                          │ïëàñòèêîâûå) 4% - 250, 500 ìë │                                            

                                                                                                                                                                    

│Ìàïðîëó [Ìàïðîòèëèí]                              │àíòèäåïðåññàíò [N06AA21]                │ôèëìòàáëåòêè 10, 25, 50, 75 ìã│Hexal Pharma GmbH (Ãåðìàíèÿ)  │005199,       

                                                                                                                                                      │01.08.94      

                                                                                                                                                                    

│Ìàïðîòèáåíå [Ìàïðîòèëèí]                          │àíòèäåïðåññàíò [N06AA21]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ludwig Merckle GmbH (Àâñòðèÿ) │005970,       

                                                                                          │25, 50, 75 ìã                                               │18.04.95      

                                                                                                                                                                    

│Ìàïðîòèëèí [Ìàïðîòèëèí]                           │àíòèäåïðåññàíò [N06AA21]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │CT-Arzneimittel Chemishe      │003969,       

                                                                                          │25, 50, 75 ìã                 │Tempelchof GmbH (Ãåðìàíèÿ)    │01.06.94      

                                                                                                                                                                    

│Ìàðàòîíèê {ãëþêîçà 82.75 ã, ôðóêòîçà 8.5 ã,       │ðåãèäðàòèðóþùåå ñðåäñòâî [A07CA]        │ãðàíóëÿò                      │Krka (ÑÔÐÞ)                   │002111,       

│íàòðèÿ öèòðàò 1.4 ã, íàòðèÿ õëîðèä 0.4 ã,                                                                                                             │21.05.91      

│ëèìîííàÿ êèñëîòà 4.94 ã}                                                                                                                                            

                                                                                                                                                                    

│Ìàðâåëîí {äåçîãåñòðåë 0.15 ìã, ýòèíèëýñòðàäèîë    │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA09]      │òàáëåòêè                      │Organon (Íèäåðëàíäû)          │002058,       

│0.03 ìã}                                                                                                                                              │12.03.91      

                                                                                                                                                                    

│Ìàðâåëîí {äåçîãåñòðåë 0.15 ìã, ýòèíèëýñòðàäèîë    │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA09]      │òàáëåòêè 0.15 ìã/0.03 ìã      │Organon (Èíäîíåçèÿ)           │003186,       

│0.03 ìã}                                                                                                                                              │03.08.93      

                                                                                                                                                                    

│Ìàðèíèë Êó10 [Óáèäåêàðåíîí]                       │àíòèîêñèäàíòíîå ñðåäñòâî [C01EB09]      │êàïñóëû 50 ìã; êðåì 1%        │Np Av (Øâåöèÿ)                │003896,       

                                                                                                                                                      │06.05.94       

                                                                                                                                                                    

│Ìàðèïåí [Ïåíàìåöèëëèí]                            │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │òàáëåòêè                      │Biogal (Âåíãðèÿ)              │2297,         

                                                  │[J01CE06]                                                                                           │21.06.72,      

                                                                                                                                                      │27.03.87      

                                                                                                                                                                    

│Ìàðêàèí [Áóïèâàêàèí]                              │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [N01BB01] │ðàñòâîð äëÿ èíúåêöèé          │Astra (Øâåöèÿ)                │006354,       

                                                                                          │(ôëàêîíû) 0.25%, 0.5%                                       │07.08.95      

                                                                                                                                                                    

│Ìàðêàèí Àäðåíàëèí {ïðîêàèí 2.5 ìã, ýïèíåôðèí 5.5  │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [N01BA52] │ðàñòâîð äëÿ èíúåêöèé          │Astra (Øâåöèÿ)                │006945,       

│ìêã - 0.25%; ïðîêàèí 5 ìã, ýïèíåôðèí 5.5 ìêã -                                            │(ôëàêîíû) 0.25%, 0.5%                                       │26.12.95      

│0.5%}                                                                                                                                                               

                                                                                                                                                                    

│Ìàðêîôåí [Èáóïðîôåí]                              │ÍÏÂÑ [M02AA13]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Amoun Pharmaceutical          │006920,       

                                                                                          │400 ìã; ñóñïåíçèÿ îðàëüíàÿ    │Industries Co, Apic (Åãèïåò)  │20.12.95      

                                                                                          │100 ìã|5 ìë                                                               

                                                                                                                                                                    

│Ìàòîèí {ôåíèòîèí 0.1 ã, ìåòèëôåíîáàðáèòàë 0.1 ã}  │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AB52]    │òàáëåòêè 200 ìã               │Labohain-wolf (Áåëüãèÿ)       │002649,       

                                                                                                                                                      │07.10.92      

                                                                                                                                                                    

│Ìåáåêñ [Ìåáåíäàçîë]                               │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CA01]   │òàáëåòêè 100 ìã; ñóñïåíçèÿ    │Cipla Ltd (Èíäèÿ)             │003195,       

                                                                                          │îðàëüíàÿ 100 ìã|5 ìë                                        │05.08.93      

                                                                                                                                                                    

│Ìåáåíäàçîë [Ìåáåíäàçîë]                           │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CA01]   │òàáëåòêè 100 ìã               │Confab (Êàíàäà)               │003075,       

                                                                                                                                                      │17.06.93      

                                                                                                                                                                    

│Ìåáåíäàçîë [Ìåáåíäàçîë]                           │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CA01]   │òàáëåòêè 100 ìã               │Mesco Laboratories Ltd (Èíäèÿ)│003846,       

                                                                                                                                                      │12.04.94      

                                                                                                                                                                    

│Ìåáåíäàçîë [Ìåáåíäàçîë]                           │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CA01]   │òàáëåòêè æåâàòåëüíûå 100 ìã   │Tamilnadu Dadha               │005256,       

                                                                                                                        │Pharmaceuticals Ltd (Èíäèÿ)   │22.08.94      

                                                                                                                                                                    

│Ìåâàêîð [Ëîâàñòàòèí]                              │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AB02]   │òàáëåòêè 10, 40 ìã            │Merck Sharp & Dohme (ÑØÀ)     │002800,       

                                                                                                                                                      │12.01.93      

                                                                                                                                                                    

│Ìåâàêîð [Ëîâàñòàòèí]                              │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AB02]   │òàáëåòêè 10, 20, 40 ìã        │Merck Sharp & Dohme B.V.      │006907,       

                                                                                                                        │(Ãîëëàíäèÿ)                   │19.12.95      

                                                                                                                                                                    

│Ìåãàëàê {îêñåòàêàèí, àëìàñèëàò}                   │àíòàöèäíîå ñðåäñòâî [A02AX]             │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Krewel Meuselbach GmbH        │007234,       

                                                                                          │250 ìë                        │(Ãåðìàíèÿ)                    │26.06.96      

                                                                                                                                                                    

│Ìåãàëàê àëìàñèëàò [Àëìàñèëàò]                     │àíòàöèäíîå ñðåäñòâî [A02AD05]           │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Krewel Meuselbach GmbH        │007235,       

                                                                                          │250 ìë                        │(Ãåðìàíèÿ)                    │26.06.96      

                                                                                                                                                                    

│Ìåãàöèëëèí îðàë [Ôåíîêñèìåòèëïåíèöèëëèí]          │àíòèáèîòèê, ïåíèöèëëèí [J01CE02]        │òàáëåòêè ðàñòâîðèìûå 600000,  │Grunenthal GmbH (Ãåðìàíèÿ)    │007512,       

                                                                                          │1000000 ÌÅ; ãðàíóëû äëÿ                                     │15.05.96      

                                                                                          │ïðèãîòîâëåíèÿ îðàëüíîé                                                    

                                                                                          │ñóñïåíçèè (ôëàêîíû) 300000                                                

                                                                                          │ÌÅ/5 ìë - 100 ìë /â êîìïëåêòå │                                            

                                                                                          │ñ ðàñòâîðèòåëåì/                                                          

                                                                                                                                                                    

│Ìåãåéñ [Ìåãåñòðîë]                                │ïðîãåñòàãåí [G03DB02]                   │òàáëåòêè 40 ìã                │Bristol-Myers Squibb (ÑØÀ)    │002350,       

                                                                                                                                                      │16.01.92      

                                                                                                                                                                    

│Ìåãåéñ [Ìåãåñòðîë]                                │ïðîãåñòàãåí [G03DB02]                   │òàáëåòêè 160 ìã               │Bristol-Myers Squibb (ÑØÀ)    │006839,       

                                                                                                                                                      │17.11.95      

                                                                                                                                                                    

│Ìåäàçåïàì [Ìåäàçåïàì]                             │òðàíêâèëèçàòîð [N05BA03]                │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Pharmachim (ÍÐÁ)              │2991, 30.10.90 │

                                                                                          │îáîëî÷êîé 10 ìã                                                            

                                                                                                                                                                    

│Ìåäàçåïàì ÀÂÄ [Ìåäàçåïàì]                         │òðàíêâèëèçàòîð [N05BA03]                │òàáëåòêè 10 ìã                │Arzneimittelwerk Dresden GmbH │005566,       

                                                                                                                        │(Ãåðìàíèÿ)                    │14.12.94       

                                                                                                                                                                    

│Ìåäàçîë [Ìåòðîíèäàçîë]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî               │òàáëåòêè 250 ìã; òàáëåòêè     │Belupo (Õîðâàòèÿ)             │005736,       

                                                  │[G01AF01][J01XD01]                      │âàãèíàëüíûå 500 ìã                                          │13.02.95      

                                                                                                                                                                    

│Ìåäîâåíò [Àìáðîêñîë]                              │îòõàðêèâàþùåå ñðåäñòâî [R05CB06]        │òàáëåòêè 30 ìã; êàïñóëû 75    │Medochemie Ltd (Êèïð)         │003633,       

                                                                                          │ìã; ýëèêñèð 15 ìã|5 ìë                                      │20.01.94      

                                                                                                                                                                    

│Ìåäîâèð [Àöèêëîâèð]                               │ïðîòèâîâèðóñíîå ñðåäñòâî                │òàáëåòêè 200, 400, 800 ìã;    │Medochemie Ltd (Êèïð)         │006464,       

                                                  │[D06BB03][J05AB01]                      │êðåì (òóáû) 5%; ïîðîøîê äëÿ                                 │04.09.95      

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 250, 500 ìã│                                            

                                                                                                                                                                    

│Ìåäîãëèöèí [Ëèíêîìèöèí]                           │àíòèáèîòèê, àçàëèä [J01FF02]            │ðàñòâîð äëÿ èíúåêöèé          │Medochemie Ltd (Êèïð)         │003734,       

                                                                                          │(ôëàêîíû) 600 ìã - 2 ìë;                                    │25.02.94      

                                                                                          │êàïñóëû 250, 500 ìã                                                       

                                                                                                                                                                    

│Ìåäîêëàöèä [Ãëèêëàçèä]                            │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 80 ìã                │Medochemie Ltd (Êèïð)         │003205,       

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BB09]                                                                       │09.08.93      

                                                                                                                                                                    

│Ìåäîìèöèí [Äîêñèöèêëèí]                           │àíòèáèîòèê, òåòðàöèêëèí                 │êàïñóëû 100 ìã                │Medochemie Ltd (Êèïð)         │003880,       

                                                  │ïîëóñèíòåòè÷åñêèé [J01AA02]                                                                         │26.04.94      

                                                                                                                                                                    

│Ìåäîñòàòèí [Ëîâàñòàòèí]                           │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AB02]   │òàáëåòêè 20 ìã                │Medochemie Ltd (Êèïð)         │005619,       

                                                                                                                                                      │04.01.95      

                                                                                                                                                                    

│Ìåäîôëþêîí [Ôëóêîíàçîë]                           │ïðîòèâîãðèáêîâîå ñðåäñòâî [J02AC01]     │êàïñóëû 50, 150, 200 ìã       │Medochemie Ltd (Êèïð)         │003879,       

                                                                                                                                                      │26.04.94      

                                                                                                                                                                    

│Ìåäîöåô [Öåôîïåðàçîí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA32]      │ëèîôèëèç.ïîðîøîê äëÿ          │Medochemie Ltd (Êèïð)         │003132,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │01.07.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 1 ã, 2 ã                                               

                                                                                                                                                                    

│Ìåäîöèïðèí [Öèïðîôëîêñàöèí]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │ôèëìòàáëåòêè 250, 500 ìã      │Medochemie Ltd (Êèïð)         │005122,       

                                                  │[J01MA02]                                                                                           │13.07.94      

                                                                                                                                                                    

│Ìåäðîë [Ìåòèëïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB04]           │òàáëåòêè 4 ìã, 16 ìã          │Upjohn (Áåëüãèÿ)              │002318,       

                                                                                                                                                      │10.01.92      

                                                                                                                                                                    

│Ìåäðîë [Ìåòèëïðåäíèçîëîí]                         │ãëþêîêîðòèêîñòåðîèä [H02AB04]           │òàáëåòêè 32 ìã, 100 ìã        │Upjohn (Áåëüãèÿ)              │003480,       

                                                                                                                                                      │01.11.93      

                                                                                                                                                                    

│Ìåçàêîë [Ìåñàëàçèí]                               │ïðîòèâîìèêðîáíîå ñðåäñòâî [A07EC02]     │òàáëåòêè 400 ìã               │Sun Pharmaceutical Industries │002575,       

                                                                                                                        │Ltd (Èíäèÿ)                   │28.07.92      

                                                                                                                                                                    

│Ìåçèì ôîðòå {ïàíêðåàòèí 140 ìã - àìèëàçà 4200 ÌÅ, │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │äðàæå                         │Berlin-Chemie Feb (ÃÄÐ)       │01148, 19.03.85│

│ëèïàçà 3500 ÌÅ, ïðîòåàçà 250 ÌÅ}                  │[A09AA02]                                                                                                         

                                                                                                                                                                    

│Ìåçèì ôîðòå 16000 {àìèëàçà 12000 ÌÅ, ëèïàçà 16000 │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Berlin-Chemie AG (Ãåðìàíèÿ)   │007431,       

│ÌÅ, ïðîòåàçà 720 ÌÅ}                              │[A09AA02]                                                                                           │11.04.96      

                                                                                                                                                                    

│Ìåçèì ôîðòå 3500 {ïàíêðåàòèí 140 ìã (àìèëàçà 4200 │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Berlin-Chemie AG (Ãåðìàíèÿ)   │007432,       

│ÌÅ, ëèïàçà 3500 ÌÅ, ïðîòåàçà 250 ÌÅ)}             │[A09AA02]                                                                                           │11.04.96      

                                                                                                                                                                    

│Ìåêñàâèò {ïàðàöåòàìîë 0.5 ã, àñêîðáèíîâàÿ êèñëîòà │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè øèïó÷èå              │Ludwig Merckle GmbH (Àâñòðèÿ) │002493,       

│0.2 ã}                                            │ñðåäñòâî [N02BE51]                                                                                  │02.06.92       

                                                                                                                                                                    

│Ìåêñàëåí [Ïàðàöåòàìîë]                            │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ñèðîï        │Ludwig Merckle GmbH (Àâñòðèÿ) │002494,       

                                                  │ñðåäñòâî [N02BE01]                      │(ôëàêîíû) 200 ìã|5 ìë; ñâå÷è                                │02.06.92       

                                                                                          │125, 250, 500, 1000 ìã                                                    

                                                                                                                                                                    

│Ìåêñèòèë [Ìåêñèëåòèí]                             │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BB02]     │êàïñóëû 50, 200 ìã; ðàñòâîð   │Boehringer Ingelheim (ÔÐÃ)    │00735,        

                                                                                          │äëÿ èíúåêöèé (àìïóëû) 250 ìã                                │10.08.93,     

                                                                                          │- 10 ìë                                                     │19.02.80      

                                                                                                                                                                     

│Ìåêñèòèë [Ìåêñèëåòèí]                             │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BB02]     │êàïñóëû ðåòàðä 360 ìã         │Boehringer Ingelheim          │007218,       

                                                                                                                        │International GmbH (Ãåðìàíèÿ) │18.06.96      

                                                                                                                                                                    

│Ìåëèïðàìèí [Èìèïðàìèí]                            │àíòèäåïðåññàíò [N06AA02]                │äðàæå 25 ìã                   │Egis (Âåíãðèÿ)                │2670,         

                                                                                                                                                      │10.11.81,     

                                                                                                                                                      │23.06.92      

                                                                                                                                                                    

│Ìåëèïðàìèí [Èìèïðàìèí]                            │àíòèäåïðåññàíò [N06AA02]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Egis (Âåíãðèÿ)                │2820, 06.02.86 │

                                                                                          │25 ìã/2 ìë                                                                

                                                                                                                                                                    

│Ìåëèïðàìèí [Èìèïðàìèí]                            │àíòèäåïðåññàíò [N06AA02]                │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Egit (Âåíãðèÿ)                │2067,         

                                                                                          │2 ìë                                                        │01.07.70,     

                                                                                                                                                      │28.02.84      

                                                                                                                                                                    

│Ìåëëåðèë [Òèîðèäàçèí]                             │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC02]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Sandoz Pharma Ltd (Øâåéöàðèÿ) │006451,       

                                                                                          │10, 25, 50, 100 ìã                                          │29.08.95      

                                                                                                                                                                    

│Ìåëëåðèë [Òèîðèäàçèí]                             │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC02]     │òàáëåòêè â îáîëî÷êå èç ñàõàðà │Sandoz Urunleri Ilac (Òóðöèÿ) │002310,       

                                                                                          │10, 25, 100 ìã                                              │29.12.91      

                                                                                                                                                                    

│Ìåíåôëîêñ [Îôëîêñàöèí]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Mustafa Nevzat Ilac Sanayi AS │003151,       

                                                  │[J01MA01]                               │îáîëî÷êîé 200 ìã              │(Òóðöèÿ)                      │08.07.93      

                                                                                                                                                                    

│Ìåíçèì {ïàíêðåàòèí 0.192 ã, æåë÷è êîìïîíåíòû 25   │ïèùåâàðèòåëüíîå ôåðìåíòíîå ñðåäñòâî     │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Menon Pharma (Èíäèÿ)          │002663,       

│ìã, ãåìèöåëëþëàçà 50 ìã}                          │[A09AA02]                               │îáîëî÷êîé; òàáëåòêè â                                       │13.10.92      

                                                                                          │îáîëî÷êå èç ñàõàðà                                                        

                                                                                                                                                                    

│Ìåíîãîí [Ìåíîòðîïèí] {ôîëëèêóëîñòèìóëèðóþùèé      │ôîëëèêóëîñòèìóëèðóþùåå ñðåäñòâî         │ëèîôèëèç.ïîðîøîê äëÿ          │Ferring Arzneimittel GmbH     │005720,       

│ãîðìîí 75 ÌÅ, ëþòåèíèçèðóþùèé ãîðìîí 75 ÌÅ}       │[G03GA02]                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Ãåðìàíèÿ)                    │06.02.95      

                                                                                          │ðàñòâîðà (àìïóëû) /â                                                      

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/ 75 │                                            

                                                                                          │ÌÅ ÔÑÃ/75 ÌÅ Ëà                                                          

                                                                                                                                                                    

│Ìåíîðåñò [Ýñòðàäèîë]                              │ýñòðîãåí [G03CA03]                      │ïëàñòûðü òðàíäåðìàëüíûé 25    │Rhone-Poulenc Rorer (Ôðàíöèÿ) │006961,       

                                                                                          │ìêã|êâ. ñì, 50 ìêã|êâ. ñì, 75 │                              │26.01.96      

                                                                                          │ìêã|êâ. ñì, 100 ìêã|êâ. ñì                                                

                                                                                                                                                                    

│Ìåïèâàñòåçèí [Ìåïèâàêàèí]                         │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [N01BB03] │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Espe (Ãåðìàíèÿ)               │003379,       

                                                                                          │30 ìã - 1.8 ìë                                              │12.10.93      

                                                                                                                                                                    

│Ìåïèäîíò [Ìåïèâàêàèí]                             │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [N01BB03] │ðàñòâîð äëÿ èíúåêöèé          │Molteni Pharmaceuticals       │002953,       

                                                                                          │(êàïñóëû-àìïóëû) 3% - 1.8 ìë; │(Èòàëèÿ)                      │31.03.93      

                                                                                          │ðàñòâîð äëÿ èíúåêöèé ñ                                                    

                                                                                          │àäðåíàëèíîì 1:100000                                                      

                                                                                          │(êàïñóëû-àìïóëû) 2% - 1.8 ìë                                              

                                                                                                                                                                    

│Ìåïèêàòîí [Ìåïèâàêàèí]                            │ìåñòíîàíåñòåçèðóþùåå ñðåäñòâî [N01BB03] │ðàñòâîð äëÿ èíúåêöèé          │Weimer Pharma (Ãåðìàíèÿ)      │006852,       

                                                                                          │(êàðòðèäæè) 3%                                              │22.11.95      

                                                                                                                                                                     

│Ìåðëèò [Ëîðàçåïàì]                                │òðàíêâèëèçàòîð [N05BA06]                │òàáëåòêè 2 ìã                 │Ebewe Arzneimittel GmbH       │006632,       

                                                                                                                        │(Àâñòðèÿ)                     │31.01.96      

                                                                                                                                                                     

│Ìåðëèò [Ëîðàçåïàì]                                │òðàíêâèëèçàòîð [N05BA06]                │òàáëåòêè 1, 2.5 ìã            │Ebewe (Àâñòðèÿ)               │002658,       

                                                                                                                                                      │27.10.92      

                                                                                                                                                                     

│Ìåðîíåì [Ìåðîïåíåì]                               │àíòèáèîòèê, êàðáîïåíåì [J01DH02]        │ëèîôèëèç.ïîðîøîê äëÿ          │Zeneca Ltd (Âåëèêîáðèòàíèÿ)   │007063,       

                                                                                          │ïðèãîòîâëåíèÿ âíóòðèìûøå÷íîãî │                              │07.02.96      

                                                                                          │ðàñòâîðà (ôëàêîíû) 500 ìã /â                                               

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Ìåðîíåì [Ìåðîïåíåì]                               │àíòèáèîòèê, êàðáîïåíåì [J01DH02]        │ëèîôèëèç.ïîðîøîê äëÿ          │Zeneca Ltd (Âåëèêîáðèòàíèÿ)   │006815,       

                                                                                          │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                  │10.11.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 500, 1000                                              

                                                                                          │ìã                                                                        

                                                                                                                                                                    

│Ìåðñèëîí {äåçîãåñòðåë 0.15 ìã, ýòèíèëýñòðàäèîë    │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA09]      │òàáëåòêè 0.02 ìã/0.15 ìã      │Organon (Ãîëëàíäèÿ)           │003583,       

│0.02 ìã}                                                                                                                                              │13.12.93      

                                                                                                                                                                    

│Ìåñòèíîí [Ïèðèäîñòèãìèí áðîìèä]                   │àíòèõîëèíýñòåðàçíîå ñðåäñòâî [N07AA02]  │òàáëåòêè 10 ìã; äðàæå 60 ìã;  │Hoffmann La Roche (Øâåéöàðèÿ) │00172,        

                                                                                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                              │02.11.87,     

                                                                                          │1 ìã/1 ìë; ðàñòâîð äëÿ                                      │29.10.71      

                                                                                          │èíúåêöèé (ôëàêîíû) 25 ìã - 5                                              

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ìåñöèëëèí [Àìïèöèëëèí]                            │ïåíèöèëëèí øèðîêîãî ñïåêòðà, àíòèáèîòèê │êàïñóëû 250, 500 ìã           │Mesco Laboratories Ltd (Èíäèÿ)│003860,       

                                                  │[J01CA01]                                                                                           │18.04.94      

                                                                                                                                                                    

│Ìåòàäîêñèë                                        │ñðåäñòâî äëÿ ëå÷åíèÿ àëêîãîëèçìà [V03AA]│òàáëåòêè 500 ìã; ðàñòâîð äëÿ  │Laboratoire Baldacci Spa      │002053,       

                                                                                          │èíúåêöèé (àìïóëû) 300 ìã - 5  │(Èòàëèÿ)                      │01.03.91      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ìåòàêåëüôèí {ñóëüôàäîêñèí 500 ìã, ïèðèìåòàìèí 25  │ïðîòèâîïëàçìîäèéíîå ñðåäñòâî [P01BD51]  │òàáëåòêè 525 ìã               │Farmitalia Carlo Erba (Èòàëèÿ)│003461,       

│ìã}                                                                                                                                                   │28.10.93      

                                                                                                                                                                    

│Ìåòàìîë [Ìåòîêëîïðàìèä]                           │äîôàìèí-áëîêàòîð öåíòðàëüíûé [A03FA01]  │òàáëåòêè 10 ìã                │Cts Chemical Industries Ltd   │005961,       

                                                                                                                        │(Èçðàèëü)                     │13.04.95      

                                                                                                                                                                    

│Ìåòåîñïàçìèë {àëâåðèí 60 ìã, ñèìåòèêîí 300 ìã}    │ñïàçìîëèòè÷åñêîå ñðåäñòâî [A02DA]       │êàïñóëû 60 ìã/300 ìã          │Laboratoires Mayoly-Spindler  │006129,       

                                                                                                                        │(Ôðàíöèÿ)                     │01.06.95      

                                                                                                                                                                    

│Ìåòåðãèí [Ìåòèëýðãîìåòðèí] {ñïîðûíüè àëêàëîèä}    │àëüôà-àäðåíîñòèìóëÿòîð [G02AB01]        │òàáëåòêè â îáîëî÷êå èç ñàõàðà │Sandoz Urunleri Ilac (Òóðöèÿ) │002208,       

                                                                                          │0.125 ìã                                                    │19.08.91      

                                                                                                                                                                    

│Ìåòèçîë [Òèàìàçîë]                                │àíòèòèðåîèäíîå ñðåäñòâî [H03BB02]       │òàáëåòêè 5 ìã                 │Polfa (Ïîëüøà)                │3010, 28.01.91 │

                                                                                                                                                                    

│Ìåòèëýðãîáðåâèí [Ìåòèëýðãîìåòðèí] {ñïîðûíüè       │àëüôà-àäðåíîñòèìóëÿòîð [G02AB01]        │ðàñòâîð (àìïóëû) 0.1, 0.2     │Hemofarm D.D. (Þãîñëàâèÿ)     │003947,       

│àëêàëîèä}                                                                                 │ìã/ìë; êàïëè îðàëüíûå                                       │30.05.94      

                                                                                          │(ôëàêîíû) 0.25 ìã/ìë                                                      

                                                                                                                                                                    

│Ìåòèëýðãîìåòðèí [Ìåòèëýðãîìåòðèí] {ñïîðûíüè       │àëüôà-àäðåíîñòèìóëÿòîð [G02AB01]        │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Pharmachim (Áîëãàðèÿ)         │003929,       

│àëêàëîèä}                                                                                 │0.125 ìã                                                    │20.05.94      

                                                                                                                                                                    

│Ìåòèëýðãîìåòðèí [Ìåòèëýðãîìåòðèí] {ñïîðûíüè       │àëüôà-àäðåíîñòèìóëÿòîð [G02AB01]        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Spofa Praha SA (×åõèÿ)        │007202,       

│àëêàëîèä}                                                                                 │0.2 ìã/ìë                                                   │31.05.96      

                                                                                                                                                                    

│Ìåòèíäîë [Èíäîìåòàöèí]                            │ÍÏÂÑ [M02AA23]                          │ìàçü                          │Polfa (Ïîëüøà)                │2792, 06.02.85 │

                                                                                                                                                                     

│Ìåòèíäîë [Èíäîìåòàöèí]                            │ÍÏÂÑ [M01AB01]                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Polfa (Ïîëüøà)                │2867, 31.08.87 │

                                                                                          │3% - 2 ìë                                                                 

                                                                                                                                                                     

│Ìåòèíäîë [Èíäîìåòàöèí]                            │ÍÏÂÑ [M01AB01]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa (Ïîëüøà)                │2868, 31.08.87 │

                                                                                          │25 ìã                                                                     

                                                                                                                                                                     

│Ìåòèíäîë [Èíäîìåòàöèí]                            │ÍÏÂÑ [M01AB01]                          │òàáëåòêè ðåòàðä 75 ìã         │Polfa (Ïîëüøà)                │2902, 15.08.88 │

                                                                                                                                                                    

│Ìåòèíäîë [Èíäîìåòàöèí]                            │ÍÏÂÑ [M01AB01]                          │äðàæå 25 ìã                   │Polfa, Rzeszowskie Zaklady    │2647,         

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │08.12.80,     

                                                                                                                                                      │28.09.94      

                                                                                                                                                                    

│Ìåòèïðåä [Ìåòèëïðåäíèçîëîí]                       │ãëþêîêîðòèêîñòåðîèä [H02AB04]           │òàáëåòêè 4 ìã, 16 ìã; ïîðîøîê │Orion (Ôèíëÿíäèÿ)             │01079, 04.05.84│

                                                                                          │äëÿ ïðèãîòîâëåíèÿ                                                         

                                                                                          │èíúåêöèîííîãî ðàñòâîðà 40                                                 

                                                                                          │ìã/ìë, 250 ìã/ìë                                                          

                                                                                                                                                                    

│Ìåòîãåêñàë [Ìåòîïðîëîë]                           │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè 50, 100 ìã           │Hexal Pharma GmbH (Ãåðìàíèÿ)  │006551,       

                                                  │[C07AB02]                                                                                           │25.09.95      

                                                                                                                                                                    

│Ìåòîêëîïðàìèä [Ìåòîêëîïðàìèä]                     │äîôàìèí-áëîêàòîð öåíòðàëüíûé [A03FA01]  │òàáëåòêè 10 ìã                │Biocraft Laboratories Inc     │002356,       

                                                                                                                        │(ÑØÀ)                         │17.01.92      

                                                                                                                                                                    

│Ìåòîêëîïðàìèä [Ìåòîêëîïðàìèä]                     │äîôàìèí-áëîêàòîð öåíòðàëüíûé [A03FA01]  │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Polfarma (Ïîëüøà)             │007184,       

                                                                                          │èíúåêöèé (àìïóëû) 5 ìã/ìë - 2 │                              │23.04.96      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Ìåòîêëîïðàìèä [Ìåòîêëîïðàìèä]                     │äîôàìèí-áëîêàòîð öåíòðàëüíûé [A03FA01]  │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Promed Exports Pvt Ltd (Èíäèÿ)│003385,       

                                                                                          │èíúåêöèé (àìïóëû) 5 ìã/ìë - 2 │                              │06.10.93      

                                                                                          │ìë; ðàñòâîð îðàëüíûé                                                      

                                                                                          │(ôëàêîíû) 5 ìã|5 ìë - 30 ìë                                               

                                                                                                                                                                    

│Ìåòîêñàëåí [Ìåòîêñàëåí]                           │ôîòîñåíñèáèëèçèðóþùåå ñðåäñòâî [D05AD02]│êàïñóëû 10 ìã; ëîñüîí         │Lyka Labs Ltd (Èíäèÿ)         │003532,       

                                                                                                                                                      │30.11.93      

                                                                                                                                                                    

│Ìåòîëîë [Ìåòîïðîëîë]                              │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè 50, 100 ìã           │Ludwig Merckle GmbH (Àâñòðèÿ) │003330,       

                                                  │[C07AB02]                                                                                           │13.09.93      

                                                                                                                                                                    

│Ìåòîïðåññ [Ìåòîïðîëîë]                            │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè                      │M.J.Pharmaceuticals Ltd       │003373,       

                                                  │[C07AB02]                                                             │(Èíäèÿ)                       │05.10.93      

                                                                                                                                                                    

│Ìåòîïðîëîë [Ìåòîïðîëîë]                           │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè 50 ìã                │Polfa, Rzeszowskie Zaklady    │005590,       

                                                  │[C07AB02]                                                             │Farmaceutyczne SA (Ïîëüøà)    │21.12.94      

                                                                                                                                                                    

│Ìåòîïðîëîë ÎÔ [Ìåòîïðîëîë]                        │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè 50, 100 ìã           │Ostpharm Arzneimittel GmbH &  │006814,       

                                                  │[C07AB02]                                                             │Co Kg (Ãåðìàíèÿ)              │09.11.95      

                                                                                                                                                                    

│Ìåòîïðîëîë ÎÔ 200 ðåòàðä [Ìåòîïðîëîë]             │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ostpharm Arzneimittel GmbH &  │006533,       

                                                  │[C07AB02]                               │200 ìã                        │Co Kg (Ãåðìàíèÿ)              │21.09.95      

                                                                                                                                                                    

│Ìåòîïðîëîë-Ðàòèîôàðì [Ìåòîïðîëîë]                 │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè 50, 100 ìã           │Ratiopharm GmbH & Co          │005129,       

                                                  │[C07AB02]                                                             │(Ãåðìàíèÿ)                    │14.07.94      

                                                                                                                                                                    

│Ìåòîïðîëîë-Òåâà [Ìåòîïðîëîë]                      │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Teva Pharmaceutical           │007576,       

                                                  │[C07AB02]                               │50, 100 ìã                    │Industries Ltd (Èçðàèëü)      │05.06.96      

                                                                                                                                                                    

│Ìåòîòðåêñàò [Ìåòîòðåêñàò]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │ðàñòâîð äëÿ èíúåêöèé          │Delta West (Àâñòðàëèÿ)        │006177,       

                                                                                          │(ôëàêîíû) 25 ìã/ìë                                          │13.06.95       

                                                                                                                                                                    

│Ìåòîòðåêñàò [Ìåòîòðåêñàò]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │òàáëåòêè 2.5, 5, 10 ìã;       │Ebewe Arzneimittel GmbH       │003417,       

                                                                                          │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │(Àâñòðèÿ)                     │13.10.93       

                                                                                          │èíôóçèîííîãî ðàñòâîðà                                                     

                                                                                          │(àìïóëû) 500 ìã - 5 ìë                                                    

                                                                                                                                                                     

│Ìåòîòðåêñàò [Ìåòîòðåêñàò]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │ëèîôèëèç.ïîðîøîê äëÿ          │Lachema (×åõîñëîâàêèÿ)        │2910, 02.12.88 │

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 5 ìã, 50 ìã│                                             

                                                                                                                                                                    

│Ìåòîòðåêñàò [Ìåòîòðåêñàò]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │ðàñòâîð äëÿ èíúåêöèé          │Lachema (×åõèÿ)               │003112,       

                                                                                          │(ôëàêîíû) 5 ìã/2 ìë, 20 ìã/2                                │29.06.93      

                                                                                          │ìë, 50 ìã/5 ìë, 1000 ìã/20 ìë │                                            

                                                                                                                                                                    

│Ìåòîòðåêñàò [Ìåòîòðåêñàò]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lederle (ÑØÀ)                 │003122,       

                                                                                          │2.5 ìã; ðàñòâîð äëÿ èíúåêöèé                                │30.06.93      

                                                                                          │ñ êîíñåðâàíòîì (ôëàêîíû) 25                                               

                                                                                          │ìã/ìë - 2, 10 ìë; ðàñòâîð äëÿ │                                            

                                                                                          │èíúåêöèé áåç êîíñåðâàíòà                                                  

                                                                                          │(ôëàêîíû) 25 ìã/ìë - 2, 4, 8, │                                            

                                                                                          │10 ìë; ëèîôèëèç.ïîðîøîê äëÿ                                               

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 20, 50,                                                

                                                                                          │1000 ìã                                                                   

                                                                                                                                                                    

│Ìåòîòðåêñàò [Ìåòîòðåêñàò]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │òàáëåòêè 2.5 ìã               │Remedica Ltd - Minnex (Êèïð)  │006807,       

                                                                                                                                                      │09.11.95      

                                                                                                                                                                    

│Ìåòîòðåêñàò [Ìåòîòðåêñàò]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │òàáëåòêè 2.5 ìã;              │Rhone-Poulenc Rorer (Ôðàíöèÿ) │003091,       

                                                                                          │ëèîôèëèç.ïîðîøîê äëÿ                                        │23.06.93      

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 5, 20, 50, │                                            

                                                                                          │500, 1000 ìã                                                              

                                                                                                                                                                    

│Ìåòîòðåêñàò [Ìåòîòðåêñàò]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │ðàñòâîð äëÿ èíúåêöèé          │Tissen Laboratories,          │005568,       

                                                                                          │(ôëàêîíû) 25, 50, 100 ìã      │Bio-Therabel (Áåëüãèÿ)        │15.12.94      

                                                                                                                                                                    

│Ìåòîòðåêñàò [Ìåòîòðåêñàò]                         │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │ðàñòâîð äëÿ èíúåêöèé          │David Bull Laboratories       │003139,       

                                                                                          │(ôëàêîíû) 50 ìã/2 ìë, 0.5     │(Àâñòðàëèÿ)                   │02.07.93      

                                                                                          │ã/20 ìë, 1 ã/10 ìë, 5 ã/50 ìë │                                            

                                                                                                                                                                    

│Ìåòîòðåêñàò (Ýìòåêñàò) [Ìåòîòðåêñàò]              │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │ðàñòâîð äëÿ èíúåêöèé          │Mir Pharmaceutical            │007672,       

                                                                                          │(ôëàêîíû) 25 ìã/ìë - 20, 40 ìë│Inc/pharmachemie B.V.         │23.07.96      

                                                                                                                        │(íèäåðëàíäû) (ÑØÀ)                          

                                                                                                                                                                    

│Ìåòîòðåêñàò-Òåâà [Ìåòîòðåêñàò]                    │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │ëèîôèëèç.ïîðîøîê (ôëàêîíû) 50 │Teva Pharmaceutical           │005518,       

                                                                                          │ìã; ðàñòâîð äëÿ èíúåêöèé      │Industries Ltd (Èçðàèëü)      │22.11.94      

                                                                                          │(àìïóëû) 2.5 ìã/ìë - 2 ìë;                                                

                                                                                          │ðàñòâîð äëÿ èíúåêöèé                                                      

                                                                                          │(ôëàêîíû) 2.5 ìã/ìë - 2 ìë;                                               

                                                                                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                            

                                                                                          │25 ìã/ìë - 1 ìë, 2 ìë;                                                    

                                                                                          │ðàñòâîð äëÿ èíúåêöèé                                                      

                                                                                          │(ôëàêîíû) 25 ìã/ìë - 2, 4, 8, │                                            

                                                                                          │20, 40, 200 ìë; ðàñòâîð äëÿ                                               

                                                                                          │èíúåêöèé (ôëàêîíû) 100 ìã/ìë                                              

                                                                                          │- 10, 50 ìë                                                               

                                                                                                                                                                     

│Ìåòîòðåêñàò-ÝÁÅÂÅ [Ìåòîòðåêñàò]                   │öèòîñòàòè÷åñêîå ñðåäñòâî [L01BA01]      │ðàñòâîð äëÿ èíúåêöèé          │Ebewe Arzneimittel GmbH       │006635,       

                                                                                          │(ôëàêîíû) 10 ìã/1 ìë, 50 ìã/5 │(Àâñòðèÿ)                     │31.01.96      

                                                                                          │ìë; êîíöåíòðàò äëÿ                                                         

                                                                                          │ïðèãîòîâëåíèÿ èíôóçèîííîãî                                                

                                                                                          │ðàñòâîðà 1 ã/10 ìë, 5 ã/50 ìë │                                            

                                                                                                                                                                     

│Ìåòïàìèä [Ìåòîêëîïðàìèä]                          │äîôàìèí-áëîêàòîð öåíòðàëüíûé [A03FA01]  │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Sifar Ilaclary Sanayi AS      │002499,       

                                                                                          │èíúåêöèé (àìïóëû) 10 ìã - 2 ìë│(Òóðöèÿ)                      │31.01.92      

                                                                                                                                                                     

│Ìåòðîãèë [Ìåòðîíèäàçîë]                           │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Unique Pharmaceutical         │01092,        

                                                                                          │500 ìã - 100 ìë               │Laboratories (Èíäèÿ)          │04.06.84,     

                                                                                                                                                      │04.08.94      

                                                                                                                                                                    

│Ìåòðîãèë [Ìåòðîíèäàçîë]                           │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 200, 400 ìã          │Unique Pharmaceutical         │003063,       

                                                                                                                        │Laboratories (Èíäèÿ)          │16.06.93      

                                                                                                                                                                    

│Ìåòðîãèë [Ìåòðîíèäàçîë]                           │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │ñóñïåíçèÿ îðàëüíàÿ            │Unique Pharmaceutical         │003620,       

                                                                                          │(ôëàêîíû)200 ìã|5 ìë          │Laboratories (Èíäèÿ)          │28.12.93      

                                                                                                                                                                    

│Ìåòðîãèë [Ìåòðîíèäàçîë]                           │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Unique Pharmaceutical         │005374,       

                                                                                          │100 ìã - 20 ìë                │Laboratories (Èíäèÿ)          │29.09.94      

                                                                                                                                                                    

│Ìåòðîãèë [Ìåòðîíèäàçîë]                           │ïðîòèâîìèêðîáíîå ñðåäñòâî [D06BX01]     │æåëå (òóáû)                   │Unique Pharmaceutical         │006440,       

                                                                                                                        │Laboratories (Èíäèÿ)          │28.08.95      

                                                                                                                                                                    

│Ìåòðîäèí [Óðîôîëëèòðîïèí]                         │ôîëëèêóëîñòèìóëèðóþùåå ñðåäñòâî         │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Ares-Serono Group (Øâåéöàðèÿ) │002095,       

                                                  │[G03GA04]                               │èíúåêöèîííîãî ðàñòâîðà                                      │02.04.91      

                                                                                          │(àìïóëû) 75 ÌÅ /â êîìïëåêòå ñ │                                            

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Ìåòðîäèí Â× [Óðîôîëëèòðîïèí]                      │ôîëëèêóëîñòèìóëèðóþùåå ñðåäñòâî         │ëèîôèëèç.ïîðîøîê äëÿ          │Serono Pharma Spa (Èòàëèÿ)    │005789,       

                                                  │[G03GA04]                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │27.02.95      

                                                                                          │ðàñòâîðà (àìïóëû) 75, 150 ÌÅ                                              

                                                                                          │/â êîìïëåêòå ñ ðàñòâîðèòåëåì                                              

                                                                                          │- àìïóëû 1 ìë/                                                            

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 250 ìã               │Confab (Êàíàäà)               │003485,       

                                                                                                                                                      │03.11.93      

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 200, 400 ìã          │Cox Pharmaceuticals           │005298,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │06.09.94      

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 200, 250, 400 ìã     │Grossons Pharmaceutical       │003453,       

                                                                                                                        │(Èíäèÿ)                       │25.10.93      

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 200, 400 ìã          │Mesco Laboratories Ltd (Èíäèÿ)│003847,       

                                                                                                                                                      │12.04.94      

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │ðàñòâîð äëÿ âíóòðèâåííîãî     │Polfa (Ïîëüøà)                │2885, 15.02.88 │

                                                                                          │ââåäåíèÿ (àìïóëû) 0.5% - 20 ìë│                                            

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │ðàñòâîð äëÿ èíôóçèé           │Polfa (Ïîëüøà)                │003164,       

                                                                                          │èçîòîíè÷åñêèé (åìêîñòè                                      │19.07.93      

                                                                                          │ïîëèýòèëåíîâûå) 0.5% - 100 ìë │                                            

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Promed Exports Pvt Ltd (Èíäèÿ)│003145,       

                                                                                          │0.5% - 100 ìë; ðàñòâîð äëÿ                                  │07.07.93      

                                                                                          │èíúåêöèé (àìïóëû) 0.5% - 10 ìë│                                             

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 200, 400 ìã          │Promed Exports Pvt Ltd (Èíäèÿ)│005529,       

                                                                                                                                                      │28.11.94       

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 200 ìã               │Rima Pharmaceutical Ltd       │002962,       

                                                                                                                        │(Èðëàíäèÿ)                    │13.04.93      

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 250 ìã               │Rivopharm (Íèäåðëàíäû)        │003087,       

                                                                                                                                                      │17.06.93      

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 250 ìã               │Rivopharm SA (Øâåéöàðèÿ)      │003086,       

                                                                                                                                                      │17.06.93      

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 250 ìã               │Watson Laboratories Inc (ÑØÀ) │002476,       

                                                                                                                                                      │31.01.92      

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Wave International (Èíäèÿ)    │006967,       

                                                                                          │200, 400, 600 ìã                                            │10.01.96      

                                                                                                                                                                    

│Ìåòðîíèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 250 ìã               │(Óêðàèíà)                     │94/158/13     

                                                                                                                                                                    

│Ìåòðîíèäàçîë â/â Áðàóí [Ìåòðîíèäàçîë]             │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │B.Braun Melsungen AG          │007599,       

                                                                                          │500 ìã|100 ìë - 100 ìë        │(Ãåðìàíèÿ)                    │21.06.96      

                                                                                                                                                                    

│Ìåòðîíèäàçîë Êâàëèìåä [Ìåòðîíèäàçîë]              │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Laboratoires Solymes, Roussel │006965,       

                                                                                          │0.5%; ðàñòâîð äëÿ èíôóçèé     │Uclaf Groupe (Ôðàíöèÿ)        │09.01.96      

                                                                                          │(ìåøêè ïëàñòèêîâûå) 0.5%                                                  

                                                                                                                                                                    

│Ìåòðîíèäàçîë Íèêîìåä [Ìåòðîíèäàçîë]               │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 250, 500 ìã; ñâå÷è 1 │Nycomed Dak AS (Äàíèÿ)        │006105,       

                                                                                          │ã; ðàñòâîð äëÿ èíôóçèé                                      │25.05.95      

                                                                                          │(ôëàêîíû) 5 ìã/ìë                                                         

                                                                                                                                                                    

│Ìåòðîíèäàçîë-Òåâà [Ìåòðîíèäàçîë]                  │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 250, 500 ìã          │Teva Pharmaceutical           │003589,       

                                                                                                                        │Industries Ltd (Èçðàèëü)      │16.12.93      

                                                                                                                                                                    

│Ìåòôîðìèí [Ìåòôîðìèí]                             │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 500 ìã               │Polfa (Ïîëüøà)                │2886, 15.02.88 │

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BA02]                                                                                     

                                                                                                                                                                    

│Ìèàêàëüöèê [Êàëüöèòîíèí]                          │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Sandoz Pharma (Øâåéöàðèÿ)     │002615,       

                                                  │[H05BA01]                               │50 ÌÅ - 1 ìë                                                │10.09.92      

                                                                                                                                                                    

│Ìèàêàëüöèê [Êàëüöèòîíèí]                          │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │àýðîçîëü íàçàëüíûé 14 äîç -   │Sandoz Pharma (Øâåéöàðèÿ)     │005496,       

                                                  │[H05BA01]                               │50, 100 ÌÅ                                                  │15.11.94      

                                                                                                                                                                    

│Ìèàíñàí [Ìèàíñåðèí]                               │àíòèäåïðåññàíò [N06AX03]                │òàáëåòêè 10, 30 ìã            │Zorka (Þãîñëàâèÿ)             │01244, 18.02.86│

                                                                                                                                                                    

│Ìèàíñåðèí [Ìèàíñåðèí]                             │àíòèäåïðåññàíò [N06AX03]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │CT-Arzneimittel Chemishe      │003572,       

                                                                                          │10, 30 ìã                     │Tempelchof GmbH (Ãåðìàíèÿ)    │09.12.93      

                                                                                                                                                                    

│Ìèáèðîí [Àñòåìèçîë]                               │H1-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 10 ìã                │Faran Laboratories SA (Ãðåöèÿ)│003853,       

                                                  │[R06AX11]                                                                                           │15.04.94      

                                                                                                                                                                    

│Ìèâàêðîí [Ìèâàêóðèÿ õëîðèä]                       │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03AC10]     │ðàñòâîð äëÿ âíóòðèâåííîãî     │Glaxo-Wellcome                │007527,       

                                                                                          │ââåäåíèÿ (àìïóëû) 5, 10, 25 ìë│(Âåëèêîáðèòàíèÿ)              │21.05.96      

                                                                                                                                                                    

│Ìèãðåíîë {ïàðàöåòàìîë 500 ìã, êîôåèí 65 ìã}       │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Four Venturis Enterprises     │006836,       

                                                  │ñðåäñòâî [N02BE51]                                                    │(ÑØÀ)                         │15.11.95      

                                                                                                                                                                     

│Ìèãðåíîë ÏÌ {ïàðàöåòàìîë 500 ìã, äèôåíãèäðàìèí 38 │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Four Venturis Enterprises     │006837,       

│ìã}                                               │ñðåäñòâî [N02BE51]                                                    │(ÑØÀ)                         │15.11.95      

                                                                                                                                                                     

│Ìèäîêàëì [Òîëïåðèçîí]                             │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03BX04]     │äðàæå 50 ìã                   │Gedeon Richter (Âåíãðèÿ)      │2071,         

                                                                                                                                                      │01.07.70,     

                                                                                                                                                      │26.04.84,     

                                                                                                                                                      │27.02.95      

                                                                                                                                                                    

│Ìèäîêàëì [Òîëïåðèçîí]                             │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03BX04]     │äðàæå 150 ìã                  │Gedeon Richter (Âåíãðèÿ)      │006430,       

                                                                                                                                                      │23.08.95      

                                                                                                                                                                    

│Ìèäîêàëì [Òîëïåðèçîí]                             │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03BX04]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Gedeon Richter (Âåíãðèÿ)      │006573,       

                                                                                          │1 ìë                                                        │28.09.95      

                                                                                                                                                                    

│Ìèäîêàëì [Òîëïåðèçîí]                             │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03BX04]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Themis Chemicals Ltd (Èíäèÿ)  │002972,       

                                                                                          │50 ìã                                                       │20.04.93      

                                                                                                                                                                    

│Ìèäðèàöèë [Òðîïèêàìèä]                            │ì-õîëèíîáëîêàòîð [S01FA06]              │êàïëè ãëàçíûå (ôëàêîíû) 0.5%, │Alcon-Kouvrer SA (Áåëüãèÿ)    │007082,       

                                                                                          │1%                                                          │14.02.96      

                                                                                                                                                                    

│Ìèäðóì [Òðîïèêàìèä]                               │ì-õîëèíîáëîêàòîð [S01FA06]              │êàïëè ãëàçíûå 0.4%            │Ankerpharm GmbH, Ankerwerk    │003298,       

                                                                                                                        │Rudolstadt (ÔÐÃ)              │02.09.93      

                                                                                                                                                                    

│Ìèêàöèí [Àìèêàöèí]                                │àíòèáèîòèê, àìèíîãëèêîçèä [J01GB06]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Aristo Pharmaceutical Ltd     │003674,       

                                                                                          │250 ìã - 2 ìë                 │(Èíäèÿ)                       │07.02.94      

                                                                                                                                                                    

│Ìèêîáóòîë [Ýòàìáóòîë]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │òàáëåòêè 400 ìã               │Cadila Laboratories Ltd       │01604, 09.06.89│

                                                                                                                        │(Èíäèÿ)                                     

                                                                                                                                                                    

│Ìèêîáóòîë [Ýòàìáóòîë]                             │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK02] │òàáëåòêè 100 ìã               │Cadila Laboratories Ltd       │003399,       

                                                                                                                        │(Èíäèÿ)                       │08.10.93      

                                                                                                                                                                    

│Ìèêîçîëîí {ìàçèïðåäîí 2.05 ìã, ìèêîíàçîë 20 ìã -  │ãëþêîêîðòèêîñòåðîèä+ïðîòèâîìèêðîáíîå    │ìàçü                          │Gedeon Richter (ÂÍÐ)          │2512,         

│1 ã}                                              │ñðåäñòâî [D07BA]                                                                                    │02.02.77,     

                                                                                                                                                      │19.12.88      

                                                                                                                                                                    

│Ìèêîñåïòèí {óíäåöèëåíîâàÿ êèñëîòà 1.5 ã,          │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AE04]     │ìàçü                          │Lechiva (×åõèÿ)               │2256,         

│óíäåöèëåíàò öèíêà 4.5 ã}                                                                                                                              │05.12.84,     

                                                                                                                                                      │09.06.94,     

                                                                                                                                                      │29.07.71      

                                                                                                                                                                    

│Ìèêîñïîð [Áèôîíàçîë]                              │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC10]     │êðåì 1%; ðàñòâîð 1%           │Bayer AG (ÔÐÃ)                │01463, 25.08.88│

                                                                                                                                                                    

│Ìèêîñïîð êðåì â íàáîðå äëÿ ëå÷åíèÿ íîãòåé         │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC10]     │êðåì (äîçàòîð) 10 ã /â        │Bayer AG (Ãåðìàíèÿ)           │007160,       

│[Áèôîíàçîë]                                                                               │êîìïëåêòå ñ 15 ïîëîñêàìè                                    │20.03.96      

                                                                                          │âîäîñòîéêîãî ëåéêîïëàñòûðÿ ñ                                              

                                                                                          │øàáåðîì/                                                                  

                                                                                                                                                                    

│Ìèêîöåì [Óíäåöèëåíîâàÿ êèñëîòà]                   │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AE04]     │êðåì (òóáû)                   │Paul Hauser Chepharin         │005231,       

                                                                                                                        │(Àâñòðèÿ)                     │18.08.94      

                                                                                                                                                                    

│Ìèêðèñòèí [Àöåòèëñàëèöèëîâàÿ êèñëîòà]             │ÍÏÂÑ [N02BA01]                          │òàáëåòêè 500 ìã               │Oranienburger Pharmawerk GmbH │005850,       

                                                                                                                        │(Ãåðìàíèÿ)                    │13.03.95      

                                                                                                                                                                    

│Ìèêðîãèíîí {ëåâîíîðãåñòðåë 0.15 ìã,               │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA07]      │äðàæå                         │Schering AG (ÔÐÃ)             │003062,       

│ýòèíèëýñòðàäèîë 0.03 ìã - äðàæå 21; æåëåçà                                                                                                            │16.06.93      

│ôóìàðàò 75 ìã - äðàæå 7}                                                                                                                                            

                                                                                                                                                                     

│Ìèêðîçåð [Áåòàãèñòèí]                             │ïðåïàðàò ãèñòàìèíà [N07CA01]            │òàáëåòêè 8 ìã; êàïëè îðàëüíûå │Prodotti Formenti Srl (Èòàëèÿ)│007592,       

                                                                                          │(ôëàêîíû) 1.25% - 30 ìë                                     │20.06.96      

                                                                                                                                                                     

│Ìèêðîëþò [Ëåâîíîðãåñòðåë]                         │ïðîãåñòàãåí [G03AC03]                   │äðàæå 0.03 ìã                 │Schering AG (Ãåðìàíèÿ)        │006883,       

                                                                                                                                                      │08.12.95      

                                                                                                                                                                     

│Ìèêðîíîð [Íîðýòèñòåðîí]                           │ïðîãåñòàãåí [G03DC02]                   │òàáëåòêè 350 ìã               │Cilag (Âåëèêîáðèòàíèÿ)        │003817,       

                                                                                                                                                      │04.04.94      

                                                                                                                                                                     

│Ìèêðîôëîêñ [Öèïðîôëîêñàöèí]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 250, 500 ìã          │Micro Nova Pharmaceuticals    │005371,       

                                                  │[J01MA02]                                                             │Private Ltd (Èíäèÿ)           │27.09.94      

                                                                                                                                                                    

│Ìèêðîôîëëèí ôîðòå [Ýòèíèëýñòðàäèîë]               │ýñòðîãåí [G03CA01]                      │òàáëåòêè 0.05 ìã              │Gedeon Richter (Âåíãðèÿ)      │2070,         

                                                                                                                                                      │01.07.70,     

                                                                                                                                                      │05.12.94,     

                                                                                                                                                      │26.04.84      

                                                                                                                                                                    

│Ìèêñòàðä 10 HM ïåíôèëë [Èíñóëèí-Êîìá] {èíñóëèí    │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Novo Nordisk (Äàíèÿ)          │003270,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 10%; èíñóëèí                                                    │(ãèëüçû ñòåêëÿííûå äëÿ                                      │26.08.93      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 90%}                                                        │øïðèöðó÷êè) 100 ÌÅ/ìë - 1.5                                               

                                                                                          │ìë, 3 ìë                                                                  

                                                                                                                                                                    

│Ìèêñòàðä 20 HM ïåíôèëë [Èíñóëèí-Êîìá] {èíñóëèí    │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Novo Nordisk (Äàíèÿ)          │003271,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 20%; èíñóëèí                                                    │(ãèëüçû ñòåêëÿííûå äëÿ                                      │26.08.93      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 80%}                                                        │øïðèöðó÷êè) 100 ÌÅ/ìë - 1.5                                               

                                                                                          │ìë, 3 ìë                                                                  

                                                                                                                                                                    

│Ìèêñòàðä 30 HM ïåíôèëë [Èíñóëèí-Êîìá] {èíñóëèí    │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Novo Nordisk (Äàíèÿ)          │003272,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 30%; èíñóëèí                                                    │(ãèëüçû ñòåêëÿííûå äëÿ                                      │26.08.93      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 70%}                                                        │øïðèöðó÷êè) 100 ÌÅ/ìë - 1.5                                               

                                                                                          │ìë, 3 ìë                                                                  

                                                                                                                                                                    

│Ìèêñòàðä 40 HM ïåíôèë [Èíñóëèí-Êîìá] {èíñóëèí     │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Novo Nordisk (Äàíèÿ)          │003273,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 40%; èíñóëèí                                                    │(ãèëüçû ñòåêëÿííûå äëÿ                                      │26.08.93      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 60%}                                                        │øïðèöðó÷êè) 100 ÌÅ/ìë - 1.5                                               

                                                                                          │ìë, 3 ìë                                                                  

                                                                                                                                                                    

│Ìèêñòàðä 50 HM ïåíôèë [Èíñóëèí-Êîìá] {èíñóëèí     │èíñóëèí êîìáèíèðîâàííûé [A10AA03]       │ñóñïåíçèÿ äëÿ èíúåêöèé        │Novo Nordisk (Äàíèÿ)          │003274,       

│íåéòðàëüíûé, ÷åëîâå÷åñêèé 50%; èíñóëèí                                                    │(ãèëüçû ñòåêëÿííûå äëÿ                                      │26.08.93      

│èçîôàí-ïðîòàìèí, ÷åëîâå÷åñêèé 50%}                                                        │øïðèöðó÷êè) 100 ÌÅ/ìë - 1.5                                               

                                                                                          │ìë, 3 ìë                                                                  

                                                                                                                                                                    

│Ìèë-Ïàð [Ìàãíèÿ ãèäðîêñèä] {ìàãíèÿ ãèäðîêñèä 3.75 │àíòàöèäíîå ñðåäñòâî [A02AA04]           │ñóñïåíçèÿ îðàëüíàÿ 3.75       │Sterling Health               │005627,       

│ìë, ïàðàôèí æèäêèé 1.25 ìë - 5 ìë}                                                        │ìë/1.25 ìë|5 ìë               │(Âåëèêîáðèòàíèÿ)              │10.01.95      

                                                                                                                                                                    

│Ìèëâàíå {ãåñòîäåí 0.05 ìã, ýòèíèëýñòðàäèîë 0.03   │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA05]      │äðàæå                         │Schering AG (Ãåðìàíèÿ)        │007639,       

│ìã - äðàæå æåëòûå; ãåñòîäåí 0.07 ìã,                                                                                                                  │11.07.96      

│ýòèíèëýñòðàäèîë 0.04 ìã - äðàæå êîðè÷íåâûå;                                                                                                                         

│ãåñòîäåí 0.1 ìã, ýòèíèëýñòðàäèîë 0.03 ìã - äðàæå                                                                                                                    

│áåëûå}                                                                                                                                                              

                                                                                                                                                                    

│Ìèëåðàí [Áóñóëüôàí]                               │öèòîñòàòè÷åñêîå ñðåäñòâî [L01AB01]      │òàáëåòêè 2 ìã                 │Wellcome Foundation Ltd       │003645,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │28.01.94      

                                                                                                                                                                    

│Ìèëê îô ìàãíåçèÿ [Ìàãíèÿ ãèäðîêñèä]               │àíòàöèäíîå ñðåäñòâî [A02AA04]           │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Smithkline Beecham Consumer   │007252,       

                                                                                          │415 ìã|5 ìë - 300 ìë;         │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

                                                                                          │òàáëåòêè 300 ìã                                                           

                                                                                                                                                                     

│Ìèëóðèò [Àëëîïóðèíîë]                             │êñàíòèíîêñèäàçû èíãèáèòîð [M04AA01]     │òàáëåòêè 100 ìã               │Egit (Âåíãðèÿ)                │006301,       

                                                                                                                                                      │15.07.95      

                                                                                                                                                                     

│Ìèíàëüãàí {ìåòàìèçîë 0.5 ã,                       │àíàëüãåòè÷åñêîå è ñïàçìîëèòè÷åñêîå      │òàáëåòêè; ðàñòâîð äëÿ         │Menon Pharma/hamax (Èíäèÿ)    │002777,       

│äèôåíèëïèïåðèäèíýòèëàöåòàìèä áðîììåòèëàò 5 ìã,    │ñðåäñòâî [N02BB52]                      │èíúåêöèé (àìïóëû) 2 ìë, 5 ìë                                │28.12.92      

│ïèïåðèäèíýòîêñèêàðáìåòîêñè áåíçîôåíîí 0.1 ìã -                                                                                                                       

│òàáëåòêà; ìåòàìèçîë 0.5 ã,                                                                                                                                          

│äèôåíèëïèïåðèäèíýòèëàöåòàìèä áðîììåòèëàò 2 ìã,                                                                                                                      

│ïèïåðèäèíýòîêñèêàðáìåòîêñè áåíçîôåíîí 0.2 ìã - 1                                                                                                                     

│ìë}                                                                                                                                                                 

                                                                                                                                                                    

│Ìèíèäèàá [Ãëèïèçèä]                               │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 5 ìã                 │Farmitalia Carlo Erba (Èòàëèÿ)│01011,        

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BB07]                                                                       │21.09.93,     

                                                                                                                                                      │29.06.83      

                                                                                                                                                                    

│Ìèíèçèñòîí {ëåâîíîðãåñòðåë 0.125 ìã,              │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA07]      │äðàæå                         │Jenapharm GmbH (Ãåðìàíèÿ)     │01227,        

│ýòèíèëýñòðàäèîë 0.03 ìã}                                                                                                                              │12.07.94,     

                                                                                                                                                      │25.12.85      

                                                                                                                                                                    

│Ìèíèïðåññ [Ïðàçîçèí]                              │àëüôà-àäðåíîáëîêàòîð [C02CA01]          │òàáëåòêè 1, 2, 5 ìã           │Pfizer Corporation (Áåëüãèÿ)  │007242,       

                                                                                                                                                      │10.07.96      

                                                                                                                                                                    

│Ìèíèôàæ (Ïîíäåðàë) [Ôåíôëóðàìèí]                  │àíîðåêñèãåííîå ñðåäñòâî [A08AA02]       │êàïñóëû ðåòàðä 60 ìã          │Laboratoires Servier (Ôðàíöèÿ)│01184, 19.07.85│

                                                                                                                                                                    

│Ìèíîöèí [Ìèíîöèêëèí]                              │àíòèáèîòèê, òåòðàöèêëèí                 │òàáëåòêè 50, 100 ìã; êàïñóëû  │Lederle (ÑØÀ)                 │003659,       

                                                  │ïîëóñèíòåòè÷åñêèé [J01AA08]             │50 ìã; ðàñòâîð äëÿ èíúåêöèé                                 │01.02.94      

                                                                                          │(ôëàêîíû) 100 ìã - 3 ìë                                                   

                                                                                                                                                                    

│Ìèíóëåò {ãåñòîäåí 0.075 ìã, ýòèíèëýñòðàäèîë 0.03  │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA10]      │òàáëåòêè                      │Wyeth Pharma GmbH (Ãåðìàíèÿ)  │005165,       

│ìã}                                                                                                                                                   │21.07.94      

                                                                                                                                                                    

│Ìèîâèí [Íèòðîãëèöåðèí]                            │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │ìàçü 2%                       │Cadila Laboratories Ltd       │002156,       

                                                                                                                        │(Èíäèÿ)                       │17.06.91      

                                                                                                                                                                    

│Ìèîãàðä [Íèôåäèïèí]                               │ÁÌÊÊ [C08CA05]                          │êàïñóëû 10 ìã                 │United Pharmaceutical         │003043,       

                                                                                                                        │Manufactoring Co Ltd          │08.06.93      

                                                                                                                        │(Èîðäàíèÿ)                                  

                                                                                                                                                                    

│Ìèîëàñòàí [Òåòðàçåïàì]                            │òðàíêâèëèçàòîð [M03BA]                  │òàáëåòêè 50 ìã                │Laboratoires Clin-Midy        │01279, 22.05.86│

                                                                                                                        │(Ôðàíöèÿ)                                   

                                                                                                                                                                    

│Ìèîëãèí [Òåîôèëëèí]                               │áðîíõîäèëàòèðóþùåå ñðåäñòâî [R03DA04]   │êàïñóëû                       │Amoun Pharmaceutical          │003973,       

                                                                                                                        │Industries Co, Apic (Åãèïåò)  │02.06.94      

                                                                                                                                                                    

│Ìèîïðèë [Ýíàëàïðèë]                               │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 2.5, 5, 10 ìã        │Unique Pharmaceutical         │006439,       

                                                                                                                        │Laboratories (Èíäèÿ)          │28.08.95      

                                                                                                                                                                    

│Ìèîñïðåé {áåíçèëíèêîòèíîâàÿ êèñëîòà 0.18 ã,       │ìåñòíîðàçäðàæàþùåå ñðåäñòâî [M02AX]     │àýðîçîëü                      │Lek (Þãîñëàâèÿ)               │00830, 21.11.80│

│íèêîòèíàìèä 0.18 ã, ìåíòîë 0.16 ã}                                                                                                                                  

                                                                                                                                                                    

│Ìèðåíèë [Ôëóôåíàçèí]                              │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AB02]     │äðàæå 1 ìã                    │Polfa (Ïîëüøà)                │2171,         

                                                                                                                                                      │02.10.70,     

                                                                                                                                                      │21.03.85      

                                                                                                                                                                    

│Ìèðîöåô [Öåôòàçèäèì]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA11]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pliva (ÑÔÐÞ)                  │01599, 27.04.89│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                                    

                                                                                          │(ôëàêîíû) 0.5, 1, 2 ã                                                     

                                                                                                                                                                     

│Ìèñîëèí [Ïðèìèäîí]                                │ïðîòèâîñóäîðîæíîå ñðåäñòâî [N03AA03]    │òàáëåòêè 250 ìã; ñóñïåíçèÿ    │Zeneca-ICI (Âåëèêîáðèòàíèÿ)   │003604,       

                                                                                          │(ôëàêîíû) 250 ìã|5 ìë                                       │20.12.93      

                                                                                                                                                                     

│Ìèñòàáðîí [Ìåñíà]                                 │îòõàðêèâàþùåå ñðåäñòâî [R05CB05]        │ðàñòâîð äëÿ èíãàëÿöèé         │Polfa, Krakowskie Zaklady     │007172,       

                                                                                          │(àìïóëû) 600 ìã - 3 ìë;       │Farmaceutyczne SA (Ïîëüøà)    │29.03.96      

                                                                                          │ðàñòâîð äëÿ âíóòðèïîëîñòíûõ                                                

                                                                                          │âëèâàíèé (àìïóëû) 600 ìã - 3                                              

                                                                                          │ìë                                                                        

                                                                                                                                                                     

│Ìèñòàáðîí [Ìåñíà]                                 │îòõàðêèâàþùåå ñðåäñòâî [R05CB05]        │ðàñòâîð äëÿ èíãàëÿöèé         │Ucb SA (Áåëüãèÿ)              │00667,        

                                                                                          │(àìïóëû) 20% - 3 ìë                                         │05.10.90,     

                                                                                                                                                      │16.04.79      

                                                                                                                                                                    

│Ìèòîêñàíòðîí [Ìèòîêñàíòðîí]                       │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DB07]      │ðàñòâîð äëÿ èíúåêöèé          │Polfa, Jelfa (Ïîëüøà)         │005581,       

                                                                                          │(ôëàêîíû) 20 ìã - 10 ìë                                     │16.12.94      

                                                                                                                                                                    

│Ìèòîêñàíòðîí ÀÂÄ [Ìèòîêñàíòðîí]                   │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DB07]      │ðàñòâîð äëÿ èíúåêöèé          │Arzneimittelwerk Dresden GmbH │007171,       

                                                                                          │(ôëàêîíû) 2 ìã/ìë - 5, 10,    │(Ãåðìàíèÿ)                    │01.04.96      

                                                                                          │12.5, 15 ìë                                                               

                                                                                                                                                                    

│Ìèòîêñàíòðîí ÀÂÄ 25 [Ìèòîêñàíòðîí]                │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DB07]      │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Arzneimittelwerk Dresden GmbH │002943,       

                                                                                          │èíôóçèîííîãî ðàñòâîðà 25 ìã - │(ÔÐÃ)                         │31.03.93      

                                                                                          │12.5 ìë                                                                   

                                                                                                                                                                    

│Ìèòîìèöèí-Ñ [Ìèòîìèöèí]                           │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DC03]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Kyowa Hakko Kogyo Co Ltd      │00598, 20.06.78│

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(ßïîíèÿ)                                    

                                                                                                                                                                    

│Ìîáèëàò {ìóêîïîëèñàõàðèäíûé ïîëèýôèð ñåðíîé       │ìåñòíîðàçäðàæàþùåå ñðåäñòâî [M02AC]     │ìàçü; ãåëü                    │Luitpold Pharma GmbH          │006659,       

│êèñëîòû 0.2 ã, ñàëèöèëîâàÿ êèñëîòà 2 ã, ýêñòðàêò                                                                        │(Ãåðìàíèÿ)                    │05.03.96      

│íàäïî÷å÷íèêîâ 1 ã - 100 ã}                                                                                                                                          

                                                                                                                                                                    

│Ìîáèëèçèí {ìóêîïîëèñàõàðèäíûé ïîëèýôèð ñåðíîé     │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî äëÿ      │ìàçü                          │Luitpold Pharma (Ãåðìàíèÿ)    │006658,       

│êèñëîòû 0.2 ã, ñàëèöèëàò íàòðèÿ 2 ã,              │ìåñòíîãî ïðèìåíåíèÿ [M02AC]                                                                         │05.03.96      

│ôëóôåíàìèíîâàÿ êèñëîòà 3 ã - 100 ã}                                                                                                                                 

                                                                                                                                                                    

│Ìîâîí [Ïèðîêñèêàì]                                │ÍÏÂÑ [M02AA07]                          │êàïñóëû 10, 20 ìã             │Ipca Laboratories Ltd (Èíäèÿ) │005995,       

                                                                                                                                                      │25.04.95      

                                                                                                                                                                    

│Ìîãàäîí [Íèòðàçåïàì]                              │òðàíêâèëèçàòîð [N05CD02]                │òàáëåòêè                      │Galenika (Þãîñëàâèÿ)          │00412,        

                                                                                                                                                      │07.10.76,     

                                                                                                                                                      │12.09.88      

                                                                                                                                                                    

│Ìîäåêåéò [Ôëóôåíàçèí]                             │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AB02]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Squibb & Sons (Âåëèêîáðèòàíèÿ)│00178,        

                                                                                          │25 ìã/ìë - 0.5 ìë, 1 ìë;                                    │25.03.83,     

                                                                                          │ðàñòâîð äëÿ èíúåêöèé                                        │29.10.71      

                                                                                          │(ôëàêîíû) 25 ìã/ìë - 10 ìë                                                

                                                                                                                                                                    

│Ìîäèâèä [Öåôîäèçèì]                               │àíòèáèîòèê, öåôàëîñïîðèí [J01DA25]      │ëèîôèëèç.ïîðîøîê äëÿ          │Hoechst AG (Ãåðìàíèÿ)         │005421,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │25.10.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 0.25, 0.5, │                                            

                                                                                          │1, 2 ã                                                                    

                                                                                                                                                                    

│Ìîäèòåí [Ôëóôåíàçèí]                              │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AB02]     │òàáëåòêè 1, 2.5, 5 ìã         │Bristol-Myers Squibb,         │006646,       

                                                                                                                        │E.R.Squibb & Sons Ltd         │19.02.96      

                                                                                                                        │(Âåëèêîáðèòàíèÿ)                            

                                                                                                                                                                    

│Ìîäèòåí äåïî [Ôëóôåíàçèí]                         │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AB02]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Bristol-Myers Squibb          │007473,       

                                                                                          │25 ìã/ìë - 0.5, 1 ìë; ðàñòâîð │(Ãåðìàíèÿ)                    │25.04.96       

                                                                                          │äëÿ èíúåêöèé (ôëàêîíû) 25                                                 

                                                                                          │ìã/ìë - 10 ìë                                                             

                                                                                                                                                                     

│Ìîäèòåí-äåïî [Ôëóôåíàçèí]                         │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AB02]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Krka (Ñëîâåíèÿ)               │00103,        

                                                                                          │25 ìã/1 ìë                                                  │11.02.71,     

                                                                                                                                                      │13.02.84,     

                                                                                                                                                      │28.10.94      

                                                                                                                                                                    

│Ìîäóðåòèê {àìèëîðèä 5 ìã, ãèäðîõëîðîòèàçèä 50 ìã} │äèóðåòè÷åñêîå êîìáèíèðîâàííîå ñðåäñòâî  │òàáëåòêè 5 ìã/50 ìã           │Merck Sharp & Dohme           │00611,        

                                                  │[C03EA01]                                                             │(Íèäåðëàíäû)                  │22.08.78,     

                                                                                                                                                      │22.09.93      

                                                                                                                                                                    

│Ìîëèêîð [Íîðôåíåôðèí]                             │âàçîêîíñòðèêòîðíîå ñðåäñòâî [C01CA05]   │òàáëåòêè 2 ìã                 │Sbrolek (ÑÔÐÞ)                │002309,       

                                                                                                                                                      │23.12.91      

                                                                                                                                                                    

│Ìîëñèäîìèí [Ìîëñèäîìèí]                           │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DX12]     │òàáëåòêè 2 ìã, 4 ìã; òàáëåòêè │Polfa, Warszawskie Zaklady    │005578,       

                                                                                          │ðåòàðä 8 ìã                   │Farmaceutyczne SA (Ïîëüøà)    │16.12.94      

                                                                                                                                                                    

│Ìîíèçèä [Èçîñîðáèä ìîíîíèòðàò]                    │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20, 40 ìã            │Pharmachim (ÍÐÁ)              │3007, 21.01.91 │

                                                                                                                                                                    

│Ìîíèçîë [Èçîñîðáèä ìîíîíèòðàò]                    │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20, 40 ìã            │Zorka Pharma (Þãîñëàâèÿ)      │007574,       

                                                                                                                                                      │05.06.96      

                                                                                                                                                                    

│Ìîíî Ìàê [Èçîñîðáèä ìîíîíèòðàò]                   │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20, 40 ìã            │Heinrich Mack Nachf.          │006457,       

                                                                                                                        │(Ãåðìàíèÿ)                    │04.09.95      

                                                                                                                                                                    

│Ìîíî Ìàê äåïî [Èçîñîðáèä ìîíîíèòðàò]              │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè ðåòàðä 100 ìã        │Heinrich Mack Nachf.          │005109,       

                                                                                                                        │(Ãåðìàíèÿ)                    │08.07.94      

                                                                                                                                                                    

│Ìîíîêëàò-Ï [Ôàêòîð ñâåðòûâàíèÿ êðîâè VIII è IX â  │ãåìîñòàòè÷åñêîå ñðåäñòâî [B02BD]        │ëèîôèëèç.ïîðîøîê äëÿ          │Armour Pharmaceuticals        │002898,       

│êîìáèíàöèè] {ôàêòîð ñâåðòûâàíèÿ êðîâè VIII}                                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │Company (ÑØÀ)                 │11.03.93      

                                                                                          │ðàñòâîðà (ôëàêîíû) 1000 ÌÅ /â │                                            

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Ìîíîêëèí [Äîêñèöèêëèí]                            │àíòèáèîòèê, òåòðàöèêëèí                 │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Doms Adrian      │005989,       

                                                  │ïîëóñèíòåòè÷åñêèé [J01AA02]             │100 ìã                        │(Ôðàíöèÿ)                     │24.04.95      

                                                                                                                                                                    

│Ìîíîëèí NPH Ó-40 [Èíñóëèí-ÑðÄ] {èíñóëèí,          │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Biobras S/a (Áðàçèëèÿ)        │006368,       

│ìîíîêîìïîíåíòíûé ñâèíîé}                                                                  │(ôëàêîíû) 40 ÅÄ/ìë                                          │07.08.95      

                                                                                                                                                                    

│Ìîíîëèí Ëåíòå Ó-40 [Èíñóëèí-ÑðÄ] {èíñóëèí         │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Biobras S/a (Áðàçèëèÿ)        │006374,       

│èçîôàí-ïðîòàìèí, ìîíîêîìïîíåíòíûé ñâèíîé}                                                 │(ôëàêîíû) 40 ÅÄ/ìë                                          │07.08.95      

                                                                                                                                                                    

│Ìîíîëèí Ðåãóëÿð Ó-40 [Èíñóëèí-ÁÄ] {èíñóëèí,       │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Biobras S/a (Áðàçèëèÿ)        │006373,       

│ìîíîêîìïîíåíòíûé ñâèíîé}                                                                  │(ôëàêîíû) 40 ÅÄ/ìë                                          │07.08.95      

                                                                                                                                                                    

│Ìîíîëîíã [Èçîñîðáèä ìîíîíèòðàò]                   │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20, 40 ìã; êàïñóëû   │Isis Pharma GmbH (ÔÐÃ)        │002744,       

                                                                                          │ðåòàðä 50 ìã                                                │11.12.92      

                                                                                                                                                                    

│Ìîíîíèò [Èçîñîðáèä ìîíîíèòðàò]                    │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Komindex (Ïîëüøà)             │002622,       

                                                                                          │10, 20, 40 ìã                                               │10.09.92      

                                                                                                                                                                    

│Ìîíîíèòðàò ÎÔ [Èçîñîðáèä ìîíîíèòðàò]              │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20, 40 ìã; êàïñóëû   │Ostpharm Arzneimittel GmbH &  │007550,       

                                                                                          │ðåòàðä 40, 60 ìã              │Co Kg (Ãåðìàíèÿ)              │30.05.96      

                                                                                                                                                                    

│Ìîíîïðèë [Ôîçèíîïðèë]                             │ÀÊÔ áëîêàòîð [C09AA09]                  │òàáëåòêè 10, 20 ìã            │Bristol-Myers Squibb (Èòàëèÿ) │006957,       

                                                                                                                                                      │04.01.96      

                                                                                                                                                                     

│Ìîíîñàí [Èçîñîðáèä ìîíîíèòðàò]                    │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 20 ìã                │Pro.Med.Cs (×åõèÿ)            │003141,       

                                                                                                                                                      │05.07.93      

                                                                                                                                                                     

│Ìîíîñàí [Èçîñîðáèä ìîíîíèòðàò]                    │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 40 ìã                │Pro.Med.Cs (×åõèÿ)            │006770,       

                                                                                                                                                      │31.10.95      

                                                                                                                                                                     

│Ìîíî÷èíêâå [Èçîñîðáèä ìîíîíèòðàò]                 │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │òàáëåòêè 40 ìã                │Instituto Lusofarmaco (Èòàëèÿ)│007216,       

                                                                                                                                                      │18.06.96      

                                                                                                                                                                     

│Ìîíî÷èíêâå ðåòàðä [Èçîñîðáèä ìîíîíèòðàò]          │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │êàïñóëû ðåòàðä 50 ìã          │Instituto Lusofarmaco (Èòàëèÿ)│007217,       

                                                                                                                                                      │18.06.96      

                                                                                                                                                                    

│Ìîíóðàë [Ôîñôîìèöèí]                              │àíòèáèîòèê [J01XX01]                    │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Zambon Groupp Spa (Èòàëèÿ)    │005945,       

                                                                                          │îðàëüíîé ñóñïåíçèè (ñàøå) 3 ã │                              │11.04.95      

                                                                                                                                                                    

│Ìîðàäîë [Áóòîðôàíîë]                              │îïèîèäíûõ ðåöåïòîðîâ àãîíèñò-àíòàãîíèñò │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │ICN-Galenika (Þãîñëàâèÿ)      │006599,       

                                                  │[N02AF01]                               │2 ìã/ìë                                                     │28.11.95      

                                                                                                                                                                    

│Ìîðèàìèí-Ñ-2 {àìèíîêèñëîòû, ñîðáèòîë}             │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ    │ðàñòâîð äëÿ èíôóçèé           │Roussel Morishita Co, Ltd     │003193,       

                                                  │[B05BA10]                               │(êîíòåéíåðû ïëàñòèêîâûå) 200, │(ßïîíèÿ)                      │05.08.93      

                                                                                          │500 ìë                                                                    

                                                                                                                                                                    

│Ìîòèëèóì [Äîìïåðèäîí]                             │äîôàìèí-áëîêàòîð [A03FA03]              │òàáëåòêè ëàêèðîâàííûå 10 ìã   │Janssen Pharmaceutica         │002640,       

                                                                                                                        │(Áåëüãèÿ)                     │01.10.92      

                                                                                                                                                                    

│Ìîòèëèóì [Äîìïåðèäîí]                             │ïðîòèâîðâîòíîå ñðåäñòâî [A03FA03]       │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Janssen Pharmaceutica         │007058,       

                                                                                          │1 ìã/ìë                       │(Áåëüãèÿ)                     │07.02.96      

                                                                                                                                                                    

│Ìîòðèí [Èáóïðîôåí]                                │ÍÏÂÑ [M02AA13]                          │òàáëåòêè 200, 400 ìã          │Upjohn (Âåëèêîáðèòàíèÿ)       │002611,       

                                                                                                                                                      │10.09.92      

                                                                                                                                                                    

│Ìîòðèí [Èáóïðîôåí]                                │ÍÏÂÑ [M02AA13]                          │òàáëåòêè 600 ìã               │Upjohn (Âåëèêîáðèòàíèÿ)       │003617,       

                                                                                                                                                      │24.12.93      

                                                                                                                                                                    

│Ìîýêñ [Ìîýêñèïðèë]                                │ÀÊÔ áëîêàòîð [C09AA]                    │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Schwarz Pharma AG (Ãåðìàíèÿ)  │006862,       

                                                                                          │7.5, 15 ìã                                                  │28.11.95      

                                                                                                                                                                    

│ÌÏÀ 250 [Ìåäðîêñèïðîãåñòåðîí]                     │ïðîãåñòàãåí [G03DA02]                   │òàáëåòêè 250 ìã               │Hexal Pharma GmbH (Ãåðìàíèÿ)  │003958,       

                                                                                                                                                      │31.05.94      

                                                                                                                                                                    

│ÌÏÀ 500 [Ìåäðîêñèïðîãåñòåðîí]                     │ïðîãåñòàãåí [G03DA02]                   │òàáëåòêè 500 ìã               │Hexal Pharma GmbH (Ãåðìàíèÿ)  │003958,       

                                                                                                                                                      │31.05.94      

                                                                                                                                                                    

│ÌÑÒ êîíòèíóñ [Ìîðôèí]                             │àíàëüãåòè÷åñêîå íàðêîòè÷åñêîå ñðåäñòâî  │òàáëåòêè 10, 30, 60, 100, 200 │Mundipharma GmbH (Àâñòðèÿ)    │003992,       

                                                  │[N02AA01]                               │ìã                                                          │09.06.94      

                                                                                                                                                                    

│Ìóêàðòðèí [Ìóêàðòðèí]                             │ðåãåíåðàöèè ñòèìóëÿòîð [M01AX12]        │ðàñòâîð äëÿ âíóòðèìûøå÷íûõ    │Pharmachim (Áîëãàðèÿ)         │2860, 12.03.87 │

                                                                                          │èíúåêöèé (àìïóëû) 1 ìë                                                    

                                                                                                                                                                    

│Ìóêî Ñàíèãåí [Àöåòèëöèñòåèí]                      │îòõàðêèâàþùåå ñðåäñòâî [R05CB01]        │ãðàíóëû 100, 200 ìã           │Thiemann GmbH (Ãåðìàíèÿ)      │007072,       

                                                                                                                                                      │13.02.96      

                                                                                                                                                                    

│Ìóêîáåíå [Àöåòèëöèñòåèí]                          │îòõàðêèâàþùåå ñðåäñòâî [R05CB01]        │ïîðîøîê ðàñòâîðèìûé (ïàêåòû)  │Ludwig Merckle GmbH (Àâñòðèÿ) │005021,       

                                                                                          │100, 200 ìã                                                 │20.06.94      

                                                                                                                                                                    

│Ìóêîáåíå [Àöåòèëöèñòåèí]                          │îòõàðêèâàþùåå ñðåäñòâî [R05CB01]        │òàáëåòêè øèïó÷èå 100, 200,    │Ludwig Merckle GmbH (Àâñòðèÿ) │006861,       

                                                                                          │600 ìã                                                      │28.11.95      

                                                                                                                                                                     

│Ìóêîäèí [Êàðáîöèñòåèí]                            │îòõàðêèâàþùåå ñðåäñòâî [R05CB03]        │êàïñóëû 375 ìã; ñèðîï         │Zorka Pharma (Þãîñëàâèÿ)      │007207,       

                                                                                          │(ôëàêîíû) 200 ìë - 2.5%, 5%                                 │04.06.96      

                                                                                                                                                                     

│Ìóêîìèñò [Àöåòèëöèñòåèí]                          │îòõàðêèâàþùåå ñðåäñòâî [R05CB01]        │ðàñòâîð 20%                   │Bristol-Myers Company (Àíãëèÿ)│00243, 23.06.75│

                                                                                                                                                                    

│Ìóêîïðîíò [Êàðáîöèñòåèí]                          │îòõàðêèâàþùåå ñðåäñòâî [R05CB03]        │êàïñóëû 375 ìã; ñèðîï         │Heinrich Mack Nachf.          │003682,       

                                                                                          │(ôëàêîíû) 250 ìã|5 ìë - 200 ìë│(Ãåðìàíèÿ)                    │09.02.94      

                                                                                                                                                                    

│Ìóêîñîë [Êàðáîöèñòåèí]                            │îòõàðêèâàþùåå ñðåäñòâî [R05CB03]        │êàïñóëû 375 ìã; ñèðîï         │Cts Chemical Industries Ltd   │006262,       

                                                                                          │(ôëàêîíû) 250 ìã|5 ìë         │(Èçðàèëü)                     │11.07.95      

                                                                                                                                                                    

│Ìóêîñîëüâàí [Àìáðîêñîë]                           │îòõàðêèâàþùåå ñðåäñòâî [R05CB06]        │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Boehringer Ingelheim (ÔÐÃ)    │003267,       

                                                                                          │èíôóçèîííîãî ðàñòâîðà                                       │25.08.93      

                                                                                          │(ôëàêîíû) 1000 ìã - 50 ìë                                                 

                                                                                                                                                                    

│Ìóêîôëþèä [Ìåñíà]                                 │îòõàðêèâàþùåå ñðåäñòâî [R05CB05]        │àýðîçîëü íàçàëüíûé            │Ucb SA (Áåëüãèÿ)              │00928,        

                                                                                                                                                      │08.07.82,     

                                                                                                                                                      │24.09.93      

                                                                                                                                                                    

│Ìóëüòè-òàáñ ñ Âèòàìèíîì Ñ [Àñêîðáèíîâàÿ êèñëîòà]  │âèòàìèí [A11GA01]                       │òàáëåòêè æåâàòåëüíûå          │Ferrosan AG (Äàíèÿ)           │007046,       

│{àñêîðáèíîâàÿ êèñëîòà 180 ìã}                                                                                                                         │02.02.96      

                                                                                                                                                                    

│Ìóëüòèëîàä-Êó 250                                 │êîíòðàöåïòèâíîå âíóòðèìàòî÷íîå ñðåäñòâî │êîíòðàöåïòèâ âíóòðèìàòî÷íûé   │Multilan (Øâåéöàðèÿ)          │00875, 26.08.81│

                                                  │[G02BA02]                                                                                                         

                                                                                                                                                                    

│Ìóëüòèñåô [Öåôóðîêñèì]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA06]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Mustafa Nevzat Ilac Sanayi AS │005087,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Òóðöèÿ)                      │05.07.94      

                                                                                          │(ôëàêîíû) 250, 750, 1500 ìã                                               

                                                                                          │/â êîìïëåêòå ñ ðàñòâîðèòåëåì/ │                                            

                                                                                                                                                                    

│Ìóíäèçàë ãåëü [Õîëèí ñàëèöèëàò]                   │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Mundipharma GmbH (Ãåðìàíèÿ)   │005289,       

                                                  │ñðåäñòâî [N02BA03]                                                                                  │01.09.94      

                                                                                                                                                                    

│Ìóñêóðîí [Ïàíêóðîíèÿ áðîìèä]                      │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03AC01]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Sun Pharmaceutical Industries │003692,       

                                                                                          │4 ìã - 2 ìë                   │Ltd (Èíäèÿ)                   │11.02.94      

                                                                                                                                                                    

│Ìóòàìèöèí [Ìèòîìèöèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DC03]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Bristol-Myers Squibb (ÑØÀ)    │002774,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │22.12.92      

                                                                                          │(ôëàêîíû) 5, 20, 40 ìã                                                    

                                                                                                                                                                    

│Íàâåëüáèí [Âèíîðåëüáèí] {áàðâèíêà àëêàëîèä}       │öèòîñòàòè÷åñêîå ñðåäñòâî [L01CA04]      │ðàñòâîð äëÿ èíúåêöèé          │Pierre Fabre Medicament       │003750,       

                                                                                          │(ôëàêîíû) 10 ìã/1 ìë, 50 ìã/5 │(Ôðàíöèÿ)                     │11.03.94      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Íàâîáàí [Òðîïèçåòðîí]                             │ñåðîòîíèíîâûõ ðåöåïòîðîâ àíòàãîíèñò     │êàïñóëû 5 ìã; ðàñòâîð äëÿ     │Sandoz Pharma (Øâåéöàðèÿ)     │002454,       

                                                  │[A04AA03]                               │èíúåêöèé (àìïóëû) 5 ìã - 5 ìë │                              │24.04.92      

                                                                                                                                                                    

│Íàçàêîðò [Òðèàìöèíîëîí]                           │ãëþêîêîðòèêîñòåðîèä [R01AD]             │àýðîçîëü íàçàëüíûé            │Rhone-Poulenc Rorer (ÑØÀ)     │006318,       

                                                                                          │äîçèðîâàííûé 55 ìêã|äîçà                                    │26.07.95      

                                                                                                                                                                    

│Íàçåíñïðàé Å-ðàòèîôàðì [Êñèëîìåòàçîëèí]           │àëüôà-àäðåíîñòèìóëÿòîð [R01AA07]        │ôëàêîíû ñ äîçèðóþùèì êëàïàíîì │Ratiopharm GmbH & Co          │003412,       

                                                                                          │10 ìë                         │(Ãåðìàíèÿ)                    │12.10.93      

                                                                                                                                                                    

│Íàçåíñïðàé Ê-ðàòèîôàðì [Êñèëîìåòàçîëèí]           │àëüôà-àäðåíîñòèìóëÿòîð [R01AA07]        │àýðîçîëü íàçàëüíûé            │Ratiopharm GmbH & Co (ÔÐÃ)    │003117,       

                                                                                                                                                      │30.06.93      

                                                                                                                                                                    

│Íàçèâèí [Îêñèìåòàçîëèí]                           │àëüôà-àäðåíîñòèìóëÿòîð [R01AA05]        │êàïëè (ôëàêîíû ñ ïèïåòêîé)    │E.Merck (Ãåðìàíèÿ)            │006578,       

                                                                                          │0.01%, 0.025%, 0.05%                                        │13.10.95       

                                                                                                                                                                    

│Íàçîë [Îêñèìåòàçîëèí]                             │àëüôà-àäðåíîñòèìóëÿòîð [R01AA05]        │ñïðåé íàçàëüíûé (ôëàêîíû)     │Sagmel Inc (ÑØÀ)              │007643,       

                                                                                          │0.05% - 30 ìë                                               │12.07.96       

                                                                                                                                                                    

│Íàêëîô [Äèêëîôåíàê]                               │ÍÏÂÑ [S01BC03]                          │êàïëè ãëàçíûå (ôëàêîíû) 0.1%  │Laboratoires H.Faure (Ôðàíöèÿ)│006480,       

                                                                                                                                                      │08.09.95      

                                                                                                                                                                    

│Íàêëîôåí [Äèêëîôåíàê]                             │ÍÏÂÑ [M01AB05]                          │òàáëåòêè 50 ìã; òàáëåòêè      │Krka (Ñëîâåíèÿ)               │002595,       

                                                                                          │ðåòàðä 100 ìã; ñâå÷è 50 ìã;                                 │12.08.92      

                                                                                          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │                                            

                                                                                          │2.5% - 3 ìë                                                               

                                                                                                                                                                    

│Íàêëîôåí [Äèêëîôåíàê]                             │ÍÏÂÑ [M02AA15]                          │ãåëü 1%                       │Krka (Ñëîâåíèÿ)               │006362,       

                                                                                                                                                      │07.08.95      

                                                                                                                                                                    

│Íàêîì [Ëåâîäîïà+êàðáèäîïà] {êàðáèäîïà 25 ìã,      │ïðîòèâîïàðêèíñîíè÷åñêîå ñðåäñòâî        │òàáëåòêè                      │Lek (Þãîñëàâèÿ)               │00514,        

│ëåâîäîïà 250 ìã}                                  │[N04BA02]                                                                                           │06.12.77,     

                                                                                                                                                      │16.06.88      

                                                                                                                                                                    

│Íàêñåí [Íàïðîêñåí]                                │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250 ìã               │Chung Kun Dah Corporation     │002477,       

                                                                                                                        │(Êîðåÿ Þæíàÿ)                 │22.05.92      

                                                                                                                                                                    

│Íàêñîäæèí [Íèìîðàçîë]                             │ïðîòèâîïðîòîçîéíîå ñðåäñòâî [P01AB06]   │òàáëåòêè 250, 500 ìã          │Farmitalia Carlo Erba (Èòàëèÿ)│003774,       

                                                                                                                                                      │18.03.94      

                                                                                                                                                                    

│Íàëèêñàí [Íàïðîêñåí]                              │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250 ìã               │Lyka Labs Ltd (Èíäèÿ)         │002258,       

                                                                                                                                                      │17.10.91      

                                                                                                                                                                    

│Íàëîêñîí [Íàëîêñîí]                               │îïèîèäíûõ ðåöåïòîðîâ àãîíèñò-àíòàãîíèñò │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Polfa (Ïîëüøà)                │003121,       

                                                  │[V03AB15]                               │0.4 ìã - 1 ìë                                               │30.06.93      

                                                                                                                                                                    

│Íàëîðôèí [Íàëîðôèí]                               │îïèîèäíûõ ðåöåïòîðîâ àãîíèñò-àíòàãîíèñò │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Chinoin (Âåíãðèÿ)             │2672,         

                                                  │[V03AB02]                               │5 ìã - 1 ìë                                                 │10.11.81,     

                                                                                                                                                      │25.01.93      

                                                                                                                                                                    

│Íàëôîí [Ôåíîïðîôåí]                               │ÍÏÂÑ [M01AE04]                          │òàáëåòêè 300 ìã               │Eli Lilly (ÑØÀ)               │006891,       

                                                                                                                                                      │14.12.95      

                                                                                                                                                                    

│Íàëõðîì [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò     │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [R03BC01] │êàïñóëû 100 ìã                │Fisons (Âåëèêîáðèòàíèÿ)       │003529,       

│äèíàòðèÿ}                                                                                                                                             │29.11.93      

                                                                                                                                                                    

│Íàìàãåë ÷åððè {àëãåëäðàò 0.225 ìã, ìàãíèÿ         │àíòàöèäíîå ñðåäñòâî [A02AX]             │æèäêîñòü îðàëüíàÿ (ôëàêîíû)   │Pennex Labs (ÑØÀ)             │005194,       

│ãèäðîêñèä 0.2 ã - 5 ìë}                                                                   │355 ìë                                                      │01.08.94      

                                                                                                                                                                    

│Íàíèïðóñ [Íèòðîïðóññèä íàòðèÿ]                    │âàçîäèëàòèðóþùåå ñðåäñòâî [C02DD01]     │ëèîôèëèç.ïîðîøîê äëÿ          │Pharmachim (Áîëãàðèÿ)         │2781, 11.10.84 │

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (àìïóëû) 30 ìã - 5                                               

                                                                                          │ìë /â êîìïëåêòå ñ                                                         

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Íàïà [Ïàðàöåòàìîë]                                │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ñèðîï        │Beximco Pharmaceuticals Ltd   │005332,       

                                                  │ñðåäñòâî [N02BE01]                      │(ôëàêîíû) 120 ìã|5 ìë         │(Áàíãëàäåø)                   │19.09.94      

                                                                                                                                                                    

│Íàïîòîí [Õëîðäèàçåïîêñèä]                         │òðàíêâèëèçàòîð [N05BA02]                │äðàæå 5 ìã, 10 ìã             │Terapia SA, Romferchim        │2302,         

                                                                                                                        │(Ðóìûíèÿ)                     │12.06.84,     

                                                                                                                                                      │17.10.72,     

                                                                                                                                                      │20.10.94      

                                                                                                                                                                     

│Íàïðèîñ [Íàïðîêñåí]                               │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250, 500 ìã          │Lisapharma (Èòàëèÿ)           │003747,       

                                                                                                                                                      │04.03.94      

                                                                                                                                                                     

│Íàïðîáåíå [Íàïðîêñåí]                             │ÍÏÂÑ [M01AE02]                          │ôèëìòàáëåòêè 250, 500 ìã;     │Ludwig Merckle GmbH (Àâñòðèÿ) │003789,       

                                                                                          │ñâå÷è 250, 500 ìã                                           │28.03.94      

                                                                                                                                                                     

│Íàïðîêñåí [Íàïðîêñåí]                             │ÍÏÂÑ [M01AE02]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │CT-Arzneimittel Chemishe      │003570,       

                                                                                          │250, 500 ìã; ñâå÷è 250, 500 ìã│Tempelchof GmbH (Ãåðìàíèÿ)    │09.12.93      

                                                                                                                                                                     

│Íàïðîêñåí [Íàïðîêñåí]                             │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250, 375, 500 ìã     │Mir Pharmaceutical Inc/copley │007671,       

                                                                                                                        │Pharmaceutical Inc (ÑØÀ)      │23.07.96      

                                                                                                                                                                    

│Íàïðîêñåí [Íàïðîêñåí]                             │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250, 500 ìã          │Norton Healthcare Ltd         │003247,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │18.08.93      

                                                                                                                                                                    

│Íàïðîêñåí [Íàïðîêñåí]                             │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250 ìã               │Polfa (Ïîëüøà)                │002657,       

                                                                                                                                                      │26.10.92      

                                                                                                                                                                    

│Íàïðîêñåí-Òåâà [Íàïðîêñåí]                        │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250, 375, 500 ìã     │Teva Pharmaceutical           │005570,       

                                                                                                                        │Industries Ltd (Èçðàèëü)      │15.12.94      

                                                                                                                                                                    

│Íàïðîñèí [Íàïðîêñåí]                              │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250 ìã               │Krka (ÑÔÐÞ)                   │00498, 12.09.77│

│Íàïðîñèí [Íàïðîêñåí]                              │ÍÏÂÑ [M01AE02]                          │ñâå÷è                         │Krka (Þãîñëàâèÿ)              │01213, 17.12.85│

                                                                                                                                                                    

│Íàïðîñèí [Íàïðîêñåí]                              │ÍÏÂÑ [M01AE02]                          │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Krka (ÑÔÐÞ)                   │002105,       

                                                                                          │2.5%                                                        │21.05.91      

                                                                                                                                                                    

│Íàïðîñèí [Íàïðîêñåí]                              │ÍÏÂÑ [M01AE02]                          │òàáëåòêè 250 ìã; ñâå÷è 250 ìã │Syntex Pharma AG (Øâåéöàðèÿ)  │00742,        

                                                                                                                                                      │15.10.91,     

                                                                                                                                                      │21.03.80      

                                                                                                                                                                    

│Íàðêîòàí [Ãàëîòàí]                                │íàðêîòè÷åñêîå èíãàëÿöèîííîå ñðåäñòâî    │ðàñòâîð äëÿ èíãàëÿöèîíîé      │Lechiva (×åõèÿ)               │006581,       

                                                  │[N01AB01]                               │àíåñòåçèè (ôëàêîíû) 250 ìë                                  │13.10.95      

                                                                                                                                                                    

│Íàñèãåë ÷åððè {àëãåëäðàò 0.2 ã, ìàãíèÿ ãèäðîêñèä  │àíòàöèäíîå ñðåäñòâî [A02AF]             │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Pennex Labs (ÑØÀ)             │005193,       

│0.2 ã, ñèìåòèêîí 20 ìã - 5 ìë}                                                            │355 ìë                                                      │01.08.94      

                                                                                                                                                                    

│Íàòî [Êåòîðîëàê]                                  │ÍÏÂÑ [M01AB15]                          │òàáëåòêè 10 ìã; ðàñòâîð äëÿ   │Natco Pharma Ltd (Èíäèÿ)      │003198,       

                                                                                          │èíúåêöèé (àìïóëû) 30 ìã - 1 ìë│                              │05.08.93      

                                                                                                                                                                    

│Íàòðèåâûé ãåïàðèí [Ãåïàðèí]                       │àíòèêîàãóëÿíò ïðÿìîé [B01AB01]          │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Pan Pharma (Ôðàíöèÿ)          │005368,       

                                                                                          │25000 ÌÅ                                                    │27.09.94      

                                                                                                                                                                    

│Íàòðèóì ôëóîðàòóì [Íàòðèÿ ôòîðèä]                 │ïðåïàðàò ôòîðà [A01AA01]                │òàáëåòêè äëÿ ðàññàñûâàíèÿ 1 ìã│Polfa (ÏÍÐ)                   │2943, 01.09.89 │

                                                                                                                                                                    

│Íàòðèÿ õëîðèä [Íàòðèÿ õëîðèä]                     │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05CB01]     │ðàñòâîð äëÿ èíôóçèé           │Baxter Healthcare Corp        │005717,       

                                                                                          │(êîíòåéíåðû èç ïîëèýòèëåíà -  │(Âåëèêîáðèòàíèÿ)              │06.02.95      

                                                                                          │âèàôëåêñ) 0.9%                                                            

                                                                                                                                                                    

│Íàòðèÿ õëîðèä [Íàòðèÿ õëîðèä]                     │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05CB01]     │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû  │Promed Exports Pvt Ltd (Èíäèÿ)│005267,       

                                                                                          │ïëàñòèêîâûå) 0.9% - 500, 1000 │                              │25.08.94      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Íàòðèÿ õëîðèä 0.9% [Íàòðèÿ õëîðèä]                │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05CB01]     │ðàñòâîð äëÿ èíôóçèé (ìåøî÷êè  │Ilsanta (Ëèòâà)               │007662,       

                                                                                          │ïîëèïðîïèëåíîâûå) 250, 500,                                 │22.07.96      

                                                                                          │1000 ìë                                                                   

                                                                                                                                                                    

│Íàòðèÿ õëîðèä 0.9% [Íàòðèÿ õëîðèä]                │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05CB01]     │ðàñòâîð äëÿ èíúåêöèé          │Laboratoires Aguettant        │007123,        

                                                                                          │(ôëàêîíû) 0.9%; ðàñòâîð äëÿ   │(Ôðàíöèÿ)                     │04.03.96      

                                                                                          │èíúåêöèé (ïàêåòû                                                          

                                                                                          │ïîëèõëîðâèíèëîâûå) 0.9%                                                    

                                                                                                                                                                    

│Íàòðèÿ õëîðèä 0.9% äëÿ âíóòðèâåííûõ âëèâàíèé      │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05CB01]     │ðàñòâîð äëÿ èíôóçèé           │Core Parenterals Ltd (Èíäèÿ)  │006791,       

│[Íàòðèÿ õëîðèä]                                                                           │(êîíòåéíåðû èç ïîëèýòèëåíà)                                 │03.11.95      

                                                                                          │0.9% - 500, 1000 ìë                                                       

                                                                                                                                                                    

│Íàòðèÿ õëîðèäà ðàñòâîð 1.6% [Íàòðèÿ õëîðèä]       │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05CB01]     │ðàñòâîð (êîíòåéíåðû           │Baxter (ÑØÀ)                  │007061,       

                                                                                          │ïëàñòèêîâûå) 1.6%                                           │07.02.96      

                                                                                                                                                                    

│Íàòðèÿ õëîðèäà ðàñòâîð 12% [Íàòðèÿ õëîðèä]        │ïëàçìîçàìåùàþùåå ñðåäñòâî [B05CB01]     │ðàñòâîð (êîíòåéíåðû           │Baxter (ÑØÀ)                  │007062,       

                                                                                          │ïëàñòèêîâûå) 12%                                            │07.02.96      

                                                                                                                                                                    

│Íàòóëàí [Ïðîêàðáàçèí]                             │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XB01]      │êàïñóëû 50 ìã                 │Hoffmann La Roche (Øâåéöàðèÿ) │00208,        

                                                                                                                                                      │02.11.87,     

                                                                                                                                                      │20.06.72      

                                                                                                                                                                    

│Íàø âûáîð - àíàëüãåòèê ïîêðûòûé îáîëî÷êîé         │ÍÏÂÑ [N02BA01]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Perrigo Company, USA-Upteka   │005982,       

│[Àöåòèëñàëèöèëîâàÿ êèñëîòà]                                                               │325 ìã                        │Inc (ÑØÀ)                     │20.04.95      

                                                                                                                                                                    

│Íàø âûáîð - äåòñêèé àíàëüãåòèê [Àöåòèëñàëèöèëîâàÿ │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè æåâàòåëüíûå äëÿ      │Perrigo Company, USA-Upteka   │005957,       

│êèñëîòà]                                          │ñðåäñòâî [N02BA01]                      │äåòåé 81 ìã                   │Inc (ÑØÀ)                     │13.04.95      

                                                                                                                                                                    

│Íàø âûáîð - æèäêèé àíòàöèä {àëãåëäðàò 225 ìã,     │àíòàöèäíîå ñðåäñòâî [A02AX]             │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Perrigo Company, USA-Upteka   │005958,       

│ìàãíèÿ ãèäðîêñèä 200 ìã - 5 ìë}                                                                                         │Inc (ÑØÀ)                     │13.04.95      

                                                                                                                                                                    

│Íàø âûáîð - Ìàé-ìàãíåçèÿ [Ìàãíèÿ ãèäðîêñèä]       │àíòàöèäíîå ñðåäñòâî [A02AA04]           │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)  │Perrigo Company, USA-Upteka   │006434,       

                                                                                                                        │Inc (ÑØÀ)                     │23.08.95      

                                                                                                                                                                    

│Íàø âûáîð - Ïàðàöåòàìîë [Ïàðàöåòàìîë]             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 325, 500 ìã;         │Perrigo Company, USA-Upteka   │007101,       

                                                  │ñðåäñòâî [N02BE01]                      │òàáëåòêè æåâàòåëüíûå 80 ìã;   │Inc (ÑØÀ)                     │26.02.96      

                                                                                          │ýëèêñèð (ôëàêîíû)                                                         

                                                                                                                                                                    

│Íàø âûáîð - Ðîçîâûé âèñìóò [Âèñìóòà ñóáñàëèöèëàò] │àíòèñåïòè÷åñêîå êèøå÷íîå ñðåäñòâî       │òàáëåòêè; ñóñïåíçèÿ îðàëüíàÿ  │Perrigo Company, USA-Upteka   │006435,       

│{âèñìóòà ñóáñàëèöèëàò 262 ìã - òàáëåòêà, 1 ìë}    │[A02BX05]                               │(ôëàêîíû)                     │Inc (ÑØÀ)                     │24.08.95      

                                                                                                                                                                    

│Íàø âûáîð - ñèðîï òðîéíîãî äåéñòâèÿ               │ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │ñèðîï                         │Perrigo Company, USA-Upteka   │006433,       

│{ôåíèëïðîïàíîëàìèí 6.25 ìã, õëîðôåíàìèí 1 ìã}     │ïðîñòóäû [R05X]                                                       │Inc (ÑØÀ)                     │23.08.95      

                                                                                                                                                                    

│Íàø âûáîð - ñðåäñòâî îò ãðèïïà è ïðîñòóäû         │ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │ïîðîøîê (ïàêåòèêè)            │Perrigo Company, USA-Upteka   │006436,       

│{ïàðàöåòàìîë 650 ìã, ïñåâäîýôåäðèí 60 ìã,         │ïðîñòóäû [R05X]                                                       │Inc (ÑØÀ)                     │24.08.95      

│õëîðôåíàìèí 4 ìã}                                                                                                                                                   

                                                                                                                                                                    

│Íàø âûáîð - øèïó÷èå òàáëåòêè îò áîëåé             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè øèïó÷èå              │Perrigo Company, USA-Upteka   │006116,       

│{àöåòèëñàëèöèëîâàÿ êèñëîòà 325 ìã, ëèìîííàÿ       │ñðåäñòâî [N02BA51]                                                    │Inc (ÑØÀ)                     │30.05.95      

│êèñëîòà 1 ã, íàòðèÿ ãèäðîêàðáîíàò 1.916 ã}                                                                                                                          

                                                                                                                                                                    

│Íàø âûáîð - øèïó÷èå òàáëåòêè îò ïðîñòóäû          │ñðåäñòâî äëÿ óñòðàíåíèÿ ñèìïòîìîâ       │òàáëåòêè øèïó÷èå              │Perrigo Company, USA-Upteka   │006115,       

│{àöåòèëñàëèöèëîâàÿ êèñëîòà 325 ìã,                │ïðîñòóäû [R05X]                                                       │Inc (ÑØÀ)                     │30.05.95      

│ôåíèëïðîïàíîëàìèí 15 ìã, õëîðôåíàìèí 2 ìã}                                                                                                                          

                                                                                                                                                                    

│Íàø âûáîð - ýêñòðàñèëüíûé àíàëüãåòèê              │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Perrigo Company, USA-Upteka   │005956,       

│{àöåòèëñàëèöèëîâàÿ êèñëîòà 400 ìã; êîôåèí 32 ìã}  │ñðåäñòâî [N02BA51]                                                    │Inc (ÑØÀ)                     │13.04.95      

                                                                                                                                                                    

│Íåáàãèí [Ìåòàìèçîë íàòðèÿ]                        │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ðàñòâîð äëÿ  │Ipca Laboratories Ltd (Èíäèÿ) │005192,       

                                                  │ñðåäñòâî [N02BB02]                      │èíúåêöèé (àìïóëû) 50%                                       │29.07.94      

                                                                                                                                                                     

│Íåáàëãàí {ìåòàìèçîë 2.5 ã,                        │àíàëüãåòè÷åñêîå è ñïàçìîëèòè÷åñêîå      │òàáëåòêè; ðàñòâîð äëÿ         │Ipca Laboratories Ltd (Èíäèÿ) │005794,       

│ïèïåðèäèíýòîêñèêàðáìåòîêñè áåíçîôåíîí 10 ìã,      │ñðåäñòâî [N02BB52]                      │èíúåêöèé (àìïóëû)                                           │27.02.95      

│äèôåíèëïèïåðèäèíýòèëàöåòàìèä áðîììåòèëàò 0.1 ìã - │                                                                                                                   

│1 ìë; ìåòàìèçîë 0.5 ã, ïèïåðèäèíýòîêñèêàðáìåòîêñè │                                                                                                                  

│áåíçîôåíîí 5 ìã, äèôåíèëïèïåðèäèíýòèëàöåòàìèä                                                                                                                       

│áðîììåòèëàò 0.1 ìã - òàáëåòêà}                                                                                                                                       

                                                                                                                                                                    

│Íåáöèí [Òîáðàìèöèí]                               │àíòèáèîòèê, àìèíîãëèêîçèä [J01GB01]     │ëèîôèëèç.ïîðîøîê äëÿ          │Eli Lilly (Øâåéöàðèÿ)         │00628, 02.10.78│

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                                

                                                                                          │ðàñòâîðà (àìïóëû)                                                         

                                                                                                                                                                    

│Íåáöèí [Òîáðàìèöèí]                               │àíòèáèîòèê, àìèíîãëèêîçèä [J01GB01]     │ðàñòâîð äëÿ èíúåêöèé          │Eli Lilly (Ôðàíöèÿ)           │007149,       

                                                                                          │(ôëàêîíû) 40 ìã - 1 ìë, 20 ìã │                              │18.03.96      

                                                                                          │- 2 ìë, 80 ìã - 2 ìë                                                      

                                                                                                                                                                    

│Íåâèãðàìîí [Íàëèäèêñîâàÿ êèñëîòà]                 │ïðîòèâîìèêðîáíîå ñðåäñòâî, õèíîëîí      │êàïñóëû 500 ìã                │Chinoin (Âåíãðèÿ)             │2079,         

                                                  │[G04AB01]                                                                                           │01.07.70,     

                                                                                                                                                      │09.11.83,     

                                                                                                                                                      │30.01.95      

                                                                                                                                                                    

│Íåâîôàì [Ôàìîòèäèí]                               │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 20, 40 ìã            │Mustafa Nevzat Ilac Sanayi AS │003377,       

                                                  │[A02BA03]                                                             │(Òóðöèÿ)                      │06.10.93      

                                                                                                                                                                    

│Íåãàôëîêñ [Íîðôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Cadila Laboratories Ltd       │003167,       

                                                  │[J01MA06]                                                             │(Èíäèÿ)                       │20.07.93      

                                                                                                                                                                    

│Íåãðàì [Íàëèäèêñîâàÿ êèñëîòà]                     │ïðîòèâîìèêðîáíîå ñðåäñòâî, õèíîëîí      │òàáëåòêè 500 ìã               │Krka (Ñëîâåíèÿ)               │00135,        

                                                  │[G04AB01]                                                                                           │07.05.84,     

                                                                                                                                                      │09.03.71,     

                                                                                                                                                      │28.03.94      

                                                                                                                                                                    

│Íåéïîãåí [Ôèëãðàñòèì]                             │ëåéêîïîýçà ñòèìóëÿòîð [L03AA02]         │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Hoffmann La Roche (Øâåéöàðèÿ) │005202,       

                                                                                          │30000000 ÌÅ/ìë - 1 ìë, 1.6 ìë │                              │02.08.94      

                                                                                                                                                                    

│Íåéðàìàã Ï {ïàðàöåòàìîë 400 ìã, êîôåèí 50 ìã}     │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │CT-Arzneimittel Chemishe      │007437,       

                                                  │ñðåäñòâî [N02BE51]                                                    │Tempelchof GmbH (Ãåðìàíèÿ)    │15.04.96      

                                                                                                                                                                    

│Íåéðîáåíå [Öèàíîêîáàëàìèí]                        │âèòàìèí [B03BA01]                       │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ludwig Merckle GmbH (Àâñòðèÿ) │003331,       

                                                                                          │1 ìã - 1 ìë                                                 │13.09.93      

                                                                                                                                                                    

│Íåéòðîíîðì [Öèìåòèäèí]                            │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │êàïñóëû 200 ìã; òàáëåòêè      │Ebewe Arzneimittel GmbH       │006633,       

                                                  │[A02BA01]                               │ðåòàðä 350 ìã; ðàñòâîð äëÿ    │(Àâñòðèÿ)                     │31.01.96      

                                                                                          │èíúåêöèé (àìïóëû) 200 ìã - 2                                              

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Íåëîâà {íîðýòèíîäðåë 1 ìã, ýòèíèëýñòðàäèîë 0.035  │êîíòðàöåïòèâíîå ñðåäñòâî [G03FA09]      │òàáëåòêè                      │Watson Laboratories Inc       │002297,       

│ìã}                                                                                                                     │(Áåëüãèÿ)                     │28.11.91      

                                                                                                                                                                    

│Íåëîðåí [Ëèíêîìèöèí]                              │àíòèáèîòèê, àçàëèä [J01FF02]            │êàïñóëû 500 ìã; ðàñòâîð äëÿ   │Lek (Ñëîâåíèÿ)                │002328,       

                                                                                          │èíúåêöèé (àìïóëû) 300 ìã/1                                  │14.01.92      

                                                                                          │ìë; 600 ìã/2 ìë                                                           

                                                                                                                                                                    

│Íåìåñòðàí [Ãåñòðèíîí]                             │ïðîãåñòàãåí [G03XA02]                   │êàïñóëû 2.5 ìã                │Roussel Uclaf (Ôðàíöèÿ)       │002428,       

                                                                                                                                                      │31.01.92      

                                                                                                                                                                    

│Íåìîòàí [Íèìîäèïèí]                               │ÁÌÊÊ [C08CA06]                          │ôèëìòàáëåòêè 30 ìã            │Medochemie Ltd (Êèïð)         │005124,       

                                                                                                                                                      │13.07.94      

                                                                                                                                                                     

│Íåìîöèä [Ïèðàíòåë]                                │ïðîòèâîãåëüìèíòíîå ñðåäñòâî [P02CC01]   │òàáëåòêè; ñóñïåíçèÿ îðàëüíàÿ  │Ipca Laboratories Ltd (Èíäèÿ) │01490, 27.09.88│

│Íåî-ãèëóðèòìàë [Ïðàéìàëèíà áèòàðòðàò]             │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BA08]     │òàáëåòêè 20 ìã                │Giulini Pharma GmbH (ÔÐÃ)     │00862, 25.05.81│

                                                                                                                                                                     

│Íåî-Êîäèîí {êîäåèí 25 ìã, ãðèíäåëèè ýêñòðàêò 17   │ïðîòèâîêàøëåâîå ñðåäñòâî [R05FA02]      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Laboratoires Du Docteur       │006679,       

│ìã, ãâàéÿêîñóëüôîíàò êàëèÿ 100 ìã}                                                                                      │E.Bouchara (Ôðàíöèÿ)          │29.09.95      

                                                                                                                                                                     

│Íåî-Êîäèîí {êîäåèí 90 ìã, àñêîðáèíîâàÿ êèñëîòà    │ïðîòèâîêàøëåâîå ñðåäñòâî [R05FA02]      │ñèðîï äëÿ äåòåé (ôëàêîíû) 90  │Laboratoires Du Docteur       │007378,       

│0.75 ìã, íàòðèÿ áðîìèä 1 ã, íàòðèÿ áåíçîàò 1 ã,                                           │ìã - 100 ìë; ñèðîï äëÿ        │E.Bouchara (Ôðàíöèÿ)          │29.03.96      

│èïåêàêóàíû ñèðîï 47.45 ã, òîëóàíñêîãî áàëüçàìà                                            │âçðîñëûõ (ôëàêîíû) 140 ìã -                                                

│ñèðîï 25 ã - ñèðîï äëÿ äåòåé 100 ìë; êîäåèí 140                                           │100 ìë                                                                    

│ìã, àñêîðáèíîâàÿ êèñëîòà 1.25 ã, áðîìîôîðì 100                                                                                                                      

│ìã, èïåêàêóàíû ñèðîï 25 ã, òîëóàíñêîãî áàëüçàìà                                                                                                                     

│ñèðîï 30 ã - ñèðîï äëÿ âçðîñëûõ 100 ìë}                                                                                                                             

                                                                                                                                                                    

│Íåî-ýíòåðîñåïòîë [Ëîïåðàìèä]                      │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07DA03]     │êàïñóëû 2 ìã                  │Specifar (Ãðåöèÿ)             │003851,       

                                                                                                                                                      │14.04.94      

                                                                                                                                                                    

│Íåîäîë-50 [Äèêëîôåíàê]                            │ÍÏÂÑ [M01AB05]                          │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Braun & Berk Pharmaceutical   │005621,       

                                                                                          │îáîëî÷êîé                     │Private Ltd (Èíäèÿ)           │05.01.95      

                                                                                                                                                                    

│Íåîçåïàì [Íèòðàçåïàì]                             │òðàíêâèëèçàòîð [N05CD02]                │òàáëåòêè                      │Polfa (ÏÍÐ)                   │2581,         

                                                                                                                                                      │18.05.89,     

                                                                                                                                                      │25.10.78      

                                                                                                                                                                    

│Íåîèíòåñòîïàí [Àòòàïóëãèò] {àëþìèíèÿ ñèëèêàò,     │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07BC04]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Sandoz (india) Ltd (Èíäèÿ)    │003472,       

│ìàãíèÿ ñèëèêàò}                                                                           │915 ìã                                                      │29.10.93      

                                                                                                                                                                    

│Íåîñåïòèí-Ð [Ðàíèòèäèí]                           │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Beximco Pharmaceuticals Ltd   │003539,       

                                                  │[A02BA02]                               │îáîëî÷êîé 150 ìã              │(Áàíãëàäåø)                   │06.12.93      

                                                                                                                                                                    

│Íåîñòîïàí [Àòòàïóëãèò] {àëþìèíèÿ ñèëèêàò, ìàãíèÿ  │ïðîòèâîäèàðåéíîå ñðåäñòâî [A07BC04]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Sandoz Pharma (Øâåéöàðèÿ)     │002931,       

│ñèëèêàò}                                                                                  │915 ìã                                                      │30.03.93      

                                                                                                                                                                    

│Íåîñóëèí NPH Ó-40 [Èíñóëèí-ÑðÄ] {èíñóëèí          │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Biobras S/a (Áðàçèëèÿ)        │006376,       

│èçîôàí-ïðîòàìèí, ñâèíîé}                                                                  │(ôëàêîíû) 40 ÅÄ/ìë                                          │07.08.95      

                                                                                                                                                                    

│Íåîñóëèí Ëåíòå Ó-40 [Èíñóëèí-ÑðÄ] {èíñóëèí        │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Biobras S/a (Áðàçèëèÿ)        │006375,       

│èçîôàí-ïðîòàìèí, ñâèíîé}                                                                  │(ôëàêîíû) 40 ÅÄ/ìë                                          │07.08.95      

                                                                                                                                                                    

│Íåîñóëèí Ðåãóëÿð Ó-40 [Èíñóëèí-ÁÄ] {èíñóëèí,      │èíñóëèí êîðîòêîãî äåéñòâèÿ [A10AA01]    │ðàñòâîð äëÿ èíúåêöèé          │Biobras S/a (Áðàçèëèÿ)        │006372,       

│ñâèíîé}                                                                                   │(ôëàêîíû) 40 ÅÄ/ìë                                          │07.08.95      

                                                                                                                                                                    

│Íåîòîí [Ôîñôîêðåàòèí]                             │ìåòàáîëè÷åñêîå ñðåäñòâî [C01EB06]       │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Alpha Wassermann Spa (Èòàëèÿ) │007179,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │09.04.96      

                                                                                          │(ôëàêîíû) 0.5, 1, 2, 5 ã /â                                               

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Íåîòîí [Ôîñôîêðåàòèí]                             │ìåòàáîëè÷åñêîå ñðåäñòâî [C01EB06]       │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Torrent Exports Ltd (Èíäèÿ)   │002080,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │15.03.91      

                                                                                          │(ôëàêîíû) 0.5, 1 ã /â                                                     

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Íåîôëîêñèí [Öèïðîôëîêñàöèí]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Beximco Pharmaceuticals Ltd   │005333,       

                                                  │[J01MA02]                               │250 ìã                        │(Áàíãëàäåø)                   │19.09.94      

                                                                                                                                                                    

│Íåðäèïèí [Íèêàðäèïèí]                             │ÁÌÊÊ [C08CA04]                          │òàáëåòêè 20, 30 ìã            │Medochemie Ltd (Êèïð)         │003732,       

                                                                                                                                                      │25.02.94      

                                                                                                                                                                     

│Íåòðîìèöèí [Íåòèëìèöèí]                           │àíòèáèîòèê, àìèíîãëèêîçèä [J01GB07]     │ðàñòâîð äëÿ èíúåêöèé          │Schering-Plough (ÑØÀ)         │003515,       

                                                                                          │(ôëàêîíû) 25 ìã/ìë - 2 ìë                                   │17.11.93      

                                                                                                                                                                     

│Íåòðîìèöèí [Íåòèëìèöèí]                           │àíòèáèîòèê, àìèíîãëèêîçèä [J01GB07]     │ðàñòâîð äëÿ èíúåêöèé          │Schering-Plough (Èíäîíåçèÿ)   │006005,       

                                                                                          │(ôëàêîíû) 50 ìã/2 ìë, 150                                   │26.04.95      

                                                                                          │ìã/1.5 ìë                                                                  

                                                                                                                                                                    

│Íåòðîìèöèí [Íåòèëìèöèí]                           │àíòèáèîòèê, àìèíîãëèêîçèä [J01GB07]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Schering Corporation (ÑØÀ)    │01260, 28.03.86│

                                                                                          │200 ìã - 2 ìë                                                              

                                                                                                                                                                    

│Íåóëåïòèë [Ïåðèöèàçèí]                            │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC01]     │êàïñóëû 10 ìã; êàïëè îðàëüíûå │Rhone-Poulenc Rorer (Ôðàíöèÿ) │006605,       

                                                                                          │4%                                                          │20.12.95      

                                                                                                                                                                    

│Íåóëåïòèë [Ïåðèöèàçèí]                            │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC01]     │êàïñóëû 10 ìã; ðàñòâîð        │Rhone-Poulenc (india) Ltd     │002149,       

                                                                                          │îðàëüíûé 4%                   │(Èíäèÿ)                       │29.05.91      

                                                                                                                                                                    

│Íåóëåïòèë [Ïåðèöèàçèí]                            │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AC01]     │êàïñóëû 10 ìã; êàïëè 4%       │Torrent Exports Ltd (Èíäèÿ)   │002082,       

                                                                                                                                                      │15.03.91      

                                                                                                                                                                    

│Íåóðàíèäàë {àöåòèëñàëèöèëîâàÿ êèñëîòà 0.3 ã,      │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Arzneimittelwerk (Ãåðìàíèÿ)   │005567,       

│ïàðàöåòàìîë 0.2 ã, êîôåèí 50 ìã}                  │ñðåäñòâî [N02BA51]                                                                                  │15.12.94      

                                                                                                                                                                    

│Íåóðî-Ðàòèîôàðì [Òèàìèí]                          │âèòàìèí [A11DA01]                       │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Ratiopharm GmbH & Co          │005004,       

                                                                                                                        │(Ãåðìàíèÿ)                    │15.06.94      

                                                                                                                                                                    

│Íåóðîë [Àëïðàçîëàì]                               │òðàíêâèëèçàòîð [N05BA12]                │òàáëåòêè 0.25 ìã              │Lechiva (×åõèÿ)               │005222,       

                                                                                                                                                      │12.08.94      

                                                                                                                                                                    

│Íåôðàìèí {ãèñòèäèí 0.25 ã, èçîëåéöèí 0.56 ã,      │ñðåäñòâî äëÿ ïàðåíòåðàëüíîãî ïèòàíèÿ    │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │Eczacibasi (Òóðöèÿ)           │02006, 05.11.90│

│ëåéöèí 0.88 ã, ëèçèí 0.64 ã, ìåòèîíèí 0.88 ã,     │[B05BA01]                               │5.4% - 500 ìë                                                             

│ôåíèëàëàíèí 0.88 ã, òðåîíèí 0.4 ã, òðèïòîôàí 0.2                                                                                                                    

│ã, âàëèí 0.64 ã, öèñòåèí 20 ìã, íàòðèÿ                                                                                                                              

│ãèäðîñóëüôèò 50 ìã - 100 ã}                                                                                                                                         

                                                                                                                                                                    

│Íèâàëèí [Ãàëàíòàìèí]                              │àíòèõîëèíýñòåðàçíîå ñðåäñòâî [N07AA]    │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Pharmachim (Áîëãàðèÿ)         │2375,         

                                                                                          │1 ìë - 0.1%, 0.25%, 0.5%, 1%                                │21.06.88,     

                                                                                                                                                      │25.07.74      

                                                                                                                                                                    

│Íèäàçîë [Ìåòðîíèäàçîë]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 250, 500 ìã;         │Al-Hikma Pharmaceuticals      │002588,       

                                                                                          │ñóñïåíçèÿ 125 ìã|5 ìë, 200    │(Èîðäàíèÿ)                    │05.08.92      

                                                                                          │ìã|5 ìë                                                                   

                                                                                                                                                                    

│Íèäàçîë [Ìåòðîíèäàçîë]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 500 ìã               │Dr.Ibrahim Atem Ulagay Sanayi │003021,       

                                                                                                                        │AS (Òóðöèÿ)                   │01.06.93      

                                                                                                                                                                    

│Íèäðàçèä [Èçîíèàçèä]                              │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AC01] │ðàñòâîð äëÿ èíúåêöèé          │Bristol-Myers Squibb (ÑØÀ)    │007653,       

                                                                                          │(ôëàêîíû) 100 ìã/ìë - 10 ìë                                 │19.07.96      

                                                                                                                                                                    

│Íèäðàí [Íèìóñòèí]                                 │öèòîñòàòè÷åñêîå ñðåäñòâî [L01AD06]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Sankyo Co Ltd (ßïîíèÿ)        │002868,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │22.02.93      

                                                                                          │(ôëàêîíû) 25, 50 ìã                                                       

                                                                                                                                                                    

│Íèçîðàë [Êåòîêîíàçîë]                             │ïðîòèâîãðèáêîâîå ñðåäñòâî [J02AB02]     │òàáëåòêè 200 ìã               │Gedeon Richter (Âåíãðèÿ)      │006656,       

                                                                                                                                                      │29.02.96      

                                                                                                                                                                    

│Íèçîðàë [Êåòîêîíàçîë]                             │ïðîòèâîãðèáêîâîå ñðåäñòâî [J02AB02]     │òàáëåòêè 200 ìã               │Janssen Pharmaceutica         │00948,        

                                                                                                                        │(Áåëüãèÿ)                     │15.11.82,     

                                                                                                                                                      │21.07.93       

                                                                                                                                                                    

│Íèçîðàë [Êåòîêîíàçîë]                             │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC08]     │êðåì 20 ìã/ã                  │Janssen Pharmaceutica         │003782,       

                                                                                                                        │(Áåëüãèÿ)                     │24.03.94       

                                                                                                                                                                    

│Íèçîðàë [Êåòîêîíàçîë]                             │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AC08]     │øàìïóíü (ôëàêîíû) 20 ìã/ã;    │Janssen Pharmaceutica         │006713,       

                                                                                          │øàìïóíü (åìêîñòè ïëàñòèêîâûå) │(Áåëüãèÿ)                     │17.10.95      

                                                                                          │20 ìã/ã                                                                   

                                                                                                                                                                    

│Íèçîðàë [Êåòîêîíàçîë]                             │ïðîòèâîãðèáêîâîå ñðåäñòâî [G01AF11]     │ñâå÷è âàãèíàëüíûå 400 ìã      │Janssen Pharmaceutica         │007059,       

                                                                                                                        │(Áåëüãèÿ)                     │07.02.96      

                                                                                                                                                                    

│Íèêàðäèÿ [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │êàïñóëû 5, 10 ìã; òàáëåòêè    │Unique Pharmaceutical         │003492,       

                                                                                          │ðåòàðä 20 ìã                  │Laboratories (Èíäèÿ)          │04.11.93      

                                                                                                                                                                    

│Íèêîðåòòå [Íèêîòèí]                               │ñðåäñòâî äëÿ îáëåã÷åíèÿ îòêàçà îò       │æåâàòåëüíàÿ ðåçèíêà 2 ìã, 4 ìã│Pharmacia (Øâåöèÿ)            │006618,       

                                                  │êóðåíèÿ [N07BA01]                                                                                   │05.01.96      

                                                                                                                                                                    

│Íèêîòèíåëë ÒÒÑ 10 [Íèêîòèí]                       │ñðåäñòâî äëÿ îáëåã÷åíèÿ îòêàçà îò       │òðàíñäåðìàëüíàÿ               │Ciba-Geigy (Øâåéöàðèÿ)        │006758,       

                                                  │êóðåíèÿ [N07BA01]                       │òåðàïåâòè÷åñêàÿ ñèñòåìà 10                                  │31.10.95      

                                                                                          │êâ. ñì                                                                    

                                                                                                                                                                    

│Íèêîòèíåëë ÒÒÑ 20 [Íèêîòèí]                       │ñðåäñòâî äëÿ îáëåã÷åíèÿ îòêàçà îò       │òðàíñäåðìàëüíàÿ               │Ciba-Geigy (Øâåéöàðèÿ)        │006681,       

                                                  │êóðåíèÿ [N07BA01]                       │òåðàïåâòè÷åñêàÿ ñèñòåìà 20                                  │29.09.95      

                                                                                          │êâ. ñì                                                                    

                                                                                                                                                                    

│Íèêîòèíåëë ÒÒÑ 30 [Íèêîòèí]                       │ñðåäñòâî äëÿ îáëåã÷åíèÿ îòêàçà îò       │òðàíñäåðìàëüíàÿ               │Ciba-Geigy (Øâåéöàðèÿ)        │006759,       

                                                  │êóðåíèÿ [N07BA01]                       │òåðàïåâòè÷åñêàÿ ñèñòåìà 30                                  │31.10.95      

                                                                                          │êâ. ñì                                                                    

                                                                                                                                                                    

│Íèêîôëåêñ {êàïñàèöèí 0.105 ìã, ýòèëíèêîòèíàò 20   │ìåñòíîðàçäðàæàþùåå ñðåäñòâî [M02AB]     │ìàçü                          │Reanal (Âåíãðèÿ)              │2593,         

│ìã, ýòèëåíãëèêîëü 90 ìã - 1 ã}                                                                                                                        │17.01.79,     

                                                                                                                                                      │21.06.94      

                                                                                                                                                                    

│Íèêîøïàí {íèêîòèíîâàÿ êèñëîòà 2.2 ìã, äðîòàâåðèí  │âàçîäèëàòèðóþùåå ñðåäñòâî [C04AC]       │òàáëåòêè                      │Chinoin (Âåíãðèÿ)             │2074,         

│78 ìã}                                                                                                                                                │01.06.70,     

                                                                                                                                                      │07.06.84      

                                                                                                                                                                    

│Íèìîòîï [Íèìîäèïèí]                               │ÁÌÊÊ [C08CA06]                          │òàáëåòêè 30 ìã; ðàñòâîð äëÿ   │Bayer AG (ÔÐÃ)                │01877, 25.06.90│

                                                                                          │èíôóçèé (ôëàêîíû) 10 ìã - 50                                              

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Íèðìèí [Íèòðîãëèöåðèí]                            │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Zorka Pharma (Þãîñëàâèÿ)      │005064,       

                                                                                          │èíôóçèîííîãî ðàñòâîðà                                       │30.06.94      

                                                                                          │(àìïóëû) 5 ìã - 1.6 ìë                                                    

                                                                                                                                                                    

│Íèñêîíèòðèí [Íèòðîãëèöåðèí]                       │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Bio-Therabel SA (Áåëüãèÿ)     │005258,       

                                                                                          │25 ìã/5 ìë, 50 ìã/10 ìë;                                    │22.08.94      

                                                                                          │êàïñóëû ïðîëîíãèðîâàííîãî                                                 

                                                                                          │äåéñòâèÿ 2.5, 6.5 ìã;                                                     

                                                                                          │àýðîçîëü äîçèðîâàííûé 0.4                                                 

                                                                                          │ìã|äîçà                                                                   

                                                                                                                                                                    

│Íèñòàôîðì {íèñòàòèí, àëãåëäðàò}                   │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AE]       │ìàçü                          │Eipico (Åãèïåò)               │003720,       

                                                                                                                                                      │24.02.94      

                                                                                                                                                                    

│Íèò-ðåò [Íèòðîãëèöåðèí]                           │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │òàáëåòêè 2.5 ìã               │Slovakofarma SA (Ñëîâàêèÿ)    │2849,         

                                                                                                                                                      │05.12.94,     

                                                                                                                                                      │28.10.86       

                                                                                                                                                                    

│Íèòðàäèñê [Íèòðîãëèöåðèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │òðàíñäåðìàëüíàÿ               │Searle (ÑØÀ)                  │003059,       

                                                                                          │òåðàïåâòè÷åñêàÿ ñèñòåìà                                     │15.06.93       

                                                                                          │(ïëàñòûðü) - 5 ìã|24 ÷, 10                                                

                                                                                          │ìã|24 ÷                                                                   

                                                                                                                                                                     

│Íèòðàíãèí [Íèòðîãëèöåðèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │êàïñóëû 0.2, 0.8 ìã           │Isis Pharma GmbH (ÔÐÃ)        │002745,       

                                                                                                                                                      │11.12.92      

                                                                                                                                                                     

│Íèòðàíãèí ëèêâèäóì [Íèòðîãëèöåðèí]                │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │ðàñòâîð îðàëüíûé (ôëàêîíû)    │Isis Pharma GmbH (Ãåðìàíèÿ)   │003673,       

                                                                                          │10, 20 ìë                                                   │04.02.94      

                                                                                                                                                                    

│Íèòðåíäèïèí [Íèòðåíäèïèí]                         │ÁÌÊÊ [C08CA08]                          │òàáëåòêè 10, 20 ìã            │Pharmaceutic Institute        │006931,       

                                                                                                                        │(Ïîëüøà)                      │21.12.95      

                                                                                                                                                                    

│Íèòðåïèí [Íèòðåíäèïèí]                            │ÁÌÊÊ [C08CA08]                          │òàáëåòêè 10, 20 ìã            │Zdravle (Þãîñëàâèÿ)           │003050,       

                                                                                                                                                      │08.06.93      

                                                                                                                                                                    

│Íèòðî [Íèòðîãëèöåðèí]                             │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │ìàçü 2%                       │Orion Pharmaceutica           │01084, 30.05.84│

                                                                                                                        │(Ôèíëÿíäèÿ)                                 

                                                                                                                                                                    

│Íèòðî [Íèòðîãëèöåðèí]                             │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Orion Pharmaceutica           │01769, 20.02.90│

                                                                                          │èíôóçèîííîãî ðàñòâîðà         │(Ôèíëÿíäèÿ)                                 

                                                                                          │(àìïóëû) 5 ìã/ìë - 2 ìë                                                   

                                                                                                                                                                    

│Íèòðî Ìàê [Íèòðîãëèöåðèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │êàïñóëû ðåòàðä 5 ìã           │Farmakos (ÑÔÐÞ)               │002526,       

                                                                                                                                                      │22.06.92      

                                                                                                                                                                    

│Íèòðî Ìàê [Íèòðîãëèöåðèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Heinrich Mack Nachf.          │005723,       

                                                                                          │5 ìã - 5 ìë                   │(Ãåðìàíèÿ)                    │10.02.95      

                                                                                                                                                                    

│Íèòðî Ìàê [Íèòðîãëèöåðèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │êàïñóëû ðåòàðä 2.5 ìã         │Mack (Ãåðìàíèÿ)               │00551,        

                                                                                                                                                      │17.04.90,     

                                                                                                                                                      │18.04.78      

                                                                                                                                                                    

│Íèòðî Ìàê [Íèòðîãëèöåðèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │êàïñóëû ðåòàðä 5 ìã           │Mack (Ãåðìàíèÿ)               │002570,       

                                                                                                                                                      │27.07.92      

                                                                                                                                                                    

│Íèòðî Ìàê ðåòàðä [Íèòðîãëèöåðèí]                  │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │êàïñóëû 2.5, 5 ìã             │Slovakofarma SA (Ñëîâàêèÿ)    │005158,       

                                                                                                                                                      │20.07.94      

                                                                                                                                                                    

│Íèòðî Ïîëü Èíôóç [Íèòðîãëèöåðèí]                  │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │ðàñòâîð äëÿ èíôóçèé (àìïóëû)  │G. Pohl-Boscamp GmbH & Co     │006469,       

                                                                                          │5 ìã/5 ìë, 25 ìã/25 ìë;       │(Ãåðìàíèÿ)                    │04.09.95      

                                                                                          │ðàñòâîð äëÿ èíôóçèé (ôëàêîíû) │                                            

                                                                                          │50 ìã/50 ìë                                                               

                                                                                                                                                                    

│Íèòðî-äóð [Íèòðîãëèöåðèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │ïëàñòûðü òðàíäåðìàëüíûé 0.2   │Schering-Plough (Èñïàíèÿ)     │007577,       

                                                                                          │ìã|÷, 0.4 ìã|÷, 0.6 ìã|÷                                    │11.06.96      

                                                                                                                                                                    

│Íèòðîãëèöåðèí [Íèòðîãëèöåðèí]                     │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │êàïñóëû 2.5, 6.5, 9 ìã;       │Rugby (ÑØÀ)                   │005137,       

                                                                                          │òðàíñäåðìàëüíàÿ                                             │15.07.94      

                                                                                          │òåðàïåâòè÷åñêàÿ ñèñòåìà 0.2,                                              

                                                                                          │0.4, 0.6 ìã|÷àñ                                                           

                                                                                                                                                                    

│Íèòðîãëèöåðèí Íèêîìåä [Íèòðîãëèöåðèí]             │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │òàáëåòêè ñóáëèíãâàëüíûå 0.25, │Nycomed Dak AS (Äàíèÿ)        │006106,       

                                                                                          │0.5 ìã                                                      │25.05.95      

                                                                                                                                                                    

│Íèòðîäåðì ÒÒÑ 10 [Íèòðîãëèöåðèí]                  │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │òðàíñäåðìàëüíàÿ               │Ciba-Geigy (Øâåéöàðèÿ)        │01465, 03.08.88│

                                                                                          │òåðàïåâòè÷åñêàÿ ñèñòåìà 50                                                

                                                                                          │ìã|20 êâ. ñì                                                              

                                                                                                                                                                     

│Íèòðîäåðì ÒÒÑ 5 [Íèòðîãëèöåðèí]                   │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │òðàíñäåðìàëüíàÿ               │Ciba-Geigy (Øâåéöàðèÿ)        │01465, 03.08.88│

                                                                                          │òåðàïåâòè÷åñêàÿ ñèñòåìà 25                                                

                                                                                          │ìã|10 êâ. ñì                                                               

                                                                                                                                                                    

│5-íèòðîêñ [Íèòðîêñîëèí]                           │ïðîòèâîìèêðîáíîå ñðåäñòâî, îêñèõèíîëèí  │òàáëåòêè ïîêðûòûå ïëåíî÷íîé   │Pharmachim (Áîëãàðèÿ)         │2500,         

                                                  │[G04AG06]                               │îáîëî÷êîé 50 ìã                                             │22.07.76,     

                                                                                                                                                      │25.03.87      

                                                                                                                                                                    

│Íèòðîëèíãâàë-àýðîçîë [Íèòðîãëèöåðèí]              │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │ðàñòâîð 0.4 ìã|äîçà (ôëàêîíû) │G.Pohl-Boscamp GmbH & Co      │005695,       

                                                                                          │13.6 ã|14.8 ìë                │(Ãåðìàíèÿ)                    │30.01.95      

                                                                                                                                                                    

│Íèòðîëèíãâàë-àýðîçîëü [Íèòðîãëèöåðèí]             │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │ðàñòâîð 0.4 ìã|äîçà (ôëàêîíû) │G.Pohl-Boscamp GmbH & Co      │006468,       

                                                                                          │11.2 ã|12.2 ìë                │(Ãåðìàíèÿ)                    │04.09.95      

                                                                                                                                                                    

│Íèòðîìèíò [Íèòðîãëèöåðèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │òàáëåòêè ðåòàðä 2.6 ìã        │Egis (Âåíãðèÿ)                │2879, 04.01.88 │

                                                                                                                                                                    

│Íèòðîìèíò [Íèòðîãëèöåðèí]                         │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │àýðîçîëü îðàëüíûé (ôëàêîíû)   │Egis (Âåíãðèÿ)                │003945,       

                                                                                                                                                      │27.05.94      

                                                                                                                                                                    

│Íèòðîíã [Íèòðîãëèöåðèí]                           │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │òàáëåòêè 6.5 ìã               │Krka (Þãîñëàâèÿ)              │01436, 27.04.88│

                                                                                                                                                                    

│Íèòðîíã [Íèòðîãëèöåðèí]                           │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │òàáëåòêè 2.6 ìã               │Orion Corporation, Farmos     │00838,        

                                                                                                                        │Group (Ôèíëÿíäèÿ)             │09.02.81,     

                                                                                                                                                      │25.10.93      

                                                                                                                                                                    

│Íèòðîíã [Íèòðîãëèöåðèí]                           │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │òàáëåòêè 6.5 ìã               │Rhone-Poulenc Rorer (ÑØÀ)     │006630,       

                                                                                                                                                      │29.01.96      

                                                                                                                                                                    

│Íèòðîñàí [Íèòðàçåïàì]                             │òðàíêâèëèçàòîð [N05CD02]                │òàáëåòêè 5, 10 ìã             │Sun Pharmaceutical Industries │003158,       

                                                                                                                        │Ltd (Èíäèÿ)                   │19.07.93      

                                                                                                                                                                    

│Íèòðîñîë [Íèòðîãëèöåðèí]                          │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA02]     │àýðîçîëü 0.4 ìã|äîçà - 12.5 ìë│Evopharm (Þãîñëàâèÿ)          │006774,       

                                                                                                                                                      │31.10.95      

                                                                                                                                                                    

│Íèòðîñîðáèä [Èçîñîðáèä äèíèòðàò]                  │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA08]     │òàáëåòêè 20 ìã                │Orion Corporation (Ôèíëÿíäèÿ) │006661,       

                                                                                                                                                      │20.03.96      

                                                                                                                                                                    

│Íèòðîôóíãèí {õëîðíèòðîôåíîë 0.25 ã,               │ïðîòèâîãðèáêîâîå ñðåäñòâî [D01AE]       │ðàñòâîð äëÿ íàðóæíîãî         │Galena (×åõèÿ)                │006622,       

│òðèýòèëåíãëèêîëü 2.5 ã, ýòàíîë 50% 11.2 ã}                                                │ïðèìåíåíèÿ                                                  │11.01.96      

                                                                                                                                                                    

│Íèòòèôîð [Ïåðìåòðèí]                              │ïðîòèâîïåäèêóëåçíîå ñðåäñòâî [P03AC04]  │ðàñòâîð 60 ìë                 │Biogal (Âåíãðèÿ)              │2791, 06.02.85 │

                                                                                                                                                                    

│Íèôàäèë [Íèôåäèïèí]                               │ÁÌÊÊ [C08CA05]                          │òàáëåòêè 10 ìã                │Alkaloid (Ìàêåäîíèÿ)          │003165,       

                                                                                                                                                      │19.07.93      

                                                                                                                                                                    

│Íèôåáåíå [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │êàïñóëû ðåòàðä 20 ìã; êàïëè   │Ludwig Merckle GmbH (Àâñòðèÿ) │005342,       

                                                                                          │îðàëüíûå (ôëàêîíû) 20 ìã/ìë                                 │21.09.94      

                                                                                                                                                                    

│Íèôåáåíå [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │êàïñóëû 10 ìã                 │Ludwig Merckle GmbH (Àâñòðèÿ) │005846,       

                                                                                                                                                      │28.03.95      

                                                                                                                                                                    

│Íèôåãåêñàë [Íèôåäèïèí]                            │ÁÌÊÊ [C08CA05]                          │êàïñóëû 10 ìã; òàáëåòêè       │Hexal Pharma GmbH (ÔÐÃ)       │003184,       

                                                                                          │ðåòàðä 20 ìã                                                │03.08.93      

                                                                                                                                                                    

│Íèôåãåêñàë [Íèôåäèïèí]                            │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ðåòàðä 40 ìã         │Hexal Pharma GmbH (Ãåðìàíèÿ)  │003823,        

                                                                                                                                                      │05.04.94      

                                                                                                                                                                    

│Íèôåäèêîð [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ðåòàðä 20 ìã;        │Alpha Schiapparelli           │006701,        

                                                                                          │êàïñóëû 10, 20 ìã; êàïëè      │Wassermann Spa (Èòàëèÿ)       │11.10.95      

                                                                                          │îðàëüíûå (ôëàêîíû) 20 ìã/ìë                                               

                                                                                                                                                                     

│Íèôåäèïàò-10 [Íèôåäèïèí]                          │ÁÌÊÊ [C08CA05]                          │êàïñóëû 10 ìã                 │Azupharma GmbH (Ãåðìàíèÿ)     │005235,       

                                                                                                                                                      │18.08.94      

                                                                                                                                                                     

│Íèôåäèïàò-5 [Íèôåäèïèí]                           │ÁÌÊÊ [C08CA05]                          │êàïñóëû 5 ìã                  │Azupharma GmbH (Ãåðìàíèÿ)     │005235,       

                                                                                                                                                      │18.08.94      

                                                                                                                                                                    

│Íèôåäèïàò-ðåòàðä [Íèôåäèïèí]                      │ÁÌÊÊ [C08CA05]                          │êàïñóëû 20 ìã                 │Azupharma GmbH (Ãåðìàíèÿ)     │005221,       

                                                                                                                                                      │12.08.94      

                                                                                                                                                                    

│Íèôåäèïèí [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │êàïñóëû 5, 10 ìã              │Cox Pharmaceuticals           │005299,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │06.09.94      

                                                                                                                                                                    

│Íèôåäèïèí [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │êàïñóëû 5, 10, 20 ìã          │Duomed AG (Øâåéöàðèÿ)         │005215,       

                                                                                                                                                      │10.08.94      

                                                                                                                                                                    

│Íèôåäèïèí [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │êàïñóëû 5, 10 ìã              │Norton Healthcare Ltd         │003245,       

                                                                                                                        │(Âåëèêîáðèòàíèÿ)              │18.08.93      

                                                                                                                                                                    

│Íèôåäèïèí [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │äðàæå 10 ìã                   │Pharmachim (ÍÐÁ)              │2992, 30.10.90 │

                                                                                                                                                                    

│Íèôåäèïèí [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │òàáëåòêè 10 ìã                │Pliva SA (Õîðâàòèÿ)           │006126,       

                                                                                                                                                      │30.05.95      

                                                                                                                                                                    

│Íèôåäèïèí [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa, Grodziskie Zaklady     │003928,       

                                                                                          │10 ìã                         │Farmaceutyczne SA (Ïîëüøà)    │20.05.94      

                                                                                                                                                                    

│Íèôåäèïèí [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Shenzhen Pharmaceutical       │007036,       

                                                                                          │10 ìã                         │Factory (Êèòàé)               │01.02.96      

                                                                                                                                                                    

│Íèôåäèïèí [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │êàïñóëû 5, 10 ìã; òàáëåòêè    │Stada Arzneimittel AG         │005586,       

                                                                                          │ðåòàðä 20 ìã                  │(Ãåðìàíèÿ)                    │20.12.94      

                                                                                                                                                                    

│Íèôåäèïèí 20 ðåòàðä [Íèôåäèïèí]                   │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ðåòàðä 20 ìã         │Euderma (Èòàëèÿ)              │006882,       

                                                                                                                                                      │08.12.95      

                                                                                                                                                                    

│Íèôåäèïèí-Õ-Ðàòèîôàðì [Íèôåäèïèí]                 │ÁÌÊÊ [C08CA05]                          │êàïñóëû 5, 10 ìã              │Ratiopharm GmbH & Co          │003416,       

                                                                                                                        │(Ãåðìàíèÿ)                    │12.10.93      

                                                                                                                                                                    

│Íèôåêàðä [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │êàïñóëû 10 ìã                 │Dar Al Dava (Èîðäàíèÿ)        │002965,       

                                                                                                                                                      │16.04.93      

                                                                                                                                                                    

│Íèôåêàðä [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ëàêèðîâàííûå 10 ìã   │Lek (Þãîñëàâèÿ)               │01450, 13.06.88│

                                                                                                                                                                    

│Íèôåêàðä [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ëàêèðîâàííûå ðåòàðä  │Lek D.D.Ljubljana (Ñëîâåíèÿ)  │005038,       

                                                                                          │20 ìã                                                       │24.06.94      

                                                                                                                                                                    

│Íèôåëàò [Íèôåäèïèí]                               │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ðåòàðä 20 ìã;        │Cipla Ltd (Èíäèÿ)             │005530,       

                                                                                          │êàïñóëû 5, 10 ìã                                            │28.11.94      

                                                                                                                                                                    

│Íèôåëàò [Íèôåäèïèí]                               │ÁÌÊÊ [C08CA05]                          │êàïñóëû 10 ìã                 │Biogalenique (Ôðàíöèÿ)        │003210,       

                                                                                                                                                      │09.08.93      

                                                                                                                                                                     

│Íèôåëàò [Íèôåäèïèí]                               │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ðåòàðä 20 ìã         │Biogalenique (Ôðàíöèÿ)        │003401,       

                                                                                                                                                      │08.10.93      

                                                                                                                                                                     

│Íèôåëàò [Íèôåäèïèí]                               │ÁÌÊÊ [C08CA05]                          │ôèëìòàáëåòêè 10 ìã            │Remedica Ltd - Minnex (Êèïð)  │006799,       

                                                                                                                                                      │09.11.95      

                                                                                                                                                                     

│Íèôåëàò [Íèôåäèïèí]                               │ÁÌÊÊ [C08CA05]                          │êàïñóëû 5, 10 ìã; òàáëåòêè    │Tad Pharmazeutisches Werk     │005599,       

                                                                                          │ïîêðûòûå îáîëî÷êîé 10 ìã;     │GmbH (Ãåðìàíèÿ)               │26.12.94      

                                                                                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé                                                

                                                                                          │çàìåäëåííîãî âûñâîáîæäåíèÿ 20 │                                            

                                                                                          │ìã                                                                        

                                                                                                                                                                    

│Íèôåëàò [Íèôåäèïèí]                               │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Zdravle (Þãîñëàâèÿ)           │007645,       

                                                                                          │10 ìã; òàáëåòêè ïîêðûòûå                                    │16.07.96      

                                                                                          │îáîëî÷êîé ðåòàðä 20 ìã                                                    

                                                                                                                                                                    

│Íèôåëàò Q [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Remedica Ltd - Minnex (Êèïð)  │006804,       

                                                                                          │áûñòðîãî âûñâîáîæäåíèÿ 10 ìã                                │09.11.95      

                                                                                                                                                                    

│Íèôåëàò Ð [Íèôåäèïèí]                             │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Remedica Ltd - Minnex (Êèïð)  │006796,       

                                                                                          │äëèòåëüíîãî âûñâîáîæäåíèÿ 20                                │09.11.95      

                                                                                          │ìã                                                                        

                                                                                                                                                                    

│Íèôåñàí [Íèôåäèïèí]                               │ÁÌÊÊ [C08CA05]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Pro.Med.Cs (×åõèÿ)            │003142,       

                                                                                          │10 ìã                                                       │05.07.93      

                                                                                                                                                                    

│Íèôèêàðä [Íèôåäèïèí]                              │ÁÌÊÊ [C08CA05]                          │êàïñóëû 10 ìã                 │Ranbaxy Laboratories Ltd      │002562,       

                                                                                                                        │(Èíäèÿ)                       │15.07.92      

                                                                                                                                                                    

│Íèôëóãåëü [Íèôëóìîâàÿ êèñëîòà]                    │ÍÏÂÑ [M02AA17]                          │ãåëü äëÿ íàðóæíîãî ïðèìåíåíèÿ │Laboratoires Upsa (Ôðàíöèÿ)   │005303,       

                                                                                          │(òóáû) 2.5%                                                 │07.09.94      

                                                                                                                                                                    

│Íèôëóðèë [Ìîðíèôëóìàò]                            │ÍÏÂÑ [M01AX22]                          │ñâå÷è äëÿ äåòåé 400 ìã; ñâå÷è │Laboratoires Upsa (Ôðàíöèÿ)   │005321,       

                                                                                          │äëÿ âçðîñëûõ 700 ìã                                         │12.09.94      

                                                                                                                                                                    

│Íèôëóðèë [Íèôëóìîâàÿ êèñëîòà]                     │ÍÏÂÑ [M01AX02]                          │êàïñóëû 250 ìã                │Laboratoires Upsa (Ôðàíöèÿ)   │002740,       

                                                                                                                                                      │11.12.92      

                                                                                                                                                                    

│Íèôëóðèë [Íèôëóìîâàÿ êèñëîòà]                     │ÍÏÂÑ [M02AA17]                          │êðåì äëÿ íàðóæíîãî ïðèìåíåíèÿ │Laboratoires Upsa (Ôðàíöèÿ)   │005321,       

                                                                                          │3%                                                          │12.09.94      

                                                                                                                                                                    

│Íèôòîëèäà ìàçü [Ôëóòàìèä]                         │àíòèàíäðîãåí [L02BB01]                  │ìàçü (òóáû) 2.5% - 30 ã       │(Óêðàèíà)                     │93/84/2       

                                                                                                                                                                    

│Íèöåëèí [Íèöåðãîëèí]                              │àëüôà-àäðåíîáëîêàòîð [C04AE02]          │ëèîôèëèç.ïîðîøîê äëÿ          │Menon Pharma (Èíäèÿ)          │003489,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │04.11.93      

                                                                                          │ðàñòâîðà (àìïóëû) 4 ìã /â                                                 

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Íèöåðãîëèí [Íèöåðãîëèí]                           │àëüôà-àäðåíîáëîêàòîð [C04AE02]          │ëèîôèëèç.ïîðîøîê äëÿ          │Rusan Pharma (Èíäèÿ)          │006093,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │24.05.95      

                                                                                          │ðàñòâîðà (àìïóëû) 4 ìã /â                                                 

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì/                                                

                                                                                                                                                                    

│Íî-ñïàçì [Ïðèôèíèé áðîìèä]                        │ì-õîëèíîáëîêàòîð [A03AB18]              │òàáëåòêè 30 ìã; ðàñòâîð äëÿ   │Al-Hikma Pharmaceuticals      │002279,       

                                                                                          │èíúåêöèé (àìïóëû) 7.5 ìã/ìë - │(Èîðäàíèÿ)                    │12.11.91      

                                                                                          │2 ìë; ñèðîï (ôëàêîíû) 7.5                                                 

                                                                                          │ìã|5 ìë                                                                   

                                                                                                                                                                     

│Íî-øïà [Äðîòàâåðèí]                               │ñïàçìîëèòè÷åñêîå ñðåäñòâî [A03AD02]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Chinoin (Âåíãðèÿ)             │2078,         

                                                                                          │40 ìã - 2 ìë                                                │01.07.70,     

                                                                                                                                                      │23.12.83,      

                                                                                                                                                      │30.01.95      

                                                                                                                                                                    

│Íî-øïà [Äðîòàâåðèí]                               │ñïàçìîëèòè÷åñêîå ñðåäñòâî [A03AD02]     │òàáëåòêè                      │Chinoin (Âåíãðèÿ)             │2673,          

                                                                                                                                                      │10.11.81,     

                                                                                                                                                      │19.03.92      

                                                                                                                                                                     

│Íî-øïà [Äðîòàâåðèí]                               │ñïàçìîëèòè÷åñêîå ñðåäñòâî [A03AD02]     │òàáëåòêè 40 ìã; ðàñòâîð äëÿ   │Hemofarm D.D. (Þãîñëàâèÿ)     │003802,       

                                                                                          │èíúåêöèé (àìïóëû) 40 ìã - 2 ìë│                              │29.03.94      

                                                                                                                                                                    

│Íî-øïà [Äðîòàâåðèí]                               │ñïàçìîëèòè÷åñêîå ñðåäñòâî [A03AD02]     │òàáëåòêè 40 ìã; ðàñòâîð äëÿ   │Torrent Exports Ltd (Èíäèÿ)   │002673,       

                                                                                          │èíúåêöèé (àìïóëû) 40 ìã - 2 ìë│                              │27.10.92      

                                                                                                                                                                    

│Íîáîë [Ìåòàìèçîë íàòðèÿ]                          │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ðàñòâîð äëÿ  │Menon Pharma (Èíäèÿ)          │003486,       

                                                  │ñðåäñòâî [N02BB02]                      │èíúåêöèé (àìïóëû) 2 ìë                                      │04.11.93,     

                                                                                                                                                      │15.03.94      

                                                                                                                                                                    

│Íîáðèóì [Ìåäàçåïàì]                               │òðàíêâèëèçàòîð [N05BA03]                │êàïñóëû 5 ìã                  │Galenika (Þãîñëàâèÿ)          │00413,        

                                                                                                                                                      │07.10.76,     

                                                                                                                                                      │12.09.88      

                                                                                                                                                                    

│Íîâà Ò Êó 200 Àã                                  │êîíòðàöåïòèâíîå âíóòðèìàòî÷íîå ñðåäñòâî │êîíòðàöåïòèâ âíóòðèìàòî÷íûé   │Leiras (Ôèíëÿíäèÿ)            │01017, 21.07.83│

                                                  │[G02BA02]                                                                                                         

                                                                                                                                                                    

│Íîâà ôèãóðà ãåëü {ãëèöåðèí 4%, ìàííèòîë 2%,       │äåðìàòîïðîòåêòîðíîå ñðåäñòâî [D10AX]    │ãåëü                          │Naturwaren, Dr.P.Theiss       │007148,       

│ëåöèòèí 2%, ïëþùà òðàâû ýêñòðàêò 2%, êàñòîðîâîå                                                                         │(Ãåðìàíèÿ)                    │18.03.96      

│ìàñëî 1.5%, ýòàíîë 15%, âîäà 76.095%}                                                                                                                               

                                                                                                                                                                    

│Íîâàë [Òèìîëîë]                                   │áåòà-àäðåíîáëîêàòîð [S01ED01]           │ðàñòâîð îôòàëüìîëîãè÷åñêèé    │Demo S.A. Pharmaceutical      │005499,       

                                                                                          │(ôëàêîíû) 0.25%, 0.5%         │Industry (Ãðåöèÿ)             │15.11.94      

                                                                                                                                                                    

│Íîâàíäîë [Àöåòèëñàëèöèëîâàÿ êèñëîòà]              │ÍÏÂÑ [N02BA01]                          │òàáëåòêè 300 ìã               │Zdravle (Þãîñëàâèÿ)           │003652,       

                                                                                                                                                      │31.01.94      

                                                                                                                                                                    

│Íîâàíòðîí [Ìèòîêñàíòðîí]                          │öèòîñòàòè÷åñêîå ñðåäñòâî [L01DB07]      │ðàñòâîð äëÿ ïðèãîòîâëåíèÿ     │Lederle (ÑØÀ)                 │002275,       

                                                                                          │èíôóçèîííîãî ðàñòâîðà                                       │31.10.91      

                                                                                          │êîíöåíòðèðîâàííûé (ôëàêîíû) 2 │                                            

                                                                                          │ìã/ìë - 5, 10, 12.5, 15 ìë                                                

                                                                                                                                                                    

│Íîâàñàí [Àöåòèëñàëèöèëîâàÿ êèñëîòà]               │ÍÏÂÑ [N02BA01]                          │òàáëåòêè 325 ìã               │Novopharm Ltd (Êàíàäà)        │006143,       

                                                                                                                                                      │06.06.95      

                                                                                                                                                                    

│Íîâàñåí SpC [Àöåòèëñàëèöèëîâàÿ êèñëîòà]           │ÍÏÂÑ [N02BA01]                          │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Novopharm Ltd (Êàíàäà)        │005166,       

                                                                                          │îáîëî÷êîé 325 ìã                                            │21.07.94      

                                                                                                                                                                    

│Íîâèãàí {èáóïðîôåí 0.4 ã,                         │àíàëüãåòè÷åñêîå è ñïàçìîëèòè÷åñêîå      │òàáëåòêè 400 ìã               │Dr.Reddy's Laboratories Ltd   │002550,       

│ïèïåðèäèíýòîêñèêàðáìåòîêñè áåíçîôåíîí 5 ìã,       │ñðåäñòâî [M01AE51]                                                    │(Èíäèÿ)                       │14.07.92      

│äèôåíèëïèïåðèäèíýòèëàöåòàìèä áðîììåòèëàò 0.1 ìã}                                                                                                                    

                                                                                                                                                                    

│Íîâèòðîïàí [Îêñèáóòèíèí]                          │ñïàçìîëèòè÷åñêîå ñðåäñòâî [G04BD04]     │òàáëåòêè 5 ìã                 │Cts Chemical Industries Ltd   │007026,       

                                                                                                                        │(Èçðàèëü)                     │30.01.96      

                                                                                                                                                                    

│Íîâî-Äæåñèê [Ïàðàöåòàìîë]                         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 325, 500 ìã          │Novopharm Ltd (Êàíàäà)        │003319,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │10.09.93      

                                                                                                                                                                    

│Íîâî-Äèïàì [Äèàçåïàì]                             │òðàíêâèëèçàòîð [N05BA01]                │òàáëåòêè 2, 5, 10 ìã          │Novopharm Ltd (Êàíàäà)        │005997,        

                                                                                                                                                      │26.04.95      

                                                                                                                                                                    

│Íîâî-Äîêñèëèí [Äîêñèöèêëèí]                       │àíòèáèîòèê, òåòðàöèêëèí                 │êàïñóëû 100 ìã                │Novopharm Ltd (Êàíàäà)        │006886,        

                                                  │ïîëóñèíòåòè÷åñêèé [J01AA02]                                                                         │13.12.95      

                                                                                                                                                                    

│Íîâî-Êàïòîðèë [Êàïòîïðèë]                         │ÀÊÔ áëîêàòîð [C09AA01]                  │òàáëåòêè 12.5, 25, 50 ìã      │Novopharm Ltd (Êàíàäà)        │003513,       

                                                                                                                                                      │17.11.93      

                                                                                                                                                                    

│Íîâî-Ëåêñèí [Öåôàëåêñèí]                          │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250, 500 ìã;          │Novopharm Ltd (Êàíàäà)        │003390,       

                                                                                          │ñóñïåíçèÿ îðàëüíàÿ (ôëàêîíû)                                │08.10.93      

                                                                                          │125 ìã|5 ìë, 250 ìã|5 ìë                                                  

                                                                                                                                                                    

│Íîâî-Ìåòàöèí SpC [Èíäîìåòàöèí]                    │ÍÏÂÑ [M01AB01]                          │êàïñóëû 25, 50 ìã             │Novopharm Ltd (Êàíàäà)        │005167,       

                                                                                                                                                      │21.07.94      

                                                                                                                                                                    

│Íîâî-Íèäàçîë [Ìåòðîíèäàçîë]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî [J01XD01]     │òàáëåòêè 250 ìã               │Novopharm Ltd (Êàíàäà)        │003293,       

                                                                                                                                                      │02.09.93      

                                                                                                                                                                    

│Íîâî-Íèôåäèí [Íèôåäèïèí]                          │ÁÌÊÊ [C08CA05]                          │êàïñóëû 10 ìã                 │Novopharm Ltd (Êàíàäà)        │003388,       

                                                                                                                                                      │07.10.93      

                                                                                                                                                                    

│Íîâî-Ïðàíîë [Ïðîïðàíîëîë]                         │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè 10, 20, 40, 80, 120  │Novopharm Ltd (Êàíàäà)        │003389,       

                                                                                          │ìã                                                          │07.10.93      

                                                                                                                                                                    

│Íîâî-Ðàíèäèí [Ðàíèòèäèí]                          │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Novopharm Ltd (Êàíàäà)        │005170,       

                                                  │[A02BA02]                               │150, 300 ìã                                                 │21.07.94      

                                                                                                                                                                    

│Íîâî-Ñåìèä [Ôóðîñåìèä]                            │äèóðåòè÷åñêîå ñðåäñòâî [C03CA01]        │òàáëåòêè 20, 40, 80 ìã        │Novopharm Ltd (Êàíàäà)        │005169,       

                                                                                                                                                      │21.07.94      

                                                                                                                                                                    

│Íîâî-Òðèìåë [Êî-òðèìîêñàçîë] {ñóëüôàìåòîêñàçîë    │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè 400 ìã/80 ìã, 800    │Novopharm Ltd (Êàíàäà)        │003514,       

│400 ìã, òðèìåòîïðèì 80 ìã; ñóëüôàìåòîêñàçîë 800   │ñðåäñòâî [J01EE01]                      │ìã/160 ìã                                                   │17.11.93      

│ìã, òðèìåòîïðèì 160 ìã}                                                                                                                                             

                                                                                                                                                                    

│Íîâî-Òðèïòèí [Àìèòðèïòèëèí]                       │àíòèäåïðåññàíò [N06AA09]                │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Novopharm Ltd (Êàíàäà)        │005168,       

                                                                                          │10, 25, 50 ìã                                               │21.07.94      

                                                                                                                                                                    

│Íîâî-Öèìåòèí [Öèìåòèäèí]                          │H2-ãèñòàìèíîâûõ ðåöåïòîðîâ áëîêàòîð     │òàáëåòêè 200, 300, 400, 600 ìã│Novopharm Ltd (Êàíàäà)        │003320,       

                                                  │[A02BA01]                                                                                           │10.09.93      

                                                                                                                                                                    

│Íîâîäèãàë [Äèãîêñèí]                              │êàðäèîòîíè÷åñêîå ñðåäñòâî [C01AA05]     │òàáëåòêè 0.2 ìã; ðàñòâîð äëÿ  │Eli Lilly (Ãåðìàíèÿ)          │007392,       

                                                                                          │èíúåêöèé (àìïóëû) 0.2 ìã/ìë                                 │02.04.96      

                                                                                                                                                                    

│Íîâîòèðàë {ëåâîòèðîêñèí 75 ìêã, ëèîòèðîíèí 15     │òèðåîèäíîå ñðåäñòâî [H03AA03]           │òàáëåòêè 75 ìêã/15 ìêã, 100   │Merck (ÔÐÃ)                   │003007,       

│ìêã; ëåâîòèðîêñèí 100 ìêã, ëèîòèðîíèí 20 ìêã}                                             │ìêã/20 ìêã                                                  │26.05.93      

                                                                                                                                                                    

│Íîâîôåí [Òàìîêñèôåí]                              │àíòèýñòðîãåí [L02BA01]                  │òàáëåòêè 20 ìã                │Remedica Ltd - Minnex (Êèïð)  │006809,       

                                                                                                                                                      │09.11.95      

                                                                                                                                                                    

│Íîâîöåô [Öåôóðîêñèì]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA06]      │òàáëåòêè 125, 250, 500 ìã     │Pliva (Õîðâàòèÿ)              │002838,       

                                                                                                                                                      │10.02.93      

                                                                                                                                                                    

│5-ÍÎÊ [Íèòðîêñîëèí]                               │ïðîòèâîìèêðîáíîå ñðåäñòâî, îêñèõèíîëèí  │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Lek D.D. (Ñëîâåíèÿ)           │006580,       

                                                  │[G04AG06]                               │50 ìã                                                       │13.10.95      

                                                                                                                                                                    

│ÍÎÊ [Ïåðìåòðèí]                                   │ïðîòèâîïåäèêóëåçíîå ñðåäñòâî [P03AC04]  │êðåì-øàìïóíü                  │Cts Novis Ltd (Èçðàèëü)       │006089,       

                                                                                                                                                      │23.05.95      

                                                                                                                                                                     

│Íîëâàäåêñ [Òàìîêñèôåí]                            │àíòèýñòðîãåí [L02BA01]                  │òàáëåòêè 10 ìã                │Ici (Âåëèêîáðèòàíèÿ)          │00774,        

                                                                                                                                                      │19.03.92,     

                                                                                                                                                      │26.06.80       

                                                                                                                                                                    

│Íîëâàäåêñ Ä [Òàìîêñèôåí]                          │àíòèýñòðîãåí [L02BA01]                  │òàáëåòêè 20 ìã                │Zeneca Pharma Pt (Èíäîíåçèÿ)  │006192,       

                                                                                                                                                      │16.06.95      

                                                                                                                                                                    

│Íîëâàäåêñ-ôîðòå [Òàìîêñèôåí]                      │àíòèýñòðîãåí [L02BA01]                  │òàáëåòêè 20, 40 ìã            │Ici (Âåëèêîáðèòàíèÿ)          │002693,       

                                                                                                                                                      │17.11.92      

                                                                                                                                                                    

│Íîëèöèí [Íîðôëîêñàöèí]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Krka (ÑÔÐÞ)                   │01758, 13.02.90│

                                                  │[J01MA06]                                                                                                         

                                                                                                                                                                    

│Íîìèãðýéí [Ôëóíàðèçèí]                            │ÁÌÊÊ [N07CA03]                          │êàïñóëû 5 ìã                  │Torrent Exports Ltd (Èíäèÿ)   │002293,       

                                                                                                                                                      │22.11.91      

                                                                                                                                                                    

│Íîí-îâëîí {íîðýòèñòåðîí 1 ìã, ýòèíèëýñòðàäèîë     │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA05]      │äðàæå                         │Jenapharm GmbH (Ãåðìàíèÿ)     │01230,        

│0.05 ìã}                                                                                                                                              │01.07.94,     

                                                                                                                                                      │25.12.85      

                                                                                                                                                                    

│Íîîòðîïèë [Ïèðàöåòàì]                             │íîîòðîïíîå ñðåäñòâî [N06BX03]           │êàïñóëû 400 ìã; ðàñòâîð äëÿ   │Polfa (Ïîëüøà)                │2599,         

                                                                                          │èíúåêöèé (àìïóëû) 1 ã - 5 ìë                                │09.02.79,     

                                                                                                                                                      │21.06.90      

                                                                                                                                                                    

│Íîîòðîïèë [Ïèðàöåòàì]                             │íîîòðîïíîå ñðåäñòâî [N06BX03]           │êàïñóëû 400 ìã; ðàñòâîð äëÿ   │Ucb SA (Áåëüãèÿ)              │00401,        

                                                                                          │èíúåêöèé (àìïóëû) 1 ã - 5 ìë                                │05.10.90,     

                                                                                                                                                      │24.12.76      

                                                                                                                                                                    

│Íîîòðîïèë [Ïèðàöåòàì]                             │íîîòðîïíîå ñðåäñòâî [N06BX03]           │òàáëåòêè 800, 1200 ìã;        │Ucb SA (Áåëüãèÿ)              │003725,       

                                                                                          │ðàñòâîð îðàëüíûé (ôëàêîíû)                                  │24.02.94      

                                                                                          │20%, 33%; ðàñòâîð äëÿ èíôóçèé │                                            

                                                                                          │12 ã - 60 ìë                                                              

                                                                                                                                                                    

│Íîïàí [Áóïðåíîðôèí]                               │àíàëüãåòè÷åñêîå íàðêîòè÷åñêîå ñðåäñòâî  │òàáëåòêè ñóáëèíãâàëüíûå 0.2 ìã│Cts Chemical Industries Ltd   │006995,       

                                                  │[N02AE01]                                                             │(Èçðàèëü)                     │18.01.96      

                                                                                                                                                                    

│Íîðáàêòèí [Íîðôëîêñàöèí]                          │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Ranbaxy Laboratories Ltd      │002845,       

                                                  │[J01MA06]                                                             │(Èíäèÿ)                       │15.02.93      

                                                                                                                                                                    

│Íîðâàñê [Àìëîäèïèí]                               │ÁÌÊÊ [C08CA01]                          │òàáëåòêè 5, 10 ìã             │Pfizer Corporation (Áåëüãèÿ)  │002865,       

                                                                                                                                                      │22.02.93      

                                                                                                                                                                    

│Íîðâàñê [Àìëîäèïèí]                               │ÁÌÊÊ [C08CA01]                          │òàáëåòêè 5 ìã                 │Pfizer Pt (Èíäîíåçèÿ)         │006168,       

                                                                                                                                                      │13.05.95      

                                                                                                                                                                    

│Íîðãàëàêñ [Äîêóçàò íàòðèÿ]                        │ñëàáèòåëüíîå ñðåäñòâî [A06AA02]         │ãåëü (ìèíè-êëèçìû)            │Laboratoires Norgan (Ôðàíöèÿ) │006029,       

                                                                                                                                                      │04.05.95      

                                                                                                                                                                    

│Íîðäèòðîïèí [Ñîìàòðîïèí]                          │ñîìàòîòðîïíûé ãîðìîí [H01AC01]          │ëèîôèëèç.ïîðîøîê äëÿ          │Novo Nordisk (Äàíèÿ)          │006428,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │21.08.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 4 ÌÅ/ìë,                                               

                                                                                          │12 ÌÅ/ìë /â êîìïëåêòå ñ                                                   

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Íîðäèòðîïèí ïåíñåò [Ñîìàòðîïèí]                   │ñîìàòîòðîïíûé ãîðìîí [H01AC01]          │ëèîôèëèç.ïîðîøîê äëÿ          │Novo Nordisk (Äàíèÿ)          │006427,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │21.08.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 12 ÌÅ/2                                                

                                                                                          │ìë, 24 ÌÅ/2 ìë /â êîìïëåêòå ñ │                                             

                                                                                          │íîðäèäæåêò 12, 24/                                                        

                                                                                                                                                                    

│Íîðåòèí 1/35Å {íîðýòèíîäðåë 1 ìã, ýòèíèëýñòðàäèîë │êîíòðàöåïòèâíîå ñðåäñòâî [G03FA09]      │òàáëåòêè                      │Schiapparelli Searle (ÑØÀ)    │002439,        

│0.035 ìã}                                                                                                                                             │31.01.92      

                                                                                                                                                                    

│Íîðèëåò [Íîðôëîêñàöèí]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 200, 400 ìã          │Dr.Reddy's Laboratories Ltd   │003294,       

                                                  │[J01MA06]                                                             │(Èíäèÿ)                       │02.09.93      

                                                                                                                                                                    

│Íîðèíèë {íîðýòèñòåðîí 1 ìã, ìåñòðàíîë 50 ìã}      │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA05]      │òàáëåòêè                      │Syntex Laboratories Inc (ÑØÀ) │002390,       

                                                                                                                                                      │29.01.92      

                                                                                                                                                                    

│Íîðèòèñ [Íàïðîêñåí]                               │ÍÏÂÑ [M01AE02]                          │òàáëåòêè                      │Cadila Laboratories Ltd       │01625, 09.06.89│

                                                                                                                        │(Èíäèÿ)                                     

                                                                                                                                                                    

│Íîðêîëóò [Íîðýòèñòåðîí]                           │ïðîãåñòàãåí [G03DC02]                   │òàáëåòêè                      │Gedeon Richter (Âåíãðèÿ)      │2600,         

                                                                                                                                                      │11.04.79,     

                                                                                                                                                      │12.04.90      

                                                                                                                                                                    

│Íîðêóðîí [Âåêóðîíèÿ áðîìèä]                       │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03AC03]     │ëèîôèëèç.ïîðîøîê äëÿ          │Gedeon Richter (ÂÍÐ)          │2927, 24.05.89 │

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                               

                                                                                          │ðàñòâîðà (ôëàêîíû) 4 ìã /â                                                

                                                                                          │êîìïëåêòå ñ ðàñòâîðèòåëåì -                                               

                                                                                          │àìïóëû 1 ìë/                                                              

                                                                                                                                                                    

│Íîðìàçå [Ëàêòóëîçà]                               │ñëàáèòåëüíîå ñðåäñòâî [A06AD11]         │ñèðîï                         │Inalco (Èòàëèÿ)               │01854, 31.05.90│

                                                                                                                                                                    

│Íîðìàçå [Ëàêòóëîçà]                               │ñëàáèòåëüíîå ñðåäñòâî [A06AD11]         │ñèðîï                         │Molteni (Èòàëèÿ)              │002323,       

                                                                                                                                                      │13.01.92      

                                                                                                                                                                    

│Íîðìàêñ [Íîðôëîêñàöèí]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã; êàïëè        │Ipca Laboratories Ltd (Èíäèÿ) │006751,       

                                                  │[J01MA06][S01AX12][S02AA]               │ãëàçíûå (ôëàêîíû); êàïëè                                    │26.10.95      

                                                                                          │óøíûå (ôëàêîíû)                                                           

                                                                                                                                                                    

│Íîðìàòåíñ {äèãèäðîýðãîêðèñòèí 0.5 ìã, ðåçåðïèí    │ãèïîòåíçèâíîå êîìáèíèðîâàííîå ñðåäñòâî  │äðàæå                         │Polfa (Ïîëüøà)                │002769,       

│0.1 ìã, êëîïàìèä 5 ìã}                            │[C02LA51]                                                                                           │17.12.92      

                                                                                                                                                                    

│Íîðìîê [Áðîìàçåïàì]                               │òðàíêâèëèçàòîð [N05BA08]                │òàáëåòêè 6 ìã                 │Ludwig Merckle GmbH (Àâñòðèÿ) │005681,       

                                                                                                                                                      │24.01.95      

                                                                                                                                                                    

│Íîðìîëèï [Ãåìôèáðîçèë]                            │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AC04]   │êàïñóëû 300 ìã                │Sun Pharmaceutical Industries │003051,       

                                                                                                                        │Ltd (Èíäèÿ)                   │08.06.93      

                                                                                                                                                                    

│Íîðìîñàíã [Ãåìèí] {ãåìèí 25 ìã, àðãèíèí 26.7 ìã}  │ñðåäñòâî äëÿ ëå÷åíèÿ îñòðîé ïîðôèðèè    │êîíöåíòðàò äëÿ ïðèãîòîâëåíèÿ  │Leiras (Ôèíëÿíäèÿ)            │002375,       

                                                  │[B06AB]                                 │èíôóçèîííîãî ðàñòâîðà 25 ìã/ìë│                              │28.01.92      

                                                                                                                                                                    

│Íîðîêñèí [Íîðôëîêñàöèí]                           │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Merck Sharp & Dohme           │006367,       

                                                  │[J01MA06]                                                             │(Ãîëëàíäèÿ)                   │08.08.95      

                                                                                                                                                                    

│Íîðïëàíò [Ëåâîíîðãåñòðåë]                         │ïðîãåñòàãåí [G03AC03]                   │êàïñóëû äëÿ èìïëàíòàöèé ïîä   │Leiras (Ôèíëÿíäèÿ)            │002311,       

                                                                                          │êîæó 36 ìã                                                  │29.12.91      

                                                                                                                                                                    

│Íîðïðîëàê [Õèíàãîëèä]                             │äîôàìèí-ñòèìóëÿòîð [G02CB04]            │òàáëåòêè 25, 50, 75, 150 ìêã  │Sandoz Pharma Ltd (Øâåéöàðèÿ) │007547,       

                                                                                                                                                      │28.05.96      

                                                                                                                                                                    

│Íîðôèí [Áóïðåíîðôèí]                              │àíàëüãåòè÷åñêîå íàðêîòè÷åñêîå ñðåäñòâî  │òàáëåòêè ñóáëèíãâàëüíûå 0.2 ìã│Unichem Laboratories Ltd      │002132,       

                                                  │[N02AE01]                                                             │(Èíäèÿ)                       │24.05.91      

                                                                                                                                                                    

│Íîðôëîêñ [Íîðôëîêñàöèí]                           │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Cipla Ltd (Èíäèÿ)             │002415,        

                                                  │[J01MA06]                                                                                           │31.01.92      

                                                                                                                                                                    

│Íîðôëîêñàöèí [Íîðôëîêñàöèí]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Gama Ltd (Ãðóçèÿ)             │007383,        

                                                  │[J01MA06]                                                                                           │01.04.96      

                                                                                                                                                                    

│Íîðôëîêñàöèí [Íîðôëîêñàöèí]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400 ìã               │Mesco Laboratories Ltd (Èíäèÿ)│003696,       

                                                  │[J01MA06]                                                                                           │15.02.94      

                                                                                                                                                                    

│Íîðôëîêñàöèí [Íîðôëîêñàöèí]                       │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 400, 800 ìã          │Wave International (Èíäèÿ)    │003546,       

                                                  │[J01MA06]                                                                                           │06.12.93      

                                                                                                                                                                    

│Íîðýòèñòåðîí [Íîðýòèñòåðîí]                       │ïðîãåñòàãåí [G03DC02]                   │äðàæå 0.5, 5 ìã               │Jenapharm GmbH (ÔÐÃ)          │00716,        

                                                                                                                                                      │19.03.92,     

                                                                                                                                                      │24.09.79      

                                                                                                                                                                    

│ÍÏÕ Èëåòèí II [Èíñóëèí-ÑðÄ] {èíñóëèí              │èíñóëèí ñðåäíåãî äåéñòâèÿ [A10AA02]     │ñóñïåíçèÿ äëÿ èíúåêöèé        │Eli Lilly & Elanco (ÑØÀ)      │02033, 28.12.90│

│èçîôàí-ïðîòàìèí, ìîíîêîìïîíåíòíûé ñâèíîé}                                                 │(ôëàêîíû) 40 ÅÄ/ìë - 10 ìë,                                               

                                                                                          │100 ÅÄ/ìë - 10 ìë                                                         

                                                                                                                                                                    

│Íóâèð [Òåñòîñòåðîí]                               │àíäðîãåí [G03BA03]                      │êàïñóëû 40 ìã                 │Infar (india) Ltd (Èíäèÿ)     │005571,       

                                                                                                                                                      │15.12.94      

                                                                                                                                                                    

│Íüþ-àñïåð [Àöåòèëñàëèöèëîâàÿ êèñëîòà]             │ÍÏÂÑ [N02BA01]                          │òàáëåòêè 500 ìã               │Specifar (Ãðåöèÿ)             │003524,       

                                                                                                                                                      │25.11.93      

                                                                                                                                                                    

│Îáçèäàí [Ïðîïðàíîëîë]                             │áåòà-àäðåíîáëîêàòîð [C07AA05]           │òàáëåòêè 40 ìã                │Isis Pharma GmbH (ÔÐÃ)        │00154,        

                                                                                                                                                      │14.07.71,     

                                                                                                                                                      │18.05.84,     

                                                                                                                                                      │29.06.94      

                                                                                                                                                                    

│Îáçèäàí [Ïðîïðàíîëîë]                             │áåòà-àäðåíîáëîêàòîð [C07AA05]           │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Isis-Chemie GmbH (ÔÐÃ)        │002593,       

                                                                                          │5 ìã - 5 ìë                                                 │07.08.92      

                                                                                                                                                                    

│Îâåñòèí [Ýñòðèîë]                                 │ýñòðîãåí [G03CA04]                      │òàáëåòêè                      │Organon (Íèäåðëàíäû)          │00374,        

                                                                                                                                                      │03.12.75,     

                                                                                                                                                      │05.10.90      

                                                                                                                                                                    

│Îâåñòèí [Ýñòðèîë]                                 │ýñòðîãåí [G03CA04]                      │êðåì âàãèíàëüíûé 1 ìã/ã;      │Organon (Íèäåðëàíäû)          │005630,       

                                                                                          │ñâå÷è âàãèíàëüíûå 0.5 ìã                                    │10.01.95      

                                                                                                                                                                    

│Îâåñòèí [Ýñòðèîë]                                 │ýñòðîãåí [G03CA04]                      │òàáëåòêè 2 ìã                 │Organon (Íèäåðëàíäû)          │002382,       

                                                                                                                                                      │28.01.92      

                                                                                                                                                                    

│Îâèäîí {íîðãåñòðåë 0.25 ìã, ýòèíèëýñòðàäèîë 0.05  │êîíòðàöåïòèâíîå ñðåäñòâî [G03AA06]      │òàáëåòêè                      │Gedeon Richter (Âåíãðèÿ)      │2616,         

│ìã}                                                                                                                                                   │12.04.90,     

                                                                                                                                                      │27.11.79      

                                                                                                                                                                    

│Îâðåò [Íîðãåñòðåë]                                │ïðîãåñòàãåí [G03AC]                     │òàáëåòêè                      │Wyeth Ayerst (ÑØÀ)            │005162,       

                                                                                                                                                      │21.07.94      

                                                                                                                                                                    

│Îäåñòîí [Ãèìåêðîìîí]                              │æåë÷åãîííîå ñðåäñòâî [A05AX02]          │òàáëåòêè 200 ìã               │Polfa (Ïîëüøà)                │2861, 12.03.87 │

                                                                                                                                                                    

│Îéêàìèä [Ïèðàöåòàì]                               │íîîòðîïíîå ñðåäñòâî [N06BX03]           │êàïñóëû 400 ìã; ðàñòâîð äëÿ   │Pliva SA (Õîðâàòèÿ)           │006125,       

                                                                                          │èíúåêöèé (àìïóëû) 1 ã - 5 ìë                                │30.05.95      

                                                                                                                                                                    

│Îêñàäîë [Íåôîïàì]                                 │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 30 ìã; ðàñòâîð äëÿ   │Farmatrade (Âåëèêîáðèòàíèÿ)   │007455,       

                                                  │ñðåäñòâî [N02BG06]                      │èíúåêöèé (àìïóëû) 20 ìã/ìë                                  │18.04.96      

                                                                                                                                                                     

│Îêñàäîë [Íåôîïàì]                                 │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 30 ìã; ðàñòâîð äëÿ   │I.S.I. Spa (Èòàëèÿ)           │007455,       

                                                  │ñðåäñòâî [N02BG06]                      │èíúåêöèé (àìïóëû) 20 ìã/ìë                                  │18.04.96      

                                                                                                                                                                     

│Îêñàçåïàì [Îêñàçåïàì]                             │òðàíêâèëèçàòîð [N05BA04]                │òàáëåòêè 10 ìã                │Polfa, Poznanskie Zaklady     │006591,       

                                                                                                                        │Farmaceutyczne SA (Ïîëüøà)    │02.11.95      

                                                                                                                                                                     

│Îêñàçåïàì-Ðàòèîôàðì [Îêñàçåïàì]                   │òðàíêâèëèçàòîð [N05BA04]                │òàáëåòêè 10, 50 ìã            │Ratiopharm GmbH & Co          │003778,       

                                                                                                                        │(Ãåðìàíèÿ)                    │23.03.94      

                                                                                                                                                                     

│Îêñèáðàë [Âèíêàìèí] {áàðâèíêà ìàëîãî àëêàëîèä}    │ãèïîòåíçèâíîå êîìáèíèðîâàííîå ñðåäñòâî  │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Amoun Pharmaceutical          │003616,       

                                                  │[C04AX07]                               │7.5 ìã/ìë; ñèðîï (ôëàêîíû) 10 │Industries Co, Apic (Åãèïåò)  │24.12.93      

                                                                                          │ìã|5 ìë                                                                   

                                                                                                                                                                    

│Îêñèáðàë ÑÐ [Âèíêàìèí] {áàðâèíêà ìàëîãî àëêàëîèä} │ãèïîòåíçèâíîå êîìáèíèðîâàííîå ñðåäñòâî  │êàïñóëû çàìåäëåííîãî          │Amoun Pharmaceutical          │003263,       

                                                  │[C04AX07]                               │âûñâîáîæäåíèÿ 30 ìã           │Industries Co, Apic (Åãèïåò)  │24.08.93      

                                                                                                                                                                    

│Îêñèâåíò [Îêñèòðîïèÿ áðîìèä]                      │ì-õîëèíîáëîêàòîð [R03BB02]              │àýðîçîëü äîçèðîâàííûé         │Boehringer Ingelheim          │005684,       

                                                                                          │(ôëàêîíû) 0.1 ìã|äîçà - 15 ìë │International GmbH (Ãåðìàíèÿ) │24.01.95      

                                                                                                                                                                    

│Îêñèêîðò {ãèäðîêîðòèçîí 10 ìã, îêñèòåòðàöèêëèí 30 │ãëþêîêîðòèêîñòåðîèä+ïðîòèâîìèêðîáíîå    │ìàçü                          │Jelfa SA (Ïîëüøà)             │006649,       

│ìã - 1 ã}                                         │ñðåäñòâî [D07CA01]                                                                                  │22.02.96      

                                                                                                                                                                    

│Îêñèêîðò {ãèäðîêîðòèçîí 10 ìã, îêñèòåòðàöèêëèí 30 │ãëþêîêîðòèêîñòåðîèä+ïðîòèâîìèêðîáíîå    │àýðîçîëü (ôëàêîíû) 75 ã       │Polfa, Tarchominskie Zaklady  │006640,       

│ìã - 1 ã}                                         │ñðåäñòâî [D07CA01]                                                    │Farmaceutyczne SA (Ïîëüøà)    │08.02.96      

                                                                                                                                                                    

│Îêñèòîöèí [Îêñèòîöèí]                             │ðîäîâîé äåÿòåëüíîñòè ñòèìóëÿòîð,        │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Gedeon Richter (Âåíãðèÿ)      │2085,         

                                                  │ïðåïàðàò îêñèòîöèíà [H01BB02]           │5 ÌÅ - 1 ìë                                                 │01.07.70,     

                                                                                                                                                      │22.05.84,     

                                                                                                                                                      │27.02.95      

                                                                                                                                                                    

│Îêñîðàëåí óëüòðà [Ìåòîêñàëåí]                     │ôîòîñåíñèáèëèçèðóþùåå ñðåäñòâî [D05AD02]│êàïñóëû 10 ìã                 │ICN-Galenika (Þãîñëàâèÿ)      │003334,       

                                                                                                                                                      │14.09.93      

                                                                                                                                                                    

│Îêòàâè [Ôàêòîð ñâåðòûâàíèÿ êðîâè VIII è IX â      │ãåìîñòàòè÷åñêîå ñðåäñòâî [B02BD]        │ëèîôèëèç.ïîðîøîê äëÿ          │Octapharma AG (Øâåéöàðèÿ)     │005378,       

│êîìáèíàöèè] {ôàêòîð ñâåðòûâàíèÿ êðîâè VIII}                                               │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │04.10.94      

                                                                                          │ðàñòâîðà (ôëàêîíû) 250, 500,                                              

                                                                                          │1000 ÌÅ /â êîìïëåêòå ñ                                                    

                                                                                          │ðàñòâîðèòåëåì/                                                            

                                                                                                                                                                    

│Îêòàãàì [Èììóíîãëîáóëèí (â/â ââåäåíèå)]           │èììóíîñòèìóëÿòîð [J06BA02]              │ðàñòâîð äëÿ èíúåêöèé          │Octapharma AG (Øâåéöàðèÿ)     │006355,       

                                                                                          │(ôëàêîíû) 2.5, 5, 10 ã                                      │07.08.95      

                                                                                                                                                                    

│Îêòàíàéí [Ôàêòîð ñâåðòûâàíèÿ êðîâè IX] {ôàêòîð    │ãåìîñòàòè÷åñêîå ñðåäñòâî [B02BD04]      │ëèîôèëèç.ïîðîøîê äëÿ          │Octapharma AG (Øâåéöàðèÿ)     │005754,       

│ñâåðòûâàíèÿ êðîâè IX}                                                                     │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │15.02.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 250, 500,                                              

                                                                                          │1000 ÌÅ                                                                   

                                                                                                                                                                    

│Îêòåíèñåïò                                        │àíòèñåïòè÷åñêîå ñðåäñòâî [D08A]         │ðàñòâîð äëÿ íàðóæíîãî         │Schulke & Mayr (Ãåðìàíèÿ)     │003997,       

                                                                                          │ïðèìåíåíèÿ (ôëàêîíû) 0.25,                                  │14.06.94      

                                                                                          │0.45, 1 ë                                                                 

                                                                                                                                                                    

│Îêòèëèÿ [Òåòðèçîëèí]                              │âàçîêîíñòðèêòîðíîå ñðåäñòâî [S01GA02]   │êàïëè ãëàçíûå                 │S.I.F.I. Spa (Èòàëèÿ)         │01924, 19.07.90│

                                                                                                                                                                    

│Îêóìåä [Òèìîëîë]                                  │áåòà-àäðåíîáëîêàòîð [S01ED01]           │êàïëè ãëàçíûå (ôëàêîíû)       │Promed Exports Pvt Ltd (Èíäèÿ)│006190,       

                                                                                          │0.25%, 0.5%                                                 │15.06.95      

                                                                                                                                                                    

│Îêóìîë [Òèìîëîë]                                  │áåòà-àäðåíîáëîêàòîð [S01ED01]           │êàïëè ãëàçíûå (ôëàêîíû)       │Cipla Ltd (Èíäèÿ)             │006385,       

                                                                                          │0.25%, 0.5%                                                 │09.08.95       

                                                                                                                                                                    

│Îêóìîë [Òèìîëîë]                                  │áåòà-àäðåíîáëîêàòîð [S01ED01]           │êàïëè ãëàçíûå (ôëàêîíû)       │Wave International (Èíäèÿ)    │003995,       

                                                                                          │0.25%, 0.5%                                                 │14.06.94       

                                                                                                                                                                    

│Îêóïðåñ-Å [Òèìîëîë]                               │áåòà-àäðåíîáëîêàòîð [S01ED01]           │êàïëè ãëàçíûå 0.25%, 0.5%     │Cadila Laboratories Ltd       │01541, 27.01.89│

                                                                                                                        │(Èíäèÿ)                                      

                                                                                                                                                                    

│Îêóðèë [Òèìîëîë]                                  │áåòà-àäðåíîáëîêàòîð [S01ED01]           │êàïëè ãëàçíûå 0.25%, 0.5%     │Rusan Pharma (Èíäèÿ)          │005505,       

                                                                                                                                                      │17.11.94      

                                                                                                                                                                    

│Îêóôëþð [Ôëóðáèïðîôåí]                            │ÍÏÂÑ [S01BC04]                          │ðàñòâîð îôòàëüìîëîãè÷åñêèé    │Pharm-Allergan GmbH (Ãåðìàíèÿ)│006033,       

                                                                                          │(ôëàêîíû) 0.03%                                             │06.05.95      

                                                                                                                                                                    

│Îêóôëþð ëèêâèôèëì [Ôëóðáèïðîôåí]                  │ÍÏÂÑ [S01BC04]                          │êàïëè ãëàçíûå (ôëàêîíû) 0.03% │Krka (Ñëîâåíèÿ)               │006316,       

                                                                                                                                                      │26.07.95      

                                                                                                                                                                    

│Îëäîí {àöåòèëñàëèöèëîâàÿ êèñëîòà 0.3 ã,           │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Zdravle (Þãîñëàâèÿ)           │003653,       

│ïàðàöåòàìîë 0.1 ã, êîôåèí 50 ã}                   │ñðåäñòâî [N02BA51]                                                                                  │31.01.94      

                                                                                                                                                                    

│Îëåàíäàöåòèë [Îëåàíäîìèöèí]                       │àíòèáèîòèê, ìàêðîëèä [J01FA05]          │ãðàíóëû äëÿ ïðèãîòîâëåíèÿ     │Pharmachim (ÍÐÁ)              │2325,         

                                                                                          │îðàëüíîé ñóñïåíçèè (ôëàêîíû)                                │07.05.73,     

                                                                                          │1500000 ÌÅ - 30 ã                                           │31.01.91      

                                                                                                                                                                    

│Îëåàíäîìèöèí [Îëåàíäîìèöèí]                       │àíòèáèîòèê, ìàêðîëèä [J01FA05]          │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Pharmachim (Áîëãàðèÿ)         │2322,         

                                                                                          │èíúåêöèîííîãî ðàñòâîðà                                      │07.05.73,     

                                                                                          │(ôëàêîíû) 250, 500 ìã                                       │10.11.85      

                                                                                                                                                                    

│Îëèâèí [Ýíàëàïðèë]                                │ÀÊÔ áëîêàòîð [C09AA02]                  │òàáëåòêè 10, 20 ìã            │Lek (Ñëîâåíèÿ)                │002397,       

                                                                                                                                                      │29.01.92      

                                                                                                                                                                    

│Îëèêàðä [Èçîñîðáèä ìîíîíèòðàò]                    │âàçîäèëàòèðóþùåå ñðåäñòâî [C01DA14]     │êàïñóëû ðåòàðä 40, 60 ìã      │Giulini Pharma GmbH (ÔÐÃ)     │01997, 23.10.90│

                                                                                                                                                                    

│Îëüáåòàì [Àöèïèìîêñ]                              │ãèïîëèïèäåìè÷åñêîå ñðåäñòâî [B04AX03]   │êàïñóëû 250 ìã                │Farmitalia Carlo Erba (Èòàëèÿ)│002816,       

                                                                                                                                                      │19.01.93      

                                                                                                                                                                    

│Îìåç [Îìåïðàçîë]                                  │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîòîííîãî    │êàïñóëû 20 ìã                 │Dr.Reddy's Laboratories Ltd   │002551,       

                                                  │íàñîñà èíãèáèòîð [A02BC01]                                            │(Èíäèÿ)                       │14.07.92      

                                                                                                                                                                    

│Îìåçîë [Îìåïðàçîë]                                │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîòîííîãî    │êàïñóëû 20 ìã                 │Alkaloid (Ìàêåäîíèÿ)          │005592,       

                                                  │íàñîñà èíãèáèòîð [A02BC01]                                                                          │21.12.94      

                                                                                                                                                                    

│Îìåïàð [Îìåïðàçîë]                                │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîòîííîãî    │êàïñóëû 20 ìã                 │Dee-Pharma Ltd (Èíäèÿ)        │006516,       

                                                  │íàñîñà èíãèáèòîð [A02BC01]                                                                          │20.09.95      

                                                                                                                                                                    

│Îìåïðîë [Îìåïðàçîë]                               │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîòîííîãî    │êàïñóëû 20 ìã                 │Zdravle (Þãîñëàâèÿ)           │002796,       

                                                  │íàñîñà èíãèáèòîð [A02BC01]                                                                          │12.01.93      

                                                                                                                                                                    

│Îìèçàê [Îìåïðàçîë]                                │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîòîííîãî    │êàïñóëû 20 ìã                 │Torrent Exports Ltd (Èíäèÿ)   │005009,       

                                                  │íàñîñà èíãèáèòîð [A02BC01]                                                                          │16.06.94      

                                                                                                                                                                    

│Îìíàäðåí 250 [Òåñòîñòåðîí] {òåñòîñòåðîí ïðîïèîíàò │àíäðîãåí [G03BA03]                      │ðàñòâîð äëÿ èíúåêöèé ìàñëÿíûé │Jelfa SA (Ïîëüøà)             │006617,       

│30 ìã, òåñòîñòåðîí ôåíèëïðîïèîíàò 60 ìã,                                                  │(àìïóëû) 1 ìë                                               │29.12.95      

│òåñòîñòåðîí èçîêàïðîíàò 60 ìã, òåñòîñòåðîí                                                                                                                          

│êàïðîíàò 0.1 ã, áåíçèëîâûé ñïèðò 50 ã - 1 ìë}                                                                                                                       

                                                                                                                                                                    

│Îíêîêðèñòèí [Âèíêðèñòèí] {áàðâèíêà ðîçîâîãî       │öèòîñòàòè÷åñêîå ñðåäñòâî [L01CA02]      │ðàñòâîð äëÿ âíóòðèâåííîãî     │Tamilnadu Dadha               │003048,       

│àëêàëîèä}                                                                                 │ââåäåíèÿ 1 ìã/ìë              │Pharmaceuticals Ltd (Èíäèÿ)   │08.06.93      

                                                                                                                                                                     

│Îíêîïëàòèí [Öèñïëàòèí]                            │öèòîñòàòè÷åñêîå ñðåäñòâî [L01XA01]      │ðàñòâîð äëÿ èíúåêöèé          │Tamilnadu Dadha               │003336,       

                                                                                          │(ôëàêîíû) 0.5 ìã/ìë - 20, 100 │Pharmaceuticals Ltd (Èíäèÿ)   │16.09.93      

                                                                                          │ìë                                                                         

                                                                                                                                                                    

│Îïàêîðäýí [Àìèîäàðîí]                             │àíòèàðèòìè÷åñêîå ñðåäñòâî [C01BD01]     │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Polfa, Starogardzkie Zaklady  │006870,       

                                                                                          │200 ìã                        │Farmaceutyczne SA (Ïîëüøà)    │01.12.95      

                                                                                                                                                                    

│Îïèíî ãåëü {áóôåíèí, ýñöèí}                       │âåíîòîíèçèðóþùåå ñðåäñòâî [C05CX]       │æåëå                          │Krka (ÑÔÐÞ)                   │00756,        

                                                                                                                                                      │16.05.80,     

                                                                                                                                                      │22.11.91      

                                                                                                                                                                    

│Îïèíî ðåòàðä {áóôåíèí, ýñöèí}                     │âåíîòîíèçèðóþùåå ñðåäñòâî [C05CX]       │äðàæå                         │Krka (ÑÔÐÞ)                   │00757,        

                                                                                                                                                      │16.05.80,     

                                                                                                                                                      │22.11.91      

                                                                                                                                                                    

│Îïðàäîë [Ïàðàöåòàìîë]                             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Tata Pharma (Èíäèÿ)           │002126,       

                                                  │ñðåäñòâî [N02BE01]                                                                                  │23.05.91      

                                                                                                                                                                    

│Îïòàëüãèí-Òåâà [Ìåòàìèçîë íàòðèÿ]                 │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã; ðàñòâîð äëÿ  │Teva Pharmaceutical           │005653,       

                                                  │ñðåäñòâî [N02BB02]                      │èíúåêöèé (àìïóëû) 1 ã - 2 ìë; │Industries Ltd (Èçðàèëü)      │16.01.95      

                                                                                          │êàïëè (ôëàêîíû) 500 ìã/ìë                                                 

                                                                                                                                                                    

│Îïòèêðîì [Êðîìîãëèöèåâàÿ êèñëîòà] {êðîìîãëèêàò    │ïðîòèâîàëëåðãè÷åñêîå ñðåäñòâî [S01GX01] │êàïëè ãëàçíûå 2%              │Fisons (Ôðàíöèÿ)              │006780,       

│äèíàòðèÿ}                                                                                                                                             │01.11.95      

                                                                                                                                                                    

│Îïòèìîë [Òèìîëîë]                                 │áåòà-àäðåíîáëîêàòîð [S01ED01]           │êàïëè ãëàçíûå 0.25%, 0.5%     │Sun Pharmaceutical Industries │006536,       

                                                                                                                        │Ltd (Èíäèÿ)                   │21.09.95      

                                                                                                                                                                    

│Îðàáåò [Òîëáóòàìèä]                               │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 500 ìã               │Berlin-Chemie AG (Ãåðìàíèÿ)   │007177,       

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BB03]                                                                       │09.04.96      

                                                                                                                                                                    

│Îðàíèë [Êàðáóòàìèä]                               │ñàõàðîñíèæàþùåå ñðåäñòâî äëÿ            │òàáëåòêè 500 ìã               │Berlin-Chemie Feb (ÃÄÐ)       │00137,        

                                                  │ïåðîðàëüíîãî ïðèåìà [A10BB06]                                                                       │13.06.84,     

                                                                                                                                                      │14.07.71      

                                                                                                                                                                    

│Îðàï [Ïèìîçèä]                                    │íåéðîëåïòè÷åñêîå ñðåäñòâî [N05AG02]     │òàáëåòêè 1 ìã, 4 ìã           │Gedeon Richter (Âåíãðèÿ)      │2706,         

                                                                                                                                                      │06.12.82,     

                                                                                                                                                      │12.10.94      

                                                                                                                                                                    

│Îðàñàí {íàòðèÿ õëîðèä 3.5 ã, íàòðèÿ öèòðàò 2.9 ã, │ðåãèäðàòèðóþùåå ñðåäñòâî [A07CA]        │ïîðîøîê (ïàêåòû) 18.9 ã       │Sandoz Pharma (Øâåéöàðèÿ)     │002616,       

│êàëèÿ õëîðèä 2.5 ã, ãëþêîçà 10.9 ã}                                                                                                                   │10.09.92      

                                                                                                                                                                    

│Îðàöåô [Öåôàëåêñèí]                               │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250, 500 ìã; ïîðîøîê  │Krka (Ñëîâåíèÿ)               │002940,       

                                                                                          │äëÿ ïðèãîòîâëåíèÿ ñóñïåíçèè                                 │30.03.93      

                                                                                          │250 ìã|5 ìë                                                               

                                                                                                                                                                    

│Îðâàãèë [Ìåòðîíèäàçîë]                            │ïðîòèâîìèêðîáíîå ñðåäñòâî               │òàáëåòêè 250 ìã; òàáëåòêè     │ICN-Galenika (Þãîñëàâèÿ)      │006960,       

                                                  │[G01AF01][J01XD01]                      │âàãèíàëüíûå 500 ìã                                          │09.01.96      

                                                                                                                                                                    

│Îðãàìåòðèë [Ëèíåñòðåíîë]                          │ïðîãåñòàãåí [G03DC03]                   │òàáëåòêè                      │Organon (Íèäåðëàíäû)          │00373,        

                                                                                                                                                      │03.12.75,     

                                                                                                                                                      │05.10.90      

                                                                                                                                                                    

│Îðåëîêñ [Öåôïîäîêñèì]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA33]      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Roussel Uclaf (Ôðàíöèÿ)       │003908,       

                                                                                          │100 ìã                                                      │12.05.94      

                                                                                                                                                                    

│Îðèçîëèí [Öåôàçîëèí]                              │àíòèáèîòèê, öåôàëîñïîðèí [J01DA04]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Cadila Laboratories Ltd       │003004,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Èíäèÿ)                       │26.05.93       

                                                                                          │(ôëàêîíû) 125, 500, 1000 ìã                                               

                                                                                                                                                                    

│Îðèìåòåí [Àìèíîãëþòåòèìèä]                        │ñòåðîèäîâ ñèíòåçà èíãèáèòîð [L02BG01]   │òàáëåòêè 250 ìã               │Ciba-Geigy (Øâåéöàðèÿ)        │01281, 22.05.86│

                                                                                                                                                                    

│Îðèïðèì [Êî-òðèìîêñàçîë] {ñóëüôàìåòîêñàçîë,       │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │òàáëåòêè; òàáëåòêè DS;        │Cadila Laboratories Ltd       │01089, 31.05.84│

│òðèìåòîïðèì}                                      │ñðåäñòâî [J01EE01]                      │ñóñïåíçèÿ äëÿ äåòåé           │(Èíäèÿ)                                      

                                                                                                                                                                    

│Îðèïðèì-Ï {ïîëèìèêñèí}                            │ïðîòèâîìèêðîáíîå êîìáèíèðîâàííîå        │êàïëè ãëàçíûå                 │Cadila Laboratories Ltd       │002091,       

                                                  │ñðåäñòâî [S01AA30]                                                    │(Èíäèÿ)                       │27.03.91      

                                                                                                                                                                    

│Îðèòàêñèì [Öåôîòàêñèì]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA10]      │ïîðîøîê äëÿ ïðèãîòîâëåíèÿ     │Cadila Laboratories Ltd       │002996,       

                                                                                          │èíúåêöèîííîãî ðàñòâîðà        │(Èíäèÿ)                       │26.05.93      

                                                                                          │(ôëàêîíû) 250, 500, 1000 ìã                                               

                                                                                                                                                                    

│Îðìèäîë [Àòåíîëîë]                                │áåòà1-àäðåíîáëîêàòîð ñåëåêòèâíûé        │òàáëåòêè 100 ìã               │Podravka-Belupo (ÑÔÐÞ)        │01937, 07.08.90│

                                                  │[C07AB03]                                                                                                         

                                                                                                                                                                    

│Îðíèä [Îôëîêñàöèí]                                │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │ðàñòâîð äëÿ èíôóçèé 200 ìã -  │Unique Pharmaceutical         │006438,       

                                                  │[J01MA01]                               │100 ìë                        │Laboratories (Èíäèÿ)          │28.08.95      

                                                                                                                                                                    

│Îðíèöåòèë [Îðíèòèí]                               │ãèïîàçîòåìè÷åñêîå ñðåäñòâî [A05BA]      │ëèîôèëèç.ïîðîøîê äëÿ          │Alkaloid (ÑÔÐÞ)               │00454,        

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî                                 │02.02.77,     

                                                                                          │ðàñòâîðà (ôëàêîíû)2 ã, 5 ã                                  │15.02.91      

                                                                                                                                                                    

│Îðîíàçîë [Êåòîêîíàçîë]                            │ïðîòèâîãðèáêîâîå ñðåäñòâî [J02AB02]     │òàáëåòêè 200 ìã               │Krka (ÑÔÐÞ)                   │01756, 13.02.90│

                                                                                                                                                                    

│Îðîöåòàì {ïèðàöåòàì 0.2 ã, îðîòîâàÿ êèñëîòà 10 ìã │íîîòðîïíîå ñðåäñòâî [N06BX]             │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Pharmachim (Áîëãàðèÿ)         │003875,       

│- 1 ìë}                                                                                   │5 ìë                                                        │26.04.94      

                                                                                                                                                                    

│Îðòàíîë [Îìåïðàçîë]                               │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîòîííîãî    │êàïñóëû 20 ìã                 │Lek D.D.Ljubljana (Ñëîâåíèÿ)  │005037,       

                                                  │íàñîñà èíãèáèòîð [A02BC01]                                                                          │24.06.94      

                                                                                                                                                                    

│Îðòîêëîí ÎÊÒ-3 [Ìóðîìîíàá-ÖÄ3]                    │èììóíîäåïðåññàíò [L04AA02]              │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Ortho-Pharmaceutical (ÑØÀ)    │005719,       

                                                                                          │1 ìã/ìë                                                     │06.02.95      

                                                                                                                                                                    

│Îðóíãàë [Èòðàêîíàçîë]                             │ïðîòèâîãðèáêîâîå ñðåäñòâî [J02AC02]     │êàïñóëû 100 ìã                │Janssen Pharmaceutica         │007546,       

                                                                                                                        │(Áåëüãèÿ)                     │28.05.96      

                                                                                                                                                                    

│Îñïàìîêñ [Àìîêñèöèëëèí]                           │àíòèáèîòèê, ïåíèöèëëèí øèðîêîãî ñïåêòðà │êàïñóëû 250 ìã; òàáëåòêè 500, │Biochemie GmbH (Àâñòðèÿ)      │003706,       

                                                  │[J01CA04]                               │1000 ìã; ãðàíóëû äëÿ                                        │18.02.94      

                                                                                          │ïðèãîòîâëåíèÿ îðàëüíîãî                                                   

                                                                                          │ðàñòâîðà 125 ìã|5 ìë, 250                                                 

                                                                                          │ìã|5 ìë                                                                   

                                                                                                                                                                    

│Îñïåêñèí [Öåôàëåêñèí]                             │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250, 500 ìã; òàáëåòêè │Biochemie GmbH (Àâñòðèÿ)      │003627,       

                                                                                          │ïîêðûòûå îáîëî÷êîé 500, 1000                                │17.01.94      

                                                                                          │ìã; ãðàíóëû äëÿ ïðèãîòîâëåíèÿ │                                            

                                                                                          │îðàëüíîãî ðàñòâîðà 125 ìã|5                                               

                                                                                          │ìë, 250 ìã|5 ìë                                                           

                                                                                                                                                                    

│Îñïåí [Ôåíîêñèìåòèëïåíèöèëëèí]                    │àíòèáèîòèê, ïåíèöèëëèí [J01CE02]        │êàïëè                         │Biochemie GmbH (Àâñòðèÿ)      │01409, 28.01.88│

                                                                                                                                                                    

│Îñïåí [Ôåíîêñèìåòèëïåíèöèëëèí]                    │àíòèáèîòèê, ïåíèöèëëèí [J01CE02]        │ñèðîï 750                     │Biochemie GmbH (Àâñòðèÿ)      │01409,        

                                                                                                                                                      │24.10.89,     

                                                                                                                                                      │28.01.88      

                                                                                                                                                                    

│Îñïåí [Ôåíîêñèìåòèëïåíèöèëëèí]                    │àíòèáèîòèê, ïåíèöèëëèí [J01CE02]        │òàáëåòêè 250, 500 ìã;         │Biochemie GmbH (Àâñòðèÿ)      │003628,       

                                                                                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé                                 │17.01.94       

                                                                                          │1, 1.5 ã; ñèðîï 400 ìã/ìë;                                                

                                                                                          │ãðàíóëû äëÿ ïðèãîòîâëåíèÿ                                                 

                                                                                          │îðàëüíîãî ðàñòâîðà 400 ìã/ìë                                               

                                                                                                                                                                    

│Îñïåí [Ôåíîêñèìåòèëïåíèöèëëèí]                    │àíòèáèîòèê, ïåíèöèëëèí [J01CE02]        │ñèðîï 750                     │Krka (ÑÔÐÞ)                   │01376,        

                                                                                                                                                      │16.09.87,     

                                                                                                                                                      │27.11.89      

                                                                                                                                                                    

│Îñïåí [Ôåíîêñèìåòèëïåíèöèëëèí]                    │àíòèáèîòèê, ïåíèöèëëèí [J01CE02]        │êàïëè                         │Krka (Þãîñëàâèÿ)              │01376, 16.09.87│

                                                                                                                                                                    

│Îññèí [Íàòðèÿ ôòîðèä]                             │ïðåïàðàò ôòîðà [A12CD01]                │äðàæå 40 ìã                   │Grunenthal GmbH (ÔÐÃ)         │00929,        

                                                                                                                                                      │03.08.82,     

                                                                                                                                                      │22.07.93      

                                                                                                                                                                    

│Îñòåîãåíîí {íàòðèÿ ôòîðèä, ãèäðîêñèàïàòèò}        │ðåãóëÿòîð îáìåíà êàëüöèÿ è ôîñôîðà      │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Robapharm AG (Øâåéöàðèÿ)      │005810,       

                                                  │[A12CX]                                 │800 ìã                                                      │09.03.95      

                                                                                                                                                                    

│Îñòåîõèí [Èïðèôëàâîí]                             │ðåãåíåðàöèè ñòèìóëÿòîð [M05BX01]        │òàáëåòêè 200 ìã               │Chinoin (Âåíãðèÿ)             │002093,       

                                                                                                                                                      │02.04.91      

                                                                                                                                                                    

│Îòèíóì [Õîëèí ñàëèöèëàò]                          │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │êàïëè óøíûå                   │Polfa (Ïîëüøà)                │2906, 21.09.88 │

                                                  │ñðåäñòâî [N02BA03]                                                                                                

                                                                                                                                                                    

│Îòèïàêñ {ôåíàçîí 4 ã, ëèäîêàèí 1}                 │ïðîòèâîâîñïàëèòåëüíîå ñðåäñòâî [S02D]   │êàïëè óøíûå                   │Laboratoires Biocodex         │003901,       

                                                                                                                        │(Ôðàíöèÿ)                     │10.05.94      

                                                                                                                                                                    

│Îòðèâèí [Êñèëîìåòàçîëèí]                          │àëüôà-àäðåíîñòèìóëÿòîð [R01AA07]        │êàïëè íàçàëüíûå âîäíûå 0.05%, │Ciba-Geigy (Øâåéöàðèÿ)        │003314,       

                                                                                          │0.1%                                                        │10.09.93      

                                                                                                                                                                    

│Îôëèí [Îôëîêñàöèí]                                │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │òàáëåòêè 200 ìã; ðàñòâîð äëÿ  │Dee-Pharma Ltd (Èíäèÿ)        │006514,       

                                                  │[J01MA01]                               │èíôóçèé (ôëàêîíû) 200 ìã/100                                │20.09.95      

                                                                                          │ìë                                                                        

                                                                                                                                                                    

│Îôëî [Îôëîêñàöèí]                                 │ïðîòèâîìèêðîáíîå ñðåäñòâî, ôòîðõèíîëîí  │ðàñòâîð äëÿ èíôóçèé 200 ìã -  │Unique Pharmaceutical         │006987,       

                                                  │[J01MA01]                               │100 ìë                        │Laboratories (Èíäèÿ)          │16.01.96      

                                                                                                                                                                    

│Îôðàìàêñ [Öåôòðèàêñîí]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA13]      │ëèîôèëèç.ïîðîøîê äëÿ          │Ranbaxy Laboratories Ltd      │005798,       

                                                                                          │ïðèãîòîâëåíèÿ èíúåêöèîííîãî   │(Èíäèÿ)                       │02.03.95      

                                                                                          │ðàñòâîðà (ôëàêîíû) 250, 500,                                              

                                                                                          │1000 ìã                                                                   

                                                                                                                                                                    

│Îôòàëüìî-ñåïòîíåêñ {êàðáàýòîïåíäåöèí 19 ìã,       │àíòèñåïòè÷åñêîå ñðåäñòâî [S01AX]        │êàïëè ãëàçíûå                 │Spofa (×ÑÑÐ)                  │2951, 13.10.89 │

│áîðíàÿ êèñëîòà 0.5 ìã, íàòðèÿ òåòðàáîðàò 0.1 ìã,                                                                                                                    

│õåëàòîí - 1 ìë}                                                                                                                                                     

                                                                                                                                                                    

│Îôòàëüìîòðèì {òðèìåòîïðèì, ïîëèìèêñèí Â}          │àíòèñåïòè÷åñêîå ñðåäñòâî [S01AA20]      │ðàñòâîð îôòàëüìîëîãè÷åñêèé    │Laboratorious Cusi (Èñïàíèÿ)  │003236,       

                                                                                          │(ôëàêîíû) 5 ìë                                              │16.08.93      

                                                                                                                                                                    

│Îôòàí äåêñàìåòàçîí [Äåêñàìåòàçîí]                 │ãëþêîêîðòèêîñòåðîèä [S01BA01]           │êàïëè ãëàçíûå 1 ìã/ìë         │Leiras (Ôèíëÿíäèÿ)            │006577,       

                                                                                                                                                      │29.09.95      

                                                                                                                                                                    

│Îôòàí èäó [Èäîêñóðèäèí]                           │ïðîòèâîâèðóñíîå ñðåäñòâî [S01AD01]      │êàïëè ãëàçíûå 0.1%            │Leiras (Ôèíëÿíäèÿ)            │00898,        

                                                                                                                                                      │02.03.82,     

                                                                                                                                                      │07.12.93      

                                                                                                                                                                    

│Îôòàí êàòàõðîì {öèòîõðîì Ñ 0.675 ìã, íàòðèÿ       │ðåãåíåðàöèè ñòèìóëÿòîð [S01XA]          │êàïëè ãëàçíûå                 │Star (Ôèíëÿíäèÿ)              │00639,        

│ñóêöèíàò 1 ìã, àäåíîçèí 2 ìã, íèêîòèíàìèä 20 ìã}                                                                                                      │25.10.91,     

                                                                                                                                                      │30.11.78       

                                                                                                                                                                    

│Îôòàí ïèëîêàðïèí [Ïèëîêàðïèí]                     │ì-õîëèíîìèìåòèê [S01EB01]               │êàïëè ãëàçíûå 1%, 2%          │Star (Ôèíëÿíäèÿ)              │00793,        

                                                                                                                                                      │15.09.80,      

                                                                                                                                                      │18.07.85,     

                                                                                                                                                      │19.10.92      

                                                                                                                                                                     

│Îôòàí òèìîëîë [Òèìîëîë]                           │áåòà-àäðåíîáëîêàòîð [S01ED01]           │êàïëè ãëàçíûå 0.25%, 0.5%     │Star (Ôèíëÿíäèÿ)              │01395, 19.12.87│

                                                                                                                                                                    

│Îôòåíñèí [Òèìîëîë]                                │áåòà-àäðåíîáëîêàòîð [S01ED01]           │êàïëè ãëàçíûå 0.25%, 0.5%     │Polfa (Ïîëüøà)                │002527,       

                                                                                                                                                      │25.06.92      

                                                                                                                                                                    

│Îöèä [Îìåïðàçîë]                                  │ïðîòèâîÿçâåííîå ñðåäñòâî, ïðîòîííîãî    │êàïñóëû 20 ìã                 │Cadila Laboratories Ltd       │003397,       

                                                  │íàñîñà èíãèáèòîð [A02BC01]                                            │(Èíäèÿ)                       │08.10.93      

                                                                                                                                                                    

│Ï.Ò.Á. [Ïèðàçèíàìèä]                              │ïðîòèâîòóáåðêóëåçíîå ñðåäñòâî [J04AK01] │òàáëåòêè 500 ìã               │Amoun Pharmaceutical          │006922,       

                                                                                                                        │Industries Co, Apic (Åãèïåò)  │20.12.95      

                                                                                                                                                                    

│Ïàâóëîí [Ïàíêóðîíèÿ áðîìèä]                       │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03AC01]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Infar (india) Ltd (Èíäèÿ)     │01605, 23.06.89│

                                                                                          │2 ìë                                                                      

                                                                                                                                                                    

│Ïàâóëîí [Ïàíêóðîíèÿ áðîìèä]                       │ìèîðåëàêñèðóþùåå ñðåäñòâî [M03AC01]     │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Organon (Íèäåðëàíäû)          │00334,        

                                                                                          │4 ìã - 2 ìë                                                 │03.09.91,     

                                                                                                                                                      │24.03.75      

                                                                                                                                                                    

│Ïàêñåëàäèí [Îêñåëàäèí]                            │ïðîòèâîêàøëåâîå ñðåäñòâî [R05DB09]      │êàïñóëû 40 ìã                 │Beaufour-Ipsen International  │003025,       

                                                                                                                        │(Ôðàíöèÿ)                     │01.06.93      

                                                                                                                                                                    

│Ïàêñåëàäèí [Îêñåëàäèí]                            │ïðîòèâîêàøëåâîå ñðåäñòâî [R05DB09]      │ñèðîï (ôëàêîíû)               │Beaufour-Ipsen (Ôðàíöèÿ)      │005280,       

                                                                                                                                                      │30.08.94      

                                                                                                                                                                    

│Ïàêñèë [Ïàðîêñåòèí]                               │àíòèäåïðåññàíò [N06AB05]                │òàáëåòêè 20, 30 ìã            │Smithkline Beecham            │006554,       

                                                                                                                        │Pharmaceuticals (ÑØÀ)         │27.09.95      

                                                                                                                                                                    

│Ïàëèí [Ïèïåìèäèíîâàÿ êèñëîòà]                     │ïðîòèâîìèêðîáíîå ñðåäñòâî, õèíîëîí      │êàïñóëû 200 ìã                │Lek D.D. (Ñëîâåíèÿ)           │01044,        

                                                  │[G04AB03]                                                                                           │02.03.84,     

                                                                                                                                                      │27.06.95      

                                                                                                                                                                    

│Ïàëèí [Ïèïåìèäèíîâàÿ êèñëîòà]                     │ïðîòèâîìèêðîáíîå ñðåäñòâî, õèíîëîí      │òàáëåòêè ëàêèðîâàííûå 400 ìã; │Lek (Þãîñëàâèÿ)               │01531, 13.12.88│

                                                  │[G04AB03]                               │ñâå÷è âàãèíàëüíûå 200 ìã                                                  

                                                                                                                                                                    

│Ïàëèòðåêñ [Öåôàëåêñèí]                            │àíòèáèîòèê, öåôàëîñïîðèí [J01DA01]      │êàïñóëû 250 ìã; ñóñïåíçèÿ     │Galenika (Þãîñëàâèÿ)          │00766, 26.05.80│

                                                                                          │îðàëüíàÿ 250 ìã|5 ìë                                                      

                                                                                                                                                                    

│Ïàëüãèí {ïàðàöåòàìîë, ìåòàìèçîë, êîôåèí}          │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Chemage Ltd (Èíäèÿ)           │006247,       

                                                  │ñðåäñòâî [N02BE51]                                                                                  │06.07.95      

                                                                                                                                                                    

│Ïàìáà [Àìèíîìåòèëáåíçîéíàÿ êèñëîòà]               │ãåìîñòàòè÷åñêîå ñðåäñòâî [B02AA03]      │òàáëåòêè 250 ìã; ðàñòâîð äëÿ  │Oranienburger Pharmawerk GmbH │006662,       

                                                                                          │èíúåêöèé (àìïóëû) 50 ìã - 5 ìë│(Ãåðìàíèÿ)                    │20.03.96      

                                                                                                                                                                    

│Ïàìèä [Èíäàïàìèä]                                 │ÁÌÊÊ [C03BA11]                          │òàáëåòêè ïîêðûòûå îáîëî÷êîé   │Cts Chemical Industries Ltd   │007027,       

                                                                                          │2.5 ìã                        │(Èçðàèëü)                     │30.01.96      

                                                                                                                                                                    

│Ïàìîë [Ïàðàöåòàìîë]                               │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 125, 500 ìã;         │Nycomed Dak AS (Äàíèÿ)        │006857,       

                                                  │ñðåäñòâî [N02BE01]                      │òàáëåòêè øèïó÷èå 500 ìã;                                    │24.11.95      

                                                                                          │ñâå÷è 125, 500 ìã; ðàñòâîð                                                

                                                                                          │îðàëüíûé (ôëàêîíû) 24 ìã/ìë                                               

                                                                                                                                                                    

│Ïàíàäåèí {ïàðàöåòàìîë 0.5 ã, êîäåèí 8 ìã}         │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã/8 ìã          │Sterling Health               │002817,        

                                                  │ñðåäñòâî [N02BE51]                                                    │(Âåëèêîáðèòàíèÿ)              │19.01.93      

                                                                                                                                                                    

│Ïàíàäîë [Ïàðàöåòàìîë]                             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñâå÷è 125, 250ìã              │Smithkline Beecham Consumer   │007615,        

                                                  │ñðåäñòâî [N02BE01]                                                    │Healthcare (Âåëèêîáðèòàíèÿ)   │28.06.96      

                                                                                                                                                                    

│Ïàíàäîë [Ïàðàöåòàìîë]                             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñâå÷è 125, 250 ìã             │Sterling Health Productos     │007615,       

                                                  │ñðåäñòâî [N02BE01]                                                    │Pharmaceuticos Ltd            │28.06.96      

                                                                                                                        │(Ïîðòóãàëèÿ)                                

                                                                                                                                                                     

│Ïàíàäîë áýáè ýíä èíôàíò [Ïàðàöåòàìîë]             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñóñïåíçèÿ äëÿ ïðèåìà âíóòðü   │Smithkline Beecham Consumer   │007250,       

                                                  │ñðåäñòâî [N02BE01]                      │(ôëàêîíû) 120 ìã|5 ìë - 100,  │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

                                                                                          │1000 ìë                                                                   

                                                                                                                                                                    

│Ïàíàäîë áýáè ýíä èíôàíò [Ïàðàöåòàìîë]             │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ñóñïåíçèÿ äëÿ äåòåé (ôëàêîíû) │Sterling Midy Industry        │005273,       

                                                  │ñðåäñòâî [N02BE01]                      │100 ìë                        │(Ôðàíöèÿ)                     │29.08.94      

                                                                                                                                                                    

│Ïàíàäîë äæóíèîð [Ïàðàöåòàìîë]                     │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │ïîðîøîê ðàñòâîðèìûé (ïàêåòèêè │Smithkline Beecham Consumer   │007255,       

                                                  │ñðåäñòâî [N02BE01]                      │îäíîðàçîâûå) 240 ìã           │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

                                                                                                                                                                    

│Ïàíàäîë êàïñóëû [Ïàðàöåòàìîë]                     │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │êàïñóëû 500 ìã                │Smithkline Beecham Consumer   │007257,       

                                                  │ñðåäñòâî [N02BE01]                                                    │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

                                                                                                                                                                    

│Ïàíàäîë òàáëåòêè [Ïàðàöåòàìîë]                    │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè 500 ìã               │Smithkline Beecham Consumer   │007256,       

                                                  │ñðåäñòâî [N02BE01]                                                    │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

                                                                                                                                                                    

│Ïàíàäîë òàáëåòêè äëÿ ðàñòâîðåíèÿ [Ïàðàöåòàìîë]    │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè ðàñòâîðèìûå 500 ìã   │Smithkline Beecham Consumer   │007254,       

                                                  │ñðåäñòâî [N02BE01]                                                    │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

                                                                                                                                                                    

│Ïàíàäîë ýêñòðà {ïàðàöåòàìîë 0.5 ã, êîôåèí 65 ìã}  │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè                      │Smithkline Beecham Consumer   │007251,       

                                                  │ñðåäñòâî [N02BE51]                                                    │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

                                                                                                                                                                    

│Ïàíàäîë ýêñòðà ñîëþáë {ïàðàöåòàìîë 0.5 ã, êîôåèí  │àíàëüãåòè÷åñêîå íåíàðêîòè÷åñêîå         │òàáëåòêè ðàñòâîðèìûå          │Smithkline Beecham Consumer   │007249,       

│65 ìã}                                            │ñðåäñòâî [N02BE51]                                                    │Healthcare (Âåëèêîáðèòàíèÿ)   │16.07.96      

                                                                                                                                                                    

│Ïàíàìîð ÀÒ-50 [Äèêëîôåíàê]                        │ÍÏÂÑ [M01AB05]                          │òàáëåòêè ñ êèøå÷íîðàñòâîðèìîé │Lennon Ltd (ÞÀÐ)              │005453,       

                                                                                          │îáîëî÷êîé 50 ìã                                             │02.11.94      

                                                                                                                                                                    

│Ïàíàíãèí [Êàëèÿ, ìàãíèÿ àñïàðàãèíàò] {àñïàðàãèíàò │ïðåïàðàò êàëèÿ è ìàãíèÿ [A12BA51]       │ðàñòâîð äëÿ èíúåêöèé (àìïóëû) │Gedeon Richter (Âåíãðèÿ)      │2090,         

│êàëèÿ 0.452 ã, àñïàðàãèíàò ìàãíèÿ 0.4 ã}                                                  │10 ìë                                                       │01.07.70,     

                                                                                                                                                      │26.04.84,     

                                                                                                                                                      │27.02.95      

                                                                                                                                                                    

│Ïàíàíãèí [Êàëèÿ, ìàãíèÿ àñïàðàãèíàò] {àñïàðàãèíàò │ïðåïàðàò êàëèÿ è ìàãíèÿ [A12BA51]       │äðàæå                         │Gedeon Richter (Âåíãðèÿ)      │007266,       

│êàëèÿ 175 ã, àñïàðàãèíàò ìàãíèÿ 166.3 ã}                                                                                                              │26.07.96      

                                                                                                                                                                    

└──────────────────────────────────────────────────┴────────────────────────────────────────┴──────────────────────────────┴──────────────────────────────┴───────────────┘

 

(Ïðîäîëæåíèå)

 

 



Âñå íîðìàòèâíî-ïðàâîâûå àêòû ïî ìåäèöèíå // Çäðàâîîõðàíåíèå, çäîðîâüå, çàáîëåâàíèÿ, ëå÷åíèå, ëåêàðñòâà, äîêòîðà, áîëüíèöû //

Ðåéòèíã@Mail.ru ßíäåêñ öèòèðîâàíèÿ

Copyright © Ìåäèöèíñêèé èíôîðìàöèîííûé ðåñóðñ www.hippocratic.ru, 2012 - 2024